<SEC-DOCUMENT>0001193125-23-187318.txt : 20230714
<SEC-HEADER>0001193125-23-187318.hdr.sgml : 20230714
<ACCEPTANCE-DATETIME>20230714165232
ACCESSION NUMBER:		0001193125-23-187318
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20230714
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230714
DATE AS OF CHANGE:		20230714

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Frequency Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001703647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472324450
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39062
		FILM NUMBER:		231089622

	BUSINESS ADDRESS:	
		STREET 1:		75 HAYDEN AVENUE
		STREET 2:		SUITE 300
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
		BUSINESS PHONE:		781-315-4600

	MAIL ADDRESS:	
		STREET 1:		75 HAYDEN AVENUE
		STREET 2:		SUITE 300
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d651936d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:freq="http://frequencytx.com/20230714" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-07-14_to_2023-07-14">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-07-14_to_2023-07-14">0001703647</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="freq-20230714.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-07-14_to_2023-07-14"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-14</xbrli:startDate> <xbrli:endDate>2023-07-14</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-07-14_to_2023-07-14">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(D)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-07-14_to_2023-07-14" format="ixt:datemonthdayyearen">July&#160;14, 2023</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-07-14_to_2023-07-14">FREQUENCY THERAPEUTICS, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-07-14_to_2023-07-14" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-07-14_to_2023-07-14">001-39062</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-07-14_to_2023-07-14">47-2324450</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-07-14_to_2023-07-14">75 Hayden Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-07-14_to_2023-07-14">Suite 300</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-07-14_to_2023-07-14">Lexington</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-07-14_to_2023-07-14">MA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-07-14_to_2023-07-14">02421</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-07-14_to_2023-07-14">(781)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-07-14_to_2023-07-14">315-4600</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration:underline">see</span> General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-07-14_to_2023-07-14" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-07-14_to_2023-07-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-07-14_to_2023-07-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-07-14_to_2023-07-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-07-14_to_2023-07-14">Common Stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-07-14_to_2023-07-14">FREQ</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-07-14_to_2023-07-14" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-07-14_to_2023-07-14" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2023-07-14_to_2023-07-14" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Agreement and Plan of Merger </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;14, 2023, Frequency Therapeutics, Inc. (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Frequency</span></span>&#8221; or the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Company</span></span>&#8221;), Frequency Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Merger Sub</span></span>&#8221;), and Korro Bio, Inc., a Delaware corporation (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Korro Bio</span></span>&#8221;), entered into an Agreement and Plan of Merger (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Merger Agreement</span></span>&#8221;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Korro Bio, with Korro Bio continuing as a wholly owned subsidiary of the Company and the surviving corporation of the merger (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Merger</span></span>&#8221;). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Merger Consideration </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions of the Merger Agreement, (i)&#160;immediately prior to the effective time of the Merger (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Effective Time</span></span>&#8221;), all Korro Bio preferred stock will be converted into Korro Bio common stock pursuant to the organizational documents of Korro Bio (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Korro Bio Preferred Stock Conversion</span></span>&#8221;), and (ii)&#160;at the Effective Time, (a)&#160;each outstanding share of Korro Bio common stock (excluding the Korro Bio common stock issued in the Concurrent Financing, as described below) will be converted into the right to receive a number of shares of the Company&#8217;s common stock (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Company Common Stock</span></span>&#8221;), (b) each outstanding Korro Bio stock option and warrant that has not previously been exercised prior to the closing of the Merger will be assumed by the Company and become an option or warrant, as applicable, to purchase a number of shares of Company Common Stock and (c)&#160;the Korro Bio common stock issued in the Concurrent Financing will be converted into the right to receive a number of shares of the Company&#8217;s Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of Company Common Stock that will be issued to stockholders of Korro Bio will be calculated using a formula in the Merger Agreement based on the equity value of each of Korro Bio and the Company. Korro Bio has been ascribed an aggregate equity value of approximately $325.6&#160;million and the Company&#8217;s equity value will be determined based on the value of net cash of the Company at closing of the Merger. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Concurrent Financing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Merger Agreement, immediately prior to the Effective Time, Korro Bio will consummate a financing through the sale of its common stock for aggregate gross proceeds of at least $100&#160;million based on the same aggregate equity value of Korro Bio used in the Merger (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Concurrent Financing</span></span>&#8221;). On July&#160;14, 2023, Korro Bio entered into subscription agreements with certain accredited investors for the Concurrent Financing with expected gross proceeds to Korro Bio of approximately $117&#160;million. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Conditions to the Merger </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The closing of the Merger is subject to the satisfaction or, to the extent permitted by law, the waiver of certain conditions including, among other things, (i)&#160;the required approvals by each respective party&#8217;s stockholders, (ii)&#160;the accuracy of the respective representations and warranties of each party, subject to certain materiality qualifications, (iii)&#160;compliance by the parties with their respective covenants, (iv)&#160;no law or order preventing the Merger and the other transactions contemplated by the Merger Agreement, (v)&#160;the continuous listing of the existing shares of Company Common Stock on The Nasdaq Stock Market (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Nasdaq</span></span>&#8221;) through the closing date of the Merger, (vi)&#160;the shares of Company Common Stock to be issued in the Merger being approved for listing (subject to official notice of issuance) on Nasdaq, (vii)&#160;the Concurrent Financing results in cash proceeds of not less than $100,000,000 to Korro Bio, (viii)&#160;the Registration Statement (as defined below) having become effective in accordance with the provisions of the Securities Act of 1933, as amended (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Securities Act</span></span>&#8221;), and not being subject to any stop order or proceeding seeking a stop order, and (ix)&#160;the Korro Bio Preferred Stock Conversion will have been effected as of the closing date of the Merger. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Governance </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Effective Time, the Board of Directors of the combined company is expected to consist of seven members, one of whom will be designated by the Company, four of whom will be designated by Korro Bio, and two of whom will be independent members. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Certain Other Terms of the Merger Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement contains customary representations, warranties and covenants made by the Company and Korro Bio, including covenants relating to obtaining the requisite approvals of the stockholders of the Company and Korro Bio, indemnification of directors and officers, and the Company&#8217;s and Korro Bio&#8217;s conduct of their respective businesses between the date of signing the Merger Agreement and the closing of the Merger. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Merger, the Company will prepare and file a combined registration statement on Form <span style="white-space:nowrap">S-4</span> registering the Company Common Stock to be issued to Korro Bio&#8217;s stockholders in the Merger, other than the shares issued in the Concurrent Financing (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Registration Statement</span></span>&#8221;), and proxy statement with respect to the meeting of the Company&#8217;s stockholders (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Proxy Statement</span></span>&#8221;) at which, among other things, the Company has agreed to seek the approval of the Company&#8217;s stockholders with respect to certain actions, including (i)&#160;the issuance of Company Common Stock to the Korro Bio stockholders in connection with the Merger and the other transactions contemplated under the Merger Agreement, pursuant to the Merger Agreement and Nasdaq rules, and (ii)&#160;the amendment of the Company&#8217;s certificate of incorporation to increase the number of authorized shares of Company Common Stock and to effect a reverse stock split of all outstanding shares of Company Common Stock (collectively, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Company Stockholder Matters</span></span>&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement contains certain customary termination rights, including, among others, (i)&#160;the mutual written consent of the parties, (ii)&#160;the right of either party to terminate the Merger Agreement if the Company&#8217;s stockholders fail to approve the issuance of Company Common Stock in the Merger and the Company Stockholder Matters, (iii)&#160;the right of the Company to terminate the Merger Agreement if Korro Bio does not deliver its required stockholder vote within five business days after the Registration Statement becomes effective, (iv)&#160;the right of either party to terminate the Merger Agreement if the other party&#8217;s board of directors changes or withdraws its recommendation in favor of the transactions contemplated under the Merger Agreement, (v)&#160;the right of either party to terminate the Merger Agreement if the Merger has not occurred by November 14, 2023, subject to a possible extension, (vi)&#160;the right of either party to terminate the Merger Agreement due to a material breach by the other party of any of its representations, warranties or covenants which would result in the closing conditions not being satisfied, subject to certain conditions, and (vii)&#160;the right of either party to terminate the Merger Agreement if a court of competent jurisdiction or other governmental body issues a final and <span style="white-space:nowrap">non-appealable</span> order, decree or ruling, or has taken any other action, having the effect of permanently restraining, enjoining or otherwise prohibiting the Merger and the other transactions contemplated by the Merger Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement further provides that, upon termination of the Merger Agreement under specified circumstances, Korro Bio may be required to pay the Company a termination fee of $4,000,000, or the Company may be required to pay Korro Bio a termination fee of $1,500,000. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary does not purport to be a complete description and is qualified in its entirety by reference to the full text of the Merger Agreement, which is filed herewith as Exhibit 2.1 and is incorporated by reference herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement has been attached as an exhibit to this Current Report on Form <span style="white-space:nowrap">8-K</span> (this &#8220;<span style="font-weight:bold"><span style="font-style:italic">Current Report</span></span>&#8221;) in order to provide investors and security holders with information regarding its terms. It is not intended to provide any other factual information about the Company, Korro Bio or their respective affiliates or to modify or supplement any factual disclosures about the Company, Korro Bio or their respective affiliates in public reports filed with the SEC. The Merger Agreement includes representations, warranties and covenants of the Company and Korro Bio that were made solely for the purposes of the Merger Agreement and as of specific dates, were solely for the benefit of the parties thereto, and which may be subject to important qualifications and limitations agreed to by the Company and Korro Bio in connection with the negotiated terms of the Merger Agreement. Moreover, such representations and warranties may not be accurate or complete as of any specified date, have been modified or qualified by certain disclosures between the parties made in connection with the negotiation of the Merger Agreement, which disclosures are not reflected in the Merger Agreement itself, and may apply contractual standards of materiality in a way that is different from that which may be viewed as material by the Company&#8217;s stockholders, Korro Bio&#8217;s stockholders or other security holders. In addition, the representations and warranties were made for purposes of allocating risk among the parties to the Merger Agreement and were not intended, and should not be relied upon, as statements of fact. Information concerning the subject matter of the representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the Company&#8217;s or Korro Bio&#8217;s public disclosures. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Support Agreements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution and delivery of the Merger Agreement, certain executive officers, directors and stockholders (together with their affiliates) of Korro Bio (solely in their respective capacities as Korro Bio stockholders) who beneficially own an aggregate of approximately 98% of the outstanding Korro Bio common stock and Korro Bio preferred stock (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Korro Bio Capital Stock</span></span>&#8221;) as of June&#160;30, 2023, and certain investors on the Concurrent Financing, have entered into support agreements with the Company to vote all of their shares of Korro Bio Capital Stock in favor of adoption of the Merger Agreement (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Korro Bio Support Agreements</span></span>&#8221;), pursuant to which such individuals have agreed, among other things, to vote their respective shares of Korro Bio Capital Stock in favor of the adoption of the Merger Agreement and approval of the Merger, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and against any competing acquisition proposal and against any agreement or transaction that would reasonably be expected to impede, interfere with, delay, postpone, discourage or materially and adversely affect the Merger or any of the transactions contemplated by the Merger Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Korro Bio Support Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the form of the Korro Bio Support Agreement, which is filed herewith as Exhibit 10.1 and is incorporated by reference herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution and delivery of the Merger Agreement, certain executive officers and directors of the Company (solely in their respective capacities as the Company stockholders) who beneficially own an aggregate of approximately 11.7% of the outstanding Company Common Stock as of June&#160;30, 2023 have entered into support agreements with Korro Bio to vote all of their shares of Company Common Stock in favor of approval of the Merger Agreement (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Company Support Agreements</span></span>&#8221;), pursuant to which such individuals have agreed, among other things, to vote their respective shares of Company Common Stock in favor of the issuance of Company Common Stock in the Merger and the other transactions contemplated by the Merger Agreement, against any competing acquisition proposal, and against any agreement or transaction that would reasonably be expected to materially impede, interfere with, delay, postpone, discourage or materially and adversely affect the Merger or any of the transactions contemplated by the Merger Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Company Support Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the form of Company Support Agreement, which is filed herewith as Exhibit 10.2 and is incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Lock-Up</span> Agreements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution and delivery of the Merger Agreement, certain officers and directors of the Company holding approximately 11.7% of the outstanding Company Common Stock as of June&#160;30, 2023 and certain officers, directors and stockholders of Korro Bio holding approximately 98% of the Korro Bio Capital Stock as of June&#160;30, 2023, and certain investors in the Concurrent Financing, have entered into <span style="white-space:nowrap">lock-up</span> agreements (the &#8220;<span style="font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Lock-Up</span> Agreements</span></span>&#8221;) pursuant to which they accepted certain restrictions on transfers of shares of Company Common Stock for the <span style="white-space:nowrap">180-day</span> period following the closing of the Merger, subject to certain customary exceptions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the <span style="white-space:nowrap">Lock-Up</span> Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the forms of the <span style="white-space:nowrap">Lock-Up</span> Agreements, which are filed herewith as Exhibit 10.3 and Exhibit 10.4 and are incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Contingent Value Rights Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Effective Time, if the MS Asset Disposition (as defined below) has not been completed or if additional consideration may be payable for the MS Assets (as defined below) after closing of the Merger, the Company and Computershare Inc., a Delaware corporation, and its affiliate, Computershare Trust Company, N.A., a national banking association, as rights agent (collectively, as the initial &#8220;<span style="font-weight:bold"><span style="font-style:italic">Rights Agent</span></span>&#8221;), will enter into a Contingent Value Rights Agreement (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">CVR Agreement</span></span>&#8221;), pursuant to which the Company&#8217;s common stockholders of record as of the close of business on the last business day prior to the day on which the Effective Time occurs will receive one contingent value right (each, a &#8220;<span style="font-weight:bold"><span style="font-style:italic">CVR</span></span>&#8221;) for each outstanding share of Company Common Stock held by such stockholder on such date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each CVR will represent the contractual right to receive payments from the Company upon the actual receipt by the Company or its subsidiaries of certain contingent proceeds derived from any cash consideration that is paid to the Company or its subsidiaries as a result of the sale, transfer, license, assignment or other divestiture, disposition or commercialization of any of the Company&#8217;s assets, rights and interests relating to the Company&#8217;s multiple sclerosis remyelination program (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">MS Assets</span></span>&#8221; and such disposition, a &#8220;<span style="font-weight:bold"><span style="font-style:italic">MS Asset Disposition</span></span>&#8221;), net of certain tax, transaction costs and certain other expenses. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The contingent payments under the CVR Agreement, if they become payable, will become payable to the Rights Agent for subsequent distribution to the holders of the CVRs. There can be no assurance that any holders of CVRs will receive payments with respect thereto. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The right to the contingent payments contemplated by the CVR Agreement is a contractual right only and will not be transferable, except in the limited circumstances specified in the CVR Agreement. The CVRs will not be evidenced by a certificate or any other instrument and will not be registered with the Securities and Exchange Commission (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">SEC</span></span>&#8221;). The CVRs will not have any voting or dividend rights and will not represent any equity or ownership interest in the Company or any of its affiliates. No interest will accrue on any amounts payable in respect of the CVRs. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary of the CVR Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the form of CVR Agreement, which is filed herewith as Exhibit 10.5 and is incorporated by reference herein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Changes in Control of Registrant. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information set forth in Item 1.01 and in Item 5.02 is incorporated by reference into this Item 5.01. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information disclosed under the section titled &#8220;<span style="font-style:italic">Governance</span>&#8221; under Item 1.01 above is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom" align="center"><span style="font-weight:bold">Exhibit</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit&#160;Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;2.1&#094;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d651936dex21.htm">Agreement and Plan of Merger, dated July&#160;14, 2023, by and among Frequency Therapeutics, Inc., Frequency Merger Sub, Inc., and Korro Bio, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d651936dex101.htm">Form of Support Agreement by and between Frequency Therapeutics, Inc. and certain stockholders of Korro Bio, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d651936dex102.htm">Form of Support Agreement by and between Korro Bio, Inc. and certain stockholders of Frequency Therapeutics, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d651936dex103.htm">Form of <span style="white-space:nowrap">Lock-Up</span> Agreement by and between Korro Bio, Inc. and directors, officers and certain stockholders of Korro Bio, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d651936dex104.htm">Form of <span style="white-space:nowrap">Lock-Up</span> Agreement by and between Korro Bio, Inc. and directors and officers of Frequency Therapeutics, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d651936dex105.htm">Form of CVR Agreement. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">&#094;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Registrant has omitted schedules and exhibits pursuant to Item 601(b)(2) of Regulation <span style="white-space:nowrap">S-K.</span> The Registrant agrees to furnish supplementally a copy of the omitted schedules and exhibits to the SEC upon request. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Important Information about the Merger and Where to Find It </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report relates to a proposed transaction between Frequency and Korro Bio. In connection with the proposed transaction, Frequency intends to file with the SEC a registration statement on Form <span style="white-space:nowrap">S-4</span> that will include a proxy statement of Frequency and that will constitute a prospectus with respect to shares of Frequency&#8217;s common stock to be issued in the proposed transaction (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Proxy Statement/Prospectus</span></span>&#8221;). Frequency may also file other documents with the SEC regarding the proposed transaction. This document is not a substitute for the Proxy Statement/Prospectus or any other document which Frequency may file with the SEC. INVESTORS, KORRO BIO STOCKHOLDERS AND FREQUENCY STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT ARE OR WILL BE FILED BY FREQUENCY WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND RELATED MATTERS. Investors, Korro Bio stockholders and Frequency stockholders will also be able to obtain free copies of the Proxy Statement/Prospectus (when available) and other documents containing important information about Frequency, Korro Bio and the proposed transaction that are or will be filed with the SEC by Frequency through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by Frequency will also be available free of charge on Frequency&#8217;s website at <span style="white-space:nowrap"><span style="white-space:nowrap">https://frequencytx.gcs-web.com/sec-filings</span></span> or by contacting Frequency&#8217;s investor relations department by email at investorrelations@frequencytx.com. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">No Offer or Solicitation </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made, except by means of a prospectus meeting the requirements of Section&#160;10 of the Securities Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Participants in the Solicitation </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Frequency and certain of its directors and executive officers may be deemed under SEC rules to be participants in the solicitation of proxies of Frequency stockholders in connection with the proposed transaction. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to Frequency&#8217;s stockholders in connection with the proposed transaction will be set forth in the Proxy Statement/Prospectus on Form <span style="white-space:nowrap">S-4</span> for the proposed transaction, which is expected to be filed with the SEC by Frequency. Investors and security holders of Korro Bio and Frequency are urged to read the Proxy Statement/Prospectus and other relevant documents that will be filed with the SEC by Frequency carefully and in their entirety when they become available because they will contain important information about the proposed transaction. Investors and security holders will be able to obtain free copies of the Proxy Statement/Prospectus and other documents containing important information about Korro Bio and Frequency through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by Frequency can be obtained free of charge by directing a written request to Frequency Therapeutics, Inc., 75 Hayden Avenue, Suite 300 Lexington, MA 02421. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cautionary Statement Regarding Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain statements contained in this filing may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding the Merger and the conversion of equity interests contemplated by the Merger Agreement, the issuance of Frequency common stock, the Concurrent Financing, the composition of the Board of Directors of the combined company, the expected filing of the proxy statement/prospectus by Frequency, the expected entry into the CVR Agreement and the contingent payments contemplated by the CVR Agreement. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;likely,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (i)&#160;the risk that the conditions to the closing of the proposed transaction are not satisfied, including the failure to timely or at all obtain stockholder approval for the proposed transaction or the failure to timely or at all obtain any required regulatory clearances; (ii)&#160;uncertainties as to the timing of the consummation of the proposed transaction and the ability of each of Frequency and Korro Bio to consummate the proposed transaction; (iii)&#160;the ability of Frequency and Korro Bio to integrate their businesses successfully and to achieve anticipated synergies; (iv)&#160;the possibility that other anticipated benefits of the proposed transaction will not be realized, including without limitation, anticipated revenues, expenses, earnings and other financial results, and growth and expansion of the combined company&#8217;s operations, and the anticipated tax treatment of the combination; (v)&#160;potential litigation relating to the proposed transaction that could be instituted against Frequency, Korro Bio or their respective directors; (vi)&#160;possible disruptions from the proposed transaction that could harm Frequency&#8217;s and/or Korro Bio&#8217;s respective businesses; (vii)&#160;the ability of Frequency and Korro Bio to retain, attract and hire key personnel; (viii)&#160;potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the proposed transaction; (ix)&#160;potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect Frequency&#8217;s or Korro Bio&#8217;s financial performance; (x)&#160;certain restrictions during the pendency of the proposed transaction that may impact Frequency&#8217;s or Korro Bio&#8217;s ability to pursue certain business opportunities or strategic transactions; (xi)&#160;legislative, regulatory and economic developments; (xii)&#160;unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management&#8217;s response to any of the aforementioned factors; and (xiii)&#160;such other factors as are set forth in Frequency&#8217;s periodic public filings with the SEC, including but not limited to those described under the heading &#8220;Risk Factors&#8221; in Frequency&#8217;s Form <span style="white-space:nowrap">10-Q</span> for the fiscal year ended March&#160;31, 2023. Frequency can give no assurance that the conditions to the proposed transaction will be satisfied. Except as required by applicable law, Frequency undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">FREQUENCY THERAPEUTICS, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: July&#160;14, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David L. Lucchino</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">David L. Lucchino</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">President and Chief Executive Officer</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d651936dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>by and among: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FREQUENCY THERAPEUTICS, INC.; </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FREQUENCY MERGER SUB, INC.; </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KORRO BIO, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of JULY&nbsp;14, 2023 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I DEFINITIONS AND INTERPRETATIVE PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Other Definitional and Interpretative Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II THE MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organizational Documents; Directors and Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conversion of Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Contingent Value Right</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing of Korro&#146;s Transfer Books</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Surrender of Korro Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Calculation of Net Cash</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Further Action</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Withholding</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III REPRESENTATIONS AND WARRANTIES OF KORRO</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Due Organization; Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organizational Documents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authority; Binding Nature of Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Vote Required</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT> Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Capitalization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title to Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Real Property; Leasehold</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Agreements, Contracts and Commitments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance; Permits; Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legal Proceedings; Orders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee and Labor Matters; Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Financial Advisors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Transactions with Affiliates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Privacy and Data Security</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Concurrent Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Other Representations or Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF FREQUENCY AND MERGER SUB</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Due Organization; Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organizational Documents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authority; Binding Nature of Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Vote Required</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT> Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Capitalization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SEC Filings; Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title to Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Real Property; Leasehold</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance; Permits; Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legal Proceedings; Orders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee and Labor Matters; Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Transactions with Affiliates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Financial Advisors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Valid Issuance; No Bad Actor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Privacy and Data Security</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Opinion of Financial Advisor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Other Representations or Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of Korro&#146;s Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of Frequency&#146;s Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Access and Investigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Solicitation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notification of Certain Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>MS Asset Disposition</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Registration Statement; Proxy Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Korro Stockholder Written Consent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frequency Stockholder Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Efforts; Regulatory Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Disclosures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frequency Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frequency Restricted Stock Units</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frequency ESPP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification of Officers and Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Listing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legends</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Officers and Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination of Certain Agreements and Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;16 Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Allocation Certificate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Nasdaq Reverse Split</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Obligations of Merger Sub</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Takeover Statutes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.26</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stockholder Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.27</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Concurrent Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.28</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frequency Equity Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.29</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frequency 401(k)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI CONDITIONS TO CONSUMMATION OF THE MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions Precedent to Obligations of Each Party</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions Precedent to Obligations of Korro</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions Precedent to Obligations of</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frustration of Closing Conditions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII CLOSING DELIVERIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing Deliveries of Korro</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing Deliveries of Frequency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII TERMINATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Expenses; Termination Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX GENERAL PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-Survival</FONT> of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement; Counterparts; Exchanges by Electronic Transmission or Facsimile</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Applicable Law; Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assignability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cooperation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Other Remedies; Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Third-Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EXHIBITS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Frequency Stockholder Support Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Korro Stockholder Support Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Frequency <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Korro <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit E</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Korro Stockholder Written Consent</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit F</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CVR Agreement</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">T<SMALL>HIS</SMALL> A<SMALL>GREEMENT</SMALL> <SMALL>AND</SMALL> P<SMALL>LAN</SMALL> <SMALL>OF</SMALL> M<SMALL>ERGER</SMALL> (this
&#147;<B>Agreement</B>&#148;)<B> </B>is made and entered into as of July&nbsp;14, 2023, by and among F<SMALL>REQUENCY</SMALL> T<SMALL>HERAPEUTICS</SMALL>, I<SMALL>NC</SMALL>., a Delaware corporation <B>(</B>&#147;<B>Frequency</B>&#148;),
F<SMALL>REQUENCY</SMALL> M<SMALL>ERGER</SMALL> S<SMALL>UB</SMALL> I<SMALL>NC</SMALL>., a Delaware corporation and wholly owned subsidiary of Frequency <B>(</B>&#147;<B>Merger Sub</B>&#148;),<B> </B>and K<SMALL>ORRO</SMALL> B<SMALL>IO</SMALL>,
I<SMALL>NC</SMALL>.,<B> </B>a Delaware corporation (&#147;<B>Korro</B>&#148;).<B> </B>Certain capitalized terms used in this Agreement are defined in <U>Section</U><U></U><U>&nbsp;1.1</U>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Frequency
and Korro intend to effect a merger of Merger Sub with and into Korro (the &#147;<B>Merger</B>&#148;) in accordance with this Agreement and Delaware Law. Upon consummation of the Merger, Merger Sub will cease to exist and Korro will become a wholly
owned subsidiary of Frequency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. The board of directors of Frequency (the &#147;<B>Frequency Board</B>&#148;) has (i)&nbsp;determined
that the Contemplated Transactions are fair to, advisable and in the best interests of Frequency and its stockholders, (ii)&nbsp;approved and declared advisable this Agreement and the Contemplated Transactions, including the issuance of shares of
Frequency Capital Stock to the stockholders of Korro pursuant to the terms of this Agreement, (iii)&nbsp;determined that the Charter Amendment Proposals are advisable and in the best interests of Frequency and its stockholders, (iv)&nbsp;determined
to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of Frequency vote to (a)&nbsp;approve this Agreement and thereby approve the Contemplated Transactions and (b)&nbsp;authorize the issuance
of the Frequency Capital Stock in accordance with Nasdaq Listing Rule 5635 (the &#147;<B>Nasdaq Issuance Proposal</B>&#148;) and (v)&nbsp;agreed to determine to recommend, upon the terms and subject to the conditions set forth in this Agreement, as
promptly as practicable after the forms thereof are mutually agreed to by Frequency and Korro, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of Frequency vote to (a)&nbsp;authorize sufficient
Frequency Common Stock for the issuance of Frequency Capital Stock to the stockholders of Korro pursuant to the terms of this Agreement (the &#147;<B>Authorized Share Increase Proposal</B>&#148;), and (b)&nbsp;approve an amendment to
Frequency&#146;s certificate of incorporation to effect the Nasdaq Reverse Split (the &#147;<B>Reverse Stock Split Proposal</B>&#148; and, together with the Authorized Share Increase Proposal, the &#147;<B>Charter Amendment Proposals</B>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. The board of directors of Merger Sub (the &#147;<B>Merger Sub Board</B>&#148;) has (i)&nbsp;determined that the Contemplated
Transactions are fair to, advisable, and in the best interests of Merger Sub and its sole stockholder, (ii)&nbsp;approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&nbsp;determined to recommend, upon the terms
and subject to the conditions set forth in this Agreement, that the stockholder of Merger Sub votes to adopt this Agreement and thereby approve the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. Concurrently with the execution and delivery of this Agreement and as a condition and inducement to Korro&#146;s willingness to enter into
this Agreement, the stockholders, officers and directors of Frequency set forth on <U>Section A</U> of the Frequency Disclosure Schedule (solely in their capacity as stockholders of Frequency) are executing support agreements in favor of Korro in
substantially the form attached hereto as <U>Exhibit A</U> (the &#147;<B>Frequency Stockholder Support </B><B>Agreement</B>&#148;),<B> </B>pursuant to which such Persons have, subject to the terms and conditions set forth therein, agreed to vote all
of their shares of Frequency Capital Stock in favor of this Agreement, the Nasdaq Issuance Proposal and the Charter Amendment Proposals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. Concurrently with the execution and delivery of this Agreement and as a condition and
inducement to Frequency&#146;s willingness to enter into this Agreement, the officers, directors and stockholders (together with their Affiliates) of Korro set forth on <U>Section A</U> of the Korro Disclosure Schedule (solely in their capacity as
stockholders of Korro) are executing support agreements in favor of Frequency in substantially the form attached hereto as <U>Exhibit B</U> (the &#147;<B>Korro Stockholder Support Agreement</B>&#148;),<B> </B>pursuant to which such Persons have,
subject to the terms and conditions set forth therein, agreed to vote all of their shares of Korro Capital Stock in favor of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">F. Concurrently with the execution and delivery of this Agreement and as a condition and inducement to Korro&#146;s willingness to enter into
this Agreement, the officers and directors of Frequency set forth on <U>Section B</U> of the Frequency Disclosure Schedule are executing <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements in substantially the form attached hereto as
<U>Exhibit C</U> (collectively, the <B>&#147;Frequency <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">G.
Concurrently with the execution and delivery of this Agreement and as a condition and inducement to Frequency&#146;s willingness to enter into this Agreement, the officers, directors and stockholders of Korro set forth on <U>Section B</U> of the
Korro Disclosure Schedule are executing <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements in substantially the form attached hereto as <U>Exhibit D</U> (collectively, the &#147;<B>Korro <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreements</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">H. It is expected that promptly after the Registration Statement is declared effective under the Securities Act,
the stockholders of Korro sufficient to adopt and approve this Agreement and the Merger as required under Delaware Law and Korro&#146;s Organizational Documents will execute and deliver an action by written consent in order to obtain the Required
Korro Stockholder Vote in substantially the form attached hereto as <U>Exhibit E</U> (each, a &#147;<B>Korro Stockholder Written Consent</B>&#148;<B> </B>and collectively, the &#147;<B>Korro Stockholder Written Consents</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I. Concurrently with the execution and delivery of this Agreement, certain investors have executed a Subscription Agreement by and among Korro
and the Persons named therein (representing an aggregate commitment no less than the Concurrent Investment Amount), pursuant to which such Persons will have agreed to purchase the number of shares of Korro Common Stock set forth therein immediately
prior to the Effective Time in connection with the Concurrent Financing (the &#147;<B>Subscription Agreement</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">J. Each of the
parties hereto intends that, for United States federal income tax purposes, the Merger will qualify as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Internal Revenue Code of 1986, as amended (the
&#147;<B>Code</B>&#148;) and the Treasury Regulations, with respect to which each of Frequency, Merger Sub, and Korro are a &#147;party to a reorganization&#148; under Section&nbsp;368(b) of the Code, and this Agreement is intended to constitute a
&#147;plan of reorganization&#148; for purposes of Sections 354, 361 and 368 of the Code and within the meaning of Section&nbsp;368 of the Code and Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-2(g)</FONT> (the
&#147;<B>Intended Tax Treatment</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Parties, intending to be legally bound, agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
AND INTERPRETATIVE PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Definitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) For purposes of the Agreement (including this <U>Section</U><U></U><U>&nbsp;1.1</U>): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>2023 Equity Incentive Plan</B>&#148; shall mean an equity incentive plan of Frequency in form and substance as agreed to by Frequency and Korro (such
agreement not to be unreasonably withheld, conditioned or delayed by either Party), reserving for issuance a number of shares of Frequency Common Stock to be mutually agreed upon by Korro and Frequency (such agreement not to be unreasonably
withheld, conditioned or delayed by either Party). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>2023 ESPP</B>&#148; shall mean an &#147;employee stock purchase plan&#148; of Frequency in
form and substance as agreed to by Frequency and Korro (such agreement not to be unreasonably withheld, conditioned or delayed by either Party), reserving for issuance a number of shares of Frequency Common Stock to be mutually agreed upon by Korro
and Frequency (such agreement not to be unreasonably withheld, conditioned or delayed by either Party). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>2023 Plans</B>&#148; shall mean both the
2023 ESPP and the 2023 Equity Incentive Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Acceptable Confidentiality Agreement</B>&#148; means a confidentiality agreement containing terms
not materially less restrictive in the aggregate to the counterparty thereto than the terms of the Confidentiality Agreement, except such confidentiality agreement need not contain any standstill,
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> or no hire provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquisition Inquiry</B>&#148; means, with respect to a Party, an
inquiry, indication of interest or request for information (other than an inquiry, indication of interest or request for information made or submitted by Korro, on the one hand, or Frequency, on the other hand, to the other Party) that would
reasonably be expected to lead to an Acquisition Proposal, other than, as applicable, with respect to the MS Asset Disposition and the Concurrent Financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquisition Proposal</B>&#148; means, with respect to a Party, any offer or proposal, whether written or oral (other than an offer or proposal made
or submitted by or on behalf of Korro or any of its Affiliates, on the one hand, or by or on behalf of Frequency or any of its Affiliates, on the other hand, to the other Party) contemplating or otherwise relating to any Acquisition Transaction with
such Party, other than, as applicable, with respect to the MS Asset Disposition and the Concurrent Financing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquisition Transaction</B>&#148;
means any transaction or series of related transactions (other than, as applicable, the MS Asset Disposition and the Concurrent Financing) involving: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any merger, consolidation, amalgamation, share exchange, business combination, issuance
of securities, acquisition of securities, reorganization, recapitalization, tender offer, exchange offer or other similar transaction: (A)&nbsp;in which a Party is a constituent entity, (B)&nbsp;in which a Person or &#147;group&#148; (as defined in
the Exchange Act and the rules promulgated thereunder) of Persons directly or indirectly acquires beneficial or record ownership of securities representing more than 20% of the outstanding securities of any class of voting securities of a Party or
any of its Subsidiaries or (C)&nbsp;in which a Party or any of its Subsidiaries issues securities representing more than 20% of the outstanding securities of any class of voting securities of such Party or any of its Subsidiaries; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute or
account for 20% or more of the consolidated book value or the fair market value of the assets of a Party and its Subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under common control
with such other Person. For purposes of this definition, &#147;<U>control</U>&#148; when used with respect to any Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of
voting securities or partnership or other ownership interests, by contract or otherwise, and the terms &#147;<U>controlling</U>&#148; and &#147;<U>controlled</U>&#148; have correlative meanings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means any day other than a day on which banks in the State of New York are authorized or obligated to be closed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Cash</B> <B>and</B> <B>Cash Equivalents</B>&#148; means all (i)&nbsp;cash and cash equivalents and (ii)&nbsp;marketable securities, in each case
determined in accordance with GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>COBRA</B>&#148; means the Consolidated Omnibus Budget Reconciliation Act of 1985, as set forth in
Section&nbsp;4980B of the Code and Part 6 of Title I of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Combined Corporation</B>&#148; means, collectively, Frequency and each of its
Subsidiaries immediately following the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Concurrent Financing</B>&#148; means an acquisition of shares of Korro Common Stock to be
consummated immediately prior to the Effective Time pursuant to the Subscription Agreement with aggregate gross cash proceeds of at least the Concurrent Investment Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Concurrent Financing Allocation Percentage</B>&#148; means the quotient (rounded to four decimal places) determined by <I><U>dividing</U></I>
(A)&nbsp;the Concurrent Financing Proceeds <I><U>by</U></I> (B)&nbsp;the Aggregate Valuation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Concurrent Financing Merger Shares</B>&#148;
means, subject to <U>Section</U><U></U><U>&nbsp;2.4(f)</U>, the product determined by <I><U>multiplying</U></I> (i)&nbsp;the Post-Closing Frequency Shares <I>by </I>(ii)&nbsp;the Concurrent Financing Allocation Percentage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Concurrent Financing Proceeds</B>&#148; means the proceeds resulting from the Concurrent Financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Concurrent Investment Amount</B>&#148; means $100,000,000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Confidentiality Agreement</B>&#148;<B> </B>means the Confidentiality Agreement, dated as of
March&nbsp;20, 2023, by and between Korro and Frequency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Consent</B>&#148;<B> </B>means any approval, consent, ratification, permission, waiver
or authorization (including any Governmental Authorization). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Contemplated Transactions</B>&#148;<B> </B>means the Merger<B> </B>and the other
transactions contemplated by the Agreement, including the CVR Agreement (if applicable), the Concurrent Financing and the Charter Amendment Proposals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Contract</B>&#148;<B> </B>means, with respect to any Person, any written agreement, contract, subcontract, lease (whether for real or personal
property), mortgage, license, or other legally binding commitment or undertaking of any nature to which such Person is a party or by which such Person or any of its assets are bound or affected under applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Delaware Law</B>&#148;<B> </B>means the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Delaware Law Amendment Approval</B>&#148;<B> </B>means the final Governmental Authorization (including signing by the Delaware Governor into law) of
the amendments to the voting requirements under &#167; 242 of Title 8 of Delaware Law contemplated by An Act to Amend Title 8 of the Delaware Code Relating to the General Corporation Law, S. 114, Gen. Assem. (2023). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Effect</B>&#148;<B> </B>means any effect, change, event, circumstance, or development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Employee Plan</B>&#148;<B> </B>means (i)&nbsp;each &#147;employee benefit plan&#148; within the meaning of Section&nbsp;3(3) of ERISA whether or not
subject to ERISA; (ii)&nbsp;any other plan, program, policy, agreement or arrangement providing for stock options, stock purchases, restricted stock, restricted stock units, phantom equity, other equity or equity-based incentives, bonuses,
commissions, severance, retention, deferred compensation, change in control, transaction, vacation, retirement, pension, profit-sharing, post-retirement health and welfare, fringe, life insurance, perquisites, health, medical, dental, vision,
welfare, employee assistance or similar benefits; and (iii)&nbsp;all other plans, programs, policies, agreements or arrangements (whether written or unwritten) providing compensation or benefits to any employee, officer, director, individual
independent contractor and other <FONT STYLE="white-space:nowrap">non-employee</FONT> service provider. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Encumbrance</B>&#148;<B> </B>means any
lien, pledge, hypothecation, charge, mortgage, security interest, lease, license, option, easement, reservation, servitude, adverse title, claim, infringement, interference, option, right of first refusal, preemptive right, community property
interest or restriction or encumbrance of any nature (including any restriction on the voting of any security, any restriction on the transfer of any security or other asset, any restriction on the receipt of any income derived from any asset, any
restriction on the use of any asset and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Enforceability Exceptions</B>&#148;<B> </B>means the (i)&nbsp;Laws of general application relating to bankruptcy, insolvency and the relief of
debtors and (ii)&nbsp;rules of law governing specific performance, injunctive relief and other equitable remedies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Entity</B>&#148;<B> </B>means any corporation (including any nonprofit corporation), partnership
(including any general partnership, limited partnership or limited liability partnership), joint venture, estate, trust, company (including any company limited by shares, limited liability company or joint stock company), firm, society or other
enterprise, association, organization or entity, and each of its successors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Environmental Law</B>&#148;<B> </B>means any federal, state, local
or foreign Law relating to pollution or protection of human health or the environment (including ambient air, surface water, ground water, land surface or subsurface strata), including any law or regulation relating to emissions, discharges,
releases or threatened releases of Hazardous Materials, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA</B>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA Affiliate</B>&#148;<B> </B>means, with respect to any Entity, any other Person that would be treated as a single employer with such Entity,
part of the same &#147;controlled group&#148; as such Entity or under common control with such Entity under Sections 414(b),(c),(m) or (o)&nbsp;of the Code, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148;<B> </B>means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Associate</B>&#148;<B> </B>means any current or former employee, officer, director, consultant, independent contractor or other <FONT
STYLE="white-space:nowrap">non-employee</FONT> service provider of Frequency or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Balance Sheet</B>&#148; means
the audited balance sheet of Frequency for the years ended December&nbsp;31, 2021 and December&nbsp;31, 2022<B>.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Capital
Stock</B>&#148;<B> </B>means the Frequency Common Stock and the Frequency Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Capitalization Representations</B>&#148;<B>
</B>means the representations and warranties of Frequency and Merger Sub set forth in <U>Sections 4.6(a)</U> and <U>4.6(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency
Contract</B>&#148; means any Contract: (i)&nbsp;to which Frequency is a party, (ii)&nbsp;by which Frequency or any Frequency IP Rights or any other asset of Frequency is or may become bound or under which Frequency has, or may become subject to, any
obligation or (iii)&nbsp;under which Frequency has or may acquire any right or interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Covered Person</B>&#148; means, with respect
to Frequency as an &#147;issuer&#148; for purposes of Rule 506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Employee Plan</B>&#148; means any Employee Plan (other than the 2023 Plans) that Frequency or any of its Subsidiaries (i)&nbsp;sponsors,
maintains, administers, or contributes to, or (ii)&nbsp;provides benefits under or through, or (iii)&nbsp;has any obligation to contribute to or provide benefits under or through, or (iv)&nbsp;may reasonably be expected to have any Liability with
respect to, or (v) utilizes to provide benefits to or otherwise cover any Frequency Associate (or their spouses, dependents, or beneficiaries). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency ESPP</B>&#148; means the Frequency 2019 Employee Stock Purchase Plan, as amended from
time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Fundamental Representations</B>&#148; means the representations and warranties of Frequency and Merger Sub set forth in
<U>Sections 4.1(a)</U>, <U>4.1(b)</U>, <U>4.2</U>, <U>4.3</U>, <U>4.4</U> and <U>4.21</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency IP Rights</B>&#148; means all Intellectual
Property owned, licensed or controlled by Frequency that is necessary for, or used or held for use in, the operation of the business of Frequency as presently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency IP Rights Agreement</B>&#148; means any Contract governing, related or pertaining to any Frequency IP Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Lease Agreement</B>&#148; means that certain Lease Agreement, dated January&nbsp;7, 2020, by and between Frequency and HCP/King 75 Hayden
LLC, as may be amended or supplemented from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Material Adverse Effect</B>&#148; means any Effect that, considered together
with all other Effects that have occurred prior to the date of determination of the occurrence of a Frequency Material Adverse Effect, has had or would reasonably be expected to have a material adverse effect on the business, assets, liabilities,
financial condition or results of operations of Frequency or its Subsidiaries, taken as a whole; <U>provided</U>, <U>however</U>, that Effects arising or resulting from the following, alone or in combination, shall not be taken into account in
determining whether there has been a Frequency Material Adverse Effect: (i)&nbsp;the announcement of the Agreement, the pendency or the consummation of the Contemplated Transactions, including any adverse change in customer, supplier, governmental,
landlord, employee or similar relationships resulting therefrom or with respect thereto, (ii)&nbsp;the taking of any action, or the failure to take any action, by Frequency that is expressly required under the terms of the Agreement, (iii)&nbsp;any
natural disaster or epidemics, pandemics or other force majeure events, or any act or threat of terrorism or war, any armed hostilities or terrorist activities (including any escalation or general worsening of any of the foregoing) anywhere in the
world or any governmental or other response or reaction to any of the foregoing, (iv)&nbsp;any change in GAAP or applicable Law or the interpretation thereof, (v)&nbsp;general economic, financial and capital markets, political conditions or
conditions generally affecting the industries in which Frequency and its Subsidiaries operate, or (vi)&nbsp;any failure of Frequency to meet any projections, business plans or forecasts (provided that, this clause (vi)&nbsp;shall not prevent a
determination that any change or effect underlying such failure to meet projections, business plans or forecasts has resulted in a Frequency Material Adverse Effect (to the extent such change or effect is not otherwise excluded from this definition
of Frequency Material Adverse Effect)); except in each case with respect to clauses (iii), (iv) and (v), to the extent disproportionately affecting Frequency and its Subsidiaries, taken as a whole, relative to other similarly situated companies in
the industries in which Frequency and its Subsidiaries operate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Net Cash</B>&#148;<B> </B>means without duplication, (i)&nbsp;Frequency&#146;s Cash and
Cash Equivalents (including any MS Asset Proceeds received, or to be received, by Frequency or any of its Subsidiaries prior to or on the Closing Date pursuant to the MS Asset Disposition), <I><U>minus</U></I> (ii)&nbsp;fees and expenses of
Frequency incurred in connection with the Contemplated Transactions, including for the avoidance of doubt, Transaction Expenses of Frequency to the extent unpaid as of the Closing, <I><U>minus</U></I> (iii)&nbsp;unpaid indebtedness for borrowed
money of Frequency and its Subsidiaries, <I><U>minus</U></I> (iv)&nbsp;any and all Liabilities of Frequency (A)&nbsp;to any Frequency Associate for change in control or transaction bonuses, retention bonuses, severance or similar compensatory
payments or benefits that are due and payable as a result of the completion of the Contemplated Transactions, together with any other event (including the employer portion of any payroll Taxes payable with respect thereto), (B) with respect to the
unfunded or underfunded portion of any defined benefit pension plan, accrued employer contributions to a defined contribution pension plan, post-retirement health and welfare benefit plan, and supplemental executive retirement plan, and
(C)&nbsp;accrued but unpaid bonuses, severance and vacation or paid time off (including the employer portion of any payroll Taxes payable with respect thereto), <I><U>plus</U></I> (v)&nbsp;all prepaid expenses set forth on
<U>Section</U><U></U><U>&nbsp;1.1(a)</U> of the Frequency Disclosure Schedule, <I><U>plus</U></I> (vi)&nbsp;expenses paid, or Liabilities incurred, prior to Closing, that are approved in writing by Korro to be covered by Frequency&#146;s D&amp;O
insurance in excess of the deductible and within overall policy limits, <I><U>plus</U></I> (vii)&nbsp;deposits set forth on <U>Section</U><U></U><U>&nbsp;1.1(a)</U> of the Frequency Disclosure Schedule, <I><U>minus</U></I> (viii)&nbsp;the sum of
Frequency&#146;s consolidated short-term and long-term contractual obligations accrued at the Closing Date (but excluding deferred revenue and any accruals otherwise accounted for in Frequency Net Cash), <I><U>minus</U></I> (ix)&nbsp;all costs and
expenses relating to the winding down of Frequency&#146;s or any of its Subsidiaries prior research and development activities, including any such accounts payable or accrued expenses associated with the termination of any contractual arrangement of
Frequency contemplated hereby, <I><U>minus</U></I> (x)&nbsp;any <FONT STYLE="white-space:nowrap">pre-payment,</FONT> termination <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;end-of-term&#148;</FONT></FONT> or similar fee
or charge payable to any lender in connection with the repayment of indebtedness by Frequency at or prior to the Effective Time, <I><U>minus</U></I> (xi)&nbsp;any accounts payable and accrued expenses (other than accrued expenses which are
Transaction Expenses and excluding any accruals otherwise accounted for in Frequency Net Cash), <I><U>minus</U></I> (xii)&nbsp;all payables or obligations, whether absolute, contingent or otherwise, related to the Frequency Lease Agreement (net of
any rights of Frequency to receive payments relating to the property subject to the Frequency Lease Agreement), <I><U>minus</U></I> (xiii) <I></I>the employer portion of any payroll Taxes payable as a result of the vesting and settlement of each
outstanding and unvested Frequency Restricted Stock Unit pursuant to <U>Section</U><U></U><U>&nbsp;5.13</U>) and <I><U>minus</U></I> (xiv)&nbsp;all costs, fees and expenses relating to the legal matter(s) set forth on
<U>Section</U><U></U><U>&nbsp;1.1(a)</U> of the Frequency Disclosure Schedule and any settlement(s) related thereto. For avoidance of doubt, the Cash and Cash Equivalents received in the Concurrent Financing will be excluded from the calculation of
Frequency Net Cash. Each component of Frequency Net Cash, to the extent applicable, shall be determined (a)&nbsp;in a manner consistent with <U>Annex A</U>, (b)&nbsp;to the extent not inconsistent with clause (a)&nbsp;above, the manner in which such
items were historically determined and in accordance with the financial statements (including any related notes) contained or incorporated by reference in the Frequency SEC Documents and the Frequency Balance Sheet, and (c)&nbsp;to the extent not
addressed in clauses (a)&nbsp;or (b) above, GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Options</B>&#148;<B> </B>means options to purchase shares of Frequency Common Stock
granted by Frequency pursuant to the Frequency 2014 Stock Incentive Plan, as amended from time to time or the Frequency 2019 Incentive Award Plan, as amended from time to time, but excluding the Frequency ESPP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Registered IP</B>&#148;<B> </B>means all Frequency IP Rights that are owned or
exclusively licensed by Frequency that are registered, filed or issued under the authority of, with or by any Governmental Authority, including all Patents, registered copyrights and registered trademarks and all applications for any of the
foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Restricted Stock Units</B>&#148;<B> </B>means a restricted stock unit award covering shares of Frequency Common Stock that
is subject to vesting conditions based on continued employment or service or subject to performance-based vesting conditions (or a combination of both) granted under the Frequency 2019 Incentive Award Plan, as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Triggering Event</B>&#148; shall be deemed to have occurred if: (i)&nbsp;Frequency shall have failed to include in the Proxy Statement the
Frequency Board Recommendation, (ii)&nbsp;the Frequency Board or any committee thereof shall have made a Frequency Board Adverse Recommendation Change or approved, endorsed or recommended any Acquisition Proposal (other than with Korro) or
(iii)&nbsp;Frequency shall have entered into any letter of intent or similar document or any Contract relating to any Acquisition Proposal (other than an Acceptable Confidentiality Agreement permitted pursuant to
<U>Section</U><U></U><U>&nbsp;5.4</U>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Frequency Underwater Options</B>&#148; means Frequency Options with an exercise price equal to or
greater than $1.00 per share (as adjusted for any stock splits or reverse stock splits after the date hereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>GAAP</B>&#148; means United
States generally accepted accounting principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148;<B> </B>means any: (i)&nbsp;nation, state, commonwealth,
province, territory, county, municipality, district or other jurisdiction of any nature, (ii)&nbsp;federal, state, local, municipal, foreign, supra-national or other government, (iii)&nbsp;governmental or quasi-governmental authority of any nature
(including any governmental division, department, agency, commission, bureau, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any
taxing authority) or (iv)&nbsp;self-regulatory organization (including Nasdaq). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authorization</B>&#148;<B> </B>means any:
(i)&nbsp;permit, license, certificate, franchise, permission, variance, exception, order, approval, clearance, registration, qualification or authorization issued, granted, given or otherwise made available by or under the authority of any
Governmental Authority or pursuant to any Law or (ii)&nbsp;right under any Contract with any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Hazardous
Materials</B>&#148;<B> </B>means any pollutant, chemical, substance and any toxic, infectious, carcinogenic, reactive, corrosive, ignitable or flammable chemical, or chemical compound, or hazardous substance, material or waste, whether solid, liquid
or gas, that is subject to regulation, control or remediation under any Environmental Law, including without limitation, crude oil or any fraction thereof, and petroleum products or <FONT STYLE="white-space:nowrap">by-products.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Intellectual Property</B>&#148;<B> </B>means any and all intellectual property and similar
proprietary rights throughout the world, including any and all state, United States, international and/or foreign or other territorial or regional rights in, arising out of or associated with any of the following: (i)&nbsp;United States, foreign and
international patents, patent applications, including all provisionals, nonprovisionals, substitutions, divisional, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> reissues,
renewals, extensions, supplementary protection certificates, reexaminations, term extensions, confirmations, certificates of invention and the equivalents of any of the foregoing, and statutory invention registrations (collectively,
&#147;<B>Patents</B>&#148;),<B> </B>(ii) trademarks, service marks, trade names, domain names, corporate names, brand names, URLs or other names and locators associated with the internet, trade dress, logos and other source identifiers, including
registrations and applications for registration thereof and goodwill associated therewith and symbolized thereby, (iii)&nbsp;works of authorship (whether or not copyrightable) and all copyrights, copyrightable works, derivative works, including
registrations and applications for registration thereof, and all renewals, extensions, restorations or reversions of the foregoing, including all rights of authorship, use, publication, publicity, reproduction, distribution, income, performance and
transformation, (iv)&nbsp;software, including all source code, object code, firmware, development tools files, records and data, all media on which any of the foregoing is recorded, and all related documentation, (v)&nbsp;all inventions, invention
disclosures, improvements, formulae, customer lists, trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> (including recipes, specifications, formulae, manufacturing and other processes, operating procedures, methods, techniques and all
research and development information), technology, technical data, databases, data collections, confidential information and other proprietary rights and intellectual property, whether patentable or not, and all documentation relating to any of the
foregoing and (vi)&nbsp;all rights to sue or recover and retain damages and costs and attorneys&#146; fees for the past, present or future infringement, dilution, misappropriation, or other violation of any of the foregoing anywhere in the world.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>IRS</B>&#148;<B> </B>means the United States Internal Revenue Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Key Employee</B>&#148;<B> </B>means, with respect to any Person, (i)&nbsp;an executive officer of such Person; and (ii)&nbsp;any employee of such
Person, that reports directly to the board of directors of such Person, or to an executive officer of such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Knowledge</B>&#148;<B>
</B>means, with respect to an individual, that such individual is actually aware of the relevant fact or such individual would reasonably be expected to know such fact in the ordinary course of the performance of such individual&#146;s employment
responsibilities. Any Person that is an Entity shall have Knowledge if any executive officer or director of such Person as of the date such knowledge is imputed has or should reasonably be expected to have Knowledge of such fact or other matter.
With respect to any matters relating to Intellectual Property, such awareness or reasonable expectation to have knowledge does not require any such individual to conduct or have conducted or obtain or have obtained any freedom to operate opinions of
counsel or any Intellectual Property rights clearance searches. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro 2019 Plan</B>&#148; means the Korro 2019 Stock Incentive Plan, as amended
from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Associate</B>&#148;<B> </B>means any current or former employee, consultant, officer, director, independent contractor
or other <FONT STYLE="white-space:nowrap">non-employee</FONT> service provider of Korro or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Balance
Sheet</B>&#148; means the audited balance sheets of Korro for the years ended December&nbsp;31, 2021 and December&nbsp;31, 2022<B>.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro
Board</B>&#148; means the board of directors of Korro. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Capital Stock</B>&#148;<B> </B>means Korro Common Stock and Korro Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Capitalization Representations</B>&#148; means the representations and warranties of Korro set forth in <U>Sections 3.6(a)</U> and
<U>3.6(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Common Stock</B>&#148; means the common stock, $0.001 par value per share, of Korro. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Contract</B>&#148;<B> </B>means any Contract: (i)&nbsp;to which Korro or any of its Subsidiaries is a Party, (ii)&nbsp;by which Korro or any of
its Subsidiaries is or may become bound or under which Korro or any of its Subsidiaries has, or may become subject to, any obligation or (iii)&nbsp;under which Korro or any of its Subsidiaries has or may acquire any right or interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Employee Plan</B>&#148; means any Employee Plan that Korro or any of its Subsidiaries (i)&nbsp;sponsors, maintains, administers, or contributes
to, or (ii)&nbsp;provides benefits under or through, or (iii)&nbsp;has any obligation to contribute to or provide benefits under or through, or (iv)&nbsp;may reasonably be expected to have any Liability with respect to, or (v)&nbsp;utilizes to
provide benefits to or otherwise cover any Korro Associate (or their spouses, dependents, or beneficiaries). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Fundamental
Representations</B>&#148;<B> </B>means the representations and warranties of Korro set forth in <U>Sections 3.1(a)</U>, <U>3.1(b)</U>, <U>3.2</U>, <U>3.3</U>, <U>3.4</U> and <U>3.20</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro IP Rights</B>&#148;<B> </B>means all Intellectual Property owned, licensed, or controlled by Korro or its Subsidiaries that is necessary for,
or used or held for use in, the operation of the business of Korro and its Subsidiaries as presently conducted or proposed to be conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro IP Rights Agreement</B>&#148;<B> </B>means any Contract governing, related to or pertaining to any Korro IP Rights other than any confidential
information provided under confidentiality agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Material Adverse Effect</B>&#148;<B> </B>means any Effect that, considered together
with all other Effects that have occurred prior to the date of determination of the occurrence of a Korro Material Adverse Effect, has had or would reasonably be expected to have a material adverse effect on the business, assets, liabilities,
financial condition or results of operations of Korro or its Subsidiaries, taken as a whole; <U>provided</U>, <U>however</U>, that Effects arising or resulting from the following, alone or in combination, shall not be taken into account in
determining whether there has been a Korro Material Adverse Effect: (i)&nbsp;the announcement of the Agreement, the pendency or the consummation of the Contemplated Transactions, including any adverse change in customer, supplier, governmental,
landlord, employee or similar relationships resulting therefrom or with respect thereto, (ii)&nbsp;the taking of any action, or the failure to take any action, by Korro that is expressly required under the terms of the Agreement, (iii)&nbsp;any
natural disaster or epidemics, pandemics or other force majeure events, or any act or threat of terrorism or war, any armed hostilities or terrorist activities (including any escalation or general worsening of any of the foregoing) anywhere in the
world or any governmental or other response or reaction to any of the foregoing, (iv)&nbsp;any change in GAAP or applicable Law or the interpretation thereof, (v)&nbsp;general economic, financial and capital markets, political conditions or
conditions generally affecting the industries in which Korro and its Subsidiaries operate, (v)&nbsp;any failure of Korro to meet any projections, business plans or forecasts (provided that, this clause (vi)&nbsp;shall not prevent a determination
that any change or effect underlying such failure to meet projections, business plans or forecasts has resulted in a Korro Material Adverse Effect (to the extent such change or effect is not otherwise excluded from this definition of Korro Material
Adverse Effect)); except in each case with respect to clauses (iii), (iv) and (v), to the extent disproportionately affecting Korro and its Subsidiaries, taken as a whole, relative to other similarly situated companies in the industries in which
Korro and its Subsidiaries operate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Merger Shares</B>&#148;<B> </B>means, subject to <U>Section</U><U></U><U>&nbsp;2.4(f)</U>,
the product determined by <I><U>multiplying</U></I> (i)&nbsp;the Post-Closing Frequency Shares <I>by </I>(ii)&nbsp;the Korro Allocation Percentage, in which: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &#147;<B>Aggregate Valuation</B>&#148;<B> </B>means the sum of (A)&nbsp;the Korro Equity Value, <I><U>plus</U></I> (B)&nbsp;the Frequency
Valuation, <I><U>plus</U></I> (C)&nbsp;the Concurrent Financing Proceeds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<B>Frequency Allocation Percentage</B>&#148; means
the quotient (rounded to four decimal places) determined by <I><U>dividing</U></I> (A)&nbsp;the Frequency Valuation <I><U>by</U></I> (B)&nbsp;the Aggregate Valuation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<B>Frequency Equity Value</B>&#148; means (A)&nbsp;if Frequency Net Cash is $22,000,000 or less at Closing, then $12,500,000, (B)
if Frequency Net Cash is more than $22,000,000 but less than or equal to $25,000,000 at Closing, then $15,000,000 or (C)&nbsp;if Frequency Net Cash is more than $25,000,000 at Closing, then an amount equal to (i)&nbsp;Frequency Net Cash
<I><U>minus</U></I> (ii) $10,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) &#147;<B>Frequency Outstanding Shares</B>&#148; means, subject to
<U>Section</U><U></U><U>&nbsp;2.4(f)</U> (including, without limitation, the effects of the Nasdaq Reverse Split), the total number of shares of Frequency Common Stock outstanding immediately prior to the Effective Time expressed on a fully-diluted
basis, and assuming, without limitation or duplication, (A)&nbsp;the issuance of shares of Frequency Common Stock in respect of all Frequency Options that are not Frequency Underwater Options that will be outstanding as of immediately prior to the
Effective Time, (B)&nbsp;the settlement in shares of Frequency Common Stock of Frequency Restricted Stock Units that vest solely based on the holder&#146;s employment or service and that are outstanding as of immediately prior to the Effective Time
on a net settlement basis as provided in <U>Section</U><U></U><U>&nbsp;5.13</U> and (C)&nbsp;the exclusion of shares of Frequency Common Stock held by Frequency as treasury stock or owned by Korro or any of its Subsidiaries or any Subsidiary of
Frequency immediately prior to the Effective Time. Notwithstanding any of the foregoing, Frequency Underwater Options shall not be included in the total number of shares of Frequency Common Stock outstanding for purposes of determining the Frequency
Outstanding Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) &#147;<B>Frequency Valuation</B>&#148; means (A)&nbsp;the Frequency Equity Value <I><U>plus</U></I>
(B)&nbsp;Frequency Net Cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) &#147;<B>Korro Allocation Percentage</B>&#148;<B> </B>means the quotient (rounded to four decimal
places) determined by <I><U>dividing</U></I> (A)&nbsp;the Korro Equity Value <I><U>by</U></I> (B)&nbsp;the Aggregate Valuation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)
&#147;<B>Korro Equity Value</B>&#148;<B> </B>means $325,639,194.78. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) &#147;<B>Post-Closing Frequency Shares</B>&#148;<B> </B>mean
the quotient determined by <I><U>dividing</U></I> (A)&nbsp;the Frequency Outstanding Shares <I>by</I> (B)&nbsp;the Frequency Allocation Percentage. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, the Concurrent Financing Proceeds shall not be included in the
calculation or determination of the Korro Equity Value, the Frequency Valuation or any component thereof. Set forth on <U>Annex B</U> attached hereto is an illustrative example of the calculation of Korro Merger Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Option Ex</B><B>change Ratio</B>&#148;<B> </B>means the quotient obtained by dividing (i)&nbsp;the number of Korro Merger Shares by
(ii)&nbsp;the number of Korro Outstanding Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Options</B>&#148; means options to purchase Korro Common Stock granted by Korro pursuant
to the Korro 2019 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Outstanding Shares</B>&#148; means the total number of shares of Korro Common Stock outstanding immediately prior
to the Effective Time (after giving effect to the Korro Preferred Stock Conversion, but without giving effect to the Concurrent Financing) expressed on a fully-diluted and <FONT STYLE="white-space:nowrap">as-converted</FONT> to Korro Common Stock
basis and assuming, without limitation or duplication, the issuance of all shares of Korro Common Stock that would be issued assuming the acceleration and exercise and conversion of all Korro Options and Korro Warrants outstanding as of immediately
prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Preferred Stock</B>&#148; means the preferred stock, $0.001 par value per share, of Korro. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Registered IP</B>&#148; means all Korro IP Rights that are owned or exclusively licensed by Korro or any of its Subsidiaries that are
registered, filed, issued or otherwise granted under the authority of, with or by any Governmental Authority, including all Patents, registered copyrights and registered trademarks and all applications and registrations for any of the foregoing.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Restricted Stock Awards</B>&#148; means restricted stock awards under the Korro 2019 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Triggering Event</B>&#148; shall be deemed to have occurred if: (i)&nbsp;the Korro Board or any committee thereof shall have made any change in
the Korro Board Recommendation or approved, endorsed or recommended any Acquisition Proposal or (ii)&nbsp;Korro shall have entered into any letter of intent or similar document or any Contract relating to any Acquisition Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Korro Warrants</B>&#148; means the warrants issued under the Warrant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Law</B>&#148;<B> </B>means any federal, state, national, supra-national, foreign, local or municipal or other law. statute, constitution, principle
of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Authority (including
under the authority of Nasdaq or the Financial Industry Regulatory Authority). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Legal Proceeding</B>&#148;<B> </B>means any action, suit,
litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise
involving, any court or other Governmental Authority or any arbitrator or arbitration panel, which, for avoidance of doubt, includes the legal matter(s) set forth on <U>Section</U><U></U><U>&nbsp;1.1(a)</U> of the Frequency Disclosure Schedule. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>MS Asset Proceeds</B>&#148; means the net proceeds, if any, resulting from the MS Asset Disposition
actually received by Frequency or its Subsidiaries prior to or on the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Multiemployer Plan</B>&#148;<B> </B>means a
&#147;multiemployer plan,&#148; as defined in Section&nbsp;3(37) or 4001 (a)(3) of ERISA </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Multiple Employer Plan</B>&#148;<B> </B>means a
&#147;multiple employer plan&#148; as described in Section&nbsp;413(c) of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Multiple Employer Welfare Arrangement</B>&#148;<B> </B>means a
&#147;multiple employer welfare arrangement&#148; within the meaning of Section&nbsp;3(40) of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Nasdaq</B>&#148;<B> </B>means The Nasdaq
Stock Market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Nasdaq Reverse Split</B>&#148;<B> </B>means a reverse stock split of all outstanding shares of Frequency Common Stock at a reverse
stock split ratio as mutually agreed to by Frequency and Korro that is effected by Frequency for the purpose of maintaining compliance with Nasdaq listing standards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Notice Period</B>&#148; means a period of at least five Business Days commencing on the date the Frequency Board notifies Korro in writing of its
intent to make a Frequency Board Adverse Recommendation Change. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Order</B>&#148;<B> </B>means any judgment, order, writ, injunction, ruling,
decision or decree of (that is binding on a Party), or any plea agreement, corporate integrity agreement, resolution agreement, or deferred prosecution agreement with, or any settlement under the jurisdiction of, any court or Governmental Authority.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Ordinary Course of Business</B>&#148;<B> </B>means, in the case of each of Korro and Frequency, such actions taken in the ordinary course of its
normal operations and consistent with its past practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Organizational Documents</B>&#148;<B> </B>means, with respect to any Person (other
than an individual), (i)&nbsp;the certificate or articles of association or incorporation or organization or limited partnership or limited liability company, and any joint venture, limited liability company, operating or partnership agreement and
other similar documents adopted or filed in connection with the creation, formation or organization of such Person and (ii)&nbsp;all bylaws, regulations and similar documents or agreements relating to the organization or governance of such Person,
in each case, as amended or supplemented. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Party</B>&#148;<B> or </B>&#147;<B>Parties</B>&#148;<B> </B>means Korro, Frequency and Merger Sub.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Encumbrance</B>&#148;<B> </B>means (i)&nbsp;any statutory liens for current Taxes not yet due and payable or for Taxes that are being
contested in good faith and for which adequate reserves have been made on the Korro Balance Sheet or the Frequency Balance Sheet, as applicable, in accordance with GAAP, (ii)&nbsp;liens that have arisen in the Ordinary Course of Business and that do
not (in any case or in the aggregate) materially detract from the value of the assets subject thereto or materially impair the operations of Korro or Frequency, as applicable, (iii)&nbsp;statutory liens to secure obligations to landlords, lessors or
renters under leases or rental agreements, (iv)&nbsp;deposits or pledges made in connection with, or to secure payment of, workers&#146; compensation, unemployment insurance or similar programs mandated by Law, (v)&nbsp;statutory liens in favor of
carriers, warehousemen, mechanics and materialmen, to secure claims for labor, materials or supplies and (vi)&nbsp;liens arising under applicable securities Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148;<B> </B>means any individual, Entity or Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Personal Information</B>&#148;<B> </B>means (i)&nbsp;data and information concerning an identifiable natural person, or (ii)&nbsp;any information
that is regulated or protected by one or more Privacy Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Privacy Laws</B>&#148;<B> </B>mean Laws relating to privacy, security and/or
collection, use or other processing of Personal Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Representatives</B>&#148;<B> </B>means, with respect to any Person, such
Person&#146;s directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors and representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Sarbanes-Oxley
Act</B>&#148;<B> </B>means the Sarbanes-Oxley Act of 2002. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; means the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148;<B> </B>means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsequent Transaction</B>&#148; means any Acquisition Transaction (with all references to 20% in the definition of Acquisition Transaction being
treated as references to 50% for these purposes). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148;<B> </B>means, with respect to a Person, an Entity of which more than 50%
of the voting power of the equity securities or equity interests is owned, directly or indirectly, by such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Superior Offer</B>&#148;
means an unsolicited bona fide written Acquisition Proposal (with all references to 20% in the definition of Acquisition Transaction being treated as references to 70% for these purposes) that: (i)&nbsp;was not obtained or made as a direct or
indirect result of a breach of (or in violation of) the Agreement and (ii)&nbsp;is on terms and conditions that the Korro Board or the Frequency Board, as applicable, determines in good faith, based on such matters that it deems relevant (including
the likelihood of consummation thereof, the financing terms thereof and any termination or <FONT STYLE="white-space:nowrap">break-up</FONT> fees and conditions to consummation), as well as any written offer by the other Party to the Agreement to
amend the terms of the Agreement, and following consultation with its outside legal counsel and financial advisors, if any, are more favorable, from a financial point of view, to Korro&#146;s stockholders or Frequency&#146;s stockholders, as
applicable, than the terms of the Contemplated Transactions and is not subject to any financing conditions (and if financing is required, such financing is then fully committed to the third party). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax</B>&#148;<B> </B>means any federal, state, local, foreign or other tax, including any income tax, franchise tax, capital gains tax, gross
receipts tax, value-added tax, surtax, estimated tax, unemployment tax, excise tax, ad valorem tax, transfer tax, stamp tax, sales tax, use tax, property tax, business tax, withholding tax, payroll tax, customs duty, alternative or <FONT
STYLE="white-space:nowrap">add-on</FONT> minimum or other tax or similar charge (whether imposed directly or through withholding and whether or not disputed), and including any fine, penalty, addition to tax, interest or additional amount imposed by
a Governmental Authority with respect thereto (or attributable to the nonpayment thereof). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Return</B>&#148;<B> </B>means any return (including any information return), report, statement,
declaration, claim or refund, estimate, schedule, notice, notification, form, election, certificate or other document or information, and any amendment or supplement to any of the foregoing, filed or required to be filed with any Governmental
Authority (or provided to a payee) in connection with the determination, assessment, collection or payment of any Tax or in connection with the administration, implementation or enforcement of or compliance with any Law relating to any Tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Transaction Expenses</B>&#148;<B> </B>means, with respect to Frequency, the aggregate amount (without duplication) of all costs, fees and expenses
incurred by Frequency or any of its Subsidiaries (including Merger Sub), or for which Frequency or any of its Subsidiaries are or may become liable in connection with the Contemplated Transactions and the negotiation, preparation and execution of
this Agreement or any other agreement, document, instrument, filing, certificate, schedule, exhibit, letter or other document prepared or executed in connection with the Contemplated Transactions, including (A)&nbsp;any fees and expenses of legal
counsel and accountants, the maximum amount of fees and expenses payable to financial advisors, investment bankers, brokers, consultants, tax advisors, transfer agents, proxy solicitor and other advisors of Frequency; (B)&nbsp;the premiums,
commissions and other fees paid or payable in connection with obtaining Frequency&#146;s D&amp;O tail policy as set forth in <U>Section</U><U></U><U>&nbsp;5.15(d)</U>; and (C)&nbsp;the CVR Fees (if
any).<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Regulations</B>&#148;<B> </B>means the United States Treasury regulations
promulgated under the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>WARN Act</B>&#148; means the Worker Adjustment and Retraining Notification Act of 1988, as amended, and any similar
or related law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Warrant Agreement</B>&#148; means that certain Warrant to Purchase Common Stock, by and between Korro and Silicon Valley Bank,
issued on January&nbsp;22, 2021 for 162,000 shares of Korro Common Stock at an exercise price of $0.58 per share (subject to adjustments). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Each of the following terms is defined in the Section set forth opposite such term: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Section</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">401(k) Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.29</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Accounting Firm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.8(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Allocation Certificate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.22</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Anticipated Closing Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.8(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Assumed Option</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.4(f)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Assumed Warrant</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.4(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Authorized Share Increase Proposal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cash Determination Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.8(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Certificate of Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Charter Amendment Proposals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.2</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Section</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Code</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Costs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Current Offering Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.14</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CVR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.5(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CVR Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.5(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CVR Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.5(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">D&amp;O Indemnified Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">D&amp;O tail policy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.15(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Delivery Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.8(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dispute Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.8(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Disqualifying Event</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.22</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Drug Regulatory Agency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.14(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Effective Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exchange Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.7(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FDA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.14(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FDCA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.14(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Final Frequency Net Cash</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.8(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Form <FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.7(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Board Adverse Recommendation Change</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.9(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Board Recommendation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.9(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Certifications</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.7(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Closing Certificate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.2(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.6(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Designee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.19(a)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Disclosure Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Article IV</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency IT Systems</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.23(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Material Contract</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.13(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Net Cash Calculation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.8(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Net Cash Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.8(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.14(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.6(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Product Candidates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.14(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Regulatory Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.14(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Real Estate Leases</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.11</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Stockholder Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.9(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Stockholder Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.9(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Frequency Stockholder Support Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Information Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.8(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Intended Tax Treatment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Board Recommendation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.8(c)</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Section</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Certification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.7(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Closing Certificate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.3(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Designee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.19(a)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Disclosure Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Article III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.7(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro IT Systems</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.22(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Material Contract</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.13(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.14(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Preferred Stock Conversion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.4(h)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Product Candidates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.14(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Real Estate Leases</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.11</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Regulatory Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.14(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Stockholder Support Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Korro Stockholder Written Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Liability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Merger Sub</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Merger Sub Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MS Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.6</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MS Asset Disposition</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.6</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Nasdaq Issuance Proposal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ordinary Course Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.16(f)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Outside Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">8.1(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PHSA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.14(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.5(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Privacy Policies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Proxy Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.7(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Purchasers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.23</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Registration Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.7(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Required Frequency Stockholder Vote</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Required Korro Stockholder Vote</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Response Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.8(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Reverse Stock Split Proposal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Rights Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.5(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subscription Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Surviving Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Transaction Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.26</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Transfer Tax</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Warrant Exchange Ratio</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.4(i)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Other Definitional and Interpretative Provisions</U>. The words &#147;hereof,&#148;
&#147;herein&#148; and &#147;hereunder&#148; and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The captions herein are included for convenience of
reference only and shall be ignored in the construction or interpretation hereof. References to Sections, Exhibits and Schedules are to Sections, Exhibits and Schedules of this Agreement unless otherwise specified. Any capitalized terms used in any
Exhibit or Schedule but not otherwise defined therein shall have the meaning as defined in this Agreement. Any singular term in this Agreement shall be deemed to include the plural, and any plural term the singular, the masculine gender shall
include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine gender. Whenever the words &#147;include,&#148; &#147;includes&#148; or
&#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation,&#148; whether or not they are in fact followed by those words or words of like import. The word &#147;or&#148; is not
exclusive. &#147;Writing,&#148; &#147;written&#148; and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References to any agreement or Contract are to that agreement or
Contract as amended, modified or supplemented from time to time in accordance with the terms hereof and thereof. References to any Person include the successors and permitted assigns of that Person. References to any statute are to that statute and
to the rules and regulations promulgated thereunder, in each case as amended, modified, <FONT STYLE="white-space:nowrap">re-enacted</FONT> thereof, substituted, from time to time. References to &#147;$&#148; and &#147;dollars&#148; are to the
currency of the United States. All accounting terms used herein will be interpreted, and all accounting determinations hereunder will be made, in accordance with GAAP unless otherwise expressly specified. References from or through any date shall
mean, unless otherwise specified, from and including or through and including, respectively. All references to &#147;days&#148; shall be to calendar days unless otherwise indicated as a &#147;Business Day.&#148; Except as otherwise specifically
indicated, for purposes of measuring the beginning and ending of time periods in this Agreement (including for purposes of &#147;Business Day&#148; and for hours in a day or Business Day), the time at which a thing, occurrence or event shall begin
or end shall be deemed to occur in the Eastern time zone of the United States. The Parties agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting Party shall not be applied in the construction or
interpretation of this Agreement. The Parties agree that the Korro Disclosure Schedule or the Frequency Disclosure Schedule shall be arranged in sections and subsections corresponding to the numbered and lettered sections and subsections contained
in <U>Article III</U> or <U>Article IV</U> respectively. The disclosures in any section or subsection of the Korro Disclosure Schedule or the Frequency Disclosure Schedule shall qualify other sections and subsections in <U>Article III</U> or
<U>Article IV</U> respectively, to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections and subsections. The words &#147;delivered&#148; or &#147;made available&#148; mean, with
respect to any documentation, that prior to 7:00 p.m. (New York City time) on the date that is the day prior to the date of this Agreement, a copy of such material has been posted to and made available by a Party to the other Party and its
Representatives in the electronic data room maintained by such disclosing Party for the purposes of the Contemplated Transactions. The inclusion of any information in the Korro Disclosure Schedule or Frequency Disclosure Schedule (or any update
thereto) shall not be deemed to be an admission or acknowledgement, in and of itself, that such information is required by the terms hereof to be disclosed, is material, has resulted in or would result in a Korro Material Adverse Effect or Frequency
Material Adverse Effect, as the case may be, or is outside the Ordinary Course of Business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE MERGER </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>The
Merger</U>. Upon the terms and subject to the conditions set forth in this Agreement and subject to the applicable provisions of Delaware Law, at the Closing, Frequency and Korro shall cause Merger Sub to be merged with and into Korro, whereupon the
separate existence of Merger Sub shall cease and Korro shall continue as the Surviving Corporation of the Merger and as a wholly owned subsidiary of Frequency (the &#147;<B>Surviving Corporation</B>&#148;). At the Closing, Frequency and Korro shall
cause the Merger to be consummated and effective under Delaware Law by executing and filing with the Secretary of State of the State of Delaware a certificate of merger with respect to the Merger, satisfying the applicable requirements of Delaware
Law (the &#147;<B>Certificate of Merger</B>&#148;).<B> </B>The Merger shall become effective at the time of the filing of such Certificate of Merger and the acceptance by the Secretary of State of the State of Delaware, or at such later time as may
be specified in such Certificate of Merger with the consent of Frequency and Korro (the time as of which the Merger becomes effective being referred to as the &#147;<B>Effective Time</B>&#148;).<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Closing</U>. Subject to the satisfaction or waiver of the conditions set forth in this Agreement, the consummation of the Merger (the
&#147;<B>Closing</B>&#148;)<B> </B>shall take place remotely, (a)&nbsp;no later than the second Business Day after all the conditions precedent set forth in <U>Article VI</U> shall have been satisfied or waived (other than those conditions that, by
their nature, are to be satisfied at the Closing (provided such conditions would be so satisfied)) or (b)&nbsp;at such other time, date and place as the Parties may mutually agree in writing. The date on which the Closing actually takes place is
referred to as the &#147;<B>Closing Date</B>&#148;.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Organizational Documents; Directors and Officers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Certificate of Incorporation</U>. The certificate of incorporation of the Surviving Corporation shall be amended and restated at or
prior to the Effective Time as set forth in an exhibit to the Certificate of Merger, and as so amended and restated shall be the certificate of incorporation of the Surviving Corporation until thereafter amended as provided by Delaware Law.
Frequency shall further take all actions necessary so that the certificate of incorporation of Frequency shall remain in effect following the Effective Time, until thereafter amended as provided by Delaware Law and, provided, however, that at or
prior to the Effective Time, Frequency shall file one or more amendments to its certificate of incorporation to (i)&nbsp;change the name of Frequency to &#147;Korro Bio, Inc.&#148;, (ii) effect the Nasdaq Reverse Split and the Authorized Share
Increase Proposal and (iii)&nbsp;make such other changes as are mutually agreeable to Frequency and Korro. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Bylaws</U>. The bylaws
of the Surviving Corporation shall be amended and restated as of the Effective Time to be the same as the bylaws of Merger Sub as in effect immediately prior to the Effective Time (with the name of Korro as the Surviving Corporation&#146;s name)
until thereafter amended in accordance with Delaware Law and as provided in the Surviving Corporation&#146;s Organizational Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Directors and Officers</U>. The directors and officers, each to hold office in accordance with the provisions of Delaware Law and the
Surviving Corporation&#146;s Organizational Documents immediately after the Effective Time, shall be as set forth in <U>Section</U><U></U><U>&nbsp;5.18</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <U>Conversion of Shares</U><U>; Korro Options; Korro Preferred Stock and Korro
Warrants</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) At the Effective Time (after giving effect to the Korro Preferred Stock Conversion), by virtue of the Merger and
without any further action on the part of Frequency, Merger Sub, Korro or any stockholder of Korro, subject to <U>Section</U><U></U><U>&nbsp;2.4(d)</U>, the Korro Common Stock outstanding immediately prior to the Effective Time (excluding Korro
Common Stock issued in the Concurrent Financing) shall be converted solely into the right to receive a number of shares of Frequency Common Stock equal to the amount of Korro Merger Shares multiplied by the applicable stockholder&#146;s percentage
interest in Korro as set forth on the Allocation Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) At the Effective Time, by virtue of the Merger and without any further
action on the part of Frequency, Merger Sub, Korro or any stockholder of Korro, subject to <U>Section</U><U></U><U>&nbsp;2.4(d)</U>, the Korro Common Stock issued in the Concurrent Financing shall be converted solely into the right to receive a
number of shares of Frequency Common Stock equal to the amount of Concurrent Financing Merger Shares multiplied by the percentage of the Concurrent Financing Proceeds represented by the applicable stockholder&#146;s investment in the Concurrent
Financing, as set forth on the Allocation Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If any Korro Common Stock outstanding immediately prior to the Effective Time
is unvested or is subject to a repurchase option or a risk of forfeiture under any applicable restricted stock, profits interests, restricted stock unit award agreement or other similar agreement with Korro, then the shares of Frequency Common Stock
issued in exchange for such Korro Common Stock will to the same extent be unvested and subject to the same repurchase option or risk of forfeiture, and such shares of Frequency Common Stock shall accordingly be marked with appropriate legends. Korro
shall take all actions that may be necessary to ensure that, from and after the Effective Time, Frequency is entitled to exercise any such repurchase option or other right set forth in any such restricted stock unit award agreement or other
agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) No fractional shares of Frequency Common Stock shall be issued in connection with the Merger, and no certificates or scrip
for any such fractional shares shall be issued, with no cash being paid for any fractional share eliminated by such rounding. Any fractional shares of Frequency Common Stock a holder of Korro Common Stock would otherwise be entitled to receive shall
be aggregated together first prior to eliminating any remaining fractional share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) At the Effective Time, by virtue of the Merger and
without any further action on the part of Frequency, Merger Sub, Korro or any stockholder of Korro, each share of common stock, $0.01 par value per share, of Merger Sub issued and outstanding immediately prior to the Effective Time shall be
converted into and exchanged for one validly issued, fully paid and nonassessable share of common stock, $0.001 par value per share, of the Surviving Corporation. If applicable, each stock certificate of Merger Sub evidencing ownership of any such
shares shall, as of the Effective Time, evidence ownership of such shares of common stock of the Surviving Corporation until presented for transfer or exchange. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) If, between the date of this Agreement and the Effective Time, the outstanding Korro
Common Stock or Frequency Common Stock shall have been changed into, or exchanged for, a different number of shares or a different class, by reason of any stock dividend, subdivision, reclassification, recapitalization, split (including the Nasdaq
Reverse Split to the extent such split has not previously been taken into account in calculating Korro Merger Shares), combination or exchange of shares or other like change, Korro Merger Shares shall, to the extent necessary, be equitably adjusted
to reflect such change to the extent necessary to provide the holders of Korro Common Stock and Frequency Common Stock with the same economic effect as contemplated by this Agreement prior to such stock dividend, subdivision, reclassification,
recapitalization, split, combination or exchange of shares or other like change; <U>provided</U>, <U>however</U>, that nothing herein will be construed to permit Korro or Frequency to take any action with respect to Korro Common Stock or Frequency
Common Stock, respectively, that is prohibited or not expressly permitted by the terms of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Each Korro Option
outstanding immediately prior to the Effective Time shall automatically be converted, at the Effective Time, into an option (an &#147;<B>Assumed Option</B>&#148;) to acquire, on the same terms and conditions (including, without limitation, the same
vesting and exercisability terms and conditions) as were applicable under the Korro 2019 Plan and option agreement to such Korro Option immediately prior to the Effective Time, the number of shares of Frequency Common Stock under the Assumed Option
determined by multiplying the number of shares of Korro Common Stock subject to such Korro Option immediately prior to the Effective Time (on a fully-diluted basis but before giving effect to the Concurrent Financing) by the Korro Option Exchange
Ratio as set forth on the Allocation Certificate , rounding down to the nearest whole number of shares, at a per share exercise price determined by dividing the per share exercise price of such Korro Option immediately prior to the Effective Time by
the Korro Option Exchange Ratio, rounding up to the nearest whole cent, and Frequency shall assume the Korro 2019 Plan; provided, that the conversion of the Korro Options will be made in a manner consistent with Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.424-1,</FONT> such that the conversion will not constitute a &#147;modification&#148; of such Korro Option for purposes of Section&nbsp;409A or Section&nbsp;424 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) All Korro Preferred Stock shall be converted into Korro Common Stock as of immediately prior to the Effective Time in accordance with, and
pursuant to the terms and conditions of, the Organizational Documents of Korro (the &#147;<B>Korro Preferred Stock Conversion</B>&#148;).<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each Korro Warrant outstanding immediately prior to the Effective Time shall automatically be converted, at the Effective Time, into a
warrant (an &#147;<B>Assumed Warrant</B>&#148;) to acquire, on the same terms and conditions (including, without limitation, the exercisability terms and conditions) as were applicable under the Warrant Agreement to such Korro Warrant immediately
prior to the Effective Time, the number of shares of Frequency Common Stock under the Assumed Warrant determined by multiplying the number of shares of Korro Common Stock subject to such Korro Warrant immediately prior to the Effective Time by the
applicable holder&#146;s percentage interest in Korro with respect to such Korro Warrant as set forth on the Allocation Certificate (such percentage interest, the &#147;<B>Warrant Exchange Ratio</B>&#148;), rounding down to the nearest whole number
of shares, at a per share exercise price determined by dividing the per share exercise price of such Korro Warrant immediately prior to the Effective Time by the Warrant Exchange Ratio, rounding up to the nearest whole cent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 <U>Contingent Value Right</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Effective Time, unless (i)&nbsp;the MS Asset Disposition has been consummated prior to or on the Closing Date and
(ii)&nbsp;all MS Asset Proceeds are taken into account in the Final Frequency Net Cash and there are no contingent payments, licenses, fees or royalties, equity securities or other <FONT STYLE="white-space:nowrap">non-cash</FONT> assets or rights
that may be payable by any acquiror of any MS Assets or otherwise as a result of the MS Asset Disposition after the Closing Date, Frequency shall declare a distribution (the &#147;<B><FONT STYLE="white-space:nowrap">Pre-Closing</FONT>
Distribution</B>&#148;) to holders of Frequency Common Stock of record (as described below), the right to receive one contingent value right (each, a &#147;<B>CVR</B>&#148;) for each outstanding share of Frequency Common Stock held by such
stockholder as of such date, each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in
the form attached hereto as <U>Exhibit F</U>, to be entered into between Frequency and Computershare Trust Company, N.A. (or such other nationally recognized rights agent agreed to between Frequency and Korro) (the &#147;<B>Rights Agent</B>&#148;),
with such revisions thereto requested by the Rights Agent that are not, individually or in the aggregate, materially detrimental to the holders of CVRs and reasonably acceptable to Korro and Frequency, (the &#147;<B>CVR Agreement</B>&#148;). The
record date for the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Distribution shall be the close of business on the last Business Day prior to the day on which the Effective Time occurs and the payment date for the <FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Distribution shall be three Business Days after the Effective Time; provided that the payment of such dividend may be conditioned upon the occurrence of the Effective Time. In connection with the <FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Distribution, Frequency shall cause the CVR Agreement to be duly authorized, executed and delivered by Frequency and the Exchange Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Frequency agrees to pay all reasonable costs and fees associated with any action permitted by this <U>Section</U><U></U><U>&nbsp;2.5</U>
(the &#147;<B>CVR Fees</B>&#148;), which shall be deducted from Frequency Net Cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 <U>Closing of Korro</U><U>&#146;</U><U>s Transfer
Books</U>. At the Effective Time: (a)&nbsp;all Korro Common Stock outstanding immediately prior to the Effective Time shall be treated in accordance with <U>Section</U><U></U><U>&nbsp;2.4(a)</U>, and all holders of certificates representing Korro
Common Stock that were outstanding immediately prior to the Effective Time shall cease to have any rights as stockholders of Korro (other than the right to receive the Korro Merger Shares) and (b)&nbsp;the stock transfer books of Korro shall be
closed with respect to all Korro Common Stock outstanding immediately prior to the Effective Time. No further transfer of any such Korro Common Stock shall be made on such stock transfer books after the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 <U>Surrender of Korro Common Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) On or prior to the Closing Date, Frequency and Korro shall jointly select a reputable bank, transfer agent or trust company to act as
exchange agent in the Merger (the &#147;<B>Exchange Agent</B>&#148;). At the Effective Time, Frequency shall deposit with the Exchange Agent evidence of book-entry shares representing the shares of Frequency Capital Stock issuable pursuant to
<U>Section</U><U></U><U>&nbsp;2.4(a)</U> in exchange for Korro Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Promptly after the Effective Time, the Parties shall cause the Exchange Agent to mail to
the Persons who were record holders of Korro Common Stock that were converted into the right to receive Korro Merger Shares: (i)&nbsp;a letter of transmittal in customary form and containing such provisions as Frequency may reasonably specify and
(ii)&nbsp;instructions for effecting the surrender of Korro Common Stock in exchange for book-entry shares of Frequency Capital Stock. Upon surrender of a duly executed letter of transmittal and such other documents as may be reasonably required by
the Exchange Agent or Frequency, the holder of such Korro Common Stock shall be entitled to receive in exchange therefor book-entry shares representing Korro Merger Shares (in a number of whole shares of Frequency Capital Stock) that such holder has
the right to receive pursuant to the provisions of <U>Section</U><U></U><U>&nbsp;2.4(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) No dividends or other distributions
declared or made with respect to Frequency Capital Stock with a record date after the Effective Time shall be paid to the holder of any Korro Common Stock with respect to the shares of Frequency Capital Stock that such holder has the right to
receive in the Merger until such holder delivers a duly executed letter of transmittal (at which time (or, if later, on the applicable payment date) such holder shall be entitled, subject to the effect of applicable abandoned property, escheat or
similar Laws, to receive all such dividends and distributions, without interest). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Any shares of Frequency Capital Stock deposited
with the Exchange Agent that remain undistributed to holders of Korro Common Stock as of the date that is 180 days after the Closing Date shall be delivered to Frequency upon demand, and any holders of Korro Common Stock who have not theretofore
delivered a duly executed letter of transmittal in accordance with this <U>Section</U><U></U><U>&nbsp;2.7</U> shall thereafter look only to Frequency for satisfaction of their claims for Frequency Capital Stock and any dividends or distributions
with respect to shares of Frequency Capital Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) No Party shall be liable to any holder of any Korro Common Stock or to any other
Person with respect to any shares of Frequency Capital Stock (or dividends or distributions with respect thereto) or for any cash amounts delivered to any public official pursuant to any applicable abandoned property Law, escheat Law or similar Law.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 <U>Calculation of Net Cash</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Not less than ten Business Days prior to the anticipated date for Closing as mutually agreed in good faith by Frequency and Korro (the
&#147;<B>Anticipated Closing Date</B>&#148;),<B> </B>Frequency will deliver to Korro a schedule (the &#147;<B>Frequency Net Cash Schedule</B>&#148;, and the date of delivery of the Frequency Net Cash Schedule, the &#147;<B>Delivery
Date</B>&#148;)<B> </B>setting forth, in reasonable detail, Frequency&#146;s good faith, estimated calculation of Frequency Net Cash (the &#147;<B>Frequency Net Cash Calculation</B>&#148;)<B> </B>as of the close of business on the Closing Date (the
&#147;<B>Cash Determination Time</B>&#148;)<B> </B>prepared and certified by Frequency&#146;s chief financial officer (or if there is no chief financial officer at such time, the principal financial and accounting officer for Frequency). Frequency
shall make available to Korro (electronically to the greatest extent possible), as reasonably requested by Korro, the work papers and <FONT STYLE="white-space:nowrap">back-up</FONT> materials used or useful in preparing the Frequency Net Cash
Schedule and, if reasonably requested by Korro, Frequency&#146;s accountants and counsel at reasonable times and upon reasonable notice. The Frequency Net Cash Calculation shall include Frequency&#146;s determination, as of the Cash Determination
Time, of the defined terms in <U>Section</U><U></U><U>&nbsp;1.1(a)</U> necessary to calculate Korro Merger Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Within five Business Days after the Delivery Date (the last day of such period, the
&#147;<B>Response Date</B>&#148;), Korro shall have the right to dispute any part of the Frequency Net Cash Calculation by delivering a written notice to that effect to Frequency (a &#147;<B>Dispute Notice</B>&#148;). Any Dispute Notice shall
identify in reasonable detail and to the extent known the nature and amounts of any proposed revisions to the Frequency Net Cash Calculation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, on or prior to the Response Date, Korro notifies Frequency in writing that it has no objections to the Frequency Net Cash Calculation
or, if prior to 5:00 p.m. (New York City time) on the Response Date, Korro has failed to deliver a Dispute Notice as provided in <U>Section</U><U></U><U>&nbsp;2.8(b)</U>, then the Frequency Net Cash Calculation as set forth in the Frequency Net Cash
Schedule shall be deemed to have been finally determined for purposes of this Agreement and to represent the Frequency Net Cash at the Cash Determination Time (the &#147;<B>Final Frequency Net Cash</B>&#148;) for purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) If Korro delivers a Dispute Notice on or prior to 5:00 p.m. (New York City time) on the Response Date, then Representatives of Frequency
and Korro shall promptly, and in no event later than one calendar day after the Response Date, meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of Frequency Net Cash, which agreed upon
Frequency Net Cash amount shall be deemed to have been finally determined for purposes of this Agreement and to represent the Final Frequency Net Cash for purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) If Representatives of Frequency and Korro are unable to negotiate an agreed-upon determination of Final Frequency Net Cash pursuant to
<U>Section</U><U></U><U>&nbsp;2.8(d)</U> within two calendar days after delivery of the Dispute Notice (or such other period as Frequency and Korro may mutually agree upon), then any remaining disagreements as to the calculation of Frequency Net
Cash shall be referred to an independent auditor of recognized national standing jointly selected by Frequency and Korro or another independent auditor of recognized national standing mutually agreed upon by Frequency and Korro (the
&#147;<B>Accounting Firm</B>&#148;). Frequency shall promptly deliver to the Accounting Firm all work papers and <FONT STYLE="white-space:nowrap">back-up</FONT> materials used in preparing the Frequency Net Cash Schedule, and Frequency and Korro
shall use commercially reasonable efforts to cause the Accounting Firm to make its determination within five calendar days of accepting its selection. Frequency and Korro shall be afforded the opportunity to present to the Accounting Firm any
material related to the unresolved disputes and to discuss the issues with the Accounting Firm; <I>provided</I>, <I>however</I>, that no such presentation or discussion shall occur without the presence of a Representative of each of Frequency and
Korro. The determination of the Accounting Firm shall be limited to the disagreements submitted to the Accounting Firm. The determination of the amount of Frequency Net Cash made by the Accounting Firm shall be made in writing delivered to each of
Frequency and Korro, shall be final and binding on Frequency and Korro and shall be deemed to have been finally determined for purposes of this Agreement and to represent the Final Frequency Net Cash for purposes of this Agreement. The Parties shall
delay the Closing until the resolution of the matters described in this <U>Section</U><U></U><U>&nbsp;2.8(e)</U>. The fees and expenses of the Accounting Firm shall be allocated between Frequency and Korro in the same proportion that the disputed
amount of the Frequency Net Cash that was unsuccessfully disputed by such Party (as finally determined by the Accounting Firm) bears to the total disputed amount of the Frequency Net Cash amount and such portion of the costs and expenses of the
Accounting Firm borne by Korro and any other fees, costs or expenses incurred by Korro following the Anticipated Closing Date in connection with the procedures set forth in this <U>Section</U><U></U><U>&nbsp;2.8(e)</U> shall be deducted from the
final determination of the amount of Frequency Net Cash, to the extent of available amounts. If this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Section</U><U></U><U>&nbsp;2.8(e)</U> applies as to the determination of the Final Frequency Net Cash described in <U>Section</U><U></U><U>&nbsp;2.8(a)</U>, upon resolution of the matter in
accordance with this <U>Section</U><U></U><U>&nbsp;2.8(e)</U>, the Parties shall not be required to determine Frequency Net Cash again even though the Closing Date may occur later than the Anticipated Closing Date, except that either Frequency and
Korro may require a redetermination of the Final Frequency Net Cash if the Closing Date is more than ten calendar days after the Anticipated Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 <U>Further Action</U>. If, at any time after the Effective Time, any further action is determined by the Surviving Corporation to be
necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full right, title and possession of and to all rights and property of Korro, then the officers and manager of the Surviving Corporation
shall be fully authorized, and shall use their and its commercially reasonable efforts (in the name of Korro, in the name of Merger Sub, in the name of the Surviving Corporation and otherwise) to take such action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10 <U>Withholding</U>. Each of the Exchange Agent, Frequency and the Surviving Corporation shall be entitled to deduct and withhold from any
consideration deliverable pursuant to this Agreement (including the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Distribution) such amounts as are required to be deducted or withheld from such consideration under the Code or under any other
applicable Law. To the extent such amounts are so deducted or withheld, and remitted to the appropriate taxing authority, such amounts shall be treated for all purposes under this Agreement as having been paid to the Person to whom such amounts
would otherwise have been paid. Frequency shall use commercially reasonable efforts to give reasonable advance notice of any required deduction or withholding to Korro (other than where such deduction or withholding is with respect to an amount
treated as compensation under the Code or is due to a failure of the payee to provide any applicable Tax forms required under the letter of transmittal described under <U>Section</U><U></U><U>&nbsp;2.7</U> or the failure of Korro to provide the
certificate described in <U>Section</U><U></U><U>&nbsp;5.16(b)</U>) and shall reasonably cooperate with Korro to eliminate or reduce any such required deduction or withholding. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF KORRO </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth in the written disclosure schedule delivered by Korro to Frequency (the &#147;<B>Korro Disclosure Schedule</B>&#148;),<B>
</B>Korro represents and warrants to Frequency and Merger Sub as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Due Organization; Subsidiaries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Korro is a corporation or other legal entity duly incorporated or otherwise organized, validly existing and in good standing under the
Laws of the jurisdiction of its incorporation or organization and has all necessary power and authority: (i)&nbsp;to conduct its business in the manner in which its business is currently being conducted, (ii)&nbsp;to own or lease and use its
property and assets in the manner in which its property and assets are currently owned or leased and used and (iii)&nbsp;to perform its obligations under all Contracts by which it is bound. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of Korro and its Subsidiaries is licensed and qualified to do business, and is in
good standing (to the extent applicable in such jurisdiction), under the Laws of all jurisdictions where the nature of its business in the manner in which its business is currently being conducted requires such licensing or qualification other than
in jurisdictions where the failure to be so qualified individually or in the aggregate would not be reasonably expected to have a Korro Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as set forth on <U>Section</U><U></U><U>&nbsp;3.1(c)</U> of the Korro Disclosure Schedule, Korro has no Subsidiaries and Korro does
not directly or indirectly own any capital stock of, or any equity ownership or profit sharing interest of any nature in, or control directly or indirectly, any other Entity. Korro is not and has not otherwise been, directly or indirectly, a party
to, member of or participant in any partnership, joint venture or similar business entity. Korro has not agreed and is not obligated to make, or is bound by any Contract under which it may become obligated to make, any future investment in or
capital contribution to any other Entity. Korro has not, at any time, been a general partner of, and has not otherwise been liable for any of the debts or other obligations of, any general partnership, limited partnership or other Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Organizational Documents</U>. Korro has delivered to Frequency accurate and complete copies of Korro&#146;s Organizational Documents.
Korro is not in breach or violation of its Organizational Documents in any material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Authority; Binding Nature of
Agreement</U>. Korro has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and to consummate the Contemplated Transactions. The Korro Board (at meetings duly called and held) has
(i)&nbsp;determined that the Contemplated Transactions are fair to, advisable and in the best interests of Korro and its stockholders, (ii)&nbsp;approved and declared advisable this Agreement and the Contemplated Transactions and
(iii)&nbsp;determined to recommend the Korro Board Recommendation to the stockholders of Korro. This Agreement has been duly executed and delivered by Korro and assuming the due authorization, execution and delivery by Frequency and Merger Sub,
constitutes the legal, valid and binding obligation of Korro, enforceable against Korro in accordance with its terms, subject to the Enforceability Exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <U>Vote Required</U>. The affirmative vote of the holders of at least 66% of the then outstanding shares of Korro Preferred Stock, voting
as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis (the &#147;<B>Required Korro</B> <B>Stockholder Vote</B>&#148;),<B> </B>is the only vote of the holders of any class or series of Korro Capital Stock necessary to
adopt and approve this Agreement and approve the Contemplated Transactions. No interest in Korro is subject to any appraisal or dissenters rights in connection with the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.5 <U><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT> Consents</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to obtaining the Required Korro Stockholder Vote and the filing of the Certificate of Merger required by Delaware Law, neither
(x)&nbsp;the execution, delivery or performance of this Agreement by Korro, nor (y)&nbsp;the consummation of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) contravene, conflict with or result in a violation of any of the provisions of the Organizational Documents of Korro or its
Subsidiaries; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) contravene, conflict with or result in a material violation of,<B>
</B>or give any Governmental Authority or other Person the right to challenge the Contemplated Transactions or to exercise any remedy or obtain any relief under, any Law or any Order to which Korro or its Subsidiaries, or any of the assets owned or
used by Korro or its Subsidiaries, is subject; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) contravene, conflict with or result in a material violation of any of
the terms or requirements of, or give any Governmental Authority the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by Korro or its Subsidiaries or that otherwise relates to the business
of Korro, or any of the assets owned, leased or used by Korro; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) contravene, conflict with or result in a violation or
breach of, or result in a default under, any provision of any Korro Material Contract, or give any Person the right to: (A)&nbsp;declare a default or exercise any remedy under any Korro Material Contract, (B)&nbsp;any material payment, rebate,
chargeback, penalty or change in delivery schedule under any such Korro Material Contract, (C)&nbsp;accelerate the maturity or performance of any Korro Material Contract or (D)&nbsp;cancel, terminate or modify any term of any Korro Material
Contract, except in the case of any nonmaterial breach, default, penalty or modification; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) result in the imposition
or creation of any Encumbrance upon or with respect to any asset owned or used by Korro or its Subsidiaries (except for Permitted Encumbrances). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except for (i)&nbsp;any Consent set forth on <U>Section</U><U></U><U>&nbsp;3.5</U> of the Korro Disclosure Schedule under any Korro
Contract, (ii)&nbsp;the Required Korro Stockholder Vote, (iii)&nbsp;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to Delaware Law and (iv)&nbsp;such consents, waivers, approvals, orders,
authorizations, registrations, declarations and filings as may be required under applicable federal and state securities laws, neither Korro nor any of its Subsidiaries was, is or will be required to make any filing with or give any notice to, or to
obtain any Consent from, any Person in connection with (x)&nbsp;the execution, delivery or performance of this Agreement or (y)&nbsp;the consummation of the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Korro Board has taken and will take all actions necessary to ensure that the restrictions applicable to business combinations
contained in Section&nbsp;203 of Delaware Law are, and will be, inapplicable to the execution, delivery and performance of this Agreement and to the consummation of the Contemplated Transactions. No other state takeover statute or similar Law
applies or purports to apply to the Merger, this Agreement or any of the other Contemplated Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6 <U>Capitalization</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The authorized Korro Capital Stock as of the date of this Agreement consists of (i) 117,138,030 shares of Korro Common Stock, of which (a)
5,662,169 shares have been issued and are outstanding as of the date of this Agreement and (b)&nbsp;Korro Warrants exercisable for 162,000 shares of Korro Common Stock have been issued and are outstanding as of the date of this Agreement, and (ii)
97,714,516 shares of Korro Preferred Stock, of which (a) 4,000,000 shares </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
have been designated Series Seed 1 Preferred Stock, all of which are issued and outstanding as of the date of this Agreement, (b) 2,000,000 shares have been designated Series Seed 2 Preferred
Stock, all of which are issued and outstanding as of the date of this Agreement, (c) 7,780,769 shares have been designated Series Seed 3 Preferred Stock, all of which are issued and outstanding as of the date of this Agreement, (d) 40,848,216 shares
have been designated Series A Preferred Stock, all of which are issued and outstanding as of the date of this Agreement, (e) 22,222,223 shares have been designated Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, all of which are
issued and outstanding as of the date of this Agreement and (f) 20,863,308 shares have been designated Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock, all of which are issued and are outstanding as of the date of this Agreement.
Korro does not hold any shares of its capital stock in its treasury. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) All of the outstanding shares of Korro Common Stock have been
duly authorized and validly issued, and are fully paid and nonassessable and are free of any Encumbrances other than under applicable securities Laws. None of the outstanding shares of Korro Common Stock is entitled or subject to any preemptive
right, right of participation, right of maintenance or any similar right. None of the outstanding shares of Korro Common Stock is subject to any right of first refusal in favor of Korro. Except as contemplated herein, there is no Korro Contract
relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of Korro Common Stock. Korro is not under any
obligation, nor is Korro bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of Korro Common Stock or other securities. <U>Section</U><U></U><U>&nbsp;3.6(b)</U> of the
Korro Disclosure Schedule accurately and completely describes all repurchase rights held by Korro with respect to shares of Korro Common Stock (including shares issued pursuant to the exercise of stock options) and specifies which of those
repurchase rights are currently exercisable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except for the Korro 2019 Plan and the Korro Options and Korro Restricted Stock Awards
granted thereunder, Korro does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation for any Person and there were no other equity or equity-based awards outstanding as of the
date of this Agreement. As of the date of this Agreement, Korro has reserved 15,048,960 shares of Korro Common Stock for issuance under the Korro 2019 Plan, of which 685,175 shares have been issued and are currently outstanding pursuant to Korro
Restricted Stock Awards, 766,069 shares have been issued and are currently outstanding pursuant to the exercise of Korro Options, Korro Options to purchase 12,837,152 shares of Korro Common Stock have been granted and are currently outstanding, and
760,564 shares of Korro Common Stock remain available for future issuance pursuant to the Korro 2019 Plan. <U>Section</U><U></U><U>&nbsp;3.6(c)</U> of the Korro Disclosure Schedule sets forth a true and complete list, as of the date of this
Agreement, of each outstanding Korro Option and Korro Restricted Stock Award: (i)&nbsp;the name (or employee identification number) of the holder, (ii)&nbsp;the number of shares of Korro Common Stock subject to such Korro Option or Korro Restricted
Stock Award, (iii)&nbsp;the exercise price of each Korro Option, (iv)&nbsp;the date on which such Korro Option or Korro Restricted Stock Award was granted, (v)&nbsp;the applicable vesting schedule, including any acceleration provisions, and the
number of vested and unvested shares, (vi)&nbsp;the expiration date, as applicable, and (vii)&nbsp;whether the Korro Option is intended to be an &#147;incentive stock option&#148; (as defined in the Code) or a
<FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option. Korro has made available to Frequency accurate and complete copies of the following: (A)&nbsp;the standard form of agreement evidencing Korro Options and Korro Restricted Stock
Awards; and (B)&nbsp;each agreement evidencing a Korro Option or Korro Restricted Stock Award that does not conform in all material respects to the standard form agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Except as set forth on <U>Section</U><U></U><U>&nbsp;3.6(c)</U> of the Korro Disclosure
Schedule, there is no: (i)&nbsp;outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares of the capital stock or other securities of Korro, (ii)&nbsp;outstanding security, instrument or
obligation that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of Korro, (iii)&nbsp;stockholder rights plan (or similar plan commonly referred to as a &#147;poison pill&#148;) or Contract
under which Korro is or may become obligated to sell or otherwise issue any shares of its capital stock or any other securities or (iv)&nbsp;condition or circumstance that may give rise to or provide a basis for the assertion of a claim by any
Person to the effect that such Person is entitled to acquire or receive any shares of capital stock or other securities of Korro. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) All
outstanding shares of Korro Common Stock, and other securities of Korro have been issued and granted in compliance with (i)&nbsp;all applicable securities laws and other applicable Law and (ii)&nbsp;all requirements set forth in applicable
Contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7 <U>Financial Statements</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.7(a)</U> of the Korro Disclosure Schedule includes true and complete copies of (i)&nbsp;the Korro Balance
Sheet and the related audited statements of operations and comprehensive loss, convertible preferred stock and stockholders&#146; deficit and cash flows for the years ended December&nbsp;31, 2021 and December&nbsp;31, 2022 (the &#147;<B>Korro
Audited Financial Statements</B>&#148;), and (ii)&nbsp;Korro&#146;s unaudited balance sheet and the related unaudited statements of operations and comprehensive loss, convertible preferred stock and stockholders&#146; deficit and cash flows for the
three months ended March&nbsp;31, 2023 (the &#147;<B>Korro Interim Financial Statements</B>&#148; and collectively, with the Korro Audited Financial Statements, the &#147;<B>Korro</B> <B>Financial Statements</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Korro Financial Statements (i)&nbsp;were prepared in accordance with GAAP (except the Korro Interim Financial Statements may not have
notes thereto and other presentation items that may be required by GAAP and are subject to normal and recurring <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments that are not reasonably expected to be material in amount) applied on a
consistent basis unless otherwise noted therein throughout the periods indicated and (ii)&nbsp;fairly present, in all material respects, the financial position of Korro as of the respective dates thereof and the results of operations and cash flows
of Korro for the periods covered thereby. Other than as expressly disclosed in the Korro Financial Statements, there has been no material change in Korro&#146;s accounting methods or principles that would be required to be disclosed in Korro&#146;s
financial statements in accordance with GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) There have been no formal internal investigations regarding financial reporting or
accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer, or general counsel of Korro, the Korro Board or any committee thereof, other than ordinary course
audits or reviews of accounting policies and practices or internal controls. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Korro maintains a system of internal control over financial reporting that is sufficient
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance
(i)&nbsp;that Korro maintains records that in reasonable detail accurately and fairly reflect Korro&#146;s transactions and dispositions of assets, (ii)&nbsp;that transactions are recorded as necessary to permit preparation of financial statements
in accordance with GAAP, (iii)&nbsp;that receipts and expenditures are made only in accordance with authorizations of management and the Korro Board and (iv)&nbsp;regarding prevention or timely detection of the unauthorized acquisition, use or
disposition of Korro&#146;s assets that could have a material effect on Korro&#146;s financial statements. Korro has evaluated the effectiveness of Korro&#146;s internal control over financial reporting. Korro has disclosed to Korro&#146;s auditors
(and made available to Frequency a summary of the significant aspects of such disclosure)&nbsp;(A) all significant deficiencies, if any, in the design or operation of internal control over financial reporting that are reasonably likely to adversely
affect Korro&#146;s ability to record, process, summarize and report financial information and (B)&nbsp;any fraud that involves management or other employees who have a significant role in Korro or its Subsidiaries&#146; internal control over
financial reporting. Except as disclosed in the Korro Financial Statements, Korro&#146;s internal control over financial reporting is effective and Korro has not identified any material weaknesses in the design or operation of Korro&#146;s internal
control over financial reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Korro Financial Statements are in a form that is compliant with the applicable requirements of
the Securities Act or the Exchange Act (as the case may be) for inclusion in the Proxy Statement and the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.8
<U>Absence of Changes</U>. Except as set forth on <U>Section</U><U></U><U>&nbsp;3.8</U> of the Korro Disclosure Schedule, since January&nbsp;1, 2022, Korro and its Subsidiaries have conducted their business only in the Ordinary Course of Business
(except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto) and there has not been any (a)&nbsp;Korro Material Adverse Effect or (b)&nbsp;action, event or occurrence that would have
required consent of Frequency pursuant to <U>Section</U><U></U><U>&nbsp;5.1</U> of this Agreement had such action, event or occurrence taken place after the execution and delivery of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.9 <U>Absence of Undisclosed Liabilities</U>. Neither Korro nor any of its Subsidiaries has any liability, indebtedness, obligation, expense,
claim, deficiency, guaranty or endorsement of any kind, whether accrued, absolute, contingent, matured, unmatured or otherwise (each a &#147;<B>Liability</B>&#148;), in each case, of a type required to be reflected or reserved for on a balance sheet
prepared in accordance with GAAP, except for: (a)&nbsp;Liabilities disclosed, reflected or reserved against in the Korro Balance Sheet, (b)&nbsp;normal and recurring current Liabilities that have been incurred by Korro or its Subsidiaries since the
date of the Korro Balance Sheet in the Ordinary Course of Business (none of which relates to any breach of contract, breach of warranty, tort, infringement, or violation of Law), (c) Liabilities for performance of obligations of Korro or any of its
Subsidiaries under Korro Contracts, (d)&nbsp;Liabilities incurred in connection with the Contemplated Transactions and (e)&nbsp;Liabilities described in <U>Section</U><U></U><U>&nbsp;3.9</U> of the Korro Disclosure Schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.10 <U>Title to Assets</U>. Each of Korro and its Subsidiaries has good and valid title to, or, in the case of leased properties and assets,
valid leasehold interests in, all tangible properties or tangible assets and equipment used or held for use in its business or operations or purported to be owned by it, including: (a)&nbsp;all tangible assets reflected on the Korro Balance Sheet
and (b)&nbsp;all other tangible assets reflected in the books and records of Korro as being owned by Korro. All of such assets are owned or, in the case of leased assets, leased by Korro or any of its Subsidiaries free and clear of any Encumbrances,
other than Permitted Encumbrances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.11 <U>Real Property; Leasehold</U>. Neither Korro nor any of its Subsidiaries owns or has
ever owned any real property. Korro has made available to Frequency (a)&nbsp;an accurate and complete list of all real properties with respect to which Korro directly or indirectly holds a valid leasehold interest as well as any other real estate
that is in the possession of or leased by Korro or any of its Subsidiaries and (b)&nbsp;copies of all leases under which any such real property is possessed (the &#147;<B>Korro</B> <B>Real Estate Leases</B>&#148;), each of which is in full force and
effect, with no existing material default thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.12 <U>Intellectual Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Section </U><U>3.12(a)</U> of the Korro Disclosure Schedule is an accurate, true and complete listing of all Korro Registered IP
including for each item (i)&nbsp;the record owner (and name of any other Person with an ownership interest in such item of Korro Registered IP, if any), jurisdiction (or, with respect to domain names, the applicable registrar), status, date and
registration or application number of each item, as applicable, (ii)&nbsp;the name of the record owner and any other Person that has an ownership interest in such item of Korro Registered IP, and the nature of such ownership interest, and
(iii)&nbsp;any actions that are required to be taken within 180 days of the Closing Date, including the payment of any registration, maintenance or renewal fees or the filing of or response to any documents, applications or certificates, for the
purposes of prosecuting, obtaining, perfecting, maintaining or renewing any Korro Registered IP. <U>Section</U><U></U><U>&nbsp;3.12(a)</U> of the Korro Disclosure Schedule also sets forth, as of the date of this Agreement, a list of all internet
domain names with respect to which Korro or any of its Subsidiaries are the registrant and, with respect to each domain name, the record owner of such domain name and if different, the legal and beneficial owner(s) of such domain name and the
applicable domain name registrar. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Section </U><U>3.12(b)</U> of the Korro Disclosure Schedule accurately identifies (i)&nbsp;all
Korro Contracts pursuant to which any Korro IP Rights are licensed to Korro (other than (A)&nbsp;any <FONT STYLE="white-space:nowrap">non-customized</FONT> software that (1)&nbsp;is so licensed solely in executable or object code form pursuant to a
nonexclusive, internal use software license and other Intellectual Property associated with such software and (2)&nbsp;is not incorporated into, or material to the development, manufacturing, or distribution of, any of Korro&#146;s or its
Subsidiaries&#146; products or services, (B)&nbsp;any Intellectual Property licensed on a nonexclusive basis ancillary to the purchase or use of equipment, reagents or other materials, (C)&nbsp;any confidential information provided under
confidentiality agreements and (D)&nbsp;agreements between Korro or its Subsidiaries and their respective employees in Korro&#146;s standard form thereof) and (ii)&nbsp;whether the license or licenses granted to Korro or its Subsidiaries are
exclusive or nonexclusive. Each Korro Contract listed in <U>Section</U><U></U><U>&nbsp;3.12(b)</U> of the Korro Disclosure Schedule is in full force and effect and constitutes a legal, valid, and binding obligation of Korro or its Subsidiaries and
each other party thereto, and is enforceable against Korro or its Subsidiaries and each other party thereto in accordance with its terms. Neither Korro, its Subsidiaries, nor, to the Knowledge of Korro, any other party to any Korro Contract listed
in <U>Section</U><U></U><U>&nbsp;3.12(b)</U> of the Korro Disclosure Schedule has been or is, or has been or is alleged to be, in material default under, or has provided or received any notice of, breach under, or intention to terminate (including
by <FONT STYLE="white-space:nowrap">non-renewal),</FONT> any Korro Contract listed in <U>Section</U><U></U><U>&nbsp;3.12(b)</U> of the Korro Disclosure Schedule. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except for instances that would not reasonably be expected to have, individually or in
the aggregate, a Korro Material Adverse Effect, <U>Section</U><U></U><U>&nbsp;3.12(c)</U> of the Korro Disclosure Schedule accurately identifies each Korro Contract pursuant to which any Person has been granted any license under, or otherwise has
received or acquired any right (whether or not currently exercisable) or interest in, any Korro IP Rights (other than (i)&nbsp;any confidential information provided under confidentiality agreements and (ii)&nbsp;any Korro IP Rights nonexclusively
licensed to academic collaborators, suppliers or service providers for the sole purpose of enabling such academic collaborator, supplier or service providers to provide services for Korro&#146;s or its Subsidiaries&#146; benefit). Each Korro
Contract listed in <U>Section</U><U></U><U>&nbsp;3.12(c)</U> of the Korro Disclosure Schedule is in full force and effect and constitutes a legal, valid, and binding obligation of Korro or its Subsidiaries and each other party thereto, and is
enforceable against Korro or its Subsidiaries and each other party thereto in accordance with its terms. Neither Korro or its Subsidiaries nor, to the Knowledge of Korro, any other party to any Korro Contract listed in
<U>Section</U><U></U><U>&nbsp;3.12(c)</U> of the Korro Disclosure Schedule has been or is, or has been or is alleged to be, in material default under, or has provided or received any notice of, breach under, or intention to terminate (including by <FONT
STYLE="white-space:nowrap">non-renewal),</FONT> any Korro Contract listed in <U>Section</U><U></U><U>&nbsp;3.12(c)</U> of the Korro Disclosure Schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Except as identified on <U>Section</U><U></U><U>&nbsp;3.12(d)</U> of the Korro Disclosure Schedule, neither Korro nor any of its
Subsidiaries is bound by, and no Korro IP Rights are subject to, any Contract containing any covenant or other provision that in any way limits or restricts the ability of Korro or any of its Subsidiaries to use, exploit, assert, or enforce any
Korro IP Rights anywhere in the world. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Korro or one of its Subsidiaries exclusively owns all right, title, and interest to and in the
Korro IP Rights (other than (i)&nbsp;Korro IP Rights licensed to Korro, or <FONT STYLE="white-space:nowrap">co-owned</FONT> rights each as identified in <U>Section</U><U></U><U>&nbsp;3.12(b)</U> of the Korro Disclosure Schedule, (ii)&nbsp;any <FONT
STYLE="white-space:nowrap">non-customized</FONT> software that (A)&nbsp;is licensed to Korro or its Subsidiaries solely in executable or object code form pursuant to a nonexclusive, internal use software license and other Intellectual Property
associated with such software and (B)&nbsp;is not incorporated into, or material to the development, manufacturing, or distribution of, any of Korro&#146;s or its Subsidiaries&#146; products or services and (iii)&nbsp;any Intellectual Property
licensed on a nonexclusive basis ancillary to the purchase or use of equipment, reagents or other materials), in each case, free and clear of any Encumbrances (other than Permitted Encumbrances). Without limiting the generality of the foregoing:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To the Knowledge of Korro, all documents and instruments necessary to register or apply for or renew registration of
Korro Registered IP have been validly executed, delivered, and filed in a timely manner with the appropriate Governmental Authority. To the Knowledge of Korro, Korro has filed all statements of use and paid all renewal and maintenance fees,
annuities and other fees with respect to the Korro Registered IP that are due or payable as of the date of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Except for instances that would not reasonably be expected to have,
individually or in the aggregate, a Korro Material Adverse Effect, each Person who is or was an employee, contractor or consultant of Korro or any of its Subsidiaries and who is or was involved in the creation, discovery, reduction to practice or
development of any Intellectual Property for Korro or any of its Subsidiaries has signed a valid, enforceable written agreement containing a present assignment of all right, title and interest in and to such Intellectual Property to Korro or such
Subsidiary and confidentiality provisions protecting trade secrets and confidential information of Korro and its Subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To the Knowledge of Korro, no current or former member, officer, director, or employee of Korro or any of its
Subsidiaries has any claim, right (whether or not currently exercisable), or interest to or in any Korro IP Rights purported to be owned by Korro. To the Knowledge of Korro, no employee of Korro or any of its Subsidiaries is (A)&nbsp;bound by or
otherwise subject to any Contract restricting him or her from performing his or her duties for Korro or such Subsidiary or (B)&nbsp;in breach of any Contract with any former employer or other Person concerning Korro IP Rights purported to be owned
by Korro or such Subsidiary or confidentiality provisions protecting trade secrets and confidential information comprising Korro IP Rights purported to be owned by Korro or such Subsidiary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) No funding, facilities, or personnel of any Governmental Authority were used, directly or indirectly, to develop or
create, in whole or in part, any Korro IP Rights in which Korro or any of its Subsidiaries has an ownership interest, and no educational institution has any right to, or right to royalties for, or to impose any requirement on the manufacture or
commercialization of any product incorporating, any Korro IP Rights. No Governmental Authority has any right to (including any <FONT STYLE="white-space:nowrap">&#147;step-in&#148;</FONT> or
<FONT STYLE="white-space:nowrap">&#147;march-in&#148;</FONT> rights with respect to), ownership of, commercialization of, or right to royalties or other payments for any Korro IP Rights. Without limiting the generality of the foregoing, no invention
claimed or covered by any Patent within the Korro IP Rights (A)&nbsp;was conceived or reduced to practice in connection with any research activities funded, in whole or in part, by the federal government of the United States or any agency thereof,
(B)&nbsp;is a &#147;subject invention&#148; as that term is described in 35 U.S.C. Section&nbsp;201(e), or (C)&nbsp;is otherwise subject to the provisions of the Bayh-Dole Act or any similar Law of any other jurisdiction, including with respect to
any Patents that are part of the Korro IP Rights. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) Korro and each of its Subsidiaries has taken reasonable steps to
maintain the confidentiality of and otherwise protect, maintain and enforce its rights in all proprietary information that Korro or such Subsidiary holds, or purports to hold, as confidential or a trade secret. To the Knowledge of Korro, neither
Korro nor any of its Subsidiaries has made any of its trade secrets or other material confidential or proprietary information that it intended to maintain as confidential information available to any other Person except pursuant to written
agreements requiring such Person to maintain the confidentiality of such trade secrets or confidential information. To the Knowledge of Korro, there have been no material security breaches, outages, violations or unauthorized access to any of the
proprietary information that Korro or any of its Subsidiaries holds, or purports to hold, as confidential or a trade secret. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) Neither Korro nor any of its Subsidiaries has assigned or otherwise transferred ownership of, or agreed to assign or
otherwise transfer ownership of, any Korro IP Rights to any other Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) To the Knowledge of Korro, neither Korro nor any of its Subsidiaries
has taken or failed to take any action that could be reasonably expected to result in the abandonment, invalidity, cancellation, forfeiture, relinquishing, invalidation or unenforceability of any Korro IP Rights (including with respect to any
trademark, a failure to exercise adequate quality controls or an assignment in gross without the accompanying goodwill). Each item of Korro IP Rights has been duly maintained and is not expired, abandoned or cancelled. To the Knowledge of Korro,
each of the Patents included in the Korro IP Rights identifies each and every inventor of the claims thereof as determined in accordance with the applicable laws of the jurisdiction in which such Patent is issued or pending. To the Knowledge of
Korro, neither Korro nor any of its Subsidiaries has engaged in patent or copyright misuse or any fraud or inequitable conduct in connection with any Korro IP Right. To the Knowledge of Korro, each of Korro and its Subsidiaries and their respective
patent counsel have complied with its duty of candor and disclosure and have made no material misrepresentations in the filings submitted to the applicable Governmental Authorities with respect to all Patents included in the Korro IP Rights for
which Korro or any of its Subsidiaries is responsible for prosecuting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) To the Knowledge of Korro, the Korro IP
Rights constitute all Intellectual Property necessary for Korro to conduct its business as currently conducted or proposed to be conducted; <U>provided</U>, <U>however</U>, that the foregoing representation is not a representation with respect to
noninfringement of Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Korro has delivered, or made available to Frequency, a complete and accurate copy of all
Korro IP Rights Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) To the Knowledge of Korro, the manufacture, marketing, sale, offering for sale, importation, use or
intended use or other disposal of any product as currently sold or under development by Korro does not violate any license or agreement between Korro or its Subsidiaries and any other third party in any material respect, and, to the Knowledge of
Korro, does not infringe or misappropriate any valid and issued Patent right or other Intellectual Property of any other Person, which infringement or misappropriation would reasonably be expected to have a Korro Material Adverse Effect. To the
Knowledge of Korro, no third party is infringing upon any Patents owned by Korro within the Korro IP Rights, or otherwise violating any Korro IP Rights Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) As of the date of this Agreement, neither Korro nor any of its Subsidiaries is a party to any Legal Proceeding (including, but not limited
to, opposition, interference or other proceeding in any patent or other government office) contesting the validity, ownership or right to use, sell, offer for sale, license or dispose of any Korro IP Rights. None of the Korro IP Rights have been
adjudged invalid or unenforceable in whole or part, and all Korro IP Rights are in full force and effect. No Korro IP Rights have been subject to any interference, derivation, reexamination (including ex parte reexamination, inter partes
reexamination, inter partes review, or post grant review), reissue, cancellation, opposition, claim, allegation or other action, including any proceeding in which the scope, validity, inventorship, ownership or enforceability of any Korro IP Rights
is being, has been, or could reasonably be expected to be, contested or challenged. Neither Korro nor any of its Subsidiaries has received any written notice asserting that any Korro IP Rights or the proposed use, sale, offer for sale, license or
disposition of products, methods, or processes claimed or covered thereunder infringes or misappropriates or violates the rights of any other Person or that Korro or any of its Subsidiaries has otherwise infringed, misappropriated or otherwise
violated any Intellectual Property of any Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To the Knowledge of Korro, no trademark (whether registered or unregistered) or trade
name owned, used, or applied for by Korro conflicts or interferes with any trademark (whether registered or unregistered) or trade name owned, used, or applied for by any other Person except as would not have a Korro Material Adverse Effect. None of
the goodwill associated with or inherent in any trademark (whether registered or unregistered) in which Korro or its Subsidiaries has or purports to have an ownership interest has been impaired as determined by Korro in accordance with GAAP.
<U>Section</U><U></U><U>&nbsp;3.12(i)</U> of the Korro Disclosure Schedule sets forth all material unregistered trademarks included in the Korro IP Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Except (i)&nbsp;as would reasonably not be expected to have a Korro Material Adverse Effect, (ii)&nbsp;as may be set forth in <U>Sections
3.12(a)</U> or <U>3.12(b)</U> of the Korro Disclosure Schedule or (iii)&nbsp;as contained in license, distribution or service agreements entered into in the Ordinary Course of Business by Korro: (A)&nbsp;neither Korro nor any of its Subsidiaries is
bound by any Contract to indemnify, defend, hold harmless, or reimburse any other Person with respect to any Intellectual Property infringement, misappropriation, or similar claim which is material to Korro or any of its Subsidiaries, taken as a
whole and (B)&nbsp;neither Korro nor any of its Subsidiaries has ever assumed, or agreed to discharge or otherwise take responsibility for, any existing or potential liability of another Person for infringement, misappropriation, or violation of any
Intellectual Property right, which assumption, agreement or responsibility remains in force as of the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Neither
Korro nor any of its Subsidiaries is party to any Contract that, as a result of such execution, delivery and performance of this Agreement, will (i)&nbsp;cause the grant, assignment, or transfer to any other third party of any license or other right
to or in any Korro IP Rights, (ii)&nbsp;result in breach of, default under, termination of, or acceleration or modification of such Contract with respect to any Korro IP Rights, (iii)&nbsp;alter, encumber, impair or extinguish, or result in any
Encumbrance with respect to, the right of Korro or the Surviving Corporation and its Subsidiaries to use, sell or license or enforce any Korro IP Rights or portion thereof, or (iv)&nbsp;result in Korro or any of its Subsidiaries being bound by or
subject to any exclusivity obligations, <FONT STYLE="white-space:nowrap">non-compete</FONT> or other restrictions on the operation or scope of their respective businesses, or to any obligation to grant any rights in or to any Korro IP Rights,
except, in each of (i), (ii), (iii) and (iv), for the occurrence of any such grant or impairment that would not individually or in the aggregate, reasonably be expected to result in a Korro Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.13 <U>Agreements, Contracts and Commitments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Section </U><U>3.13(a)</U> of the Korro Disclosure Schedule lists the following Korro Contracts in effect as of the date of this
Agreement (each, a &#147;<B>Korro</B> <B>Material Contract</B>&#148; and collectively, the &#147;<B>Korro</B> <B>Material Contracts</B>&#148;): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) each Korro Contract that is a collective bargaining agreement or other agreement or arrangement with any labor union, works
council or labor organization; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) each Korro Contract for the employment or engagement of any individual
on an employee, consulting or other basis that provides for annual base compensation in excess of $350,000; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) each
Korro Contract with any Korro Associate that provides for retention, change in control, transaction or other similar payments or benefits, whether or not payable as a result of the Contemplated Transactions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) each Korro Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of
Business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) each Korro Contract containing (A)&nbsp;any covenant limiting the freedom of Korro or any of its
Subsidiaries or the Surviving Corporation to engage in any line of business or compete with any Person, or limiting the development, manufacture, or distribution of Korro&#146;s products or services, (B)&nbsp;any most-favored pricing arrangement,
(C)&nbsp;any exclusivity provision or (D)&nbsp;any <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provision; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) each Korro Contract (A)&nbsp;pursuant to which any Person granted Korro an exclusive license under any Intellectual
Property, or (B)&nbsp;pursuant to which Korro granted any Person an exclusive license under any Korro IP Rights; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)
each Korro Contract relating to capital expenditures and requiring payments after the date of this Agreement in excess of $100,000 pursuant to its express terms and not cancelable without penalty; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) each Korro Contract relating to the disposition or acquisition of material assets or any ownership interest in any
Entity, in each case, involving payments in excess of $100,000 after the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) each Korro Contract
relating to any mortgages, indentures, loans, notes or credit agreements, security agreements or other agreements or instruments relating to the borrowing of money or extension of credit in excess of $100,000 or creating any material Encumbrances
with respect to any assets of Korro or any loans or debt obligations with officers or directors of Korro; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) each Korro
Contract requiring payment by or to Korro after the date of this Agreement in excess of $500,000 pursuant to its express terms relating to: (A)&nbsp;any distribution agreement (identifying any that contain exclusivity provisions), (B) any agreement
involving provision of services or products with respect to any preclinical or clinical development activities of Korro, (C)&nbsp;any dealer, distributor, joint marketing, alliance, joint venture, cooperation, development or other agreement
currently in force under which Korro or any of its Subsidiaries has continuing obligations to develop or market any product, technology or service, or any agreement pursuant to which Korro or any of its Subsidiaries has continuing obligations to
develop any Intellectual Property that will not be owned, in whole or in part, by Korro or such Subsidiary or (D)&nbsp;any Contract to license any patent, trademark registration, service mark registration, trade name or copyright registration to or
from any third party to manufacture or produce any product, service or technology of Korro or any of its Subsidiaries or any Contract to sell, distribute or commercialize any products or service of Korro or any of its Subsidiaries, in each case,
except for Korro Contracts entered into in the Ordinary Course of Business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi) each Korro Contract with any Person, including any financial advisor,
broker, finder, investment banker or other Person, providing advisory services to Korro in connection with the Contemplated Transactions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii) each Korro Contract to which Korro or any of its Subsidiaries is a party or by which any of their assets and properties
is currently bound, which involves annual obligations of payment by, or annual payments to, Korro or such Subsidiary in excess of $100,000; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii) a Korro Real Estate Lease; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv) a Contract disclosed in or required to be disclosed in <U>Section</U><U></U><U>&nbsp;3.12(a)</U> or
<U>Section</U><U></U><U>&nbsp;3.12(b)</U> of the Korro Disclosure Schedule; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv) any other Korro Contract that is not
terminable at will (with no penalty or payment) by Korro or any of its Subsidiaries, and (A)&nbsp;which involves payment or receipt by Korro or such Subsidiary after the date of this Agreement under any such agreement, contract or commitment of more
than $250,000 in the aggregate, or obligations after the date of this Agreement in excess of $250,000 in the aggregate or (B)&nbsp;that is material to the business or operations of Korro and its Subsidiaries taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Korro has delivered or made available to Frequency accurate and complete copies of all Korro Material Contracts, including all amendments
thereto. There are no Korro Material Contracts that are not in written form. Korro has not, nor to the Knowledge of Korro, as of the date of this Agreement, has any other party to a Korro Material Contract, breached, violated or defaulted under, or
received notice that it breached, violated or defaulted under, any of the terms or conditions of any Korro Material Contract in such manner as would permit any other party to cancel or terminate any such Korro Material Contract, or would permit any
other party to seek damages which would reasonably be expected to have a Korro Material Adverse Effect. As to Korro and its Subsidiaries, as of the date of this Agreement, each Korro Material Contract is valid, binding, enforceable and in full force
and effect, subject to the Enforceability Exceptions. No Person is renegotiating, or has a right pursuant to the terms of any Korro Material Contract to change, any material amount paid or payable to Korro under any Korro Material Contract or any
other material term or provision of any Korro Material Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.14 <U>Compliance; Permits; Restrictions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Korro and each of its Subsidiaries is, and since January&nbsp;1, 2020 has been, in material compliance with all applicable Laws. No
investigation, claim, suit, proceeding, audit, Order, or other action by any Governmental Authority is pending or, to the Knowledge of Korro, threatened against Korro or any of its Subsidiaries. There is no agreement or Order binding upon Korro or
any of its Subsidiaries which (i)&nbsp;has or could reasonably be expected to have the effect of prohibiting or materially impairing any business practice of Korro or any of its Subsidiaries, any acquisition of material property by Korro or any of
its Subsidiaries or the conduct of business by Korro or any of its Subsidiaries as currently conducted, (ii)&nbsp;is reasonably likely to have an adverse effect on Korro&#146;s ability to comply with or perform any covenant or obligation under this
Agreement or (iii)&nbsp;is reasonably likely to have the effect of preventing, delaying, making illegal or otherwise interfering with the Contemplated Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of Korro and its Subsidiaries holds all required Governmental Authorizations that
are material to the operation of the business of Korro as currently conducted (collectively, the &#147;<B>Korro</B> <B>Permits</B>&#148;).<B> </B><U>Section</U><U></U><U>&nbsp;3.14(b)</U> of the Korro Disclosure Schedule identifies each Korro
Permit. Each of Korro and its Subsidiaries is in material compliance with the terms of Korro Permits. No Legal Proceeding is pending or, to the Knowledge of Korro, threatened, which seeks to revoke, substantially limit, suspend, or materially modify
any Korro Permit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) There are no Legal Proceedings pending or, to the Knowledge of Korro, threatened with respect to an alleged
material violation by Korro or any of its Subsidiaries of the Federal Food, Drug, and Cosmetic Act <B>(</B>&#147;<B>FDCA</B>&#148;)<B>, </B>the Public Health Service Act <B>(</B>&#147;<B>PHSA</B>&#148;),<B> </B>Food and Drug Administration
<B>(</B>&#147;<B>FDA</B>&#148;)<B> </B>regulations adopted thereunder, the Controlled Substances Act or any other Law promulgated by the FDA or other Governmental Authority responsible for regulation of the development, testing, manufacturing,
processing, storage, labeling, sale, marketing, advertising, distribution and importation or exportation of drug products <B>(</B>&#147;<B>Drug Regulatory Agency</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each of Korro and its Subsidiaries holds all required material Governmental Authorizations issuable by any Drug Regulatory Agency
necessary for the conduct of the business of Korro as currently conducted, and, as applicable, the development, testing, manufacturing, processing, storage, labeling, sale, marketing, advertising, distribution and importation or exportation, as
currently conducted, of any of its products or product candidates (the &#147;<B>Korro</B> <B>Product Candidates</B>&#148;)<B> </B>(collectively, the &#147;<B>Korro</B> <B>Regulatory Permits</B>&#148;)<B> </B>and no such Korro Regulatory Permit has
been (i)&nbsp;revoked, withdrawn, suspended, cancelled or terminated or (ii)&nbsp;modified in any material, adverse manner. Korro has timely maintained and is in compliance in all material respects with the Korro Regulatory Permits and neither Korro
nor any of its Subsidiaries has, since January&nbsp;1, 2020, received any written notice or other written communication from any Drug Regulatory Agency regarding (A)&nbsp;any material violation of or failure to comply materially with any term or
requirement of any Korro Regulatory Permit or (B)&nbsp;any revocation, withdrawal, suspension, cancellation, termination or material modification of any Korro Regulatory Permit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) All clinical trials, preclinical studies and other studies and tests conducted by or on behalf of, or sponsored by, Korro and its
Subsidiaries or in which Korro Product Candidates have participated, were and, if still pending, are being conducted in compliance in all material respects with the applicable regulations of the Drug Regulatory Agencies and other applicable Law,
including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58 and 312. Neither Korro nor any of its Subsidiaries has received any written notices, correspondence, or other communications from any Drug Regulatory Agency requiring, or, to the
Knowledge of Korro, any action to place a clinical hold order on, or otherwise terminate, delay, or suspend any clinical studies conducted by or on behalf of, or sponsored by, Korro or any of its Subsidiaries or in which Korro Product Candidates
have participated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Neither Korro nor any of its Subsidiaries, and, to the Knowledge of Korro, any contract
manufacturer with respect to any Korro Product Candidate, is the subject of any pending or, to the Knowledge of Korro, threatened investigation in respect of its business or products by the FDA pursuant to its &#147;Fraud, Untrue Statements of
Material Facts, Bribery, and Illegal Gratuities&#148; Final Policy set forth in 56 Fed. Reg. 46191 (September 10, 1991) and any amendments thereto, or any other applicable Law. To the Knowledge of Korro, neither Korro nor any of its Subsidiaries nor
any contract manufacturer with respect to any Korro Product Candidate has committed any acts, made any statement, or failed to make any statement, in each case in respect of Korro&#146;s business or products that would violate the FDA&#146;s
&#147;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#148; Final Policy, and any amendments thereto, or any other applicable Law. None of Korro, any of its Subsidiaries, and to the Knowledge of Korro, any contract
manufacturer with respect to any Korro Product Candidate, or any of their respective officers, employees or agents has been convicted of any crime or engaged in any conduct that could result in a debarment or exclusion under (i) 21 U.S.C.
Section&nbsp;335a, (ii)&nbsp;42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7,</FONT> or (iii)&nbsp;any other applicable Law. To the Knowledge of Korro, no debarment or exclusionary claims, actions, proceedings or investigations in respect
of their business or products are pending or threatened against Korro, any of its Subsidiaries, and to the Knowledge of Korro, any contract manufacturer with respect to any Korro Product Candidate, or any of its respective officers, employees or
agents. Neither Korro nor any of its Subsidiaries is a party to or has any reporting obligations under any corporate integrity agreements, monitoring agreements, deferred or <FONT STYLE="white-space:nowrap">non-prosecution</FONT> agreements, consent
decrees, settlement orders, or similar agreements with or imposed by any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) All manufacturing operations
conducted by, or to the Knowledge of Korro, for the benefit of, Korro or its Subsidiaries in connection with any Korro Product Candidate, since January&nbsp;1, 2020, have been and are being conducted in compliance in all material respects with
applicable Laws, including the FDA&#146;s standards for current good manufacturing practices, including applicable requirements contained in 21 C.F.R. Parts 210, 211, <FONT STYLE="white-space:nowrap">600-680,</FONT> and 1271, and the respective
counterparts thereof promulgated by Governmental Authorities in countries outside the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) No laboratory or manufacturing
site owned by Korro or its Subsidiaries, and to the Knowledge of Korro, no manufacturing site of a contract manufacturer or laboratory, with respect to any Korro Product Candidate, (i)&nbsp;is subject to a Drug Regulatory Agency shutdown or import
or export prohibition or (ii)&nbsp;has since January&nbsp;1, 2020 received any unresolved Form FDA 483, notice of violation, warning letter, untitled letter, or similar correspondence or notice from the FDA or other Governmental Authority alleging
or asserting material noncompliance with any applicable Law, and, to the Knowledge of Korro, neither the FDA nor any other Governmental Authority is considering such action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.15 <U>Legal Proceedings; Orders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) There is no pending Legal Proceeding and, to the Knowledge of Korro, no Person has threatened in writing to commence any Legal Proceeding:
(i)&nbsp;that involves Korro or any of its Subsidiaries or any Korro Associate (in his or her capacity as such) or any of the material assets owned or used by Korro or any of its Subsidiaries or (ii)&nbsp;that challenges, or that may have the effect
of preventing, delaying, making illegal or otherwise interfering with, the Contemplated Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) There is no Order to which Korro or any of its Subsidiaries, or any of the material
assets owned or used by Korro or any of its Subsidiaries, is subject. To the Knowledge of Korro, no officer or other Key Employee of Korro or any of its Subsidiaries is subject to any Order that prohibits such officer or employee from engaging in or
continuing any conduct, activity or practice relating to the business of Korro or any of its Subsidiaries or to any material assets owned or used by Korro or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.16 <U>Tax Matters</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
Each of Korro and each of its Subsidiaries has timely filed all income Tax Returns and all other material Tax Returns that were required to be filed by or with respect to it under applicable Law. All such Tax Returns were correct and complete in all
material respects and have been prepared in material compliance with all applicable Law. Subject to exceptions as would not be material, no claim has ever been made by a Governmental Authority in a jurisdiction where Korro or any of its Subsidiaries
does not file a particular type of Tax Return that Korro or any of its Subsidiaries is subject to taxation by that jurisdiction that would be the subject of such a Tax Return. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) All material amounts of Taxes due and owing by Korro and each of its Subsidiaries (whether or not shown on any Tax Return) have been
timely paid. The unpaid Taxes of Korro and each of its Subsidiaries for periods (or portions thereof) ending on or prior to the date of the Korro Balance Sheet do not materially exceed the accruals for current Taxes set forth on the Korro Balance
Sheet. Since the date of the Korro Balance Sheet, neither Korro nor any of its Subsidiaries has incurred any material Liability for Taxes outside the Ordinary Course of Business or otherwise inconsistent with past custom and practice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each of Korro and each of its Subsidiaries has withheld and paid to the appropriate Governmental Authority all material Taxes required to
have been withheld and paid in connection with any amounts paid or owing to any employee, independent contractor, creditor, stockholder, or other third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) There are no Encumbrances for material Taxes (other Encumbrances described in clause (i)&nbsp;of the definition of &#147;Permitted
Encumbrances&#148;) upon any of the assets of Korro or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) No deficiencies for a material amount of Taxes with
respect to Korro or any of its Subsidiaries have been claimed, proposed or assessed by any Governmental Authority in writing that have not been timely paid in full. There are no pending (or, based on written notice, threatened) material audits,
assessments, examinations or other actions for or relating to any Liability in respect of Taxes of Korro or any of its Subsidiaries. Neither Korro nor any of its Subsidiaries has waived any statute of limitations in respect of material Taxes or
agreed to any extension of time with respect to a material Tax assessment or deficiency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Neither Korro nor any of its Subsidiaries is
a party to any Tax allocation, Tax sharing or similar agreement (including indemnity arrangements), other than customary indemnification provisions in commercial Contracts entered into in the Ordinary Course of Business with vendors, customers,
lenders, or landlords (an &#147;<B>Ordinary Course Agreement</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Neither Korro nor any of its Subsidiaries has been a member of an affiliated group
filing a consolidated U.S. federal income Tax Return (other than a group the common parent of which is Korro). Neither Korro nor any of its Subsidiaries has any material Liability for the Taxes of any Person (other than Korro) under Treasury
Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of state, local, or foreign law), as a transferee or successor, by Contract (other than an Ordinary Course Agreement) or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Neither Korro nor any of its Subsidiaries has distributed stock of another Person, or has had its stock distributed by another Person, in
a transaction that was purported or intended to be governed in whole or in part by Section&nbsp;355 of the Code or Section&nbsp;361 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Neither Korro nor any of its Subsidiaries has entered into any transaction identified as a &#147;reportable transaction&#148; for purposes
of Treasury Regulations Sections <FONT STYLE="white-space:nowrap">1.6011-4(b)(2)</FONT> or <FONT STYLE="white-space:nowrap">301.6111-2(b)(2).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Neither Korro nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of
deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i)&nbsp;change in, or use of improper, method of accounting for a taxable period ending on or prior to the Closing Date;
(ii)&nbsp;&#147;closing agreement&#148; as described in Section&nbsp;7121 of the Code (or any corresponding or similar provision of state, local or foreign income Tax law) executed on or prior to the Closing Date; (iii)&nbsp;installment sale or open
transaction disposition made on or prior to the Closing Date; (iv)&nbsp;prepaid amount, advance payments or deferred revenue received or accrued on or prior to the Closing Date other than in respect of such amounts reflected in the Korro Balance
Sheet or received in the Ordinary Course of Business since the date of the Korro Balance Sheet; or (v)&nbsp;intercompany transaction or excess loss amount described in Treasury Regulations under Section&nbsp;1502 of the Code (or any corresponding or
similar provision of state, local or foreign income Tax Law). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Section </U><U>3.16(k)</U> of the Korro Disclosure Schedule sets
forth the entity classification of Korro and each of its Subsidiaries for U.S. federal income tax purposes. Neither Korro nor any of its Subsidiaries has made an election or taken any other action to change its federal and state income tax
classification from such classification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Neither Korro nor any of its Subsidiaries has taken or knowingly failed to take any action,
nor to the Knowledge of Korro, are there any facts or circumstances, in each case, that would reasonably be expected to prevent or impede the Merger from qualifying for the Intended Tax Treatment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.17 <U>Employee and Labor Matters; Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Neither Korro nor any of its Subsidiaries is a party to, bound by the terms of, or has a duty to bargain under, any collective bargaining
agreement or other Contract with a labor union, works council or labor organization representing any Korro Associate, and there are no labor unions, works council or labor organizations representing or, to the Knowledge of Korro, purporting to
represent or seeking to represent any Korro Associates, including through the filing of a petition for representation election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
<U>Section </U><U>3.17(b)</U> of the Korro Disclosure Schedule lists all material Korro Employee Plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As applicable with respect to
each material Korro Employee Plan, Korro has made available to Frequency, true and complete copies of (i)&nbsp;the plan document, including all amendments thereto, and in the case of an unwritten Employee Plan, a written description of all material
terms thereof, (ii)&nbsp;all related trust instruments or other funding-related documents and insurance contracts, (iii)&nbsp;the summary plan description and each summary of material modifications thereto, (iv)&nbsp;the financial statements for the
most recent year for which such financial statements are available (in audited form, if available or required by ERISA) and, where applicable, annual reports with any Governmental Authority (<I>e.g.</I>,<I> </I>Form 5500 and all schedules thereto),
(v) the most recent IRS determination or opinion letter, (vi)&nbsp;written results of any required compliance testing for the three most recent plan years, and (vii)&nbsp;all material, <FONT STYLE="white-space:nowrap">non-routine</FONT> notices,
filings or correspondence during the past three years with any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each Korro Employee Plan that is intended to
be qualified under Section&nbsp;401(a) of the Code has received a favorable determination letter or may rely on a favorable opinion letter with respect to such qualified status from the IRS to the effect that such plan is qualified under
Section&nbsp;401(a) of the Code and the related trust is exempt from federal income Taxes under Section&nbsp;501(a) of the Code. To the Knowledge of Korro, nothing has occurred that would reasonably be expected to cause the loss of the qualified
status of any such Korro Employee Plan or the Tax exempt status of any related trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Each Korro Employee Plan has been established,
maintained and operated in compliance, in all material respects, with its terms and all applicable Laws, including, without limitation, the Code and ERISA. No Legal Proceeding (other than those relating to routine claims for benefits) is pending or,
to the Knowledge of Korro, threatened with respect to any Korro Employee Plan. All material payments and/or contributions required to have been made with respect to all Korro Employee Plans have been made in accordance with the terms of the
applicable Korro Employee Plan and applicable Law in all material respects and neither the Korro nor any Korro ERISA Affiliate has any material liability for any such unpaid contributions with respect to any Korro Employee Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Neither Korro, any of its Subsidiaries nor any of their ERISA Affiliates maintains, contributes to or is required to contribute to, or has
any Liability with respect to (i)&nbsp;any &#147;employee benefit plan&#148; (within the meaning of Section&nbsp;3(2) of ERISA) that is or was subject to Title IV or Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code, (ii)&nbsp;a
Multiemployer Plan, (iii)&nbsp;any Multiple Employer Plan, or (iv)&nbsp;any Multiple Employer Welfare Arrangement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) No Korro Employee Plan provides for medical or other welfare benefits to any service
provider beyond termination of service or retirement, other than (i)&nbsp;pursuant to COBRA or an analogous state law requirement (the full cost of which is borne by such Person or such Person&#146;s dependents or beneficiaries) or
(ii)&nbsp;continuation coverage through the end of the month in which such termination or retirement occurs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) No Korro Employee Plan
is subject to any law of a foreign jurisdiction outside of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each Korro Employee Plan that constitutes in any part a
nonqualified deferred compensation plan within the meaning of Section&nbsp;409A of the Code has been operated and maintained in all material respects in operational and documentary compliance with Section&nbsp;409A of the Code and applicable
guidance thereunder. No payment to be made under any Korro Employee Plan is, or to the Knowledge of Korro, will be, subject to the penalties of Section&nbsp;409A(a)(1) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Korro and its Subsidiaries are, and since January&nbsp;1, 2020 have been, in material compliance in all material respects with all
applicable Laws respecting labor, employment and employment practices, including terms and conditions of employment, worker classification, tax withholding, prohibited discrimination, harassment, equal employment, fair employment practices, meal and
rest periods, immigration status, employee safety and health, wages (including overtime wages), compensation, and hours of work. There are no Legal Proceedings pending or, to the Knowledge of Korro, threatened or reasonably anticipated against Korro
or any of its Subsidiaries relating to any Korro Associate. Korro is not a party to a conciliation agreement, consent decree or other agreement or Order with any federal, state, or local agency or Governmental Authority with respect to employment
practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Korro has not taken any action which would constitute a &#147;plant closing&#148; or &#147;mass layoff&#148; within the
meaning of the WARN Act, issued any notification of a plant closing or mass layoff required by the WARN Act (nor has Korro or any of its Subsidiaries has been under any requirement or obligation to issue any such notification), or incurred any
Liability or obligation under the WARN Act that remains unsatisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) There has never been, nor to the Knowledge of Korro has there
been any threat of, any strike, slowdown, work stoppage, lockout, job action, union, organizing activity, question concerning representation or any similar activity or dispute, affecting Korro or its Subsidiaries. No event has occurred within the
past six months, and no condition or circumstance exists, that would reasonably be expected to give rise to or provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, job action, union organizing activity, question
concerning representation or any similar activity or dispute. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) There is no contract, agreement, plan or arrangement to which Korro or
any of its Subsidiaries is a party or by which it is bound to make any payment or compensate any Korro Associate for Taxes incurred pursuant to the Code, including, but not limited to, Section&nbsp;4999 or Section&nbsp;409A of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) Neither the execution and delivery of this Agreement, the shareholder approval of this
Agreement, nor the consummation of the Contemplated Transactions (either alone or in conjunction with any other event, including without limitation, a termination of employment) will result in any (i)&nbsp;payment (including severance, forgiveness
of indebtedness or otherwise) or benefit becoming due to Korro Associate, (ii)&nbsp;increase in any benefits or the compensation payable under any Korro Employee Plan, (iii)&nbsp;acceleration of the time of payment, funding or vesting of any such
compensation or benefits or any loan forgiveness, (iv)&nbsp;restriction on the right of Korro or any of its Subsidiaries or, after the consummation of Contemplated Transactions, the Surviving Corporation, to merge, amend, terminate or transfer any
Korro Employee Plan, or (v)&nbsp;&#147;excess parachute payment&#148; (within the meaning of Section&nbsp;280G of the Code). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.18
<U>Environmental Matters</U>. Since January&nbsp;1, 2020, Korro and each of its Subsidiaries has complied with all applicable Environmental Laws, which compliance includes the possession by Korro of all permits and other Governmental Authorizations
required under applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be in compliance that, individually or in the aggregate, would not result in a Korro Material Adverse Effect. Neither Korro
nor any of its Subsidiaries has received since January&nbsp;1, 2020, any written notice or other communication (in writing or otherwise), whether from a Governmental Authority, citizens group, employee or otherwise, that alleges that Korro or any of
its Subsidiaries is not in compliance with any Environmental law, and, to the Knowledge of Korro, there are no circumstances that may prevent or interfere with Korro&#146;s or any of its Subsidiaries&#146; compliance with any Environmental Law in
the future, except where such failure to comply would not reasonably be expected to have a Korro Material Adverse Effect. To the Knowledge of Korro: (a)&nbsp;no current or prior owner of any property leased or controlled by Korro or any of its
Subsidiaries has received since January&nbsp;1, 2020, any written notice or other communication relating to property owned or leased at any time by Korro or any of its Subsidiaries, whether from a Governmental Authority, citizens group, employee or
otherwise, that alleges that such current or prior owner or Korro or any of its Subsidiaries is not in compliance with or violated any Environmental Law relating to such property and (b)&nbsp;neither Korro nor any of its Subsidiaries has any
material liability under any Environmental Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.19 <U>Insurance</U>. Korro has made available to Frequency accurate and complete copies
of all material insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and operations of Korro and its Subsidiaries. Each of such insurance policies is in full force and effect and
Korro and its Subsidiaries are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications from insurance carriers, since January&nbsp;1, 2020, neither Korro nor any of its Subsidiaries has
received any notice or other communication regarding any actual or possible: (a)&nbsp;cancellation or invalidation of any insurance policy or (b)&nbsp;refusal or denial of any coverage, reservation of rights or rejection of any material claim under
any insurance policy. Each of Korro and its Subsidiaries has provided timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding pending against Korro or such Subsidiary for which Korro or such Subsidiary has insurance
coverage, and no such carrier has issued a denial of coverage or a reservation of rights with respect to any such Legal Proceeding, or informed Korro of its intent to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.20 <U>No Financial Advisors</U>. Except as set forth on <U>Section</U><U></U><U>&nbsp;3.20</U> of the Korro Disclosure Schedule, no broker,
finder or investment banker is entitled to any brokerage fee, finder&#146;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of
Korro. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.21 <U>Transactions with Affiliates</U>. <U>Section</U><U></U><U>&nbsp;3.21</U> of the
Korro Disclosure Schedule describes any material transactions or relationships, since January&nbsp;1, 2020, between, on one hand, Korro and, on the other hand, any (a)&nbsp;executive officer or director of Korro or any of such executive
officer&#146;s or director&#146;s immediate family members, (b)&nbsp;owner of more than five percent of the voting power of the outstanding shares of Korro Common Stock or (c)&nbsp;to the Knowledge of Korro, any &#147;related person&#148; (within
the meaning of Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act) of any such officer, director or owner (other than Korro) in the case of each of (a), (b) or (c)&nbsp;that is of the type that would be
required to be disclosed under Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.22
<U>Privacy and Data Security</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Korro and its Subsidiaries have complied with all applicable Privacy Laws and the applicable terms
of any Korro Contracts relating to privacy, security, collection or use of Personal Information of any individuals (including clinical trial participants, patients, patient family members, caregivers or advocates, physicians and other health care
professionals, clinical trial investigators, researchers, pharmacists) that interact with Korro or any of its Subsidiaries in connection with the operation of Korro&#146;s and its Subsidiaries&#146; business, except for such noncompliance as has not
had, and would not reasonably be expected to have, individually or in the aggregate, a Korro Material Adverse Effect. To the Knowledge of Korro, Korro has implemented and maintains reasonable written policies and procedures, satisfying the
requirements of applicable Privacy Laws, concerning the privacy, security, collection and use of Personal Information (the &#147;<B>Privacy Policies</B>&#148;) and has complied with the same, except for such noncompliance as has not to the Knowledge
of Korro had, and would not reasonably be expected to have, individually or in the aggregate, a Korro Material Adverse Effect. To the Knowledge of Korro, as of the date hereof, no claims have been asserted or threatened against Korro by any Person
alleging a violation of Privacy Laws, Privacy Policies and/or the applicable terms of any Korro Contracts relating to privacy, security, collection or use of Personal Information of any individuals. To the Knowledge of Korro, there have been no data
security incidents, personal data breaches or other adverse events or incidents related to Personal Information or Korro data in the custody or control of Korro or any service provider acting on behalf of Korro, in each case where such incident,
breach or event would result in a notification obligation to any Person under applicable law or pursuant to the terms of any Korro Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The information technology assets and equipment of Korro and its Subsidiaries (collectively, &#147;<B>Korro IT Systems</B>&#148;) are
adequate for, and operate and perform in all material respects as required in connection with the operation of the business of Korro and its Subsidiaries as currently conducted, and to the Knowledge of Korro, free and clear of all material bugs,
errors, defects, Trojan horses, time bombs, malware and other corruptants. Korro and its Subsidiaries have implemented and maintain commercially reasonable physical, technical and administrative safeguards to protect Personal Information processed
by or on behalf of Korro and its Subsidiaries, any other material confidential information and the integrity and security of Korro IT Systems used in connection with their businesses, and during the past three years, there have been no breaches,
violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or Liability or the duty to notify any other Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.23 <U>Concurrent Financing</U>.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Korro has delivered to Frequency true, correct and complete copies of all definitive agreements related to the Concurrent Financing,
including the Subscription Agreement, pursuant to which the Purchasers (as defined in the Subscription Agreement) party thereto (collectively, the &#147;<B>Purchasers</B>&#148;) have agreed, subject to the terms and conditions set forth therein, to
purchase the number of shares of Korro Common Stock set forth therein in connection with the transactions contemplated by this Agreement. The Subscription Agreement has not been amended or modified prior to the date of this Agreement and as of the
date hereof, no such amendment or modification is contemplated (other than amendments or modifications that are permitted by <U>Section</U><U></U><U>&nbsp;5.27</U>), and as of the date hereof, the respective obligations and commitments contained in
the Subscription Agreement have not been withdrawn or rescinded in any respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) As of the date hereof, the Subscription Agreement is
in full force and effect and is the legal, valid, binding and enforceable obligation of Korro, and, to the Knowledge of Korro, each of the Purchasers. There are no conditions precedent or other contingencies related to the funding of the full amount
of the Concurrent Financing, other than as expressly set forth in the Subscription Agreement. As of the date hereof, no event has occurred which, with or without notice, lapse of time or both, would reasonably be expected to constitute a default or
breach on the part of Korro or, to the Knowledge of Korro, any Purchaser under the Subscription Agreement. As of the date hereof, Korro has no reason to believe that any of the conditions to the Concurrent Financing as contemplated by the
Subscription Agreement will not be satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.24 <U>No Other Representations or Warranties</U>. Korro hereby acknowledges and agrees
that, except for the representations and warranties contained in this Agreement, neither Frequency nor any other person on behalf of Frequency makes any express or implied representation or warranty with respect to Frequency or with respect to any
other information provided to Korro, any of its stockholders or any of their respective Affiliates in connection with the Contemplated Transactions, and (subject to the express representations and warranties of Frequency set forth in <U>Article
IV</U> (in each case as qualified and limited by the Frequency Disclosure Schedule)) none of Korro, or any of its Representatives or stockholders, has relied on any such information (including the accuracy or completeness thereof). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF FREQUENCY AND MERGER SUB </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except (i)&nbsp;as set forth in the written disclosure schedule delivered by Frequency to Korro (the &#147;<B>Frequency Disclosure
Schedule</B>&#148;)<B> </B>or (ii)&nbsp;a<B>s </B>disclosed in the Frequency SEC<B> </B>Documents filed with the SEC on or before the day that is one (1)&nbsp;Business Day prior to the date hereof and publicly available on the SEC&#146;s Electronic
Data Gathering Analysis and Retrieval system (but (A)&nbsp;without giving effect to any amendment thereof filed with, or furnished to the SEC on or after the date hereof and (B)&nbsp;excluding any disclosures contained under the heading &#147;Risk
Factors&#148; and any disclosure of risks included in any &#147;forward-looking statements&#148; disclaimer or in any other section to the extent they are forward-looking statements or cautionary, predictive or forward-looking in nature), it being
understood that any matter disclosed in the Frequency SEC Documents shall not be deemed disclosed for purposes of <U>Sections</U><U></U><U>&nbsp;4.1(a)</U>, <U>4.1(b)</U> or <U>4.3</U>, Frequency and Merger Sub represent and warrant to Korro as
follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Due Organization; Subsidiaries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each of Frequency and its Subsidiaries (including Merger Sub) is a corporation or other legal entity duly incorporated or otherwise
organized, validly existing and in good standing under the Laws of the jurisdiction of its incorporation or organization and has all necessary power and authority: (i)&nbsp;to conduct its business in the manner in which its business is currently
being conducted, (ii)&nbsp;to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used and (iii)&nbsp;to perform its obligations under all Contracts by which it is bound.
Since the date of its formation, Merger Sub has not engaged in any activities other than in connection with or as contemplated by this Agreement. All of Frequency&#146;s Subsidiaries are wholly owned by Frequency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of Frequency and its Subsidiaries is licensed and qualified to do business, and is in good standing (to the extent applicable in such
jurisdiction), under the Laws of all jurisdictions where the nature of its business in the manner in which its business is currently being conducted requires such licensing or qualification other than in jurisdictions where the failure to be so
qualified individually or in the aggregate would not be reasonably expected to have a Frequency Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as
set forth on <U>Section</U><U></U><U>&nbsp;4.1(c)</U> of the Frequency Disclosure Schedule, Frequency has no Subsidiaries other than Merger Sub and Frequency does not directly or indirectly own any capital stock of, or any equity ownership or profit
sharing interest of any nature in, or control directly or indirectly, any other Entity other than Merger Sub. Frequency is not and has not otherwise been, directly or indirectly, a party to, member of or participant in any partnership, joint venture
or similar business entity. Frequency has not agreed and is not obligated to make, nor is Frequency bound by any Contract under which it may become obligated to make, any future investment in or capital contribution to any other Entity. Frequency
has not, at any time, been a general partner of, and has not otherwise been liable for any of the debts or other obligations of, any general partnership, limited partnership or other Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Organizational Documents</U>. Frequency has delivered to Korro accurate and complete copies of the Organizational Documents of
Frequency and Merger Sub. Neither Frequency nor Merger Sub is in breach or violation of its Organizational Documents in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Authority; Binding Nature of Agreement</U>. Each of Frequency and Merger Sub has all necessary corporate power and authority to enter
into and to perform its obligations under this Agreement and to consummate the Contemplated Transactions. The Frequency Board (at meetings duly called and held) has: (a)&nbsp;determined that the Contemplated Transactions are fair to, advisable and
in the best interests of Frequency and its stockholders, (b)&nbsp;approved and declared advisable this Agreement and the Contemplated Transactions, including the issuance of shares of Frequency Capital Stock to the stockholders of Korro pursuant to
the terms of this Agreement, (c)&nbsp;determined to recommend the Frequency Board Recommendation to the stockholders of Frequency, and (d) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determined to approve and recommend the forms of the Charter Amendment Proposals to the stockholders of Frequency as promptly as practicable after the forms thereof are mutually agreed to by
Frequency and Korro. The Merger Sub Board (by unanimous written consent) has: (x)&nbsp;determined that the Contemplated Transactions are fair to, advisable, and in the best interests of Merger Sub and its sole stockholder, (y)&nbsp;deemed advisable
and approved this Agreement and the Contemplated Transactions and (z)&nbsp;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholder of Merger Sub vote to adopt this Agreement and thereby
approve the Contemplated Transactions. This Agreement has been duly executed and delivered by Frequency and Merger Sub and, assuming the due authorization, execution and delivery by Korro, constitutes the legal, valid and binding obligation of
Frequency and Merger Sub, enforceable against each of Frequency and Merger Sub in accordance with its terms, subject to the Enforceability Exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Vote Required</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
The affirmative vote of a majority of the votes cast at the Frequency Stockholder Meeting (at which quorum is present) is the only vote of the holders of any class or series of Frequency Capital Stock necessary to approve this Agreement and the
Contemplated Transactions, including the issuance of the shares of Frequency Common Stock to the stockholders of Korro in the Merger pursuant to the terms of this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) (i) If the Frequency Stockholder Meeting occurs after the Delaware Law Amendment Approval is obtained, the only vote of the holders of any
class or series of Frequency Capital Stock necessary to approve an amendment to Frequency&#146;s certificate of incorporation to effect the Charter Amendment Proposals is a vote at the Frequency Stockholder Meeting (at which quorum is present) in
which the number of votes cast in favor of the Charter Amendment Proposals exceeds the number of votes cast against the Charter Amendment Proposals; or (ii)&nbsp;if the Delaware Law Amendment Approval is not obtained, the affirmative vote in favor
of the Charter Amendment Proposals of a majority of the outstanding shares of Frequency Common Stock entitled to vote thereon is the only vote of the holders of any class or series of Frequency Capital Stock necessary to approve an amendment to
Frequency&#146;s certificate of incorporation to affect the Charter Amendment Proposals (together with clause (a), the &#147;<B>Required Frequency Stockholder Vote</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT> Consents</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to obtaining the Required Frequency Stockholder Vote and the filing of the Certificate of Merger required by Delaware Law, neither
(x)&nbsp;the execution, delivery or performance of this Agreement by Frequency or Merger Sub, nor (y)&nbsp;the consummation of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) contravene, conflict with or result in a violation of any of the provisions of the Organizational Documents of Frequency or
its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) contravene, conflict with or result in a material violation of, or give any Governmental Authority
or other Person the right to challenge the Contemplated Transactions or to exercise any remedy or obtain any relief under, any Law or any Order to which Frequency or its Subsidiaries, or any of the assets owned or used by Frequency or its
Subsidiaries, is subject; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) contravene, conflict with or result in a material violation of any of
the terms or requirements of, or give any Governmental Authority the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by Frequency or its Subsidiaries or that otherwise relates to the
business of Frequency, or any of the assets owned, leased or used by Frequency; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) contravene, conflict with or result
in a violation or breach of, or result in a default under, any provision of any Frequency Material Contract, or give any Person the right to: (A)&nbsp;declare a default or exercise any remedy under any Frequency Material Contract, (B)&nbsp;any
material payment, rebate, chargeback, penalty or change in delivery schedule under any such Frequency Material Contract, (C)&nbsp;accelerate the maturity or performance of any Frequency Material Contract or (D)&nbsp;cancel, terminate or modify any
term of any Frequency Material Contract, except in the case of any nonmaterial breach, default, penalty or modification; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) result in the imposition or creation of any Encumbrance upon or with respect to any asset owned or used by Frequency or its
Subsidiaries (except for Permitted Encumbrances). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except for (i)&nbsp;any Consent set forth on <U>Section</U><U></U><U>&nbsp;4.5</U>
of the Frequency Disclosure Schedule under any Frequency Contract, (ii)&nbsp;the Required Frequency Stockholder Vote, (iii)&nbsp;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to Delaware Law
and (iv)&nbsp;such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal and state securities laws, neither Frequency nor any of its Subsidiaries was, is or will be
required to make any filing with or give any notice to, or to obtain any Consent from, any Person in connection with (x)&nbsp;the execution, delivery or performance of this Agreement or (y)&nbsp;the consummation of the Contemplated Transactions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Frequency Board and the Merger Sub Board have taken and will take all actions necessary to ensure that the restrictions
applicable to business combinations contained in Section&nbsp;203 of Delaware Law are, and will be, inapplicable to the execution, delivery and performance of this Agreement and to the consummation of the Contemplated Transactions. No other state
takeover statute or similar Law applies or purports to apply to the Merger, this Agreement or any of the other Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <U>Capitalization</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
The authorized capital stock of Frequency consists of (i) 200,000,000 shares of common stock, par value $0.001 per share (&#147;<B>Frequency Common Stock</B>&#148;), of which 36,926,285 shares have been issued and are outstanding as of July&nbsp;12,
2023 and (ii)&nbsp;10,000,000 shares of preferred stock, par value $0.001 per share (&#147;<B>Frequency Preferred Stock</B>&#148;), of which no shares have been issued and are outstanding as of July&nbsp;12, 2023. Frequency does not hold any shares
of its capital stock in its treasury. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) All of the outstanding shares of Frequency Common Stock have been duly authorized and
validly issued, and are fully paid and nonassessable and are free of any Encumbrances other than under applicable securities Laws. None of the outstanding shares of Frequency Common Stock is entitled or subject to any preemptive right, right of
participation, right of maintenance or any similar right and none of the outstanding shares of Frequency Common Stock is subject to any right of first refusal in favor of Frequency. Except as contemplated herein, there is no Frequency Contract
relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of Frequency Common Stock. Frequency is not under
any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of Frequency Common Stock or other securities. <U>Section</U><U></U><U>&nbsp;4.6(b)</U> of
the Frequency Disclosure Schedule accurately and completely lists all repurchase rights held by Frequency with respect to shares of Frequency Common Stock (including shares issued pursuant to the exercise of options) and specifies which of those
repurchase rights are currently exercisable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Section </U><U>4.6(c)</U> of the Frequency Disclosure Schedule sets forth a true and
complete list, as of July&nbsp;12, 2023, of each outstanding Frequency Option and Frequency Restricted Stock Unit award, including: (i)&nbsp;the name (or employee identification number) of the holder, (ii)&nbsp;the number of shares of Frequency
Common Stock subject to such Frequency Option and/or Frequency Restricted Stock Units, (iii)&nbsp;the exercise price of each Frequency Option, (iv)&nbsp;the date of grant, (v)&nbsp;the applicable vesting schedule, including any acceleration
provisions and the number of vested and unvested shares (and, if applicable, assuming achievement of the applicable performance metrics), (vi) the expiration date, as applicable, and (vii)&nbsp;whether the Frequency Option is intended to be an
&#147;incentive stock option&#148; (as defined in the Code) or a <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option. Frequency has made available to Korro accurate and complete copies of the following (except for such documents that
are filed as an exhibit to a Frequency SEC Document): (A) the standard form of agreement evidencing Frequency Options and Frequency Restricted Stock Unit awards; and (B)&nbsp;each agreement evidencing a Frequency Option or Frequency Restricted Stock
Unit award that does not conform in all material respects to the standard form agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Except as set forth on
<U>Section</U><U></U><U>&nbsp;4.6(c)</U> of the Frequency Disclosure Schedule, there is no: (i)&nbsp;outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares of the capital stock or other
securities of Frequency, (ii)&nbsp;outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of Frequency, (iii)&nbsp;stockholder rights plan (or
similar plan commonly referred to as a &#147;poison pill&#148;) or Contract under which Frequency is or may become obligated to sell or otherwise issue any shares of its capital stock or any other securities or (iv)&nbsp;condition or circumstance
that may give rise to or provide a basis for the assertion of a claim by any Person to the effect that such Person is entitled to acquire or receive any shares of capital stock or other securities of Frequency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) All outstanding shares of Frequency Common Stock and other securities of Frequency have been issued and granted in material compliance
with (i)&nbsp;all applicable securities laws and other applicable Law and (ii)&nbsp;all requirements set forth in applicable Contracts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.7 <U>SEC Filings; Financial Statements</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Frequency has filed or furnished, as applicable, on a timely basis all forms, statements, certifications, reports and documents required
to be filed or furnished by it with the SEC under the Exchange Act or the Securities Act since January&nbsp;1, 2020 (the &#147;<B>Frequency SEC </B><B>Documents</B>&#148;). As of the time it was filed with the SEC (or, if amended or superseded by a
filing prior to the date of this Agreement, then on the date of such filing), each of the Frequency SEC Documents complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act (as the case may be) and
as of the time they were filed, none of the Frequency SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. The certifications and statements required by (i)&nbsp;Rule <FONT STYLE="white-space:nowrap">13a-14</FONT> under the Exchange Act and (ii) 18 U.S.C. &#167;1350 (Section 906 of the
Sarbanes-Oxley Act) relating to the Frequency SEC Documents (collectively, the &#147;<B>Frequency Certifications</B>&#148;) are accurate and complete and comply as to form and content with all applicable Laws. As used in this
<U>Section</U><U></U><U>&nbsp;4.7</U>, the term &#147;file&#148; and variations thereof shall be broadly construed to include any manner in which a document or information is furnished, supplied or otherwise made available to the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The financial statements (including any related notes) contained or incorporated by reference in the Frequency SEC Documents:
(i)&nbsp;complied as to form in all material respects with the Securities Act and the Exchange Act, as applicable, and the published rules and regulations of the SEC applicable thereto, (ii)&nbsp;were prepared in accordance with GAAP (except as may
be indicated in the notes to such financial statements or, in the case of unaudited financial statements, as permitted by Form <FONT STYLE="white-space:nowrap">10-Q</FONT> of the SEC, and except that the unaudited financial statements may not
contain footnotes and are subject to normal and recurring <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments that are not reasonably expected to be material in amount) applied on a consistent basis unless otherwise noted therein throughout
the periods indicated and (iii)&nbsp;fairly present, in all material respects, the financial position of Frequency as of the respective dates thereof and the results of operations and cash flows of Frequency for the periods covered thereby. Other
than as expressly disclosed in the Frequency SEC Documents filed prior to the date hereof, there has been no material change in Frequency&#146;s accounting methods or principles that would be required to be disclosed in Frequency&#146;s financial
statements in accordance with GAAP. The books of account and other financial records of Frequency and each of its Subsidiaries are true and complete in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Frequency&#146;s auditor has at all times since the date of enactment of the Sarbanes-Oxley Act been: (i)&nbsp;a registered public
accounting firm (as defined in Section&nbsp;2(a)(12) of the <FONT STYLE="white-space:nowrap">Sarbanes-Oxley</FONT> Act), (ii) to the Knowledge of Frequency, &#147;independent&#148; with respect to Frequency within the meaning of Regulation <FONT
STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act and (iii)&nbsp;to the Knowledge of Frequency, in compliance with subsections (g)&nbsp;through (l) of Section&nbsp;10A of the Exchange Act and the rules and regulations promulgated by the
SEC and the Public Company Accounting Oversight Board thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Except as set forth on <U>Section</U><U></U><U>&nbsp;4.7(d)</U> of
the Frequency Disclosure Schedule, Frequency has not received any comment letter from the SEC or the staff thereof or any correspondence from Nasdaq or the staff thereof relating to the delisting or maintenance of listing of Frequency Common Stock
on Nasdaq. Frequency has not disclosed any unresolved comments in the Frequency SEC Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) There have been no formal internal investigations regarding financial reporting or
accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer, or general counsel of Frequency, the Frequency Board or any committee thereof, other than ordinary
course audits or reviews of accounting policies and practices or internal controls required by the Sarbanes-Oxley Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Except as set
forth on <U>Section</U><U></U><U>&nbsp;4.7(f)</U> of the Frequency Disclosure Schedule, Frequency is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act, the Exchange Act and the applicable listing and
governance rules and regulations of Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Frequency maintains a system of internal control over financial reporting (as defined in
Rules <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> and <FONT STYLE="white-space:nowrap">15d-l5(f)</FONT> of the Exchange Act) that is sufficient to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance (i)&nbsp;that Frequency maintains records that in reasonable detail accurately and fairly
reflect Frequency&#146;s transactions and dispositions of assets, (ii)&nbsp;that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, (iii)&nbsp;that receipts and expenditures are made only in
accordance with authorizations of management and the Frequency Board and (iv)&nbsp;regarding prevention or timely detection of the unauthorized acquisition, use or disposition of Frequency&#146;s assets that could have a material effect on
Frequency&#146;s financial statements. Frequency has evaluated the effectiveness of Frequency&#146;s internal control over financial reporting and, to the extent required by applicable Law, presented in any applicable Frequency SEC Document that is
a report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> or Form <FONT STYLE="white-space:nowrap">10-Q</FONT> (or any amendment thereto) its conclusions about the effectiveness of the internal control over financial reporting as of the end of
the period covered by such report or amendment based on such evaluation. Frequency has disclosed to Frequency&#146;s auditors and the Audit Committee of the Frequency Board (and made available to Frequency a summary of the significant aspects of
such disclosure)&nbsp;(A) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect Frequency&#146;s ability to record, process,
summarize and report financial information and (B)&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant role in Frequency or its Subsidiaries&#146; internal control over financial reporting.
Except as disclosed in the Frequency SEC Documents filed prior to the date hereof, Frequency&#146;s internal control over financial reporting is effective and Frequency has not identified any material weaknesses in the design or operation of
Frequency&#146;s internal control over financial reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Frequency&#146;s &#147;disclosure controls and procedures&#148; (as
defined in Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e)</FONT> of the Exchange Act) are designed to ensure that all information (both financial and nonfinancial) required to be disclosed by
Frequency in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such information is accumulated and
communicated to Frequency&#146;s principal executive officer and principal financial officer as appropriate to allow timely decisions regarding required disclosure and to make the Frequency Certifications and such disclosure controls and procedures
are effective. Frequency has carried out evaluation of the effectiveness of its disclosure controls and procedures as required by Rule <FONT STYLE="white-space:nowrap">13a-l5</FONT> of the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Frequency has not been and is not currently a &#147;shell company&#148; as defined under
<FONT STYLE="white-space:nowrap">Section&nbsp;12b-2</FONT> of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.8 <U>Absence of Changes</U>. Except as set forth on
<U>Section</U><U></U><U>&nbsp;4.8</U> of the Frequency Disclosure Schedule, since January&nbsp;1, 2023, Frequency and its Subsidiaries have conducted its business only in the Ordinary Course of Business (except for the execution and performance of
this Agreement and the discussions, negotiations and transactions related thereto) and there has not been any (a)&nbsp;Frequency Material Adverse Effect or (b)&nbsp;action, event or occurrence that would have required consent of Frequency pursuant
to <U>Section</U><U></U><U>&nbsp;5.2</U> of this Agreement had such action, event or occurrence taken place after the execution and delivery of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.9 <U>Absence of Undisclosed Liabilities</U>. Neither Frequency nor any of its Subsidiaries has any Liability of a type required to be
reflected or reserved for on a balance sheet prepared in accordance with GAAP, except for: (a)&nbsp;Liabilities disclosed, reflected or reserved against in the Frequency Balance Sheet, (b)&nbsp;normal and recurring current Liabilities that have been
incurred by Frequency or its Subsidiaries since the date of the Frequency Balance Sheet in the Ordinary Course of Business (none of which relates to any breach of contract, breach of warranty, tort, infringement, or violation of Law), (c)
Liabilities for performance of obligations of Frequency or any of its Subsidiaries under Frequency Contracts, (d)&nbsp;Liabilities incurred in connection with the Contemplated Transactions and the Subscription Agreement and (e)&nbsp;Liabilities
listed in <U>Section</U><U></U><U>&nbsp;4.9</U> of the Frequency Disclosure Schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.10 <U>Title to Assets</U>. Each of Frequency and
its Subsidiaries owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or tangible assets and equipment used or held for use in its business or operations or
purported to be owned by it, including: (a)&nbsp;all tangible assets reflected on the Frequency Balance Sheet and (b)&nbsp;all other tangible assets reflected in the books and records of Frequency as being owned by Frequency. All of such assets are
owned or, in the case of leased assets, leased by Frequency or any of its Subsidiaries free and clear of any Encumbrances, other than Permitted Encumbrances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.11 <U>Real Property; Leasehold</U>. Neither Frequency nor any of its Subsidiaries owns or has ever owned any real property. Frequency has
made available to Korro (a)&nbsp;an accurate and complete list of all real properties with respect to which Frequency directly or indirectly holds a valid leasehold interest as well as any other real estate that is in the possession of or leased by
Frequency or any of its Subsidiaries and (b)&nbsp;copies of all leases under which any such real property is possessed (the &#147;<B>Frequency Real Estate Leases</B>&#148;), each of which is in full force and effect, with no existing material
default thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.12 <U>Intellectual Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Section </U><U>4.12(a)</U> of the Frequency Disclosure Schedule is an accurate, true and complete listing of all Frequency Registered
IP including for each item (i)&nbsp;the record owner (and name of any other Person with an ownership interest in such item of Frequency Registered IP, if any), jurisdiction (or, with respect to domain names, the applicable registrar), status, date
and registration or application number of each item, as applicable, (ii)&nbsp;the name of the record owner and any other Person that has an ownership interest in such item of Frequency Registered IP, and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the nature of such ownership interest, and (iii)&nbsp;to the Knowledge of Frequency, any actions that are required to be taken within 180 days of the Closing Date, including the payment of any
registration, maintenance or renewal fees or the filing of or response to any documents, applications or certificates, for the purposes of prosecuting, obtaining, perfecting, maintaining or renewing any Frequency Registered IP.
<U>Section</U><U></U><U>&nbsp;4.12(a)</U> of the Frequency Disclosure Schedule also sets forth, as of the date of this Agreement, a list of all internet domain names with respect to which Frequency or any of its Subsidiaries are the registrant and,
with respect to each domain name, the record owner of such domain name and if different, the legal and beneficial owner(s) of such domain name and the applicable domain name registrar. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Section </U><U>4.12(b)</U> of the Frequency Disclosure Schedule accurately identifies (i)&nbsp;all Frequency Contracts pursuant to
which any Frequency IP Rights are licensed to Frequency (other than (A)&nbsp;any <FONT STYLE="white-space:nowrap">non-customized</FONT> software that (1)&nbsp;is so licensed solely in executable or object code form pursuant to a nonexclusive,
internal use software license and other Intellectual Property associated with such software and (2)&nbsp;is not incorporated into, or material to the development, manufacturing, or distribution of, any of Frequency&#146;s or any of its
Subsidiaries&#146; products or services, (B)&nbsp;any Intellectual Property licensed on a nonexclusive basis ancillary to the purchase or use of equipment, reagents or other materials, (C)&nbsp;any confidential information provided under
confidentiality agreements and (D)&nbsp;agreements between Frequency or its Subsidiaries and their respective employees in Frequency&#146;s standard form thereof) and (ii)&nbsp;whether the license or licenses granted to Frequency are exclusive or
nonexclusive. Each Frequency Contract listed in <U>Section</U><U></U><U>&nbsp;4.12(b) </U>of the Frequency Disclosure Schedule is in full force and effect and constitutes a legal, valid, and binding obligation of Frequency, its Subsidiaries and each
other party thereto, and is enforceable against Frequency, its Subsidiaries and each other party thereto in accordance with its terms. Neither Frequency, its Subsidiaries, nor, to the Knowledge of Frequency, any other party to any Frequency Contract
listed in <U>Section</U><U></U><U>&nbsp;4.12(b)</U> of the Frequency Disclosure Schedule has been or is, or has been or is alleged to be, in material default under, or has provided or received any notice of, breach under, or intention to terminate
(including by <FONT STYLE="white-space:nowrap">non-renewal),</FONT> any Frequency Contract listed in <U>Section</U><U></U><U>&nbsp;4.12(b)</U> of the Frequency Disclosure Schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except for instances that would not reasonably be expected to have, individually or in the aggregate, a Frequency Material Adverse Effect,
<U>Section</U><U></U><U>&nbsp;4.12(c)</U> of the Frequency Disclosure Schedule accurately identifies each Frequency Contract pursuant to which any Person has been granted any license under, or otherwise has received or acquired any right (whether or
not currently exercisable) or interest in, any Frequency IP Rights (other than (i)&nbsp;any confidential information provided under confidentiality agreements and (ii)&nbsp;any Frequency IP Rights nonexclusively licensed to academic collaborators,
suppliers or service providers for the sole purpose of enabling such academic collaborator, supplier or service providers to provide services for Frequency&#146;s or its Subsidiaries&#146; benefit). Each Frequency Contract listed in
<U>Section</U><U></U><U>&nbsp;4.12(c)</U> of the Frequency Disclosure Schedule is in full force and effect and constitutes a legal, valid, and binding obligation of Frequency, its Subsidiaries and each other party thereto, and is enforceable against
Frequency, its Subsidiaries and each other party thereto in accordance with its terms. Neither Frequency, its Subsidiaries nor, to the Knowledge of Frequency, any other party to any Frequency Contract listed in
<U>Section</U><U></U><U>&nbsp;4.12(c)</U> of the Frequency Disclosure Schedule has been or is, or has been or is alleged to be, in material default under, or has provided or received any notice of, breach under, or intention to terminate (including
by <FONT STYLE="white-space:nowrap">non-renewal),</FONT> any Frequency Contract listed in <U>Section</U><U></U><U>&nbsp;4.12(c)</U> of the Frequency Disclosure Schedule. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Except as identified on <U>Section</U><U></U><U>&nbsp;4.12(d)</U> of the Frequency
Disclosure Schedule, neither Frequency nor any of its Subsidiaries is bound by, and no Frequency IP Rights are subject to, any Contract containing any covenant or other provision that in any way limits or restricts the ability of Frequency or any of
its Subsidiaries to use, exploit, assert, or enforce any Frequency IP Rights anywhere in the world. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Frequency or one of its
Subsidiaries exclusively owns all right, title, and interest to and in the Frequency IP Rights (other than (i)&nbsp;Frequency IP Rights licensed to Frequency, or <FONT STYLE="white-space:nowrap">co-owned</FONT> rights each as identified in
<U>Section</U><U></U><U>&nbsp;4.12(c)</U> of the Frequency Disclosure Schedule, (ii)&nbsp;Frequency IP Rights that Frequency intends to abandon as identified in <U>Section</U><U></U><U>&nbsp;4.12(a)</U> of the Frequency Disclosure Schedule,
(iii)&nbsp;any <FONT STYLE="white-space:nowrap">non-customized</FONT> software that (A)&nbsp;is licensed to Frequency or its Subsidiaries solely in executable or object code form pursuant to a nonexclusive, internal use software license and other
Intellectual Property associated with such software and (B)&nbsp;is not incorporated into, or material to the development, manufacturing, or distribution of, any of Frequency or its Subsidiaries&#146; products or services and (iv)&nbsp;any
Intellectual Property licensed on a nonexclusive basis ancillary to the purchase or use of equipment, reagents or other materials), in each case, free and clear of any Encumbrances (other than Permitted Encumbrances). Without limiting the generality
of the foregoing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To the Knowledge of Frequency, all documents and instruments necessary to register or apply for or
renew registration of Frequency Registered IP have been validly executed, delivered, and filed in a timely manner with the appropriate Governmental Authority. To the Knowledge of Frequency, Frequency has filed all statements of use and paid all
renewal and maintenance fees, annuities and other fees with respect to the Frequency Registered IP that are due or payable as of the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Except for instances that would not reasonably be expected to have, individually or in the aggregate, a Frequency
Material Adverse Effect, each Person who is or was an employee, contractor or consultant of Frequency or any of its Subsidiaries and who is or was involved in the creation, discovery, reduction to practice or development of any Intellectual Property
for Frequency or any of its Subsidiaries has signed a valid, enforceable written agreement containing a present assignment of all right, title and interest in and to such Intellectual Property to Frequency or such Subsidiary and confidentiality
provisions protecting trade secrets and confidential information of Frequency and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To the
Knowledge of Frequency, no current or former member, officer, director, or employee of Frequency or any of its Subsidiaries has any claim, right (whether or not currently exercisable), or interest to or in any Frequency IP Rights purported to be
owned by Frequency. To the Knowledge of Frequency, no employee of Frequency or any of its Subsidiaries is (A)&nbsp;bound by or otherwise subject to any Contract restricting him or her from performing his or her duties for Frequency or such
Subsidiary or (B)&nbsp;in breach of any Contract with any former employer or other Person concerning Frequency IP Rights purported to be owned by Frequency or such Subsidiary or confidentiality provisions protecting trade secrets and confidential
information comprising Frequency IP Rights purported to be owned by Frequency or such Subsidiary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) No funding, facilities, or personnel of any Governmental Authority were
used, directly or indirectly, to develop or create, in whole or in part, any Frequency IP Rights in which Frequency or any of its Subsidiaries has an ownership interest, and no educational institution has any right to, or right to royalties for, or
to impose any requirement on the manufacture or commercialization of any product incorporating, any Frequency IP Rights. No Governmental Authority has any right to (including any <FONT STYLE="white-space:nowrap">&#147;step-in&#148;</FONT> or <FONT
STYLE="white-space:nowrap">&#147;march-in&#148;</FONT> rights with respect to), ownership of, commercialization of, or right to royalties or other payments for any Frequency IP Rights. Without limiting the generality of the foregoing, no invention
claimed or covered by any Patent within the Frequency IP Rights (A)&nbsp;was conceived or reduced to practice in connection with any research activities funded, in whole or in part, by the federal government of the United States or any agency
thereof, (B)&nbsp;is a &#147;subject invention&#148; as that term is described in 35 U.S.C. Section&nbsp;201(e), or (C)&nbsp;is otherwise subject to the provisions of the Bayh-Dole Act or any similar Law of any other jurisdiction, including with
respect to any Patents that are part of the Frequency IP Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) Frequency and each of its Subsidiaries has taken
reasonable steps to maintain the confidentiality of and otherwise protect, maintain and enforce its rights in all proprietary information that Frequency or such Subsidiary holds, or purports to hold, as confidential or a trade secret. To the
Knowledge of Frequency, neither Frequency nor any of its Subsidiaries has made any of its trade secrets or other material confidential or proprietary information that it intended to maintain as confidential information available to any other Person
except pursuant to written agreements requiring such Person to maintain the confidentiality of such trade secrets or confidential information. To the Knowledge of Frequency, there have been no material security breaches, outages, violations or
unauthorized access to any of the proprietary information that Frequency or any of its Subsidiaries holds, or purports to hold, as confidential or a trade secret. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) Neither Frequency nor any of its Subsidiaries has assigned or otherwise transferred ownership of, or agreed to assign or
otherwise transfer ownership of, any Frequency IP Rights to any other Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) To the Knowledge of Frequency,
neither Frequency nor any of its Subsidiaries has taken or failed to take any action that could be reasonably expected to result in the abandonment, invalidity, cancellation, forfeiture, relinquishing, invalidation or unenforceability of any
Frequency IP Rights (including with respect to any trademark, a failure to exercise adequate quality controls or an assignment in gross without the accompanying goodwill). Each item of Frequency IP Right has been duly maintained and is not expired,
abandoned or cancelled. To the Knowledge of Frequency, each of the Patents included in the Frequency IP Rights identifies each and every inventor of the claims thereof as determined in accordance with the applicable laws of the jurisdiction in which
such Patent is issued or pending. To the Knowledge of Frequency, neither Frequency nor any of its Subsidiaries has engaged in patent or copyright misuse or any fraud or inequitable conduct in connection with any Frequency IP Right. To the Knowledge
of Frequency, each of Frequency and its Subsidiaries and their respective patent counsel have complied with its duty of candor and disclosure and have made no material misrepresentations in the filings submitted to the applicable Governmental
Authorities with respect to all Patents included in the Frequency IP Rights for which Frequency or any of its Subsidiaries is responsible for prosecuting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) To the Knowledge of Frequency, the Frequency IP Rights constitute all
Intellectual Property necessary for Frequency to conduct its business as currently conducted or proposed to be conducted; <U>provided</U>, <U>however</U>, that the foregoing representation is not a representation with respect to <FONT
STYLE="white-space:nowrap">non-infringement</FONT> of Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Frequency has delivered, or made available to Korro, a
complete and accurate copy of all material Frequency IP Rights Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) To the Knowledge of Frequency, the manufacture, marketing,
offering for sale, sale, importation, use or intended use or other disposal of any product as currently sold or under development by Frequency does not violate any license or agreement between Frequency or its Subsidiaries and any third party in any
material respect, and, to the Knowledge of Frequency, does not infringe or misappropriate any valid and issued Patent right or other Intellectual Property of any other Person, which infringement or misappropriation would reasonably be expected to
have a Frequency Material Adverse Effect. To the Knowledge of Frequency, no third party is infringing upon any Patents owned by Frequency within the Frequency IP Rights, or otherwise violating any Frequency IP Rights Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) As of the date of this Agreement, neither Frequency nor any of its Subsidiaries is a party to any Legal Proceeding (including, but not
limited to, opposition, interference or other proceeding in any patent or other government office) contesting the validity, ownership or right to use, sell, offer for sale, license or dispose of any Frequency IP Rights. To the Knowledge of
Frequency, none of the Frequency IP Rights have been adjudged invalid or unenforceable in whole or part, and all Frequency IP Rights are in full force and effect. None of the Frequency IP Rights have been subject to any interference, derivation,
reexamination (including ex parte reexamination, inter partes reexamination, inter partes review, or post grant review), reissue, cancellation, opposition, claim, allegation or other action, including any proceeding in which the scope, validity,
inventorship, ownership or enforceability of any Frequency IP Rights is being, has been, or could reasonably be expected to be, contested or challenged. Neither Frequency nor any of its Subsidiaries received any written notice asserting that any
Frequency IP Rights or the proposed use, sale, offer for sale, license or disposition of products, methods, or processes claimed or covered thereunder infringes or misappropriates or violates the rights of any other Person or that Frequency or any
of its Subsidiaries have otherwise infringed, misappropriated or otherwise violated any Intellectual Property of any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To the
Knowledge of Frequency, no trademark (whether registered or unregistered) or trade name owned, used, or applied for by Frequency conflicts or interferes with any trademark (whether registered or unregistered) or trade name owned, used, or applied
for by any other Person except as would not have a Frequency Material Adverse Effect. None of the goodwill associated with or inherent in any trademark (whether registered or unregistered) in which Frequency or its Subsidiaries has or purports to
have an ownership interest has been impaired as determined by Frequency in accordance with GAAP. <U>Section</U><U></U><U>&nbsp;4.12(i)</U> of the Frequency Disclosure Schedule sets forth all material unregistered trademarks included in the Frequency
IP Rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Except (i)&nbsp;as would reasonably be expected to have a Frequency Material Adverse
Effect, (ii)&nbsp;as may be set forth in <U>Section</U><U></U><U>&nbsp;4.12(b)</U> or <U>4.12(c)</U><B> </B>of the Frequency Disclosure Schedule or as contained in license, distribution or service agreements entered into in the Ordinary Course of
Business by Frequency (A)&nbsp;neither Frequency nor any of its Subsidiaries is bound by any Contract to indemnify, defend, hold harmless, or reimburse any other Person with respect to any Intellectual Property infringement, misappropriation, or
similar claim which is material to Frequency or any of its Subsidiaries, taken as a whole and (B)&nbsp;neither Frequency nor any of its Subsidiaries has ever assumed, or agreed to discharge or otherwise take responsibility for, any existing or
potential liability of another Person for infringement, misappropriation, or violation of any Intellectual Property right, which assumption, agreement or responsibility remains in force as of the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Neither Frequency nor any of its Subsidiaries is party to any Contract that, as a result of such execution, delivery and performance of
this Agreement, will (i)&nbsp;cause the grant, assignment or transfer to any other third party of any license or other right to or in any Frequency IP Rights, (ii)&nbsp;result in breach of, default under termination of, or acceleration or
modification of such Contract with respect to any Frequency IP Rights, (iii)&nbsp;alter, encumber, impair or extinguish, or result in any Encumbrance with respect to, the right of Frequency or the Surviving Corporation and its Subsidiaries to use,
sell or license or enforce any Frequency IP Rights or portion thereof or (iv)&nbsp;result in Frequency or any of its Subsidiaries being bound by or subject to any exclusivity obligations, <FONT STYLE="white-space:nowrap">non-compete</FONT> or other
restrictions on the operation or scope of their respective businesses, or to any obligation to grant any rights in or to any Frequency IP Rights, except, in each of (i), (ii), (iii) and (iv), for the occurrence of any such grant or impairment that
would not individually or in the aggregate, reasonably be expected to result in a Frequency Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.13
<U>Agreements</U><U>, Contracts and Commitments</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Section </U><U>4.13</U> of the Frequency Disclosure Schedule lists the
following Frequency Contracts in effect as of the date of this Agreement other than the Subscription Agreement (each, a &#147;<B>Frequency Material Contract</B>&#148;<B> </B>and collectively, the &#147;<B>Frequency Material Contracts</B>&#148;):
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) each Frequency Contract that is a collective bargaining agreement or other agreement or arrangement with any labor
union, works council or labor organization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) each Frequency Contract for the employment or engagement of any
individual on an employee, consulting or other basis that provides for annual base compensation in excess of $350,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) each Frequency Contract with any Frequency Associate that provides for retention, change in control, transaction or
other similar payments or benefits, whether or not payable as a result of the Contemplated Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) each
Frequency Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) each Frequency Contract containing (A)&nbsp;any covenant limiting the freedom of Frequency or any of its Subsidiaries to
engage in any line of business or compete with any Person, or limiting the development, manufacture, or distribution of Frequency&#146;s products or services, (B)&nbsp;any most-favored pricing arrangement, (C)&nbsp;any exclusivity provision or
(D)&nbsp;any <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provision; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) each Frequency Contract (A)&nbsp;pursuant to which any Person granted
Frequency an exclusive license under any Intellectual Property, or (B)&nbsp;pursuant to which Frequency granted any Person an exclusive license under any Frequency IP Rights; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) each Frequency Contract relating to capital expenditures and requiring payments after the date of this Agreement in
excess of $100,000 pursuant to its express terms and not cancelable without penalty; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) each Frequency Contract
relating to the disposition or acquisition of material assets or any ownership interest in any Entity, in each case, involving payments in excess of $100,000 after the date of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) each Frequency Contract relating to any mortgages, indentures, loans, notes or credit agreements, security agreements or
other agreements or instruments relating to the borrowing of money or extension of credit in excess of $100,000 or creating any material Encumbrances with respect to any assets of Frequency or any loans or debt obligations with officers or directors
of Frequency; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) each Frequency Contract requiring payment by or to Frequency after the date of this Agreement in excess
of $500,000 pursuant to its express terms relating to: (A)&nbsp;any distribution agreement (identifying any that contain exclusivity provisions), (B) any agreement involving provision of services or products with respect to any preclinical or
clinical development activities of Frequency, (C)&nbsp;any dealer, distributor, joint marketing, alliance, joint venture, cooperation, development or other agreement currently in force under which Frequency or any of its Subsidiaries has continuing
obligations to develop or market any product, technology or service, or any agreement pursuant to which Frequency or any of its Subsidiaries has continuing obligations to develop any Intellectual Property that will not be owned, in whole or in part,
by Frequency or such Subsidiary or (D)&nbsp;any Contract to license any patent, trademark registration, service mark registration, trade name or copyright registration to or from any third party to manufacture or produce any product, service or
technology of Frequency or any of its Subsidiaries or any Contract to sell, distribute or commercialize any products or service of Frequency or any of its Subsidiaries, in each case, except for Frequency Contracts entered into in the Ordinary Course
of Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi) each Frequency Contract with any Person, including any financial advisor, broker, finder, investment
banker or other Person, providing advisory services to Frequency in connection with the Contemplated Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii)
each Frequency Contract to which Frequency or any of its Subsidiaries is a party or by which any of their assets and properties is currently bound, which involves annual obligations of payment by, or annual payments to, Frequency or such Subsidiary
in excess of $100,000; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii) a Frequency Real Estate Lease; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv) a Contract disclosed in or required to be disclosed in <U>Section</U><U></U><U>&nbsp;4.12(b)</U> or
<U>Section</U><U></U><U>&nbsp;4.12(c)</U> of the Frequency Disclosure Schedule; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv) any other Frequency Contract that
is not terminable at will (with no penalty or payment) by Frequency or any of its Subsidiaries, and (A)&nbsp;which involves payment or receipt by Frequency or such Subsidiary after the date of this Agreement under any such agreement, contract or
commitment of more than $250,000 in the aggregate, or obligations after the date of this Agreement in excess of $250,000 in the aggregate or (B)&nbsp;that is material to the business or operations of Frequency and its Subsidiaries taken as a whole.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Frequency has delivered or made available to Korro accurate and complete copies of all Frequency Material Contracts, including all
amendments thereto. There are no Frequency Material Contracts that are not in written form. Frequency has not, nor, to Frequency&#146;s Knowledge as of the date of this Agreement, has any other party to a Frequency Material Contract, breached,
violated or defaulted under, or received notice that it breached, violated or defaulted under, any of the terms or conditions of any Frequency Material Contract in such manner as would permit any other party to cancel or terminate any such Frequency
Material Contract, or would permit any other party to seek damages which would reasonably be expected to have a Frequency Material Adverse Effect. As to Frequency and its Subsidiaries, as of the date of this Agreement, each Frequency Material
Contract is valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. No Person is renegotiating, or has a right pursuant to the terms of any Frequency Material Contract to change, any material amount paid
or payable to Frequency under any Frequency Material Contract or any other material term or provision of any Frequency Material Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.14 <U>Compliance; Permits; Restrictions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Frequency and each of its Subsidiaries is, and since January&nbsp;1, 2020, has been in material compliance with all applicable Laws. No
investigation, claim, suit, proceeding, audit, Order, or other action by any Governmental Authority is pending or, to the Knowledge of Frequency, threatened against Frequency or any of its Subsidiaries. There is no agreement or Order binding upon
Frequency or any of its Subsidiaries which (i)&nbsp;has or could reasonably be expected to have the effect of prohibiting or materially impairing any business practice of Frequency or any of its Subsidiaries, any acquisition of material property by
Frequency or any of its Subsidiaries or the conduct of business by Frequency or any of its Subsidiaries as currently conducted, (ii)&nbsp;is reasonably likely to have an adverse effect on Frequency&#146;s ability to comply with or perform any
covenant or obligation under this Agreement or (iii)&nbsp;is reasonably likely to have the effect of preventing, delaying, making illegal or otherwise interfering with the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of Frequency and its Subsidiaries holds all required Governmental Authorizations that are material to the operation of the business
of Frequency and Merger Sub as currently conducted (collectively, the &#147;<B>Frequency Permits</B>&#148;).<B> </B><U>Section</U><U></U><U>&nbsp;4.14(b)</U> of the Frequency Disclosure Schedule identifies each Frequency Permit. Each of Frequency
and its Subsidiaries is in material compliance with the terms of the Frequency Permits. No Legal Proceeding is pending or, to the Knowledge of Frequency, threatened, which seeks to revoke, substantially limit, suspend, or materially modify any
Frequency Permit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) There are no Legal Proceedings pending or, to the Knowledge of Frequency, threatened
with respect to an alleged material violation by Frequency or any of its Subsidiaries of the FDCA, PHSA, FDA regulations adopted thereunder, the Controlled Substances Act or any other Law promulgated by a Drug Regulatory Agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each of Frequency and its Subsidiaries holds all required material Governmental Authorizations issuable by any Drug Regulatory Agency
necessary for the conduct of the business of Frequency and Merger Sub as currently conducted, and, as applicable, the development, testing, manufacturing, processing, storage, labeling, sale, marketing, advertising, distribution and importation or
exportation, as currently conducted, of any of its product candidates (the &#147;<B>Frequency Product Candidates</B>&#148;)<B> </B>(collectively, the &#147;<B>Frequency Regulatory Permits</B>&#148;)<B> </B>and no such Frequency Regulatory Permit has
been (i)&nbsp;revoked, withdrawn, suspended, cancelled or terminated or (ii)&nbsp;modified in any material, adverse manner. Frequency has timely maintained and is in compliance in all material respects with the Frequency Regulatory Permits and
neither Frequency nor any of its Subsidiaries has, since January&nbsp;1, 2020, received any written notice or other written communication from any Drug Regulatory Agency regarding (A)&nbsp;any material violation of or failure to comply materially
with any term or requirement of any Frequency Regulatory Permit or (B)&nbsp;any revocation, withdrawal, suspension, cancellation, termination or material modification of any Frequency Regulatory Permit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) All clinical trials, preclinical studies and other studies and tests conducted by or on behalf of, or sponsored by, Frequency or its
Subsidiaries, in which the Frequency Product Candidates have participated, were and, if still pending, are being conducted in compliance in all material respects with the applicable regulations of the Drug Regulatory Agencies and other applicable
Law, including, without limitation, 21&nbsp;C.F.R. Parts 50, 54, 56, 58 and 312. Other than as set forth on <U>Section</U><U></U><U>&nbsp;4.14(e)</U> of the Frequency Disclosure Schedule, neither Frequency nor any of its Subsidiaries has received
any written notices, correspondence, or other communications from any Drug Regulatory Agency requiring, or, to the Knowledge of Frequency, any action to place a clinical hold order on, or otherwise terminate, delay, or suspend any clinical studies
conducted by or on behalf of, or sponsored by, Frequency or any of its Subsidiaries or in which the Frequency Product Candidates have participated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Neither Frequency nor any of its Subsidiaries has, and, to the Knowledge of Frequency, any contract manufacturer with respect to any
Frequency Product Candidate, is the subject of any pending or, to the Knowledge of Frequency, threatened investigation in respect of its business or products by the FDA pursuant to its &#147;Fraud, Untrue Statements of Material Facts, Bribery, and
Illegal Gratuities&#148; Final Policy set forth in 56 Fed. Reg. 46191 (September 10, 1991) and any amendments thereto, or any other applicable Law. To the Knowledge of Frequency, neither Frequency nor any of its Subsidiaries nor any contract
manufacturer with respect to any Frequency Product Candidate has committed any acts, made any statement, or failed to make any statement, in each case in respect of Frequency&#146;s business or products that would violate the FDA&#146;s &#147;Fraud,
Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#148; Final Policy, and any amendments thereto, or any other applicable Law. None of Frequency, any of its Subsidiaries, and to the Knowledge of Frequency, any contract
manufacturer with respect to any Frequency Product </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Candidate, or any of their respective officers, employees or agents has been convicted of any crime or engaged in any conduct that could result in a material debarment or exclusion under (i) 21
U.S.C. Section&nbsp;335a (ii) 42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7,</FONT> or (iii)&nbsp;any other applicable Law. To the Knowledge of Frequency, no material debarment or exclusionary claims, actions, proceedings or
investigations in respect of their business or products are pending or threatened against Frequency, any of its Subsidiaries, and to the Knowledge of the Frequency, any contract manufacturer with respect to any Frequency Product Candidate, or any of
its officers, employees or agents. Neither Frequency nor any of its Subsidiaries is a party to or has any reporting obligations under any corporate integrity agreements, monitoring agreements, deferred or
<FONT STYLE="white-space:nowrap">non-prosecution</FONT> agreements, consent decrees, settlement orders, or similar agreements with or imposed by any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) All manufacturing operations conducted by, or to the Knowledge of Frequency, for the benefit of, Frequency or its Subsidiaries in
connection with any Frequency Product Candidate, since January&nbsp;1, 2020, have been and are being conducted in compliance in all material respects with applicable Laws, including the FDA&#146;s standards for current good manufacturing practices,
including applicable requirements contained in 21 C.F.R. Parts 210 and 211, and the respective counterparts thereof promulgated by Governmental Authorities in countries outside the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) No laboratory or manufacturing site owned by Frequency or its Subsidiaries, and to the Knowledge of Frequency, no manufacturing site of a
contract manufacturer or laboratory, with respect to any Frequency Product Candidate, (i)&nbsp;is subject to a Drug Regulatory Agency shutdown or import or export prohibition or (ii)&nbsp;has since January&nbsp;1, 2020, received any unresolved Form
FDA 483, notice of violation, warning letter, untitled letter, or similar correspondence or notice from the FDA or other Governmental Authority alleging or asserting material noncompliance with any applicable Law, and, to the Knowledge of Frequency,
neither the FDA nor any other Governmental Authority is considering such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.15 <U>Legal Proceedings; Orders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in <U>Section</U><U></U><U>&nbsp;4.15</U> of the Frequency Disclosure Schedule, there is no pending Legal Proceeding
and, to the Knowledge of Frequency, no Person has threatened in writing to commence any Legal Proceeding: (i)&nbsp;that involves Frequency or any of its Subsidiaries or any Frequency Associate (in his or her capacity as such) or any of the material
assets owned or used by Frequency or any of its Subsidiaries or (ii)&nbsp;that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) There is no Order to which Frequency or any of its Subsidiaries, or any of the material assets owned or used by Frequency or any of its
Subsidiaries is subject. To the Knowledge of Frequency, no officer or other Key Employee of Frequency or any of its Subsidiaries is subject to any Order that prohibits such officer or employee from engaging in or continuing any conduct, activity or
practice relating to the business of Frequency or any of its Subsidiaries or to any material assets owned or used by Frequency or any of its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.16 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each of Frequency and each of its Subsidiaries has timely filed all income Tax Returns and all other material Tax Returns that were
required to be filed by or with respect to it under applicable Law. All such Tax Returns were correct and complete in all material respects and have been prepared in material compliance with all applicable Law. Subject to exceptions as would not be
material, no claim has ever been made by a Governmental Authority in a jurisdiction where Frequency or any of its Subsidiaries does not file a particular type of Tax Return that Frequency or any of its Subsidiaries is subject to taxation by that
jurisdiction that would be the subject of such a Tax Return. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) All material amounts of Taxes due and owing by Frequency and each of its
Subsidiaries (whether or not shown on any Tax Return) have been timely paid. The unpaid Taxes of Frequency and each of its Subsidiaries for periods (or portions thereof) ending on or prior to the date of the Frequency Balance Sheet do not materially
exceed the accruals for current Taxes set forth on the Frequency Balance Sheet. Since the date of the Frequency Balance Sheet, neither Frequency nor any of its Subsidiaries has incurred any material Liability for Taxes outside the Ordinary Course of
Business or otherwise inconsistent with past custom and practice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each of Frequency and each of its Subsidiaries has withheld and
paid to the appropriate Governmental Authority all material Taxes required to have been withheld and paid in connection with any amounts paid or owing to any employee, independent contractor, creditor, stockholder, or other third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) There are no Encumbrances for material Taxes (other Encumbrances described in clause (i)&nbsp;of the definition of &#147;Permitted
Encumbrances&#148;) upon any of the assets of Frequency or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) No deficiencies for a material amount of Taxes
with respect to Frequency or any of its Subsidiaries have been claimed, proposed or assessed by any Governmental Authority in writing that have not been timely paid in full. There are no pending (or, based on written notice, threatened) material
audits, examinations, assessments or other actions for or relating to any Liability in respect of Taxes of Frequency or any of its Subsidiaries. Neither Frequency nor any of its Subsidiaries has waived any statute of limitations in respect of
material Taxes or agreed to any extension of time with respect to a material Tax assessment or deficiency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Neither Frequency nor any
of its Subsidiaries is a party to any Tax allocation, Tax sharing or similar agreement (including indemnity arrangements), other than Ordinary Course Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Neither Frequency nor any of its Subsidiaries has been a member of an affiliated group filing a consolidated U.S. federal income Tax
Return (other than a group the common parent of which is Frequency). Neither Frequency nor any of its Subsidiaries has any material Liability for the Taxes of any Person (other than Frequency and Merger Sub) under Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of state, local, or foreign law), as a transferee or successor, by Contract (other than an Ordinary Course Agreement) or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Neither Frequency nor any of its Subsidiaries has distributed stock of another Person,
or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section&nbsp;355 of the Code or Section&nbsp;361 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Neither Frequency nor any of its Subsidiaries has entered into any transaction identified as a &#147;reportable transaction&#148; for
purposes of Treasury Regulations <FONT STYLE="white-space:nowrap">Sections&nbsp;1.6011-4(b)(2)</FONT> or <FONT STYLE="white-space:nowrap">301.6111-2(b)(2).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Neither Frequency nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of
deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i)&nbsp;change in, or use of improper, method of accounting for a taxable period ending on or prior to the Closing Date;
(ii)&nbsp;&#147;closing agreement&#148; as described in Section&nbsp;7121 of the Code (or any corresponding or similar provision of state, local or foreign income Tax law) executed on or prior to the Closing Date; (iii)&nbsp;installment sale or open
transaction disposition made on or prior to the Closing Date; (iv)&nbsp;prepaid amount, advance payments or deferred revenue received or accrued on or prior to the Closing Date other than in respect of such amounts reflected in the Frequency Balance
Sheet or received in the Ordinary Course of Business since the date of the Frequency Balance Sheet; or (v)&nbsp;intercompany transaction or excess loss amount described in Treasury Regulations under Section&nbsp;1502 of the Code (or any
corresponding or similar provision of state, local or foreign income Tax Law). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Section </U><U>4.16(k)</U> of the Frequency
Disclosure Schedule sets forth the entity classification of Frequency and each of its Subsidiaries for U.S. federal income tax purposes. Neither Frequency nor any of its Subsidiaries has made an election or taken any other action to change its
federal and state income tax classification from such classification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Neither Frequency nor any of its Subsidiaries has taken or
knowingly failed to take any action, nor to the Knowledge of Frequency, are there any facts or circumstances, in each case, that would reasonably be expected to prevent or impede the Merger from qualifying for the Intended Tax Treatment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.17 <U>Employee and Labor Matters; Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Neither Frequency nor any of its Subsidiaries is a party to, bound by the terms of, or has a duty to bargain under, any collective
bargaining agreement or other Contract with a labor union, works council or labor organization representing any Frequency Associate, and there are no labor unions, works council or labor organizations representing or, to the Knowledge of Frequency,
purporting to represent or seeking to represent any Frequency Associates, including through the filing of a petition for representation election. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Section </U><U>4.17</U><U>(b)</U> of the Frequency Disclosure Schedule lists all material Frequency Employee Plans. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As applicable with respect to each material Frequency Employee Plan, Frequency has made
available to Korro, true and complete copies of (i)&nbsp;the plan document, including all amendments thereto, and in the case of an unwritten Employee Plan, a written description of all material terms thereof, (ii)&nbsp;all related trust instruments
or other funding-related documents and insurance contracts, (iii)&nbsp;the summary plan description and each summary of material modifications thereto, (iv)&nbsp;the financial statements for the most recent year for which such financial statements
are available (in audited form, if available or required by ERISA) and, where applicable, annual reports with any Governmental Authority (<I>e.g.</I>,<I> </I>Form 5500 and all schedules thereto), (v) the most recent IRS determination or opinion
letter, (vi)&nbsp;written results of any required compliance testing for the three most recent plan years, and (vii)&nbsp;all material, <FONT STYLE="white-space:nowrap">non-routine</FONT> notices, filings or correspondence during the past three
years with any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each Frequency Employee Plan that is intended to be qualified under Section&nbsp;401(a) of the
Code has received a favorable determination letter or may rely on a favorable opinion letter with respect to such qualified status from the IRS to the effect that such plan is qualified under Section&nbsp;401(a) of the Code and the related trust is
exempt from federal income Taxes under Section&nbsp;501(a) of the Code. To the Knowledge of Frequency, nothing has occurred that would reasonably be expected to cause the loss of the qualified status of any such Frequency Employee Plan or the Tax
exempt status of any related trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Each Frequency Employee Plan has been established, maintained and operated in compliance, in all
material respects, with its terms and all applicable Laws, including, without limitation, the Code and ERISA. No Legal Proceeding (other than those relating to routine claims for benefits) is pending or, to the Knowledge of Frequency, threatened
with respect to any Frequency Employee Plan. All payments and/or contributions required to have been made with respect to all Frequency Employee Plans have been made in accordance with the terms of the applicable Frequency Employee Plan and
applicable Law in all material respects and neither the Frequency nor any Frequency ERISA Affiliate has any Liability for any such unpaid contributions with respect to any Frequency Employee Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Neither Frequency, any of its Subsidiaries nor any of their ERISA Affiliates maintains, contributes to or is required to contribute to, or
has any Liability with respect to (i)&nbsp;any &#147;employee benefit plan&#148; (within the meaning of Section&nbsp;3(2) of ERISA) that is or was subject to Title IV or Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code, (ii)&nbsp;a
Multiemployer Plan, (iii)&nbsp;any Multiple Employer Plan, or (iv)&nbsp;any Multiple Employer Welfare Arrangement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) No Frequency
Employee Plan provides for medical or other welfare benefits to any service provider beyond termination of service or retirement, other than (i)&nbsp;pursuant to COBRA or an analogous state law requirement (the full cost of which is borne by such
Person or such Person&#146;s dependents or beneficiaries) or (ii)&nbsp;continuation coverage through the end of the month in which such termination or retirement occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) No Frequency Employee Plan is subject to any law of a foreign jurisdiction outside of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each Frequency Employee Plan that constitutes in any part a nonqualified deferred compensation plan within the meaning of
Section&nbsp;409A of the Code has been operated and maintained in all material respects in operational and documentary compliance with Section&nbsp;409A of the Code and applicable guidance thereunder. No payment to be made under any Frequency
Employee Plan is, or to the Knowledge of Frequency, will be, subject to the penalties of Section&nbsp;409A(a)(1) of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Frequency and its Subsidiaries are, and since January&nbsp;1, 2020 have been, in
material compliance in all material respects with all applicable Laws respecting labor, employment and employment practices, including terms and conditions of employment, worker classification, tax withholding, prohibited discrimination, harassment,
equal employment, fair employment practices, meal and rest periods, immigration status, employee safety and health, wages (including overtime wages), compensation, and hours of work. There are no Legal Proceedings pending or, to the Knowledge of
Frequency, threatened or reasonably anticipated against Frequency or any of its Subsidiaries relating to any Frequency Associate. Frequency is not a party to a conciliation agreement, consent decree or other agreement or Order with any federal,
state, or local agency or Governmental Authority with respect to employment practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Frequency has not taken any action which would
constitute a &#147;plant closing&#148; or &#147;mass layoff&#148; within the meaning of the WARN Act, issued any notification of a plant closing or mass layoff required by the WARN Act (nor has Frequency or any of its Subsidiaries been under any
requirement or obligation to issue any such notification), or incurred any liability or obligation under the WARN Act that remains unsatisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) There has never been, nor to the Knowledge of Frequency has there been any threat of, any strike, slowdown, work stoppage, lockout, job
action, union, organizing activity, question concerning representation or any similar activity or dispute, affecting Frequency or its Subsidiaries. No event has occurred within the past six months, and no condition or circumstance exists, that would
reasonably be expected to give rise to or provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, job action, union organizing activity, question concerning representation or any similar activity or dispute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) There is no contract, agreement, plan or arrangement to which Frequency or any of its Subsidiaries is a party or by which it is bound to
make any payment or compensate any Frequency Associate for Taxes incurred pursuant to the Code, including, but not limited to, Section&nbsp;4999 or Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) Neither the execution and delivery of this Agreement, the shareholder approval of this Agreement, nor the consummation of the Contemplated
Transactions (either alone or in conjunction with any other event, including without limitation, a termination of employment) will result in any (i)&nbsp;payment (including severance, forgiveness of indebtedness or otherwise) or benefit becoming due
to Frequency Associate, (ii)&nbsp;increase in any benefits or the compensation payable under any Frequency Employee Plan, (iii)&nbsp;acceleration of the time of payment, funding or vesting of any such compensation or benefits or any loan
forgiveness, (iv)&nbsp;restriction on the right of Frequency or any of its Subsidiaries or, after the consummation of Contemplated Transactions, the Surviving Corporation, to merge, amend, terminate or transfer any Frequency Employee Plan, or
(v)&nbsp;&#147;excess parachute payment&#148; (within the meaning of Section&nbsp;280G of the Code). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.18 <U>Environmental Matters</U>.
Since January&nbsp;1, 2020, Frequency and each of its Subsidiaries has complied with all applicable Environmental Laws, which compliance includes the possession by Frequency of all permits and other Governmental Authorizations required under
applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be in compliance that, individually or in the aggregate, would not result in a Frequency Material Adverse Effect. Neither Frequency nor any
of its Subsidiaries has received </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
since January&nbsp;1, 2020, any written notice or other communication (in writing or otherwise), whether from a Governmental Authority, citizens group, employee or otherwise, that alleges that
Frequency or any of its Subsidiaries is not in compliance with any Environmental Law, and, to the Knowledge of Frequency, there are no circumstances that may prevent or interfere with Frequency&#146;s or any of its Subsidiaries&#146; compliance with
any Environmental Law in the future, except where such failure to comply would not reasonably be expected to have a Frequency Material Adverse Effect. To the Knowledge of Frequency: (a)&nbsp;no current or prior owner of any property leased or
controlled by Frequency or any of its Subsidiaries has received since January&nbsp;1, 2020, any written notice or other communication relating to property owned or leased at any time by Frequency or any of its Subsidiaries, whether from a
Governmental Authority, citizens group, employee or otherwise, that alleges that such current or prior owner or Frequency or any of its Subsidiaries is not in compliance with or violated any Environmental Law relating to such property and
(b)&nbsp;neither Frequency nor any of its Subsidiaries has any material liability under any Environmental Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.19 <U>Insurance</U>.
Frequency has made available to Korro accurate and complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and operations of Frequency and its
Subsidiaries (including Merger Sub). Each of such insurance policies is in full force and effect and Frequency and its Subsidiaries (including Merger Sub) are in compliance in all material respects with the terms thereof. Other than customary end of
policy notifications from insurance carriers, since January&nbsp;1, 2020, neither Frequency nor any of its Subsidiaries has received any notice or other communication regarding any actual or possible: (a)&nbsp;cancellation or invalidation of any
insurance policy or (b)&nbsp;refusal or denial of any coverage, reservation of rights or rejection of any material claim under any insurance policy. Each of Frequency and its Subsidiaries (including Merger Sub) has provided timely written notice to
the appropriate insurance carrier(s) of each Legal Proceeding pending against Frequency or such Subsidiary for which Frequency or such Subsidiary has insurance coverage, and no such carrier has issued a denial of coverage or a reservation of rights
with respect to any such Legal Proceeding, or informed Frequency or any of its Subsidiaries of its intent to do so. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.20 <U>Transactions
with Affiliates</U>. Except as set forth in the Frequency SEC Documents filed prior to the date of this Agreement, since the date of Frequency&#146;s last proxy statement filed in 2022 with the SEC, no event has occurred that would be required to be
reported by Frequency pursuant to Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC. <U>Section</U><U></U><U>&nbsp;4.20</U> of the Frequency Disclosure Schedule identifies each Person who is (or who may be
deemed to be) an Affiliate of Frequency as of the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.21 <U>No Financial Advisors</U>. Except as set forth on
<U>Section</U><U></U><U>&nbsp;4.21</U> of the Frequency Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder&#146;s fee, opinion fee, success fee, transaction fee or other fee or commission in
connection with the Contemplated Transactions based upon arrangements made by or on behalf of Frequency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.22 <U>Valid Issuance; No Bad
Actor</U>. The Frequency Capital Stock to be issued in the Merger will, when issued in accordance with the provisions of this Agreement, be validly issued, fully paid and nonassessable. To the Knowledge of Frequency, as of the date of this Agreement
and as of the Closing, no &#147;bad actor&#148; disqualifying event described in Rule 506(d)(l)(i)-(viii) of the Securities Act (a &#147;<B>Disqualifying Event</B>&#148;)<B> </B>is applicable to Frequency or, to Frequency&#146;s Knowledge, any
Frequency Covered Person, except for a Disqualifying Event as to which Rule <FONT STYLE="white-space:nowrap">506(d)(2)(ii-iv)</FONT> or (d)(3) of the Securities Act is applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.23 <U>Privacy and Data Security</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Frequency and its Subsidiaries have complied with all applicable Privacy Laws and the applicable terms of any Frequency Contracts relating
to privacy, security, collection or use of Personal Information of any individuals (including clinical trial participants, patients, patient family members, caregivers or advocates, physicians and other health care professionals, clinical trial
investigators, researchers, pharmacists) that interact with Frequency or any of its Subsidiaries in connection with the operation of Frequency&#146;s and its Subsidiaries&#146; business, except for such noncompliance as has not had, and would not
reasonably be expected to have, individually or in the aggregate, a Frequency Material Adverse Effect. To the Knowledge of Frequency, Frequency has implemented and maintains reasonable Privacy Policies and has complied with its Privacy Policies,
except for such noncompliance as has not to the Knowledge of the Frequency had, and would not reasonably be expected to have, individually or in the aggregate, a Frequency Material Adverse Effect. To the Knowledge of Frequency, as of the date
hereof, no claims have been asserted or threatened against Frequency by any Person alleging a violation of Privacy Laws, Privacy Policies and/or the applicable terms of any Frequency Contracts relating to privacy, security, collection or use of
Personal Information of any individuals. To the Knowledge of Frequency, there have been no data security incidents, personal data breaches or other adverse events or incidents related to Personal Information or Frequency data in the custody or
control of Frequency or any service provider acting on behalf of Frequency, in each case where such incident, breach or event would result in a notification obligation to any Person under applicable law or pursuant to the terms of any Frequency
Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The information technology assets and equipment of Frequency and its Subsidiaries (collectively, &#147;<B>Frequency IT
Systems</B>&#148;) are adequate for, and operate and perform in all material respects as required in connection with the operation of the business of Frequency and its Subsidiaries as currently conducted, and to the Knowledge of Frequency, free and
clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. Frequency and its Subsidiaries have implemented and maintain commercially reasonable physical, technical and administrative safeguards to protect
Personal Information processed by or on behalf of Frequency and its Subsidiaries, any other material confidential information and the integrity and security of Frequency IT Systems used in connection with their businesses, and during the past three
years, there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.24 <U>Opinion of Financial Advisor</U>. The&nbsp;Frequency Board has received an opinion from Cowen and Company, LLC to the effect that, as
of the date of such opinion and based upon and subject to the various assumptions made, procedures followed, matters considered and limitation and qualifications on the review undertaken set forth therein, the&nbsp;Korro Equity Value was fair, from
a financial point of view, to Frequency. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.25 <U>No Other Representations or Warranties</U>. Frequency hereby acknowledges and agrees
that, except for the representations and warranties contained in this Agreement, neither Frequency nor any of its Subsidiaries nor any other person on behalf of Frequency or its Subsidiaries makes any express or implied representation or warranty
with respect to Frequency or its Subsidiaries or with respect to any other information provided to Korro, its stockholders or any of its Affiliates in connection with the Contemplated Transactions, and (subject to the express representations and
warranties of Frequency set forth in <U>Article IV</U> (in each case as qualified and limited by the Frequency Disclosure Schedule)) none of Korro, its Representatives, stockholders or members, has relied on any such information (including the
accuracy or completeness thereof). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Conduct
of Korro</U><U>&#146;</U><U>s Business</U>. From the date hereof until the earlier of the Effective Time and the termination of this Agreement in accordance with <U>Article VIII</U> (the &#147;<B><FONT STYLE="white-space:nowrap">Pre-Closing</FONT>
Period</B>&#148;), except as set forth on <U>Section</U><U></U><U>&nbsp;5.1</U> of the Korro Disclosure Schedule, as required by applicable Law, as otherwise provided by this Agreement and the Contemplated Transactions or with Frequency&#146;s prior
written consent (not to be unreasonably withheld, conditioned or delayed), Korro shall, and shall cause its Subsidiaries to, use their commercially reasonable efforts to conduct its operations in the Ordinary Course of Business and to preserve
intact the present business organizations and goodwill of the business and the present relationships of the business with material customers and suppliers. Without limiting the generality of the foregoing, during the
<FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, except as set forth in <U>Section</U><U></U><U>&nbsp;5.1</U> of the Korro Disclosure Schedule, as required by applicable Law, as otherwise specifically provided by this Agreement and the
Contemplated Transactions or with Frequency&#146;s prior written consent (not to be unreasonably withheld, conditioned or delayed), Korro shall not, and shall cause its Subsidiaries not to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) sell, lease, license or otherwise dispose of any material assets of Korro, or in either case, any interests therein, except
(i)&nbsp;pursuant to existing Contracts, (ii)&nbsp;for sales or licensing of products to customers or (iii)&nbsp;otherwise in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) take any action with respect to any equity interests of Korro or any of its Subsidiaries, including any issuance, sale, transfer,
redemption, repurchase, recapitalization, adjustment, split, combination, reclassification, dividend, distribution or any other action in respect thereof;<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) create, incur, assume, guarantee or repay (other than any mandatory repayments) any indebtedness, other than the incurrence of
indebtedness in the Ordinary Course of Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) issue, deliver, sell, grant, pledge, transfer, subject to any Encumbrance or dispose
of any Korro Capital Stock or the securities of any Subsidiary of Korro; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) create or otherwise incur any Encumbrance on any material
asset of Korro or any of its Subsidiaries, other than Permitted Encumbrances; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) make any loans, advances or capital contributions to,
or investments in, any Person other than Korro, other than in the Ordinary Course of Business in all material respects; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) adversely amend or otherwise adversely modify in any material respect or terminate
(excluding any expiration in accordance with its terms) any Contract listed in <U>Section</U><U></U><U>&nbsp;3.12</U> of the Korro Disclosure Schedule, other than any amendment or modification entered into in the Ordinary Course of Business and
containing terms not materially less favorable to Korro than the terms of such Contract in effect as of the date of this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)
enter into any Contract that would be required to be disclosed in <U>Section</U><U></U><U>&nbsp;3.12</U> of the Korro Disclosure Schedule if such Contract were in effect as of the date of this Agreement, other than any such Contract entered into in
the Ordinary Course of Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) except as required by any Korro Employee Plan or as required by applicable Law, (i)&nbsp;increase
any salary, wage or other compensation or benefit to, or enter into or amend any employment, retention, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> termination or severance agreement with, any
Korro Associate provided that such increases do not, individually or in the aggregate, result in any material increase in costs, obligations or liabilities for Korro and its Subsidiaries, (ii)&nbsp;grant or pay any bonuses to any Korro Associate,
(iii)&nbsp;establish, enter into or adopt any new Korro Employee Plan or any plan, program, policy, agreement or arrangement that would be a Korro Employee Plan if it was in effect on the date hereof or amend or modify, in a manner that would,
individually or in the aggregate, materially increase costs, obligations or liabilities for Korro and its Subsidiaries or the Surviving Corporation, any existing Korro Employee Plan or accelerate the vesting of any compensation (including stock
options, restricted stock, restricted stock units, phantom units, warrants, other shares of capital stock or rights of any kind to acquire any shares of capital stock or equity-based awards) for the benefit of any Korro Associate, (iv)&nbsp;take any
action to accelerate any payment or benefit, or the funding of any payment or benefit, payable or to be provided to any Korro Associate, (v)&nbsp;grant any new long-term incentive or equity-based awards, or amend or modify the terms of any such
outstanding awards under any Korro Employee Plan or (vi)&nbsp;hire, terminate (other than for cause), promote or change the employment status or title of any Korro Associate, except that in each case for (i)&nbsp;through (vi) in this
<U>Section</U><U></U><U>&nbsp;5.1(i)</U>, Korro shall be permitted to take any action as set forth herein in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) adopt, enter into, amend or terminate any collective bargaining agreement or Contract with any labor union, works council or labor
organization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) settle any material Legal Proceeding involving Korro or any of its Subsidiaries or relating to the transactions
contemplated by this Agreement, other than in the Ordinary Course of Business in all material respects; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) make or change any material
Tax election, change any annual Tax accounting period, enter into any closing agreement with a Governmental Authority with respect to material Taxes or settle any Tax claim with respect to material Taxes, in each case, except if such action would
not reasonably be expected to have a material and adverse effect on Korro following the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) take any action, or knowingly fail
to take any action, where such action or failure to act would reasonably be expected to prevent the Merger from qualifying for the Intended Tax Treatment; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) make any material change in any method of financial accounting or financial accounting
practice of Korro or any of its Subsidiaries, except for any such change required by reason of a change in GAAP or other applicable financial accounting standards; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) other than in connection with actions contemplated by this Agreement, adopt, approve, consent to or propose any change in the
Organizational Documents of Korro or any of its Subsidiaries; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) agree or commit to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the generality of the foregoing, nothing set forth in this <U>Section</U><U></U><U>&nbsp;5.1</U> shall restrict Korro&#146;s
right to effectuate the Concurrent Financing. Nothing contained in this Agreement shall give Frequency, directly or indirectly, the right to control or direct the operations of Korro prior to the Effective Time. Prior to the Effective Time, Korro
shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral control and supervision over its business operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Conduct of Frequency</U><U>&#146;</U><U>s Business</U>. During the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, except
as set forth on <U>Section</U><U></U><U>&nbsp;5.2</U> of the Frequency Disclosure Schedule, as required by applicable Law, as otherwise provided by this Agreement and the Contemplated Transactions or with Korro&#146;s prior written consent (not to
be unreasonably withheld, conditioned or delayed), Frequency shall, and shall cause its Subsidiaries to, use their commercially reasonable efforts to conduct its operations in the Ordinary Course of Business and to preserve intact the present
business organizations and goodwill of the business and the present relationships of the business with material customers and suppliers. Without limiting the generality of the foregoing, during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT>
Period, except as set forth in <U>Section</U><U></U><U>&nbsp;5.2</U> of the Frequency Disclosure Schedule, as required by applicable Law, as otherwise specifically provided by this Agreement and the Contemplated Transactions or with Korro&#146;s
prior written consent (not to be unreasonably withheld, conditioned or delayed), Frequency shall not, and shall cause its Subsidiaries not to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) sell, lease, license or otherwise dispose of any material assets of Frequency, or in either case, any interests therein, except
(i)&nbsp;pursuant to existing Contracts, (ii)&nbsp;for sales or licensing of products to customers or (iii)&nbsp;otherwise in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) take any action with respect to any equity interests of Frequency or any of its Subsidiaries, including any issuance, sale, transfer,
redemption, repurchase, recapitalization, adjustment, split, combination, reclassification, dividend, distribution or any other action in respect thereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) create, incur, assume, guarantee or repay (other than any mandatory repayments) any indebtedness; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) issue, deliver, sell, grant, pledge, transfer, subject to any Encumbrance or dispose of any Frequency Capital Stock or the securities of
any Subsidiary of Frequency; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) create or otherwise incur any Encumbrance on any material asset of Frequency, other than Permitted
Encumbrances; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) make any loans, advances or capital contributions to, or investments in, any Person
other than Frequency; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) adversely amend or otherwise adversely modify in any material respect or terminate (excluding any expiration in
accordance with its terms) any Contract listed in <U>Section</U><U></U><U>&nbsp;4.13</U> of the Frequency Disclosure Schedule, other than any amendment or modification entered into in the Ordinary Course of Business and containing terms, not
materially less favorable to Frequency than the terms of such Contract in effect as of the date of this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) enter into any
Contract that would be required to be disclosed in <U>Section</U><U></U><U>&nbsp;4.13</U> of the Frequency Disclosure Schedule if such Contract were in effect as of the date of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) except as required by any Frequency Employee Plan, as required by applicable Law or with respect to the adoption and approval of the 2023
Plans, (i)&nbsp;increase any salary, wage or other compensation or benefit to, or enter into or amend any employment, retention, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> termination or
severance agreement with, any Frequency Associate, other than annual increases in base compensation in the Ordinary Course of Business with respect to employees whose annual base compensation is less than $135,000 and provided that such increases do
not, individually or in the aggregate, result in any material increase in costs, obligations or liabilities for Frequency and its Subsidiaries, (ii)&nbsp;grant or pay any bonuses to any Frequency Associate, (iii)&nbsp;establish, enter into or adopt
any new Frequency Employee Plan or any plan, program, policy, agreement or arrangement that would be a Frequency Employee Plan if it was in effect on the date hereof or amend or modify, in a manner that would, individually or in the aggregate,
materially increase costs, obligations or liabilities for Frequency and its Subsidiaries or the Surviving Corporation, any existing Frequency Employee Plan or accelerate the vesting of any compensation (including stock options, restricted stock,
restricted stock units, phantom units, warrants, other shares of capital stock or rights of any kind to acquire any shares of capital stock or equity-based awards) for the benefit of any Frequency Associate, (iv)&nbsp;take any action to accelerate
any payment or benefit, or the funding of any payment or benefit, payable or to be provided to any Frequency Associate, (v)&nbsp;grant any new long-term incentive or equity-based awards, or amend or modify the terms of any such outstanding awards
under any Frequency Employee Plan or (vi)&nbsp;hire, terminate (other than for cause), promote or change the employment status or title of any Frequency Associate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) adopt, enter into, amend or terminate any collective bargaining agreement or Contract with any labor union, works council or labor
organization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) settle any material Legal Proceeding involving Frequency or relating to the transactions contemplated by this
Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) make or change any material Tax election, change any annual Tax accounting period, enter into any closing agreement with a
Governmental Authority with respect to material Taxes or settle any Tax claim with respect to material Taxes, in each case, except if such action would not reasonably be expected to have a material and adverse effect on Frequency following the
Closing; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) take any action, or knowingly fail to take any action, where such action or failure to
act would reasonably be expected to prevent the Merger from qualifying for the Intended Tax Treatment; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) make any material change in
any method of financial accounting or financial accounting practice of Frequency, except for any such change required by reason of a change in GAAP or other applicable financial accounting standards; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) other than in connection with actions contemplated by this Agreement, adopt, approve, consent to or propose any change in the
Organizational Documents of Frequency; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) agree or commit to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the generality of the foregoing, nothing set forth in this <U>Section</U><U></U><U>&nbsp;5.2</U> shall restrict
Frequency&#146;s right to effectuate the MS Asset Disposition. Nothing contained in this Agreement shall give Korro, directly or indirectly, the right to control or direct the operations of Frequency prior to the Effective Time. Prior to the
Effective Time, Frequency shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral control and supervision over its business operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Access</U><U> and Investigation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms of the Confidentiality Agreement, which the Parties agree will continue in full force following the date of this
Agreement, during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, upon reasonable notice, Frequency, on the one hand, and Korro, on the other hand, shall and shall use commercially reasonable efforts to cause such Party&#146;s
Representatives to: (i)&nbsp;provide the other Party and such other Party&#146;s Representatives with reasonable access during normal business hours to such Party&#146;s Representatives, personnel and assets and to all existing books, records, Tax
Returns, work papers and other documents and information relating to such Party and its Subsidiaries, (ii)&nbsp;provide the other Party and such other Party&#146;s Representatives with such copies of the existing books, records, Tax Returns, work
papers, product data, and other documents and information relating to such Party and its Subsidiaries, and with such additional financial, operating and other data and information regarding such Party and its Subsidiaries as the other Party may
reasonably request, (iii)&nbsp;permit the other Party&#146;s officers and other employees to meet, upon reasonable notice and during normal business hours, with the chief financial officer and other officers and managers of such Party responsible
for such Party&#146;s financial statements and the internal controls of such Party to discuss such matters as the other Party may deem reasonably necessary or appropriate, and (iv)&nbsp;provide the other Party with copies of any material notice,
report or other document filed with or sent to or received from any Governmental Authority in connection with the Contemplated Transactions. Any investigation conducted by either Frequency or Korro pursuant to this
<U>Section</U><U></U><U>&nbsp;5.3</U> shall be conducted in such manner as not to interfere unreasonably with the conduct of the business of the other Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything herein to the contrary in this
<U>Section</U><U></U><U>&nbsp;5.3</U>, no access or examination contemplated by this <U>Section</U><U></U><U>&nbsp;5.3</U> shall be permitted to the extent that it would require any Party or its Subsidiaries to waive the attorney-client privilege or
attorney work product privilege, or violate any applicable Law; provided, that such Party or its Subsidiary (i)&nbsp;shall be entitled to withhold only such information that may not be provided without causing such violation or waiver,
(ii)&nbsp;shall provide to the other Party all related information that may be provided without causing such violation or waiver (including, to the extent permitted, redacted versions of any such information) and (iii)&nbsp;shall enter into such
effective and appropriate joint-defense agreements or other protective arrangements as may be reasonably requested by the other Party in order that all such information may be provided to the other Party without causing such violation or waiver.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>No Solicitation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each of Frequency and Korro agrees that, during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, neither it nor any of its
Subsidiaries shall, nor shall it or any of its Subsidiaries authorize any of its Representatives to, directly or indirectly: (i)&nbsp;solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or
announcement of any Acquisition Proposal or Acquisition Inquiry or take any action that could reasonably be expected to lead to an Acquisition Proposal or Acquisition Inquiry, (ii)&nbsp;furnish any <FONT STYLE="white-space:nowrap">non-public</FONT>
information regarding such Party to any Person (other than Korro or Frequency) in connection with or in response to an Acquisition Proposal or Acquisition Inquiry, (iii)&nbsp;engage in discussions or negotiations with any Person with respect to any
Acquisition Proposal or Acquisition Inquiry, (iv)&nbsp;approve, endorse or recommend any Acquisition Proposal (subject to <U>Section</U><U></U><U>&nbsp;5.9</U>), (v) execute or enter into any letter of intent or any Contract contemplating or
otherwise relating to any Acquisition Transaction or (vi)&nbsp;publicly propose to do any of the foregoing; provided, however, that, notwithstanding anything contained in this <U>Section</U><U></U><U>&nbsp;5.4(a)</U> and subject to compliance with
this <U>Section</U><U></U><U>&nbsp;5.4(a)</U>, prior to the approval of this Agreement by Frequency&#146;s stockholders (i.e., the Required Frequency Stockholder Vote), Frequency may furnish <FONT STYLE="white-space:nowrap">non-public</FONT>
information regarding Frequency or its Subsidiaries to, and enter into discussions or negotiations with, any Person in response to a bona fide written Acquisition Proposal by Frequency which the Frequency Board determines in good faith, after
consultation with Frequency&#146;s financial advisors and outside legal counsel, constitutes, or is reasonably likely to result in, a Superior Offer (and is not withdrawn) if: (A)&nbsp;neither Frequency nor any Representative shall have breached
this <U>Section</U><U></U><U>&nbsp;5.4(a)</U> in any material respect, (B)&nbsp;the Frequency Board concludes in good faith based on the advice of outside legal counsel, that the failure to take such action would reasonably be expected to result in
a breach of the fiduciary duties of the Frequency Board under applicable Law, (C)&nbsp;at least two Business Days prior to initially furnishing any such <FONT STYLE="white-space:nowrap">non-public</FONT> information to, or entering into discussions
with, such Person, Frequency gives Korro written notice of the identity of such Person to Korro, and of Frequency&#146;s intention to furnish <FONT STYLE="white-space:nowrap">non-public</FONT> information to, or enter into discussions with, such
Person, (D)&nbsp;Frequency receives from such Person an executed Acceptable Confidentiality Agreement and (E)&nbsp;at least two Business Days prior to furnishing any such <FONT STYLE="white-space:nowrap">non-public</FONT> information to such Person,
Frequency furnishes such <FONT STYLE="white-space:nowrap">non-public</FONT> information to Korro (to the extent such information has not been previously furnished by Frequency to Korro). Without limiting the generality of the foregoing, Frequency
acknowledges and agrees that, in the event any Representative of Frequency takes any action that, if taken by Frequency, would constitute a breach of this <U>Section</U><U></U><U>&nbsp;5.4(a)</U> by Frequency, the taking of such action by such
Representative shall be deemed to constitute a breach of this <U>Section</U><U></U><U>&nbsp;5.4(a)</U> by Frequency for purposes of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If any Party or any Representative of such Party receives an Acquisition Proposal or
Acquisition Inquiry at any time during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, then such Party shall promptly (and in no event later than one Business Day after such Party becomes aware of such Acquisition Proposal or
Acquisition Inquiry) advise the other Party orally and in writing of such Acquisition Proposal or Acquisition Inquiry (including the identity of the Person making or submitting such Acquisition Proposal or Acquisition Inquiry, and provide a copy of
the Acquisition Proposal or Acquisition Inquiry, of if the Acquisition Proposal or Acquisition Inquiry is not written, the terms thereof). Such Party shall keep the other Party reasonably informed with respect to the status and terms of any such
Acquisition Proposal or Acquisition Inquiry and any material modification or material proposed modification thereto. In addition to the foregoing, each Party shall provide the other Party with at least four Business Days&#146; written notice of a
meeting of its board of directors (or any committee thereof) at which its board of directors (or any committee thereof) is reasonably expected to consider an Acquisition Proposal or Acquisition Inquiry it has received. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Party shall immediately cease and cause to be terminated any existing discussions, negotiations and communications with any Person
that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the destruction or return of any <FONT STYLE="white-space:nowrap">non-public</FONT> information provided to such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>Notification of Certain Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) During the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, each of Korro, on the one hand, and Frequency, on the other hand,
shall promptly notify the other (and, if in writing, furnish copies of) if any of the following occurs: (i)&nbsp;any notice or other communication is received from any Person alleging that the Consent of such Person is or may be required in
connection with any of the Contemplated Transactions, (ii)&nbsp;any Legal Proceeding against or involving or otherwise affecting such Party or its Subsidiaries is commenced, or, to the Knowledge of such Party, threatened against such Party or, to
the Knowledge of such Party, any director, officer or Key Employee of such Party, (iii)&nbsp;such Party becomes aware of any inaccuracy in any representation or warranty made by such Party in this Agreement or (iv)&nbsp;the failure of such Party to
comply with any covenant or obligation of such Party; in each case that could reasonably be expected to make the timely satisfaction of any of the conditions set forth in <U>Article VI</U> impossible or materially less likely. No such notice shall
be deemed to supplement or amend the Korro Disclosure Schedule or the Frequency Disclosure Schedule for the purpose of (A)&nbsp;determining the accuracy of any of the representations and warranties made by Korro or Frequency in this Agreement or
(B)&nbsp;determining whether any condition set forth in <U>Article VI</U> has been satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) During the <FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Period, Frequency shall use reasonable best efforts to consult with Korro during the negotiation process for, and prior to taking any material action with respect to, any amendment to, sublicence or the
potential early termination of the Frequency Lease Agreement, and shall consider any input received from Korro in good faith prior to taking any such action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Any failure by either Party to provide notice pursuant to this <U>Section</U><U></U><U>&nbsp;5.5</U> shall not be deemed to be a breach
for purposes of <U>Section</U><U></U><U>&nbsp;6.2(b)</U> or <U>6.3(b)</U>, as applicable, unless such failure to provide such notice was knowing and intentional. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>MS Asset Disposition</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Closing, Frequency shall be entitled, but under no obligation, to sell,
transfer, license, assign or otherwise divest any or all of the assets and rights relating to Frequency&#146;s MS remyelination program (the &#147;<B>MS Assets</B>&#148;) in a transaction or series of transactions (the &#147;<B>MS Asset
Disposition</B>&#148;). Subject to the provisions of this <U>Section</U><U></U><U>&nbsp;5.6(a)</U> and the CVR Agreement, Frequency may, in contemplation of the MS Asset Disposition, (a)&nbsp;establish one or more Subsidiaries to hold the MS Assets,
(b)&nbsp;transfer to any such Subsidiary any or all of the MS Assets and the liabilities and obligations related thereto and (c)&nbsp;take such other steps that are reasonably necessary to prepare for the MS Asset Disposition. For clarity, if
Frequency transfers the MS Assets to one or more Subsidiaries, the terms of this <U>Section</U><U></U><U>&nbsp;5.6</U> shall apply to such Subsidiaries in addition to Frequency. Each Party further acknowledges that Frequency may not be successful in
completing, or may determine not to proceed, with the MS Asset Disposition. Notwithstanding the foregoing, Frequency may not enter into any agreement with respect to the MS Asset Disposition that would result in a material continuing obligation or
liability without the prior written consent of Korro (not to be unreasonably withheld, conditioned or delayed), provided, however, that Frequency shall provide Korro with a copy of any agreement with respect to an MS Asset Disposition that would be
reasonably likely to result in a material continuing obligation or liability of either Frequency or Korro on or after the Effective Time at least five Business Days prior to entry into such agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that the MS Asset Disposition has not occurred on or prior to the Closing Date, for a period of one year following the
Closing Date, Frequency shall use commercially reasonable efforts to sell, transfer, assign, <FONT STYLE="white-space:nowrap">out-license</FONT> or otherwise divest the MS Assets with a term of not more than 10 years. For the avoidance of doubt, the
net proceeds from such sale, transfer, license, assignment or other divestiture or commercialization of the MS Assets following the Effective Time shall be payable to the holders of CVRs pursuant to the CVR Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U>Registration Statement; Proxy Statement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As promptly as practicable after the date of this Agreement, (i)&nbsp;Frequency shall, in cooperation with Korro, prepare and file with
the SEC a proxy statement relating to the Frequency Stockholder Meeting to be held in connection with the Merger (together with any amendments thereof or supplements thereto, the &#147;<B>Proxy Statement</B>&#148;) and (ii)&nbsp;Frequency, in
cooperation with Korro, shall prepare and file with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (the &#147;<B>Form <FONT STYLE="white-space:nowrap">S-4</FONT></B>&#148;), in which the Proxy Statement shall be
included as a part (the Proxy Statement and the Form <FONT STYLE="white-space:nowrap">S-4,</FONT> collectively, the &#147;<B>Registration Statement</B>&#148;), in connection with the registration under the Securities Act of the shares of Frequency
Common Stock to be issued by virtue of the Merger. Each of Frequency and Korro shall use their reasonable best efforts to respond promptly to any comments of the SEC or its staff and to cause the Registration Statement to become effective as
promptly as practicable, and shall take all or any action required under any applicable federal, state, securities and other Laws in connection with the issuance of shares of Frequency Common Stock pursuant to the Merger. Each of the Parties shall
furnish all information concerning itself and their Affiliates, as applicable, to the other Parties as the other Parties may reasonably request in connection with such actions and the preparation of the Registration Statement and Proxy Statement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Frequency covenants and agrees that the Registration Statement (and the letter to stockholders, notice of meeting and form of proxy
included therewith) will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein not misleading. Korro covenants and agrees that
the information supplied by or on behalf of Korro and its Subsidiaries to Frequency for inclusion in the Registration Statement (including the Korro Financial Statements) will not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make such information, in light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, Frequency makes no covenant, representation or
warranty with respect to statements made in the Registration Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), if any, based on information provided by Korro or its Subsidiaries or any of their
Representatives for inclusion therein. Korro and its legal counsel shall be given reasonable opportunity to review and comment on the Registration Statement, including all amendments and supplements thereto, prior to the filing thereof with the SEC,
and on the response to any comments on the SEC prior to the filing thereof with the SEC; <I>provided</I>, <I>however</I>, that the foregoing shall not apply to any amendment to the Registration Statement pertaining to a Frequency Board Adverse
Recommendation Change. Each of the Parties shall use commercially reasonable efforts to cause the Registration Statement to comply with the applicable rules and regulations promulgated by the SEC, to respond promptly to any comments of the SEC or
its staff and to have the Registration Statement declared effective under the Securities Act as promptly as practicable after it is filed with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each of the Parties shall cause the Proxy Statement to be mailed to Frequency&#146;s stockholders as promptly as practicable after the
Registration Statement is declared effective under the Securities Act. If Frequency, Merger Sub or Korro become aware of any event or information that, pursuant to the Securities Act or the Exchange Act, should be disclosed in an amendment or
supplement to the Registration Statement or Proxy Statement, as the case may be, then such Party, as the case may be, shall promptly inform the other Parties thereof and shall cooperate with such other Parties in filing such amendment or supplement
with the SEC and, if appropriate, in mailing such amendment or supplement to the Frequency stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Korro shall reasonably cooperate with Frequency and provide, and cause its
Representatives to provide, Frequency and its Representatives, with all true, correct and complete information regarding Korro and its Subsidiaries that is required by Law to be included in the Registration Statement or reasonably requested by
Frequency to be included in the Registration Statement. Without limiting the foregoing, Korro will use commercially reasonable efforts to cause to be delivered to Frequency a letter of Korro&#146;s independent accounting firm, dated no more than two
Business Days before the date on which the Registration Statement becomes effective (and reasonably satisfactory in form and substance to Frequency), that is customary in scope and substance for letters delivered by independent public accountants in
connection with registration statements similar to the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <U>Korro Stockholder Written Consent</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Promptly after the Registration Statement has been declared effective under the Securities Act, and in any event no later than two
Business Days thereafter, Korro shall prepare, with the cooperation of Frequency, and cause to be mailed to its stockholders an information statement, which shall include a copy of the Proxy Statement (the &#147;<B>Information Statement</B>&#148;),
and the Korro Stockholder Written Consent, in order to solicit the approval of Korro&#146;s stockholders, including but not limited to Korro&#146;s stockholders sufficient for the Required Korro Stockholder Vote in lieu of a meeting pursuant to
Section&nbsp;228 of Delaware Law, for purposes of (i)&nbsp;adopting and approving this Agreement and the Contemplated Transactions, (ii)&nbsp;acknowledging that the approval given thereby is irrevocable and that such stockholder is aware of its
rights to demand appraisal for its shares pursuant to Section&nbsp;262 of Delaware Law, a copy of which will be attached thereto, and that such stockholder has received and read a copy of Section&nbsp;262 of Delaware Law and (iii)&nbsp;acknowledging
that by its approval of the Merger it is not entitled to appraisal rights with respect to its shares in connection with the Merger and thereby waives an rights to receive payment of the fair value of its capital stock under Delaware Law. Korro shall
use its reasonable best efforts to cause Korro&#146;s stockholders sufficient for the Required Korro Stockholder Vote to execute and deliver to Korro the Korro Stockholder Written Consent promptly following delivery thereof. Promptly following
receipt of the duly executed Korro Stockholder Written Consent, Korro shall deliver a copy of the duly executed Korro Stockholder Written Consent to Frequency. Under no circumstances shall Korro assert that any other approval or consent is necessary
by its stockholders to approve this Agreement and the Contemplated Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Promptly following receipt of the Required Korro
Stockholder Vote, Korro shall prepare and mail a notice to every stockholder of Korro that did not execute the Korro Stockholder Written Consent. Such notice shall (i)&nbsp;be a statement to the effect that the Korro Board determined that the Merger
is advisable in accordance with Section&nbsp;251(b) of Delaware Law and in the best interests of the stockholders of Korro and approved and adopted this Agreement, the Merger and the other Contemplated Transactions, (ii)&nbsp;provide the
stockholders of Korro to whom it is sent with notice of the actions taken in the Korro Stockholder Written Consent, including the adoption and approval of this Agreement, the Merger and the other Contemplated Transactions in accordance with
Section&nbsp;228(e) of Delaware Law and Korro&#146;s Organizational Documents and (iii)&nbsp;include a description of the appraisal rights of Korro&#146;s stockholders available under Delaware Law, along with such other information as is required
thereunder and pursuant to applicable Law. All materials (including any amendments thereto) submitted to the stockholders of Korro in accordance with this <U>Section</U><U></U><U>&nbsp;5.8(b)</U> shall be subject to Frequency&#146;s advance review
and reasonable approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Korro agrees that: (i)&nbsp;the Korro Board shall recommend that Korro&#146;s
stockholders vote to adopt and approve this Agreement and the Contemplated Transactions and shall use commercially reasonable efforts to solicit such approval within the time set forth in <U>Section</U><U></U><U>&nbsp;5.8(a)</U> (the recommendation
of the Korro Board that Korro&#146;s stockholders vote to adopt and approve this Agreement being referred to as the &#147;<B>Korro Board Recommendation</B>&#148;) and (ii)&nbsp;the Korro Board Recommendation shall not be withdrawn or modified (and
the Korro Board shall not publicly propose to withdraw or modify the Korro Board Recommendation) in a manner adverse to Frequency, and no resolution by the Korro Board or any committee thereof to withdraw or modify the Korro Board Recommendation in
a manner adverse to Frequency or to adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any Acquisition Proposal shall be adopted or proposed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Korro&#146;s obligation to solicit the consent of its stockholders to sign the Korro Stockholder Written Consent in accordance with
<U>Section</U><U></U><U>&nbsp;5.8(a)</U> shall not be limited or otherwise affected by the commencement, disclosure, announcement or submission of any Superior Offer or other Acquisition Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <U>Frequency Stockholder Meeting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Frequency shall take all action necessary under applicable Law to call, give notice of and hold a meeting of the holders of Frequency
Common Stock to consider and vote to approve this Agreement and the Contemplated Transactions, including the issuance of the shares of Frequency Common Stock to the stockholders of Korro pursuant to the terms of this Agreement and<B> </B>the Charter
Amendment Proposals (collectively, the &#147;<B>Frequency</B> <B>Stockholder Matters</B>&#148; and such meeting, the &#147;<B>Frequency Stockholder Meeting</B>&#148;). The Frequency Stockholder Meeting shall be held as promptly as practicable after
the Registration Statement is declared effective under the Securities Act, and in any event no later than 45 days after the effective date of the Registration Statement. Frequency shall take reasonable measures to ensure that all proxies solicited
in connection with the Frequency Stockholder Meeting are solicited in compliance with all applicable Law. Notwithstanding anything to the contrary contained herein, if on the date of the Frequency Stockholder Meeting, or a date preceding the date on
which the Frequency Stockholder Meeting is scheduled, Frequency reasonably believes that (i)&nbsp;it will not receive proxies sufficient to obtain the Required Frequency Stockholder Vote, whether or not a quorum would be present or (ii)&nbsp;it will
not have sufficient shares of Frequency Common Stock represented (whether in person or by proxy) to constitute a quorum necessary to conduct the business of the Frequency Stockholder Meeting, Frequency may postpone or adjourn, or make one or more
successive postponements or adjournments of, the Frequency Stockholder Meeting as long as the date of the Frequency Stockholder Meeting is not postponed or adjourned more than an aggregate of 30 calendar days in connection with any postponements or
adjournments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Frequency agrees that, subject to <U>Section</U><U></U><U>&nbsp;5.9(c)</U>: (i) the
Frequency Board shall recommend that the holders of Frequency Common Stock vote to approve the Frequency Stockholder Matters and shall use commercially reasonable efforts to solicit such approval within the timeframe set forth in
<U>Section</U><U></U><U>&nbsp;5.9(a)</U> above, (ii)&nbsp;the Proxy Statement shall include a statement to the effect that the Frequency Board recommends that Frequency&#146;s stockholders vote to approve the Frequency Stockholder Matters (the
recommendation of the Frequency Board being referred to as the &#147;<B>Frequency </B><B>Board Recommendation</B>&#148;) and (iii)&nbsp;the Frequency Board Recommendation shall not be withheld, amended, withdrawn or modified (and the Frequency Board
shall not publicly propose to withhold, amend, withdraw or modify the Frequency Board Recommendation) in a manner adverse to Korro, and no resolution by the Frequency Board or any committee thereof to withdraw or modify the Frequency Board
Recommendation in a manner adverse to Korro or to adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any Acquisition Proposal shall be adopted or proposed (the actions set forth in the foregoing clause (iii),
collectively, a &#147;<B>Frequency </B><B>Board Adverse Recommendation Change</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary
contained in <U>Section</U><U></U><U>&nbsp;5.9(b)</U>, and subject to compliance with <U>Section</U><U></U><U>&nbsp;5.4</U> and <U>Section</U><U></U><U>&nbsp;5.9</U>, at any time prior to the approval of Frequency Stockholder Matters by the Required
Frequency Stockholder Vote, Frequency receives a bona fide written Superior Offer, the Frequency Board may make a Frequency Board Adverse Recommendation Change if, but only if, in the receipt of and on account of such Superior Offer, (i)&nbsp;the
Frequency Board determines in good faith, after consultation with its outside legal counsel, that the failure to make a Frequency Board Adverse Recommendation Change would reasonably be expected to be inconsistent with its fiduciary duties under
applicable Law, (ii)&nbsp;Frequency has, and has caused its financial advisors and outside legal counsel to, during the Notice Period, negotiate with Korro in good faith to make such adjustments to the terms and conditions of this Agreement so that
such Acquisition Proposal ceases to constitute a Superior Offer and (iii)&nbsp;if after Korro shall have delivered to Frequency a written offer to alter the terms or conditions of this Agreement during the Notice Period, the Frequency Board shall
have determined in good faith, after consultation with its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Frequency Board Recommendation would reasonably be expected to be inconsistent with its fiduciary duties
under applicable Law (after taking into account such alterations of the terms and conditions of this Agreement); <I>provided </I>that (x)&nbsp;Korro receives written notice from Frequency confirming that the Frequency Board has determined to change
its recommendation during the Notice Period, which notice shall include a description in reasonable detail of the reasons for such Frequency Board Adverse Recommendation Change, and written copies of any relevant proposed transaction agreements with
any party making a potential Superior Offer, (y)&nbsp;during any Notice Period, Korro shall be entitled to deliver to Frequency one or more counterproposals to such Acquisition Proposal and Frequency will, and cause its Representatives to, negotiate
with Korro in good faith (to the extent Korro desires to negotiate) to make such adjustments in the terms and conditions of this Agreement so that the applicable Acquisition Proposal ceases to constitute a Superior Offer and (z)&nbsp;in the event of
any material amendment to any Superior Offer (including any revision in price or percentage of the Combined Corporation that Frequency&#146;s stockholders would receive as a result of such potential Superior Offer), Frequency shall be required to
provide Korro with notice of such material amendment and the Notice Period shall be extended, if applicable, to ensure that at least two Business Days remain in the Notice Period following such notification during which the parties shall comply
again with the requirements of this <U>Section</U><U></U><U>&nbsp;5.9(c)</U> and the Frequency Board shall not make a Frequency Board Adverse Recommendation Change prior to the end of such Notice Period as so extended (it being understood that there
may be multiple extensions). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Frequency&#146;s obligation to call, give notice of and hold the Frequency Stockholder
Meeting in accordance with <U>Section</U><U></U><U>&nbsp;5.9(a)</U> shall not be limited or otherwise affected by the commencement, disclosure, announcement or submission of any Superior Offer or Acquisition Proposal, or by any withdrawal or
modification of the Frequency Board Recommendation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Nothing contained in this Agreement shall prohibit Frequency or the Frequency
Board from complying with Rules <FONT STYLE="white-space:nowrap">14d-9</FONT> and <FONT STYLE="white-space:nowrap">14e-2(a)</FONT> promulgated under the Exchange Act; provided, however, that any disclosure made by Frequency or the Frequency Board
pursuant to Rules <FONT STYLE="white-space:nowrap">14d-9</FONT> and <FONT STYLE="white-space:nowrap">14e-2(a)</FONT> shall be limited to a statement that Frequency is unable to take a position with respect to the bidder&#146;s tender offer unless
the Frequency Board determines in good faith, after consultation with its outside legal counsel, that such statement would result in a breach of its fiduciary duties under applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10 <U>Efforts; Regulatory Approvals</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Parties shall use reasonable best efforts to consummate the Contemplated Transactions. Without limiting the generality of the
foregoing, each Party: (i)&nbsp;shall make all filings and other submissions (if any) and give all notices (if any) required to be made and given by such Party in connection with the Contemplated Transactions, (ii)&nbsp;shall use commercially
reasonable efforts to obtain each Consent (if any) reasonably required to be obtained (pursuant to any applicable Law or Contract, or otherwise) by such Party in connection with the Contemplated Transactions or for such Contract to remain in full
force and effect, (iii)&nbsp;shall use commercially reasonable efforts to lift any injunction prohibiting, or any other legal bar to, the Contemplated Transactions and (iv)&nbsp;shall use commercially reasonable efforts to satisfy the conditions
precedent to the consummation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the generality of the foregoing, each Party shall use commercially
reasonable efforts to file or otherwise submit, as soon as practicable after the date of this Agreement, all applications, notices, reports and other documents reasonably required to be filed by such Party with or otherwise submitted by such Party
to any Governmental Authority with respect to the Contemplated Transactions, and to submit promptly any additional information requested by any such Governmental Authority. Frequency and Korro shall respond as promptly as is practicable to respond
in compliance with: (i)&nbsp;any inquiries or requests received from the Federal Trade Commission or the Department of Justice for additional information or documentation and (ii)&nbsp;any inquiries or requests received from any state attorney
general, foreign antitrust or competition authority or other Governmental Authority in connection with antitrust or competition matters. Each of the Parties will promptly notify the other Party of the details of any material communication it
receives from any Governmental Authority relating to the matters that are subject to this Agreement and the Contemplated Transactions, and permit the other Party to review in advance, to the extent permitted by Law, any proposed material
communication to any Governmental Authority. Each of the Parties will provide the other Party with advance notice of and, to the extent permitted by such Governmental Authority, give the other party the opportunity to attend and participate in any
meeting with the Governmental Authority in respect of any filings, investigations, or other inquiries. Subject to applicable Laws, the Parties will coordinate and cooperate fully and promptly with one another in exchanging such information and
providing such assistance as the other Party may reasonably request in connection with the foregoing. Subject to applicable Laws, each of the Parties will provide, or cause to be provided, to the other, copies of all material correspondence,
filings, or communications between them or any of their Representatives, on the one hand, and any Governmental Authority or members of its staff, on the other hand, with respect to this Agreement and the Contemplated Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11 <U>Disclosures</U>. Without limiting any Party&#146;s obligations under the
Confidentiality Agreement, no Party shall, and no Party shall permit any of its Subsidiaries or any of its Representative to, issue any press release or make any disclosure (to any customers or employees of such Party, to the public or otherwise)
regarding the Contemplated Transactions unless: (a)&nbsp;the other Party shall have approved such press release or disclosure in writing, such approval not to be unreasonably conditioned, withheld or delayed; or (b)&nbsp;such Party shall have
determined in good faith, upon the advice of outside legal counsel, that such disclosure is required by applicable Law and, to the extent practicable, before such press release or disclosure is issued or made, such Party advises the other Party of,
and consults with the other Party regarding, the text of such press release or disclosure; provided, however, that each of Korro and Frequency may make any statement in response to questions by the press, analysts, investors or those attending
industry conferences or financial analyst conference calls, so long as any such statements are consistent with previous press releases, public disclosures or public statements made by Korro and Frequency in compliance with this
<U>Section</U><U></U><U>&nbsp;5.11</U>. Notwithstanding the foregoing, a Party need not consult with any other Parties in connection with such portion of any press release, public statement or filing to be issued or made pursuant to
<U>Section</U><U></U><U>&nbsp;5.9(d)</U> or with an Acquisition Proposal, or Frequency Board Adverse Recommendation Change with respect to Frequency only pursuant to <U>Section</U><U></U><U>&nbsp;5.9(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.12 <U>Frequency Options</U>. Prior to the Closing, the Frequency Board shall have adopted appropriate resolutions and taken all other
actions necessary and appropriate to provide that the vesting and exercisability of each unexpired, unexercised and unvested Frequency Option shall be accelerated in full effective as of immediately prior to the Effective Time, contingent on the
occurrence of the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.13 <U>Frequency Restricted Stock Units</U>. Prior to the Closing, the Frequency Board shall have adopted
appropriate resolutions and taken all other actions necessary and appropriate to provide that (a)&nbsp;the vesting of each outstanding and unvested Frequency Restricted Stock Unit that vests solely based on the holder&#146;s continued employment or
service shall be accelerated in full effective as of immediately prior to the Effective Time, contingent on the occurrence of the Closing and (b)&nbsp;for each outstanding and unsettled Frequency Restricted Stock Unit that vests solely based on the
holder&#146;s continued employment or service, the holder thereof shall receive, immediately prior to the Effective Time a number of shares of Frequency Common Stock equal to the number of vested and unsettled shares of Frequency Common Stock
underlying such Frequency Restricted Stock Units. Notwithstanding anything herein to the contrary, the tax withholding obligations for each holder receiving shares of Frequency Common Stock in accordance with the preceding sentence shall be
satisfied by Frequency withholding from issuance that number of shares of Frequency Common Stock calculated by multiplying the maximum statutory withholding rate for such holder in connection with such issuance by the number of shares of Frequency
Common Stock to be issued in accordance with the preceding sentence, and rounding up to the nearest whole share and remitting such withholding in cash to the appropriate taxing authorities. For the avoidance of doubt, Frequency Restricted Stock
Units that do not vest solely based on the holder&#146;s continued employment or service shall remain outstanding and subject to the terms set forth in the Frequency 2019 Incentive Award Plan, as amended from time to time, and the applicable
Frequency Restricted Stock Unit award agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.14 <U>Frequency ESPP</U>. As soon as reasonably practicable following the date of this
Agreement, the Frequency Board shall adopt appropriate resolutions to provide that (a)&nbsp;no offering periods or purchase periods shall be commenced following or in addition to the offering period underway as of the date hereof under the Frequency
ESPP (the &#147;<B>Current Offering Period</B>&#148;), (b) no payroll deductions or other contributions shall be made or effected after the Current Offering Period with respect to the Frequency ESPP, and (c)&nbsp;each Frequency ESPP
participant&#146;s accumulated contributions under the Frequency ESPP shall be returned to the participant in accordance with the terms of the Frequency ESPP. Unless Korro requests otherwise in writing no later than ten Business Days prior to the
Closing Date, prior to the Closing Date, the Frequency Board shall adopt appropriate resolutions to provide that the Frequency ESPP is terminated immediately prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.15 <U>Indemnification of Officers and Directors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) From the Effective Time through the sixth anniversary of the date on which the Effective Time occurs, each of Frequency and the Surviving
Corporation shall indemnify and hold harmless each person who is now, or has been at any time prior to the date hereof, or who becomes prior to the Effective Time, a director or officer of Frequency or Korro, respectively (the &#147;<B>D&amp;O
Indemnified Parties</B>&#148;), against all claims, losses, liabilities, damages, judgments, fines and reasonable fees, costs and expenses, including attorneys&#146; fees and disbursements (collectively, &#147;<B>Costs</B>&#148;), incurred in
connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of or pertaining to the fact that the D&amp;O Indemnified Party is or was a director or officer of Frequency
or of Korro, whether asserted or claimed prior to, at or after the Effective Time, in each case, to the fullest extent permitted under Delaware Law. Each D&amp;O Indemnified Party will be entitled to advancement of expenses incurred in the defense
of any such claim, action, suit, proceeding or investigation from each of Frequency and the Surviving Corporation, jointly and severally, upon receipt by Frequency or the Surviving Corporation from the D&amp;O Indemnified Party of a request
therefor; provided that any such person to whom expenses are advanced provides an undertaking to Frequency, to the extent then required by Delaware Law, to repay such advances if it is ultimately determined that such person is not entitled to
indemnification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The provisions of Frequency&#146;s Organizational Documents with respect to indemnification, advancement of expenses
and exculpation of present and former directors and officers of Frequency that are presently set forth in Frequency&#146;s Organizational Documents shall not be amended, modified or repealed for a period of six years from the Effective Time in a
manner that would adversely affect the rights thereunder of individuals who, at or prior to the Effective Time, were officers or directors of Frequency, unless such modification is required by applicable Law. The Surviving Corporation&#146;s
Organizational Documents shall contain, and Frequency shall cause the certificate of incorporation of the Surviving Corporation to so contain, provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of
present and former directors and officers as those presently set forth in Frequency&#146;s Organizational Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) From and after the Effective Time, (i)&nbsp;the Surviving Corporation shall fulfill and
honor in all respects the obligations of Korro to its D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under Korro&#146;s Organizational Documents and pursuant to any indemnification
agreements between Korro and such D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time and (ii)&nbsp;Frequency shall fulfill and honor in all respects the obligations of Frequency to
its D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under Frequency&#146;s Organizational Documents and pursuant to any indemnification agreements between Frequency and such D&amp;O
Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) From and after the
Effective Time, Frequency shall maintain directors&#146; and officers&#146; liability insurance policies, with an effective date as of the Closing Date, on commercially available terms and conditions and with coverage limits customary for U.S.
public companies similarly situated to Frequency. In addition, Frequency shall purchase, prior to the Effective Time, a <FONT STYLE="white-space:nowrap">six-year</FONT> prepaid &#147;D&amp;O tail policy&#148; for the
<FONT STYLE="white-space:nowrap">non-cancellable</FONT> extension of the directors&#146; and officers&#146; liability coverage of Frequency&#146;s existing directors&#146; and officers&#146; insurance policies for a claims reporting or discovery
period of at least six years from and after the Effective Time with respect to any claim related to any period of time at or prior to the Effective Time with terms, conditions, retentions and limits of liability that are no less favorable than the
coverage provided under Frequency&#146;s existing policies as of the date of this Agreement with respect to any actual or alleged error, misstatement, misleading statement, act, omission, neglect, breach of duty or any matter claimed against a
director or officer of Frequency by reason of him or her serving in such capacity that existed or occurred at or prior to the Effective Time (including in connection with this Agreement or the Contemplated Transactions or in connection with
Frequency&#146;s initial public offering of shares of Frequency Common Stock). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) From and after the Effective Time, Frequency shall pay
all expenses, including reasonable attorneys&#146; fees, that are incurred by the persons referred to in this <U>Section</U><U></U><U>&nbsp;5.15</U> in connection with their enforcement of the rights provided to such persons in this
<U>Section</U><U></U><U>&nbsp;5.15</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The provisions of this <U>Section</U><U></U><U>&nbsp;5.15</U> are intended to be in addition
to the rights otherwise available to the current and former officers and directors of Frequency and Korro by Law, charter, statute, bylaw or agreement, and shall operate for the benefit of, and shall be enforceable by, each of the D&amp;O
Indemnified Parties, their heirs and their Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) In the event Frequency or the Surviving Corporation or any of their
respective successors or assigns (i)&nbsp;consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger or (ii)&nbsp;transfers all or substantially all of its
properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of Frequency or the Surviving Corporation, as the case may be, shall succeed to the obligations set forth in this
<U>Section</U><U></U><U>&nbsp;5.15</U>. Frequency shall cause the Surviving Corporation to perform all of the obligations of the Surviving Corporation under this <U>Section</U><U></U><U>&nbsp;5.15</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.16 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All transfer, documentary, sales, use, stamp, registration, excise, recording, registration value added and other such similar Taxes and
fees (including any penalties and interest) that become payable in connection with or by reason of the execution of this Agreement and the transactions contemplated hereby (collectively, &#147;<B>Transfer Taxes</B>&#148;) shall be borne and paid by
Frequency. Unless otherwise required by applicable law, Frequency shall timely file any Tax Return or other document with respect to such Taxes or fees (and Korro shall reasonably cooperate with respect thereto as necessary). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) At the Closing, Korro shall deliver to Frequency a certificate pursuant to Treasury Regulations Sections
<FONT STYLE="white-space:nowrap">1.1445-2(c)</FONT> and <FONT STYLE="white-space:nowrap">1.897-2(h),</FONT> together with a form of notice to the IRS in accordance with the requirements of Treasury Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;1.897-2(h),</FONT> in each case, in form and substance reasonably acceptable to Frequency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The parties intend that, for United States federal income tax purposes, the Merger shall qualify for the Intended Tax Treatment. The
Merger shall be reported by the parties for all Tax purposes in accordance with the foregoing, and no party shall take any position on any Tax Return that is inconsistent with the Intended Tax Treatment, unless otherwise required by a Governmental
Authority as a result of a &#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code. The parties shall cooperate with each other and their respective counsel to document and support the Tax treatment of the Merger as
qualifying for the Intended Tax Treatment, including by taking the actions described on <U>Section</U><U></U><U>&nbsp;5.16(c)</U> of the Korro Disclosure Schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Frequency shall use commercially reasonable efforts to promptly notify Korro, and Korro shall use commercially reasonable efforts to
promptly notify Frequency, in each case if either party becomes aware of any <FONT STYLE="white-space:nowrap">non-public</FONT> fact or circumstance that, to such party&#146;s Knowledge, would reasonably be likely to prevent or impede the Merger
from qualifying for the Intended Tax Treatment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.17 <U>Listing</U>. At or prior to the Effective Time, Frequency shall use commercially
reasonable efforts to (a)&nbsp;maintain a listing on Nasdaq until the Effective Time and to obtain approval of the listing of the Combined Corporation on Nasdaq; (b)&nbsp;to the extent required by the rules and regulations of Nasdaq, prepare and
submit to Nasdaq a notification form for the listing of the shares of Frequency Common Stock to be issued in connection with the Contemplated Transactions and to cause such shares to be approved for listing; (c)&nbsp;prepare and timely submit to
Nasdaq a notification form of the Nasdaq Reverse Split and to submit a copy of the amendment to Frequency&#146;s certificate of incorporation to effect the Nasdaq Reverse Split and other amendments contemplated by
<U>Section</U><U></U><U>&nbsp;2.4</U> certified by the Secretary of State of the State of Delaware, to Nasdaq on or before the Closing Date; and (d)&nbsp;to the extent required by Nasdaq Marketplace Rule 5110, assist Korro in preparing and filing an
initial listing application for the Frequency Common Stock on Nasdaq (the &#147;<B>Nasdaq Listing Application</B>&#148;). The Party not filing the Nasdaq Listing Application will cooperate with the other Party as reasonably requested by such filing
Party with respect to the Nasdaq Listing Application and promptly furnish to such filing Party all information concerning itself and its stockholders that may be required or reasonably requested in connection with any action contemplated by this
<U>Section</U><U></U><U>&nbsp;5.17</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.18 <U>Legends</U>. Frequency shall be entitled to place appropriate legends on the book
entries and/or certificates evidencing any shares of Frequency Capital Stock to be received in the Merger by equityholders of Korro who may be considered &#147;affiliates&#148; of Frequency for purposes of Rule 145 under the Securities Act
reflecting the restrictions set forth in Rule 145 and to issue appropriate stop transfer instructions to the transfer agent for Frequency Capital Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.19 <U>Officers and Directors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Directors and Officers of Frequency</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Frequency shall cause, effective as of the Effective Time, the Frequency Board to consist of seven (7)&nbsp;individuals,
which shall consist of (A)&nbsp;four (4) members selected by the Korro Board as set forth on <U>Section</U><U></U><U>&nbsp;5.19(a)(i)</U> of the Frequency Disclosure Schedule (each, a &#147;<B>Korro Designee</B>&#148;), (B) one (1)&nbsp;member
selected by the Frequency Board as set forth on <U>Schedule </U><U>5.19(a)(i)</U> of the Frequency Disclosure Schedule (each, a &#147;<B>Frequency Designee</B>&#148;) and (C)&nbsp;two (2) members who shall be independent. If any Korro Designee or
Frequency Designee is unable or unwilling to serve as director of Frequency, the Party appointing such Person shall designate a successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Frequency shall cause the directors and officers of Frequency listed on <U>Schedule 5.19(a)(ii)</U> of the Frequency
Disclosure Schedule to sign written resignations in forms reasonably satisfactory to Korro, dated on or before the Closing Date and effective as of the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Immediately following the Effective Time, Frequency shall take all necessary action to appoint the officers of Korro to
become the equivalent officers of Frequency until the earlier of their resignation or removal or until their respective successors are duly elected or appointed and qualified, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Directors and Officers of the Surviving Corporation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Parties shall take all actions necessary (A)&nbsp;so that from and after the Effective Time, the Surviving
Corporation&#146;s board of directors shall be constituted with those members as set forth on <U>Section</U><U></U><U>&nbsp;5.19(b)</U> of the Frequency Disclosure Schedule and (B)&nbsp;to secure the resignations of the existing members of the
committees of the Surviving Corporation, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) The Parties shall take all actions necessary so that the officers
of Korro immediately prior to the Effective Time shall, from and after the Effective Time, be the officers of the Surviving Corporation, until the earlier of their resignation or removal or until their respective successors are duly elected or
appointed and qualified, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) On the Closing Date, the Surviving Corporation shall enter into
customary indemnification agreements reasonably satisfactory to Korro with each individual to be appointed to, or serving on, the board of directors of the Surviving Corporation upon the Closing, which indemnification agreements shall continue to be
effective following the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.20 <U>Termination of Certain Agreements and Rights</U>. Korro shall cause any stockholder
agreements, voting agreements, registration rights agreements, <FONT STYLE="white-space:nowrap">co-sale</FONT> agreements and any other similar Contracts between Korro and any holders of Korro Capital Stock, including any such Contract granting any
Person investor rights, rights of first refusal, registration rights or director registration rights to be terminated immediately prior to the Effective Time, without any liability being imposed on the part of Frequency or the Surviving Corporation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.21 <U>Section 16</U><U> Matters</U>. Prior to the Effective Time, Frequency shall take all such steps as may be required to cause any
acquisitions of Frequency Common Stock and any options to purchase Frequency Common Stock in connection with the Contemplated Transactions, by each individual who is reasonably expected to become subject to the reporting requirements of
Section&nbsp;16(a) of the Exchange Act with respect to Frequency, to be exempt under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.22 <U>Allocation Certificate</U>. Korro will prepare and deliver to Frequency at least two Business Days prior to the Closing Date a
certificate signed by an executive officer of Korro in a form reasonably acceptable to Frequency setting forth (as of immediately prior to the Effective Time)&nbsp;(a) each holder of Korro Capital Stock, Korro Options or Korro Warrants,
(b)&nbsp;such holder&#146;s name and address, (c)&nbsp;the number and type of Korro Capital Stock held as of the Closing Date for each such holder or, with respect to each Korro Option or Korro Warrant, the grant date of such Korro Option or Korro
Warrant and the number of shares subject to such Korro Option or Korro Warrant, (d)&nbsp;the number of shares of Frequency Common Stock to be issued to such holder pursuant to this Agreement in respect of the Korro Capital Stock held by such holder
as of immediately prior to the Effective Time or, with respect to each Korro Option or Korro Warrant, the number of shares of Frequency Common Stock to be subject to the applicable Assumed Option or Assumed Warrant as of immediately prior to the
Effective Time following the conversion of such Korro Option or Korro Warrant into an Assumed Option in accordance with <U>Section</U><U></U><U>&nbsp;2.4(f)</U> or into an Assumed Warrant in accordance with <U>Section</U><U></U><U>&nbsp;2.4(i)</U>
(as applicable), and (e)&nbsp;each investor in the Concurrent Financing, the total investment to be made by such investor in the Concurrent Financing, the percentage of the Concurrent Financing Proceeds represented by such stockholder&#146;s
investment in the Concurrent Financing, and the number of shares of Frequency Common Stock to be issued to such holder pursuant to this Agreement (the &#147;<B>Allocation Certificate</B>&#148;). For the avoidance of doubt, the Allocation Certificate
shall be prepared in good faith, in accordance with the Organizational Documents of Korro and contracts applicable to Korro Capital Stock, Korro Options and Korro Warrants, and shall show each holder&#146;s percentage ownership interest in Korro on
a fully diluted basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.23 <U>Nasdaq Reverse Split</U>. Frequency shall submit to Frequency&#146;s stockholders at the Frequency
Stockholder Meeting the Reverse Stock Split Proposal, and the Parties shall take such other actions as shall be reasonably necessary to effectuate the Nasdaq Reverse Split. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.24 <U>Obligations of Merger Sub</U>. Frequency will take all action necessary to cause Merger Sub to perform its obligations under this
Agreement and to consummate the Merger on the terms and conditions set forth in this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.25 <U>Takeover Statutes</U>. If any takeover statute is or may become applicable to the
Contemplated Transactions, each of Korro, the Korro Board, Frequency and the Frequency Board, as applicable, shall grant such approvals and take such actions as are necessary, to the extent permitted by Law, so that the Contemplated Transactions may
be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise act to eliminate or minimize the effects of such statute or regulation on the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.26 <U>Stockholder Litigation</U>. Each Party shall keep the other Party reasonably informed regarding any stockholder litigation against
Frequency or any of its directors relating to this Agreement or the Contemplated Transactions (&#147;<B>Transaction Litigation</B>&#148;). Prior to the Closing, Frequency shall have the right to control the defense and settlement of any Transaction
Litigation, but shall reasonably consult with Korro and consider any advice from Korro and its Representatives with respect to Transaction Litigation. Frequency shall promptly advise Korro of the initiation of, and shall keep Korro reasonably
apprised of any material developments in connection with, any such Transaction Litigation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.27 <U>Concurrent Financing</U>.<U> </U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, Korro shall use commercially reasonable efforts to obtain the Concurrent Financing
on the terms and conditions described in the Subscription Agreement and satisfy the conditions to the Concurrent Financing as described in the Subscription Agreement and shall not permit any termination, amendment or modification to be made to, or
any waiver of any provision under, or any replacement of, the Subscription Agreement if such termination, amendment, modification, waiver or replacement (i)&nbsp;reduces the aggregate amount of the Concurrent Financing or (ii)&nbsp;imposes new or
additional conditions or otherwise expands, amends or modifies any of the conditions to the receipt of the Concurrent Financing, or otherwise expands, amends or modifies any other provision of the Subscription Agreement, in a manner that would
reasonably be expected to (x)&nbsp;delay or prevent the funding of the Concurrent Financing (or satisfaction of the conditions to the Concurrent Financing) at or substantially simultaneously with the Closing or (y)&nbsp;adversely impact the ability
of Korro to enforce its rights against other parties to the Subscription Agreement. Korro shall promptly deliver to Frequency copies of any such termination, amendment, modification, waiver or replacement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Korro shall use commercially reasonable efforts (i)&nbsp;to maintain in effect the Subscription Agreement, (ii)&nbsp;to enforce its rights
under the Subscription Agreement and (iii)&nbsp;to comply with its obligations under the Subscription Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Korro shall give
Frequency prompt notice (i)&nbsp;of any breach or default by any party to the Subscription Agreement or definitive agreements related to the Concurrent Financing of which Korro becomes aware, (ii)&nbsp;of the receipt of any written notice or other
written communication from any Purchaser with respect to any (x)&nbsp;actual breach, default, termination or repudiation by any party to the Subscription Agreement or definitive agreements related to the Concurrent Financing of any provisions of the
Subscription Agreement or definitive agreements related to the Concurrent Financing or (y)&nbsp;material dispute or disagreement relating to the Concurrent Financing with respect to the obligation to fund the Concurrent Financing at or substantially
simultaneously with the Closing, and (iii)&nbsp;if at any time for any reason Korro believes in good faith that it will not be able to obtain all or any portion of the Concurrent Financing on the terms and conditions, in the manner or from the
sources contemplated by the Subscription Agreement or definitive agreements related to the Concurrent Financing. Korro shall promptly provide information reasonably requested by Frequency relating to the circumstances referred to in clauses (i),
(ii) or (iii)&nbsp;of the immediately preceding sentence. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.28 <U>Frequency Equity Plan</U><U>s</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Effective Time, Frequency will use commercially reasonable efforts to cause the Frequency Board to adopt the 2023 Equity
Incentive Plan, subject to the Closing and effective as of the Effective Time, and will include provisions in the Proxy Statement for the stockholders of Frequency to approve the 2023 Equity Incentive Plan. Subject to the approval of the 2023 Equity
Incentive Plan by the stockholders of Frequency prior to the Effective Time, Frequency shall file with the SEC, promptly after the Effective Time and at Korro&#146;s expense, a registration statement on Form
<FONT STYLE="white-space:nowrap">S-8</FONT> (or any successor form), if available for use by Frequency, relating to the shares of Frequency Common Stock issuable with respect to the 2023 Equity Incentive Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Prior to the Effective Time, Frequency will use commercially reasonable efforts to cause the Frequency Board to adopt the 2023 ESPP,
subject to the Closing and effective as of the Effective Time, and will include provisions in the Proxy Statement for the stockholders of Frequency to approve the 2023 ESPP. Subject to the approval of the 2023 ESPP by the stockholders of Frequency
prior to the Effective Time, Frequency shall file with the SEC, promptly after the Effective Time and at Korro&#146;s expense, a registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (or any successor form), if available for use
by Frequency, relating to the shares of Frequency Common Stock issuable with respect to the 2023 ESPP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) For the avoidance of doubt,
approval of the 2023 Plans by the stockholders of Frequency shall not be a condition to Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.29 <U>Frequency 401(k)</U><U>
Plan</U>. Unless Korro requests otherwise in writing no later than ten Business Days prior to the Closing Date, Frequency shall, effective as of at least one (1)&nbsp;day prior to the Closing Date but subject to the Closing, terminate any Frequency
Employee Plan that is intended to meet the requirements of Section&nbsp;401(k) of the Code, and which is sponsored, or contributed to, by Frequency or any of its ERISA Affiliates (the &#147;<B>401(k) Plan</B>&#148;) and no further contributions
shall be made to the 401(k) Plan and all participant account balances in such plan shall become 100% vested. Frequency shall provide to Korro executed resolutions of the board of directors of Frequency authorizing such termination that are
sufficient to assure compliance with all applicable requirements of the Code and regulations thereunder, including such that the <FONT STYLE="white-space:nowrap">tax-qualified</FONT> status of the 401(k) Plan will be maintained at the time of
termination. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS TO CONSUMMATION OF THE MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <U>Conditions Precedent to Obligations of Each Party</U>. The obligations of each Party to effect the Merger and otherwise consummate the
Contemplated Transactions are subject to the satisfaction or, to the extent permitted by applicable law, the written waiver by each of the Parties, at or prior to the Closing, of each of the following conditions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) No temporary restraining order, preliminary or permanent injunction or other Order
preventing the consummation of the Contemplated Transactions shall have been issued by any court of competent jurisdiction or other Governmental Authority of competent jurisdiction and remain in effect and there shall not be any Law which has the
effect of making the consummation of the Contemplated Transactions illegal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Frequency shall have obtained the Required Frequency
Stockholder Vote, and Korro shall have obtained the Required Korro Stockholder Vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The approval of the listing of the additional
shares of Frequency Common Stock on Nasdaq shall have been obtained and the shares of Frequency Common Stock to be issued in the Merger pursuant to this Agreement shall have been approved for listing (subject to official notice of issuance) on
Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Subscription Agreement shall be in full force and effect and cash proceeds of not less than the Concurrent Investment
Amount shall have been received by Korro, or will be received by Korro substantially simultaneously with the Closing, in connection with the consummation of the transactions contemplated by the Subscription Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Frequency <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements and Korro <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreements will continue to be in full force and effect as of immediately following the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The Registration Statement
shall have become effective in accordance with the provisions of the Securities Act, and shall not be subject to any stop order or proceeding seeking a stop order with respect to the Registration Statement that has not been withdrawn. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Korro shall have effected the Korro Preferred Stock Conversion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <U>Conditions Precedent to Obligations of </U><U>Korro</U>. The obligations of Korro to effect the Merger and otherwise consummate the
Contemplated Transactions are subject to the satisfaction or, to the extent permitted by applicable law, the written waiver by Korro, at or prior to the Closing, of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each of the Frequency Fundamental Representations shall have been true and correct in all material respects as of the date of this
Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which
case such representations and warranties shall be true and correct as of such date). The Frequency Capitalization Representations shall have been true and correct in all respects as of the date of this Agreement and shall be true and correct on and
as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case, (x)&nbsp;for such inaccuracies which are de minimis, individually or in the aggregate or (y)&nbsp;for those representations and warranties
which address matters only as of a particular date (which representations and warranties shall have been true and correct, subject to the qualifications as set forth in the preceding clause (x), as of such particular date). The representations and
warranties of Frequency and Merger Sub contained in this Agreement (other than the Frequency Fundamental Representations and the Frequency Capitalization Representations) shall have been true and correct as of the date of this Agreement and shall be
true and correct on and as of the Closing Date with the same force and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effect as if made on the Closing Date except (i)&nbsp;in each case, or in the aggregate, where the failure to be true and correct would not reasonably be expected to have a Frequency Material
Adverse Effect (without giving effect to any references therein to any Frequency Material Adverse Effect or other materiality qualifications) or (ii)&nbsp;for those representations and warranties which address matters only as of a particular date
(which representations shall have been true and correct, subject to the qualifications as set forth in the preceding clause (i), as of such particular date) (it being understood that, for purposes of determining the accuracy of such representations
and warranties, any update of or modification to the Frequency Disclosure Schedule made or purported to have been made after the date of this Agreement shall be disregarded). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Frequency and Merger Sub shall have performed and complied in all material respects with all covenants and agreements required to be
performed or complied with by them under this Agreement at or prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) A Frequency Material Adverse Effect shall
not have occurred since the date of this Agreement and be continuing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The existing shares of Frequency Common Stock shall have been
continually listed on Nasdaq as of and from the date of this Agreement through the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Frequency shall have delivered to
Korro a certificate (the &#147;<B>Frequency Closing Certificate</B>&#148;), dated the Closing Date and signed by an executive officer of Frequency, certifying to the effect that the conditions set forth in <U>Sections </U><U>6.2(a)</U>,
<U>6.2(b)</U> and <U>6.2(c)</U> have been satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <U>Conditions Precedent to Obligations of</U><U> </U><U>Frequency</U>. The
obligations of Frequency and Merger Sub to effect the Merger and otherwise consummate the Contemplated Transactions are subject to the satisfaction or, to the extent permitted by applicable law, the written waiver by Frequency, at or prior to the
Closing, of each of the following conditions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each of the Korro Fundamental Representations shall have been true and correct in all
material respects as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the extent such representations and warranties are
specifically made as of a particular date, in which case such representations and warranties shall be true and correct as of such date). The Korro Capitalization Representations shall have been true and correct in all respects as of the date of this
Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case, (x)&nbsp;for such inaccuracies which are de minimis, individually or in the aggregate or
(y)&nbsp;for those representations and warranties which address matters only as of a particular date (which representations and warranties shall have been true and correct, subject to the qualifications as set forth in the preceding clause (x), as
of such particular date). The representations and warranties of Korro contained in this Agreement (other than the Korro Fundamental Representations and the Korro Capitalization Representations) shall have been true and correct as of the date of this
Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on the Closing Date except (i)&nbsp;in each case, or in the aggregate, where the failure to be so true and correct would not reasonably
be expected to have a Korro Material Adverse Effect (without giving effect to any references therein to any Korro Material Adverse Effect or other materiality qualifications) or (ii)&nbsp;for those </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
representations and warranties which address matters only as of a particular date (which representations shall have been true and correct, subject to the qualifications as set forth in the
preceding clause (i), as of such particular date) (it being understood that, for purposes of determining the accuracy of such representations and warranties, any update of or modification to the Korro Disclosure Schedule made or purported to have
been made after the date of this Agreement shall be disregarded). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Korro shall have performed and complied in all material respects
with all covenants and agreements required to be performed or complied with by it under this Agreement at or prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) A Korro Material Adverse Effect shall not have occurred since the date of this Agreement and be continuing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Korro shall have delivered to Frequency a certificate (the &#147;<B>Korro</B> <B>Closing Certificate</B>&#148;), dated the Closing Date
and signed by an executive officer of Korro, certifying to the effect that (i)&nbsp;the conditions set forth in <U>Sections </U><U>6.3(a)</U>, <U>6.3(b)</U> and <U>6.3(c)</U> have been satisfied and (ii)&nbsp;the information set forth in the
Allocation Certificate delivered by Korro in accordance with <U>Section</U><U></U><U>&nbsp;5.20</U> is true and accurate in all respects as of the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4 <U>Frustration of Closing Conditions</U>. Neither Frequency nor Merger Sub may rely on the failure of any conditions set forth in
<U>Sections </U><U>6.1</U> or <U>6.3</U> to be satisfied if the primary cause of such failure was the failure of Frequency or Merger Sub to perform any of its obligations under this Agreement. Korro may not rely on the failure of any conditions set
forth in <U>Sections </U><U>6.1</U> or <U>6.2</U> to be satisfied if the primary cause of such failure was the failure of Korro to perform any of its obligations under this Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CLOSING
DELIVERIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <U>Closing Deliveries of Korro</U>. The obligations of Frequency and Merger Sub to effect the Merger and otherwise
consummate the Contemplated Transactions are subject to Frequency receiving the following documents, each of which shall be in full force and effect, or the written waiver by Frequency of delivery: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Korro Stockholder Written Consents; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Allocation Certificate; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the Korro Closing Certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Closing Deliveries of </U><U>Frequency</U>. The obligations of Korro to effect the Merger and otherwise consummate the Contemplated
Transactions are subject to Korro receiving the following documents, each of which shall be in full force and effect, or the written waiver by Korro of delivery: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Frequency Net Cash Schedule; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Frequency Closing Certificate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) subject to <U>Section</U><U></U><U>&nbsp;2.5</U>, the executed CVR Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) written resignations in forms satisfactory to Korro, dated as of the Closing Date and effective as of the Closing executed by the officers
and directors of Frequency who are not to continue as officers or directors of Frequency pursuant to <U>Section</U><U></U><U>&nbsp;5.18</U> hereof. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1
<U>Termination</U>. This Agreement may be terminated, and the Merger and the Contemplated Transactions may be abandoned at any time prior to the Effective Time, whether before or (subject to the terms hereof) after approval of the Frequency
Stockholder Matters by Frequency&#146;s stockholders, unless otherwise specified below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) by mutual written consent of Frequency and
Korro; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) by either Frequency and Korro if the Merger shall not have been consummated by November&nbsp;14, 2023 (subject to possible
extension as provided in this <U>Section</U><U></U><U>&nbsp;8.1(b)</U>, the &#147;<B>Outside Date</B>&#148;); provided, however, that the right to terminate this Agreement under this <U>Section</U><U></U><U>&nbsp;8.1(b)</U> shall not be available to
Frequency or Korro if such Party&#146;s action or failure to act has been a principal cause of the failure of the Merger to occur on or before the Outside Date and such action or failure to act constitutes a breach of this Agreement, provided,
further, however, that, in the event that the SEC has not declared effective under the Securities Act the Registration Statement by the date which is 25 Business Days prior to the Outside Date, then either Frequency or Korro shall be entitled to
extend the Outside Date for an additional 60 days; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) by either Frequency and Korro if a court of competent jurisdiction or other
Governmental Authority shall have issued a final and nonappealable Order, or shall have taken any other action, having the effect of permanently restraining, enjoining or otherwise prohibiting the Contemplated Transactions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) by Frequency if the Required Korro Stockholder Vote shall not have been obtained and evidence thereof delivered to Frequency within five
Business Days of the Registration Statement becoming effective in accordance with the provisions of the Securities Act; provided, however, that once the Required Korro Stockholder Vote has been obtained, Frequency may not terminate this Agreement
pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(d)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) by either Frequency and Korro if (i)&nbsp;the Frequency Stockholder
Meeting (including any adjournments and postponements thereof) shall have been held and completed and Frequency&#146;s stockholders shall have taken a final vote on the Frequency Stockholder Matters and (ii)&nbsp;the Frequency Stockholder Matters
shall not have been approved at the Frequency Stockholder Meeting (or at any adjournment or postponement thereof) by the Required Frequency Stockholder Vote; provided, however, that the right to terminate this Agreement under this
<U>Section</U><U></U><U>&nbsp;8.1(e)</U> shall not be available to Frequency where the failure to obtain the Required Frequency Stockholder Vote shall have been caused by the action or failure to act of Frequency and such action or failure to act
constitutes a breach of this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) by Korro (at any time prior to the approval of the Frequency Stockholder Matters by the
Required Frequency Stockholder Vote) if a Frequency Triggering Event shall have occurred; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) by Frequency (at any time prior to the
adoption of this Agreement and the approval of the Contemplated Transactions by the Required Korro Stockholder Vote) if a Korro Triggering Event shall have occurred; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) by Korro, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by Frequency or Merger Sub or
if any representation or warranty of Frequency or Merger Sub shall have become inaccurate, in either case, such that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.2(a)</U> or <U>Section</U><U></U><U>&nbsp;6.2(b)</U> would not be
satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; provided that Korro is not then in material breach of any representation, warranty, covenant or agreement under this Agreement;
provided, further, that if such inaccuracy in Frequency&#146;s or Merger Sub&#146;s representations and warranties or breach by Frequency or Merger Sub is curable by Frequency or Merger Sub, then this Agreement shall not terminate pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1(h)</U> as a result of such particular breach or inaccuracy until the expiration of a <FONT STYLE="white-space:nowrap">30-day</FONT> period commencing upon delivery of written notice from Korro to Frequency or Merger
Sub of such breach or inaccuracy and its intention to terminate pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(h)</U> (it being understood that this Agreement shall not terminate pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(h)</U> as a
result of such particular breach or inaccuracy if such breach by Frequency or Merger Sub is cured prior to such termination becoming effective); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) by Frequency, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by Korro or if any
representation or warranty of Korro shall have become inaccurate, in either case, such that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.3(a)</U> or <U>Section</U><U></U><U>&nbsp;6.3(b)</U> would not be satisfied as of the time of
such breach or as of the time such representation or warranty shall have become inaccurate; provided that Frequency is not then in material breach of any representation, warranty, covenant or agreement under this Agreement; provided, further, that
if such inaccuracy in Korro&#146;s representations and warranties or breach by Korro is curable by Korro then this Agreement shall not terminate pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(i)</U> as a result of such particular breach or
inaccuracy until the expiration of a <FONT STYLE="white-space:nowrap">30-day</FONT> period commencing upon delivery of written notice from Frequency to Korro of such breach or inaccuracy and its intention to terminate pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1(i)</U> (it being understood that this Agreement shall not terminate pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(i)</U> as a result of such particular breach or inaccuracy if such breach by Korro is cured
prior to such termination becoming effective). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Party desiring to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1</U> (other than pursuant to <U>Section</U><U></U><U>&nbsp;8.1(a)</U>) shall give a notice of such termination to the other Party specifying the provisions hereof pursuant to which such termination is made and the
basis therefor described in reasonable detail. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <U>Effect of Termination</U>. In the event of the termination of this Agreement as
provided in <U>Section</U><U></U><U>&nbsp;8.1</U>, this Agreement shall be of no further force or effect; provided, however, that (a)&nbsp;this <U>Section</U><U></U><U>&nbsp;8.2</U>, <U>Section</U><U></U><U>&nbsp;8.3</U>, and <U>Article IX</U> shall
survive the termination of this Agreement and shall remain in full force and effect and (b)&nbsp;the termination of this Agreement and the provisions of <U>Section</U><U></U><U>&nbsp;8.3</U> shall not relieve any Party of any liability for fraud or
for any willful and material breach of any representation, warranty, covenant, obligation or other provision contained in this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <U>Expenses; Termination Fees</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in this <U>Section</U><U></U><U>&nbsp;8.3</U> all fees and expenses incurred in connection with this Agreement and the
Contemplated Transactions shall be paid by the Party incurring such expenses, whether or not the Merger is consummated; provided, however, that (i)&nbsp;Korro shall pay the costs and expenses incurred in relation to the filings by the Parties under
any antitrust Law applicable to this Agreement and the transactions contemplated hereby, and (ii)&nbsp;that Frequency and Korro shall share equally all fees and expenses incurred in relation to the printing and filing with the SEC of the
Registration Statement (including any financial statements and exhibits) and any amendments or supplements thereto and paid to a financial printer or the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If (i)&nbsp;this Agreement is terminated by Frequency or Korro pursuant to <U>Section</U><U></U><U>&nbsp;8.1(e)</U>, (ii) at any time
after the date of this Agreement and prior to the Frequency Stockholder Meeting an Acquisition Proposal with respect to Frequency shall have been publicly announced, disclosed or otherwise communicated to the Frequency Board (and shall not have been
withdrawn) and (iii)&nbsp;within 12 months after the date of such termination, Frequency enters into a definitive agreement with respect to a Subsequent Transaction or consummates a Subsequent Transaction, then Frequency shall pay to Korro, within
four Business Days after such entry into a definitive agreement and/or consummation of a Subsequent Transaction, a nonrefundable fee in an amount equal to $1,500,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If this Agreement is terminated by Korro pursuant to <U>Section</U><U></U><U>&nbsp;8.1(f)</U>, then Frequency shall pay to Korro, within
four Business Days after termination, a nonrefundable fee in an amount equal to $1,500,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) If this Agreement is terminated by
Frequency pursuant to <U>Section</U><U></U><U>&nbsp;8.1(d)</U> or <U>Section</U><U></U><U>&nbsp;8.1(g)</U>, then Korro shall pay to Frequency, within four Business Days after termination, a nonrefundable fee in an amount equal to $4,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) If either Party fails to pay when due any amount payable by it under this <U>Section</U><U></U><U>&nbsp;8.3</U>, then (i)&nbsp;such Party
shall reimburse the other Party for reasonable costs and expenses (including reasonable fees and disbursements of counsel) incurred in connection with the collection of such overdue amount and the enforcement by the other Party of its rights under
this <U>Section</U><U></U><U>&nbsp;8.3</U> and (ii)&nbsp;such Party shall pay to the other Party interest on such overdue amount (for the period commencing as of the date such overdue amount was originally required to be paid and ending on the date
such overdue amount is actually paid to the other Party in full) at a rate per annum equal to the &#147;prime rate&#148; (as announced by Bank of America or any successor thereto) in effect on the date such overdue amount was originally required to
be paid plus three percent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The Parties agree that, subject to <U>Section</U><U></U><U>&nbsp;8.2</U>, the payment of the fees and
expenses set forth in this <U>Section</U><U></U><U>&nbsp;8.3</U> shall be the sole and exclusive remedy of each Party following a termination of this Agreement under the circumstances described in this <U>Section</U><U></U><U>&nbsp;8.3</U> that
result in the payment of such fees, it being understood that in no event shall either Frequency or Korro be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required to pay the individual fees or damages payable pursuant to this <U>Section</U><U></U><U>&nbsp;8.3</U> on more than one occasion. Subject to <U>Section</U><U></U><U>&nbsp;8.2</U>,
following the termination of this Agreement under the circumstances described in this <U>Section</U><U></U><U>&nbsp;8.3</U> and the payment of the fees set forth in this <U>Section</U><U></U><U>&nbsp;8.3</U> by a Party, (i)&nbsp;such Party shall
have no further liability to the other Party in connection with or arising out of this Agreement or the termination thereof, any breach of this Agreement by the other Party giving rise to such termination, or the failure of the Contemplated
Transactions to be consummated, (ii)&nbsp;no other Party or their respective Affiliates shall be entitled to bring or maintain any other claim, action or proceeding against such Party or seek to obtain any recovery, judgment or damages of any kind
against such Party (or any partner, member, stockholder, director, officer, employee, Subsidiary, affiliate, agent or other representative of such Party) in connection with or arising out of this Agreement or the termination thereof, any breach by
such Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated and (iii)&nbsp;all other Parties and their respective Affiliates shall be precluded from any other remedy against such Party and its
Affiliates, at law or in equity or otherwise, in connection with or arising out of this Agreement or the termination thereof, any breach by such Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated.
Each of the Parties acknowledges that (x)&nbsp;the agreements contained in this <U>Section</U><U></U><U>&nbsp;8.3</U> are an integral part of the Contemplated Transactions, (y)&nbsp;without these agreements, the Parties would not enter into this
Agreement and (z)&nbsp;any amount payable pursuant to this <U>Section</U><U></U><U>&nbsp;8.3</U> is not a penalty, but rather is liquidated damages in a reasonable amount that will compensate the Parties in the circumstances in which such amount is
payable. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1
<U><FONT STYLE="white-space:nowrap">Non-Survival</FONT> of Representations and Warranties</U>. The representations and warranties of Korro, Frequency and Merger Sub contained in this Agreement or any certificate or instrument delivered pursuant to
this Agreement shall terminate at the Effective Time, and only the covenants that by their terms survive the Effective Time and this <U>Article IX</U> shall survive the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <U>Amendment</U>. This Agreement may be amended with the approval of the respective boards of directors of Korro, Merger Sub and Frequency
at any time (whether before or after obtaining the Required Korro Stockholder Vote and the Required Frequency Stockholder Vote); <U>provided</U>, <U>however</U>, that after any such approval of this Agreement by a Party&#146;s stockholders or
members, no amendment shall be made which by Law requires further approval of such stockholders or members without the further approval of such stockholders or members. This Agreement may not be amended except by an instrument in writing signed on
behalf of each of Korro, Merger Sub and Frequency. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <U>Waiver</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Any provision hereof may be waived by the waiving Party solely on such Party&#146;s own behalf, without the consent of any other Party. No
failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of
such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) No Party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this
Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Party and any such waiver shall not be applicable or have any effect except in
the specific instance in which it is given. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <U>Entire Agreement; Counterparts; Exchanges by Electronic Transmission or Facsimile</U>.
This Agreement and the other schedules, exhibits, certificates, instruments and agreements referred to in this Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between
any of the Parties with respect to the subject matter hereof and thereof; <U>provided</U>, <U>however</U>, that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect in accordance with its terms. This
Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all Parties by
facsimile or electronic transmission in PDF format shall be sufficient to bind the Parties to the terms and conditions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <U>Applicable Law; Jurisdiction</U>. This Agreement shall be governed by, and construed in accordance with, the laws of the State of
Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. In any action or proceeding between any of the Parties arising out of or relating to this Agreement or any of the Contemplated
Transactions, each of the Parties: irrevocably and unconditionally (a)&nbsp;consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter
jurisdiction, the Superior Court of the State of Delaware or the United States District Court for the District of Delaware, (b)&nbsp;agrees that all claims in respect of such action or proceeding shall be heard and determined exclusively in
accordance with clause (a)&nbsp;of this <U>Section</U><U></U><U>&nbsp;9.5</U>, (c) waives any objection to laying venue in any such action or proceeding in such courts, (d)&nbsp;waives any objection that such courts are an inconvenient forum or do
not have jurisdiction over any Party, (e)&nbsp;agrees that service of process upon such Party in any such action or proceeding shall be effective if notice is given in accordance with <U>Section</U><U></U><U>&nbsp;9.7</U> of this Agreement and
(f)&nbsp;irrevocably and unconditionally waives the right to trial by jury. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6 <U>Assignability</U>. This Agreement shall be binding
upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective successors and permitted assigns; <U>provided</U>, <U>however</U>, that neither this Agreement nor any of a Party&#146;s rights or obligations
hereunder may be assigned or delegated by such Party without the prior written consent of the other Party, and any attempted assignment or delegation of this Agreement or any of such rights or obligations by such Party without the other Party&#146;s
prior written consent shall be void and of no effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.7 <U>Notices</U>. All notices and other communications hereunder shall be in writing and
shall be deemed to have been duly delivered and received hereunder (a)&nbsp;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier service, (b)&nbsp;upon delivery in the case
of delivery by hand or (c)&nbsp;on the date delivered in the place of delivery if sent by email or facsimile (with a written or electronic confirmation of delivery) prior to 6:00 p.m. New York City time, otherwise on the next succeeding Business
Day, in each case to the intended recipient as set forth below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">if to Frequency or Merger Sub: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Frequency Therapeutics </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">75
Hayden Ave </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Lexington, MA 02421 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention: David Lucchino, Jim Abely </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: dlucchino@frequencytx.com, jabely@frequencytx.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">with a copy to (which shall not constitute notice): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">200 Clarendon Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Boston, MA
02116 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention: John H. Chory, Bradley C. Faris </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: john.chory@lw.com; bradley.faris@lw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">if to Korro: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Korro Bio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">One Kendall Square, Suite 600 Cambridge MA </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention: Ram Aiyar, CEO, Shelby Walker, General Counsel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: raiyar@korrobio.com, legal@korrobio.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">with a copy to (which shall not constitute notice): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Goodwin Procter LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">100
Northern Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts 02210 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention: Kingsley L. Taft, Andrew H. Goodman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: ktaft@goodwinlaw.com, agoodman@goodwinlaw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.8 <U>Cooperation</U>. Each Party agrees to cooperate fully with the other Party and to execute and deliver such further documents,
certificates, agreements and instruments and to take such other actions as may be reasonably requested by the other Party to evidence or reflect the Contemplated Transactions and to carry out the intent and purposes of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.9 <U>Severability</U>. Any term or provision of this Agreement that is invalid or
unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or
in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the Parties agree that the court making such determination shall have the power to
limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or
provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the Parties agree to replace such invalid or unenforceable term or provision with a
valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.10 <U>Other Remedies; Specific Performance</U>. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a
Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties agree
that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms (including
failing to take such actions as are required of it hereunder to consummate this Agreement) or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement
and to enforce specifically the terms and provisions hereof in any court of the United States or any state having jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity, and each of the Parties waives
any bond, surety or other security that might be required of any other Party with respect thereto. Each of the Parties further agrees that it will not oppose the granting of an injunction, specific performance or other equitable relief on the basis
that any other Party has an adequate remedy at law or that any award of specific performance is not an appropriate remedy for any reason at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.11 <U>No Third-Party Beneficiaries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the Parties and the D&amp;O
Indemnified Parties to the extent of their respective rights pursuant to <U>Section</U><U></U><U>&nbsp;5.15</U>) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> </B><B>W</B><B><SMALL>ITNESS</SMALL>
W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the Parties have caused this Agreement to be executed as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>F<SMALL>REQUENCY</SMALL> T<SMALL>HERAPEUTICS</SMALL>, I<SMALL>NC</SMALL>. </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Lucchino</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">David Lucchino</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">President &amp; Chief Executive Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>F<SMALL>REQUENCY</SMALL> M<SMALL>ERGER</SMALL> S<SMALL>UB</SMALL>, I<SMALL>NC</SMALL>.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Lucchino</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">David Lucchino</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">President</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>K<SMALL>ORRO</SMALL> B<SMALL>IO</SMALL>, I<SMALL>NC</SMALL>. </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ram Aiyar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Ram Aiyar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form of Frequency Stockholder Support Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Intentionally Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form of Korro Stockholder Support Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Intentionally Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form of Frequency <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Intentionally Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form of Korro <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Intentionally Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form of Korro Stockholder Written Consent </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Intentionally Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit F </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CVR Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Intentionally Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d651936dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FREQUENCY THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUPPORT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS SUPPORT AGREEMENT</B> (this &#147;<U>Agreement</U>&#148;), dated as of July&nbsp;14, 2023 is made by and among Frequency Therapeutics,
Inc., a Delaware corporation (&#147;<U>Frequency</U>&#148;), Korro Bio, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), and the undersigned holders (each a &#147;<U>Stockholder</U>&#148;) of shares of capital stock (the
&#147;<U>Shares</U>&#148;) of Frequency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Frequency, Frequency Merger Sub, Inc., a Delaware corporation and a wholly owned
subsidiary of Frequency (&#147;<U>Merger Sub</U>&#148;), and the Company, have entered into an Agreement and Plan of Merger, dated of even date herewith (the &#147;<U>Merger Agreement</U>&#148;), providing for the merger of Merger Sub with and into
the Company (the &#147;<U>Merger</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, each Stockholder beneficially owns and has sole or shared voting power with
respect to the number of Shares, and holds Frequency Options to acquire the number of Shares, indicated opposite such Stockholder&#146;s name on <U>Schedule</U><U></U><U>&nbsp;1</U><SUP STYLE="font-size:75%; vertical-align:top"> </SUP>attached
hereto; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, as an inducement and a condition to the willingness of the Company to enter into the Merger Agreement, each
Stockholder has agreed to enter into and perform this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, all capitalized terms used in this Agreement without
definition herein shall have the meanings ascribed to them in the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of, and as a
condition to, the Company&#146;s entering into the Merger Agreement, each Stockholder, Frequency and the Company agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreement to Vote Shares</U>. Each Stockholder agrees that, prior to the Expiration Date
(as defined in <U>Section</U><U></U><U>&nbsp;2</U> below), at any meeting of the stockholders of Frequency or any adjournment or postponement thereof, or in connection with any written consent of the stockholders of Frequency, with respect to the
Merger, the Merger Agreement or any Acquisition Proposal, such Stockholder shall: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;appear at such meeting or otherwise cause the Shares and any New Shares (as
defined in <U>Section</U><U></U><U>&nbsp;3</U> below) to be counted as present thereat for purposes of calculating a quorum; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from and after the date hereof until the Expiration Date, vote (or cause to
be voted), or deliver a written consent (or cause a written consent to be delivered) covering all of the Shares and any New Shares that Stockholder shall be entitled to so vote: (i)&nbsp;in favor of (A)&nbsp;all of the Frequency Stockholder Matters
and (B)&nbsp;any matter that could reasonably be expected to facilitate the Merger, the Concurrent Financing and the Contemplated Transactions; (ii)&nbsp;against any Acquisition Proposal, or any agreement, transaction or other matter that is
intended to, or would reasonably be expected to, impede, interfere with, delay, postpone, discourage or materially and adversely affect the consummation of the Merger, the Concurrent Financing and all of the other Contemplated Transactions; and
(iii)&nbsp;to approve any proposal to adjourn or postpone the meeting to a later date, if there are not sufficient votes for the adoption of the Merger Agreement on the date on which such meeting is held. Stockholder shall not take or commit or
agree to take any action inconsistent with the foregoing. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Expiration Date</U>. As used in this Agreement, the
term &#147;<U>Expiration Date</U>&#148; shall mean the earlier to occur of (a)&nbsp;the Effective Time, (b)&nbsp;such date and time as the Merger Agreement shall be terminated pursuant to <U>Article VIII</U> thereof or otherwise, (c)&nbsp;any
amendment to the Merger Agreement is effected without the Stockholder&#146;s written consent that increases the amount, or changes the form, of consideration payable to all stockholders of the Company pursuant to the terms of the Merger Agreement or
(d)&nbsp;the mutual written agreement of the parties to terminate this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional Acquisitions</U>. Each Stockholder agrees that any shares of capital stock or
other equity securities of Frequency that such Stockholder acquires or with respect to which such Stockholder otherwise acquires sole or shared voting power (including any proxy) after the execution of this Agreement and prior to the Expiration
Date, whether by the exercise of any Frequency Options or otherwise, including, without limitation, by gift, succession, in the event of a stock split or as a dividend or distribution of any Shares (&#147;<U>New Shares</U>&#148;), shall be subject
to the terms and conditions of this Agreement to the same extent as if they constituted the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreement to Retain Shares</U>. From and after the date hereof until the Expiration Date,
each Stockholder shall not, directly or indirectly, (a)&nbsp;sell, assign, transfer, tender, or otherwise dispose of (including, without limitation, by the creation of any Liens (as defined in <U>Section</U><U></U><U>&nbsp;5(c)</U> below)) any
Shares or any New Shares, (b)&nbsp;deposit any Shares or New Shares into a voting trust or enter into a voting agreement or similar arrangement with respect to such Shares or New Shares or grant any proxy or power of attorney with respect thereto
(other than this Agreement), (c)&nbsp;enter into any Contract, option, commitment or other arrangement or understanding with respect to the direct or indirect sale, transfer, assignment or other disposition of (including, without limitation, by the
creation of any Liens) any Shares or New Shares, or (d)&nbsp;take any action that would make any representation or warranty of such Stockholder contained herein untrue or incorrect or have the effect of preventing or disabling such Stockholder from
performing such Stockholder&#146;s obligations under this Agreement. Any action taken in violation of the foregoing sentence shall be null and void <I>ab initio</I>. Notwithstanding the foregoing, each Stockholder may make (1)&nbsp;transfers by will
or by operation of Law or other transfers for estate-planning purposes, in which case this Agreement shall bind the transferee, (2)&nbsp;with respect to such Stockholder&#146;s Frequency Options (and any Shares underlying such Frequency Options)
which expire on or prior to the Expiration Date, transfers, sale, or other disposition of Shares to Frequency (or effecting a &#147;net exercise&#148; of a Frequency Option) as payment for the (i)&nbsp;exercise price of such Stockholder&#146;s
Frequency Options and (ii)&nbsp;taxes applicable to the exercise of such Stockholder&#146;s Frequency Options, (3)&nbsp;if Stockholder is an entity, partnership or limited liability company, a transfer to one or more equityholders, partners or
members of Stockholder or to an Affiliated person, corporation, trust or other Entity controlling or under common control with Stockholder, or if Stockholder is a trust, a transfer to a beneficiary, provided that in each such case the applicable
transferee has signed a voting agreement in substantially the form hereof, (4)&nbsp;make transfers that occur by operation of law pursuant to a qualified domestic relations order or in connection with a divorce settlement, and (5)&nbsp;transfers,
sales or other dispositions as the Company may otherwise </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agree in writing in its sole discretion. If any voluntary or involuntary transfer of any Shares covered hereby shall occur (including a transfer or disposition permitted by
<U>Section</U><U></U><U>&nbsp;4(1)</U> through <U>Section</U><U></U><U>&nbsp;4(5)</U>, sale by a Stockholder&#146;s trustee in bankruptcy, or a sale to a purchaser at any creditor&#146;s or court sale), the transferee (which term, as used herein,
shall include any and all transferees and subsequent transferees of the initial transferee) shall take&nbsp;and hold such Shares subject to all of the restrictions, liabilities and rights under this Agreement, which shall continue in full force and
effect, notwithstanding that such transferee is not a Stockholder and has not executed a counterpart hereof or joinder hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties of Stockholder</U>. Each Stockholder hereby, severally but
not jointly, represents and warrants to Frequency and the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If such Stockholder is an Entity: (i)&nbsp;such Stockholder is duly
organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, organized or constituted, (ii)&nbsp;such Stockholder has all necessary power and authority to execute and deliver this Agreement, to
perform such Stockholder&#146;s obligations hereunder and to consummate the transactions contemplated hereby, and (iii)&nbsp;the execution and delivery of this Agreement, performance of such Stockholder&#146;s obligations hereunder and the
consummation of the transactions contemplated hereby by such Stockholder have been duly authorized by all necessary action on the part of such Stockholder and no other proceedings on the part of such Stockholder are necessary to authorize this
Agreement, or to consummate the transactions contemplated hereby. If&nbsp;such Stockholder is an individual, such Stockholder has the legal capacity to execute and deliver this Agreement, to perform such Stockholder&#146;s obligations hereunder and
to consummate the transactions contemplated hereby; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this Agreement has
been duly executed and delivered by or on behalf of such Stockholder and, to such Stockholder&#146;s knowledge and assuming this Agreement constitutes a valid and binding agreement of the Company and Frequency, constitutes a valid and binding
agreement with respect to such Stockholder, enforceable against such Stockholder in accordance with its terms, except as enforcement may be limited by general principles of equity whether applied in a court of Law or a court of equity and by
bankruptcy, insolvency and similar Laws affecting creditors&#146; rights and remedies generally; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such Stockholder beneficially owns the number of Shares indicated opposite
such Stockholder&#146;s name on <U>Schedule</U><U></U><U>&nbsp;1</U>, and will own any New Shares, free and clear of any liens, claims, charges or other encumbrances or restrictions of any kind whatsoever (&#147;<U>Liens</U>&#148;), and has sole or
shared, and otherwise unrestricted, voting power with respect to such Shares or New Shares and none of the Shares or New Shares is subject to any voting trust or other agreement, arrangement or restriction with respect to the voting of the Shares or
the New Shares, except as contemplated by this Agreement and the stockholder agreements and arrangements referenced in the Merger Agreement and except for customary arrangements with the Stockholder&#146;s prime broker and/or custodian; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to the knowledge of such
Stockholder, the execution and delivery of this Agreement by such Stockholder does not, and the performance by such Stockholder of his, her or its obligations hereunder and the compliance by such Stockholder with any provisions hereof will not,
violate or conflict with, result in a material breach of or constitute a default (or an event that with notice or lapse of time or both would become a material default) under, or give to others any rights of termination, amendment, acceleration or
cancellation of, or result in the creation of any Liens on any Shares or New Shares pursuant to, any agreement, instrument, note, bond, mortgage, Contract, lease, license, permit or other obligation or any order, arbitration award, judgment or
decree to which such Stockholder is a party or by which such Stockholder is bound, or any Law, statute, rule or regulation to which such Stockholder is subject or, in the event that such Stockholder is a corporation, partnership, trust or other
Entity, any bylaw or other Organizational Document of such Stockholder; except for any of the foregoing as would not reasonably be expected to prevent or delay the performance by such Stockholder of his, her or its obligations under this Agreement
in any material respect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the execution and delivery of this Agreement
by such Stockholder does not, and the performance of this Agreement by such Stockholder does not and will not, require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Authority or regulatory
authority by such Stockholder except for applicable requirements, if any, of the Exchange Act, and except where the failure to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications, would not prevent or
delay the performance by such Stockholder of his, her or its obligations under this Agreement in any material respect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no investment banker, broker, finder or other intermediary is entitled to a
fee or commission from Frequency or the Company in respect of this Agreement based upon any Contract made by or on behalf of such Stockholder; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as of the date of this Agreement, there is no Legal Proceeding pending or,
to the knowledge of such Stockholder, threatened against such Stockholder that would reasonably be expected to prevent or delay the performance by such Stockholder of his, her or its obligations under this Agreement in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Irrevocable Proxy</U>. Subject to the penultimate sentence of this
<U>Section</U><U></U><U>&nbsp;6</U>, by execution of this Agreement, each Stockholder does hereby appoint the Company and any of its designees with full power of substitution and resubstitution, as such Stockholder&#146;s true and lawful attorney
and irrevocable proxy, to the fullest extent of such Stockholder&#146;s rights with respect to the Shares, to vote and exercise all voting and related rights, including the right to sign such Stockholder&#146;s name (solely in its capacity as a
stockholder) to any Stockholder consent, if such Stockholder fails to vote his, her or its Shares solely with respect to the matters set forth in <U>Section</U><U></U><U>&nbsp;1</U> hereof by 5:00 p.m. (Eastern Time) on the day immediately preceding
the meeting date (or date upon which written consents are requested to be submitted), provided the Stockholder has received information regarding the meeting or request for written consent at least five (5)&nbsp;Business Days before such shareholder
meeting or any consent solicitation or other vote taken of the Company&#146;s stockholders. Each Stockholder intends this proxy to be irrevocable and coupled with an interest hereunder until the Expiration Date, hereby revokes any proxy previously
granted by such Stockholder with respect to the Shares and represents that none of such previously-granted proxies are irrevocable. The Stockholder hereby affirms that the proxy set forth in this <U>Section</U><U></U><U>&nbsp;6</U> is given
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in connection with, and granted in consideration of, and as an inducement to the Company, Frequency and Merger Sub to enter into the Merger Agreement and that such proxy is given to secure the
obligations of the Stockholder under <U>Section</U><U></U><U>&nbsp;1</U>. The irrevocable proxy and power of attorney granted herein shall survive the death or incapacity of such Stockholder and the obligations of such Stockholder shall be binding
on such Stockholder&#146;s heirs, personal representatives, successors, transferees and assigns. Each Stockholder hereby agrees not to grant any subsequent powers of attorney or proxies with respect to any Shares with respect to the matters set
forth in <U>Section</U><U></U><U>&nbsp;1</U> until after the Expiration Date. Notwithstanding anything contained herein to the contrary, this irrevocable proxy shall automatically terminate upon the Expiration Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>[Intentionally Omitted]</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Legal Actions</U>. Each Stockholder will not in its capacity as a stockholder of
Frequency bring, commence, institute, maintain, prosecute or voluntarily aid any Legal Proceeding which (i)&nbsp;challenges the validity or seeks to enjoin the operation of any provision of this Agreement or (ii)&nbsp;alleges that the execution and
delivery of this Agreement by such Stockholder, either alone or together with the other voting agreements and proxies to be delivered in connection with the execution of the Merger Agreement constitutes a breach of any fiduciary duty of the
Frequency Board or any member thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other Remedies; Specific Performance</U>.
Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party will be deemed cumulative with, and not exclusive of, any other remedy conferred hereby, or by Law or equity upon such party, and the exercise by a
party of any one remedy will not preclude the exercise of any other remedy. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific
terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof without the need of
posting bond in any court of the United States or any state having jurisdiction, this being in addition to any other remedy to which they are entitled at Law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Directors and Officers</U>.&nbsp;This Agreement shall apply to each Stockholder solely in such
Stockholder&#146;s capacity as a stockholder of Frequency and/or holder of Frequency Options and not in such Stockholder&#146;s capacity as a director, officer or employee of Frequency or any of its Subsidiaries or in such Stockholder&#146;s
capacity as a trustee or fiduciary of any employee benefit plan or trust.&nbsp;Notwithstanding any provision of this Agreement to the contrary, nothing in this Agreement shall (or require Stockholder to attempt to) limit or restrict a director
and/or officer of Frequency in the exercise of his or her fiduciary duties consistent with the terms of the Merger Agreement as a director and/or officer of Frequency or in his or her capacity as a trustee or fiduciary of any employee benefit plan
or trust or prevent or be construed to create any obligation on the part of any director and/or officer of Frequency or any trustee or fiduciary of any employee benefit plan or trust from taking any action in his or her capacity as such director,
officer, trustee and/or fiduciary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Ownership Interest</U>.&nbsp;Nothing contained
in this Agreement shall be deemed to vest in the Company any direct or indirect ownership or incidence of ownership of or with respect to any Shares. All rights, ownership and economic benefits of and relating to the Shares shall remain vested in
and belong to such Stockholder, and the Company does not have authority to manage, direct, superintend, restrict, regulate, govern, or administer any of the policies or operations of Frequency or exercise any power or authority to direct such
Stockholder in the voting of any of the Shares, except as otherwise provided herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.&nbsp;This Agreement shall terminate and shall have no further force or effect as of
the Expiration Date.&nbsp;Notwithstanding the foregoing, upon termination or expiration of this Agreement, no party shall have any further obligations or liabilities under this Agreement; <I>provided</I>, <I>however</I>, nothing set forth in this
<U>Section</U><U></U><U>&nbsp;12</U> or elsewhere in this Agreement shall relieve any party from liability for any fraud or for any willful and material breach of this Agreement prior to termination hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Further Assurances</U>. Each Stockholder shall, from time to time, execute and deliver, or cause to
be executed and delivered, such additional or further consents, documents and other instruments as the Company or Frequency may reasonably request for the purpose of effectively carrying out the transactions contemplated by this Agreement and the
Contemplated Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure</U>. Each Stockholder hereby agrees that Frequency and
the Company may publish and disclose in the Proxy Statement, any prospectus filed with any regulatory authority in connection with the Contemplated Transactions and any related documents filed with such regulatory authority and as otherwise required
by Law, such Stockholder&#146;s identity and ownership of Shares and the nature of such Stockholder&#146;s commitments, arrangements and understandings under this Agreement and may further file this Agreement as an exhibit to the Proxy Statement or
prospectus or in any other filing made by Frequency or the Company as required by Law or the terms of the Merger Agreement, including with the SEC or other regulatory authority, relating to the Contemplated Transactions, all subject to prior review
and a reasonable opportunity to comment by Stockholder&#146;s counsel. Prior to the Closing, each Stockholder shall not, and shall use its reasonable best efforts to cause its representatives not to, directly or indirectly, make any press release,
public announcement or other public communication without the prior written consent of Frequency and the Company, <I>provided</I> that the foregoing shall not limit or affect any actions taken by such Stockholder (or any affiliated officer or
director of such Stockholder) that would be permitted to be taken by such Stockholder, Frequency or the Company pursuant to the Merger Agreement; <I>provided</I>, <I>further</I>, that the foregoing shall not effect any actions of Stockholder the
prohibition of which would be prohibited under applicable Law and shall not prohibit Stockholder or its affiliates from making any publicly-available filings required by applicable law, regulation or legal process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice</U>. All notices and other communications hereunder shall be in writing and shall be deemed
given if delivered personally or sent by overnight courier (providing proof of delivery), by facsimile transmission (providing confirmation of transmission) or by electronic transmission (providing confirmation of transmission) to the Company or
Frequency, as the case may be, in accordance with <U>Section</U><U></U><U>&nbsp;9.7</U> of the Merger Agreement and to each Stockholder at his, her or its address or email address (providing confirmation of transmission) set forth on
<U>Schedule</U><U></U><U>&nbsp;1</U> attached hereto (or at such other address for a party as shall be specified by like notice). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. Any term or provision of this
Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or
provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the parties hereto agree that the court making
such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the
intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties hereto agree to
replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Assignability</U>. This Agreement shall be binding upon, and shall be enforceable by and inure
solely to the benefit of, the parties hereto and their respective successors and assigns; <I>provided, however</I>, that neither this Agreement nor any of a party&#146;s rights or obligations hereunder may be assigned or delegated by such party
without the prior written consent of the other parties hereto, and any attempted assignment or delegation of this Agreement or any of such rights or obligations by such party without the other party&#146;s prior written consent shall be void and of
no effect. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the parties hereto) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Waivers</U>. No waivers of any breach of this Agreement extended by the Company or Frequency to
such Stockholder shall be construed as a waiver of any rights or remedies of the Company or Frequency, as applicable, with respect to any other stockholder of Frequency who has executed an agreement substantially in the form of this Agreement with
respect to Shares held or subsequently held by such stockholder or with respect to any subsequent breach of Stockholder or any other such stockholder of Frequency. No waiver of any provisions hereof by any party shall be deemed a waiver of any other
provisions hereof by any such party, nor shall any such waiver be deemed a continuing waiver of any provision hereof by such party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Applicable Law; Jurisdiction</U>. This Agreement shall be governed by, and construed in accordance
with, the Laws of the state of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of Laws. In any action or Legal Proceeding between any of the parties arising out of or relating to this Agreement,
each of the parties: (i)&nbsp;irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the state of Delaware or to the extent such court does not have subject matter jurisdiction, the
Superior Court of the State of Delaware or the United States District Court for the District of Delaware, (ii)<U></U>&nbsp;agrees that all claims in respect of such action or Legal Proceeding shall be heard and determined exclusively in accordance
with clause (i)<U></U>&nbsp;of this <U>Section&nbsp;19</U>, (iii)<U></U>&nbsp;waives any objection to laying venue in any such action or Legal Proceeding in such courts, (iv)<U></U>&nbsp;waives any objection that such courts are an inconvenient
forum or do not have jurisdiction over any party, and (v)<U></U>&nbsp;agrees that service of process upon such party in any such action or Legal Proceeding shall be effective if notice is given in accordance with <U>Section&nbsp;15</U> of this
Agreement. Each party irrevocably consents to service of process inside or outside the territorial jurisdiction of the courts referred to in this <U>Section&nbsp;19</U> in the manner provided for notices in <U>Section</U><U></U><U>&nbsp;15</U>.
Nothing in this Agreement will affect the right of any party to serve process in any other manner permitted by applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Jury Trial</U>. The parties hereto
hereby waive any right to trial by jury with respect to any action or Legal Proceeding related to or arising out of this Agreement, any document executed in connection herewith and the matters contemplated hereby and thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Agreement Until Executed</U>. Irrespective of negotiations among the parties or the exchanging of
drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a Contract, agreement, arrangement or understanding between the parties hereto unless and until (a)&nbsp;the Frequency Board has approved, for purposes of any
applicable anti-takeover Laws and regulations and any applicable provision of the certificate of incorporation of Frequency, the Merger Agreement and the Contemplated Transactions, (b)&nbsp;the Merger Agreement is executed by all parties thereto,
and (c)&nbsp;this Agreement is executed by all parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement; Counterparts;
Exchanges by Facsimile</U>. This Agreement and the other agreements referred to in this Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the parties with
respect to the subject matter hereof and thereof. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed
Agreement (in counterparts or otherwise) by all parties by facsimile or electronic transmission via &#147;.pdf&#148; shall be sufficient to bind the parties to the terms and conditions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment</U>. This Agreement may not be amended, supplemented or modified, and no provisions hereof
may be modified or waived, except by an instrument in writing signed on behalf of each party hereto; <I>provided</I>, <I>however</I>, that the rights or obligations of any Stockholder may be waived, amended or otherwise modified in a writing signed
by Frequency, the Company and such Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fees and Expenses</U>. Except as otherwise
specifically provided herein, the Merger Agreement or any other agreement contemplated by the Merger Agreement to which a party hereto is a party, each party hereto shall bear its own expenses in connection with this Agreement and the transactions
contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voluntary Execution of Agreement</U>. This Agreement is executed
voluntarily and without any duress or undue influence on the part or behalf of the parties. Each of the parties hereby acknowledges, represents and warrants that (i)&nbsp;it has read and fully understood this Agreement and the implications and
consequences thereof; (ii)&nbsp;it has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of its own choice, or it has made a voluntary and informed decision to decline to seek such counsel; and
(iii)&nbsp;it is fully aware of the legal and binding effect of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definition of Merger Agreement</U>. For purposes
of this Agreement, the term &#147;<U>Merger Agreement</U>&#148; may include such agreement as amended or modified as long as such amendments or modifications (a)&nbsp;do not (i)&nbsp;change the form or amount of consideration payable under the
Merger Agreement, (ii)&nbsp;extend the Outside Date past November&nbsp;14, 2023 (other than any extension provided for in <U>Section</U><U></U><U>&nbsp;8.1(b)</U> of the Merger Agreement with respect to the Proxy Statement), or (iii)&nbsp;otherwise
change the terms and conditions of the Merger, the Concurrent Financing or the other Contemplated Transaction in a manner materially adverse to such Stockholder or (b)&nbsp;have been agreed to in writing by such Stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Construction</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, whenever the context requires: the singular
number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine
genders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto agree that any rule of construction to the
effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used in this Agreement, the words &#147;include&#148; and
&#147;including,&#148; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#147;without limitation.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise indicated, all references in this Agreement to
&#147;Sections,&#148; and &#147;Schedules&#148; are intended to refer to Sections of this Agreement and Schedules to this Agreement, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The underlined headings contained in this Agreement are for convenience of
reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page has Intentionally Been Left Blank</I>] </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="74%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EXECUTED as of the date first above written.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">[STOCKHOLDER]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:240pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Frequency Support Agreement </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">EXECUTED as of the date first above written. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FREQUENCY THERAPEUTICS, INC. </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>KORRO BIO, INC. </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:240pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Frequency Support Agreement </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE 1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name, Address and Email Address of Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;of&nbsp;Frequency<BR>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Frequency<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>d651936dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KORRO BIO, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUPPORT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS SUPPORT AGREEMENT</B> (this &#147;<U>Agreement</U>&#148;), dated as of July&nbsp;14, 2023 is made by and among Frequency Therapeutics,
Inc., a Delaware corporation (&#147;<U>Frequency</U>&#148;), Korro Bio, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), and the undersigned holders (each a &#147;<U>Stockholder</U>&#148;) of shares of capital stock (the
&#147;<U>Shares</U>&#148;) of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Frequency, Frequency Merger Sub, Inc., a Delaware corporation and a wholly
owned subsidiary of Frequency (&#147;<U>Merger Sub</U>&#148;), and the Company, have entered into an Agreement and Plan of Merger, dated of even date herewith (the &#147;<U>Merger Agreement</U>&#148;), providing for the merger of Merger Sub with and
into the Company (the &#147;<U>Merger</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, each Stockholder beneficially owns and has sole or shared voting power
with respect to the number of Shares, and holds Korro Options to acquire the number of Shares, indicated opposite such Stockholder&#146;s name on <U>Schedule</U><U></U><U>&nbsp;1</U><SUP STYLE="font-size:75%; vertical-align:top"> </SUP>attached
hereto; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, as an inducement and a condition to the willingness of the Company to enter into the Merger Agreement, each
Stockholder has agreed to enter into and perform this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, all capitalized terms used in this Agreement without
definition herein shall have the meanings ascribed to them in the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of, and as a
condition to, the Company&#146;s entering into the Merger Agreement, each Stockholder, Frequency and the Company agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreement to Vote Shares</U>. Each Stockholder agrees that, prior to the Expiration Date (as defined in
<U>Section</U><U></U><U>&nbsp;2</U> below), at any meeting of the stockholders of the Company or any adjournment or postponement thereof, or in connection with any written consent of the stockholders of the Company, with respect to the Merger, the
Merger Agreement or any Acquisition Proposal, such Stockholder shall: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;appear at such meeting or
otherwise cause the Shares and any New Shares (as defined in <U>Section</U><U></U><U>&nbsp;3</U> below) to be counted as present thereat for purposes of calculating a quorum; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;from and after the date hereof until the Expiration Date, vote (or cause to be voted), or deliver a
written consent (or cause a written consent to be delivered) covering all of the Shares and any New Shares that Stockholder shall be entitled to so vote: (i)&nbsp;in favor of all of the matters set forth in the Korro Stockholder Written Consent;
(ii)&nbsp;against any Acquisition Proposal, or any agreement, transaction or other matter that is intended to, or would reasonably be expected to, impede, interfere with, delay, postpone, discourage or materially and adversely affect the
consummation of the Merger, the Concurrent Financing and all of the other Contemplated Transactions; and (iii)&nbsp;to approve any proposal to adjourn or postpone the meeting to a later date, if there are not sufficient votes for the adoption of the
Merger Agreement on the date on which such meeting is held. Stockholder shall not take or commit or agree to take any action inconsistent with the foregoing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Expiration Date</U>. As used in this Agreement, the term
&#147;<U>Expiration Date</U>&#148; shall mean the earlier to occur of (a)&nbsp;the Effective Time, (b)&nbsp;such date and time as the Merger Agreement shall be terminated pursuant to <U>Article VIII</U> thereof or otherwise, (c)&nbsp;any amendment
to the Merger Agreement is effected without the Stockholder&#146;s written consent that decreases the amount, or changes the form, of consideration payable to all stockholders of the Company pursuant to the terms of the Merger Agreement or
(d)&nbsp;the mutual written agreement of the parties to terminate this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional
Acquisitions</U>. Each Stockholder agrees that any shares of capital stock or other equity securities of the Company that such Stockholder acquires or with respect to which such Stockholder otherwise acquires sole or shared voting power (including
any proxy) after the execution of this Agreement and prior to the Expiration Date, whether by the exercise of any Korro Options or otherwise, including, without limitation, by gift, succession, in the event of a stock split or as a dividend or
distribution of any Shares (&#147;<U>New Shares</U>&#148;), shall be subject to the terms and conditions of this Agreement to the same extent as if they constituted the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreement to Retain Shares</U>. From and after the date hereof until the Expiration Date, each Stockholder shall
not, directly or indirectly, (a)&nbsp;sell, assign, transfer, tender, or otherwise dispose of (including, without limitation, by the creation of any Liens (as defined in <U>Section</U><U></U><U>&nbsp;5(c)</U> below)) any Shares or any New Shares,
(b)&nbsp;deposit any Shares or New Shares into a voting trust or enter into a voting agreement or similar arrangement with respect to such Shares or New Shares or grant any proxy or power of attorney with respect thereto (other than this Agreement),
(c)&nbsp;enter into any Contract, option, commitment or other arrangement or understanding with respect to the direct or indirect sale, transfer, assignment or other disposition of (including, without limitation, by the creation of any Liens) any
Shares or New Shares, or (d)&nbsp;take any action that would make any representation or warranty of such Stockholder contained herein untrue or incorrect or have the effect of preventing or disabling such Stockholder from performing such
Stockholder&#146;s obligations under this Agreement. Any action taken in violation of the foregoing sentence shall be null and void <I>ab initio</I>. Notwithstanding the foregoing, each Stockholder may make (1)&nbsp;transfers by will or by operation
of Law or other transfers for estate-planning purposes, in which case this Agreement shall bind the transferee, (2)&nbsp;with respect to such Stockholder&#146;s Korro Options (and any Shares underlying such Korro Options) which expire on or prior to
the Expiration Date, transfers, sale, or other disposition of Shares to Korro (or effecting a &#147;net exercise&#148; of a Korro Option) as payment for the (i)&nbsp;exercise price of such Stockholder&#146;s Korro Options and (ii)&nbsp;taxes
applicable to the exercise of such Stockholder&#146;s Korro Options, (3)&nbsp;if Stockholder is an entity, partnership or limited liability company, a transfer to one or more equityholders, partners or members of Stockholder or to an Affiliated
person, corporation, trust or other Entity controlling or under common control with Stockholder, or if Stockholder is a trust, a transfer to a beneficiary, provided that in each such case the applicable transferee has signed a voting agreement in
substantially the form hereof, (4)&nbsp;make transfers that occur by operation of law pursuant to a qualified domestic relations order or in connection with a divorce settlement, and (5)&nbsp;transfers, sales or other dispositions as the Company may
otherwise agree in writing in its sole discretion. If any voluntary or involuntary transfer of any Shares covered hereby shall occur (including a transfer or disposition permitted by <U>Section</U><U></U><U>&nbsp;4(1)</U> through
<U>Section</U><U></U><U>&nbsp;4(5)</U>, sale by a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholder&#146;s trustee in bankruptcy, or a sale to a purchaser at any creditor&#146;s or court sale),
the transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of the initial transferee) shall take and hold such Shares subject to all of the restrictions, liabilities and rights under this Agreement,
which shall continue in full force and effect, notwithstanding that such transferee is not a Stockholder and has not executed a counterpart hereof or joinder hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties of Stockholder</U>. Each Stockholder hereby, severally but not jointly, represents
and warrants to Frequency and the Company as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;If such Stockholder is an Entity:
(i)&nbsp;such Stockholder is duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, organized or constituted, (ii)&nbsp;such Stockholder has all necessary power and authority to execute
and deliver this Agreement, to perform such Stockholder&#146;s obligations hereunder and to consummate the transactions contemplated hereby, and (iii)&nbsp;the execution and delivery of this Agreement, performance of such Stockholder&#146;s
obligations hereunder and the consummation of the transactions contemplated hereby by such Stockholder have been duly authorized by all necessary action on the part of such Stockholder and no other proceedings on the part of such Stockholder are
necessary to authorize this Agreement, or to consummate the transactions contemplated hereby. If such Stockholder is an individual, such Stockholder has the legal capacity to execute and deliver this Agreement, to perform such Stockholder&#146;s
obligations hereunder and to consummate the transactions contemplated hereby; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;this Agreement
has been duly executed and delivered by or on behalf of such Stockholder and, to such Stockholder&#146;s knowledge and assuming this Agreement constitutes a valid and binding agreement of the Company and Frequency, constitutes a valid and binding
agreement with respect to such Stockholder, enforceable against such Stockholder in accordance with its terms, except as enforcement may be limited by general principles of equity whether applied in a court of Law or a court of equity and by
bankruptcy, insolvency and similar Laws affecting creditors&#146; rights and remedies generally; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;such Stockholder beneficially owns the number of Shares indicated opposite such Stockholder&#146;s
name on <U>Schedule</U><U></U><U>&nbsp;1</U>, and will own any New Shares, free and clear of any liens, claims, charges or other encumbrances or restrictions of any kind whatsoever (&#147;<U>Liens</U>&#148;), and has sole or shared, and otherwise
unrestricted, voting power with respect to such Shares or New Shares and none of the Shares or New Shares is subject to any voting trust or other agreement, arrangement or restriction with respect to the voting of the Shares or the New Shares,
except as contemplated by this Agreement and the stockholder agreements and arrangements referenced in the Merger Agreement and except for customary arrangements with the Stockholder&#146;s prime broker and/or custodian; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;to the knowledge of such Stockholder, the execution and delivery of this Agreement by such
Stockholder does not, and the performance by such Stockholder of his, her or its obligations hereunder and the compliance by such Stockholder with any provisions hereof will not, violate or conflict with, result in a material breach of or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
constitute a default (or an event that with notice or lapse of time or both would become a material default) under, or give to others any rights of termination, amendment, acceleration or
cancellation of, or result in the creation of any Liens on any Shares or New Shares pursuant to, any agreement, instrument, note, bond, mortgage, Contract, lease, license, permit or other obligation or any order, arbitration award, judgment or
decree to which such Stockholder is a party or by which such Stockholder is bound, or any Law, statute, rule or regulation to which such Stockholder is subject or, in the event that such Stockholder is a corporation, partnership, trust or other
Entity, any bylaw or other Organizational Document of such Stockholder; except for any of the foregoing as would not reasonably be expected to prevent or delay the performance by such Stockholder of his, her or its obligations under this Agreement
in any material respect; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;the execution and delivery of this Agreement by such Stockholder does
not, and the performance of this Agreement by such Stockholder does not and will not, require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Authority or regulatory authority by such
Stockholder except for applicable requirements, if any, of the Exchange Act, and except where the failure to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications, would not prevent or delay the
performance by such Stockholder of his, her or its obligations under this Agreement in any material respect; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;no investment banker, broker, finder or other intermediary is entitled to a fee or commission from
Frequency or the Company in respect of this Agreement based upon any Contract made by or on behalf of such Stockholder; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;as of the date of this Agreement, there is no Legal Proceeding pending or, to the knowledge of such
Stockholder, threatened against such Stockholder that would reasonably be expected to prevent or delay the performance by such Stockholder of his, her or its obligations under this Agreement in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Irrevocable Proxy</U>. Subject to the penultimate sentence of this <U>Section</U><U></U><U>&nbsp;6</U>, by
execution of this Agreement, each Stockholder does hereby appoint the Company and any of its designees with full power of substitution and resubstitution, as such Stockholder&#146;s true and lawful attorney and irrevocable proxy, to the fullest
extent of such Stockholder&#146;s rights with respect to the Shares, to vote and exercise all voting and related rights, including the right to sign such Stockholder&#146;s name (solely in its capacity as a stockholder) to any Stockholder consent,
if such Stockholder fails to vote his, her or its Shares solely with respect to the matters set forth in <U>Section</U><U></U><U>&nbsp;1</U> hereof by 5:00 p.m. (Eastern Time) on the day immediately preceding the meeting date (or date upon which
written consents are requested to be submitted), provided the Stockholder has received information regarding the meeting or request for written consent at least five (5)&nbsp;Business Days before such shareholder meeting or any consent solicitation
or other vote taken of the Company&#146;s stockholders . Each Stockholder intends this proxy to be irrevocable and coupled with an interest hereunder until the Expiration Date, hereby revokes any proxy previously granted by such Stockholder with
respect to the Shares and represents that none of such previously-granted proxies are irrevocable. The Stockholder hereby affirms that the proxy set forth in this <U>Section</U><U></U><U>&nbsp;6</U> is given in connection with, and granted in
consideration of, and as an inducement to the Company, Frequency and Merger Sub to enter into the Merger Agreement and that such proxy is given to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
secure the obligations of the Stockholder under <U>Section</U><U></U><U>&nbsp;1</U>. The irrevocable proxy and power of attorney granted herein shall survive the death or incapacity of such
Stockholder and the obligations of such Stockholder shall be binding on such Stockholder&#146;s heirs, personal representatives, successors, transferees and assigns. Each Stockholder hereby agrees not to grant any subsequent powers of attorney or
proxies with respect to any Shares with respect to the matters set forth in <U>Section</U><U></U><U>&nbsp;1</U> until after the Expiration Date. Notwithstanding anything contained herein to the contrary, this irrevocable proxy shall automatically
terminate upon the Expiration Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>[Intentionally Omitted]</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Legal Actions</U>. Each Stockholder will not in its capacity as a stockholder of the Company bring, commence,
institute, maintain, prosecute or voluntarily aid any Legal Proceeding which (i)&nbsp;challenges the validity or seeks to enjoin the operation of any provision of this Agreement or (ii)&nbsp;alleges that the execution and delivery of this Agreement
by such Stockholder, either alone or together with the other voting agreements and proxies to be delivered in connection with the execution of the Merger Agreement, constitutes a breach of any fiduciary duty of the Company Board or any member
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Other Remedies; Specific Performance</U>. Except as otherwise provided herein, any and all remedies
herein expressly conferred upon a party will be deemed cumulative with, and not exclusive of, any other remedy conferred hereby, or by Law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any
other remedy. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof without the need of posting bond in any court of the United States or any state having
jurisdiction, this being in addition to any other remedy to which they are entitled at Law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Directors and Officers</U>.&nbsp;This Agreement shall apply to each Stockholder solely in such
Stockholder&#146;s capacity as a stockholder of the Company and/or holder of Korro Options and/or Korro Warrants and not in such Stockholder&#146;s capacity as a director, officer or employee of the Company or any of its Subsidiaries or in such
Stockholder&#146;s capacity as a trustee or fiduciary of any employee benefit plan or trust.&nbsp;Notwithstanding any provision of this Agreement to the contrary, nothing in this Agreement shall (or require Stockholder to attempt to) limit or
restrict a director and/or officer of the Company in the exercise of his or her fiduciary duties consistent with the terms of the Merger Agreement as a director and/or officer of the Company or in his or her capacity as a trustee or fiduciary of any
employee benefit plan or trust or prevent or be construed to create any obligation on the part of any director and/or officer of the Company or any trustee or fiduciary of any employee benefit plan or trust from taking any action in his or her
capacity as such director, officer, trustee and/or fiduciary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Ownership Interest</U>.&nbsp;Nothing
contained in this Agreement shall be deemed to vest in the Company any direct or indirect ownership or incidence of ownership of or with respect to any Shares. All rights, ownership and economic benefits of and relating to the Shares shall remain
vested in and belong to such Stockholder, and the Company does not have authority to manage, direct, superintend, restrict, regulate, govern, or administer any of the policies or operations of the Company or exercise any power or authority to direct
such Stockholder in the voting of any of the Shares, except as otherwise provided herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.&nbsp;This Agreement shall terminate and shall
have no further force or effect as of the Expiration Date.&nbsp;Notwithstanding the foregoing, upon termination or expiration of this Agreement, no party shall have any further obligations or liabilities under this Agreement; provided,
<I>however</I><U>, </U>nothing set forth in this <U>Section</U><U></U><U>&nbsp;12</U> or elsewhere in this Agreement shall relieve any party from liability for any fraud or for any willful and material breach of this Agreement prior to termination
hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Further Assurances</U>. Each Stockholder shall, from time to time, execute and deliver, or cause to
be executed and delivered, such additional or further consents, documents and other instruments as the Company or Frequency may reasonably request for the purpose of effectively carrying out the transactions contemplated by this Agreement and the
Contemplated Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure</U>. Each Stockholder hereby agrees that Frequency and the Company
may publish and disclose in the Proxy Statement, any prospectus filed with any regulatory authority in connection with the Contemplated Transactions and any related documents filed with such regulatory authority and as otherwise required by Law,
such Stockholder&#146;s identity and ownership of Shares and the nature of such Stockholder&#146;s commitments, arrangements and understandings under this Agreement and may further file this Agreement as an exhibit to the Proxy Statement or
prospectus or in any other filing made by Frequency or the Company as required by Law or the terms of the Merger Agreement, including with the SEC or other regulatory authority, relating to the Contemplated Transactions, all subject to prior review
and a reasonable opportunity to comment by Stockholder&#146;s counsel. Prior to the Closing, each Stockholder shall not, and shall use its reasonable best efforts to cause its representatives not to, directly or indirectly, make any press release,
public announcement or other public communication without the prior written consent of Frequency and the Company, <I>provided</I> that the foregoing shall not limit or affect any actions taken by such Stockholder (or any affiliated officer or
director of such Stockholder) that would be permitted to be taken by such Stockholder, Frequency or the Company pursuant to the Merger Agreement; <I>provided</I>, <I>further</I>, that the foregoing shall not effect any actions of Stockholder the
prohibition of which would be prohibited under applicable Law and shall not prohibit Stockholder or its affiliates from making any publicly-available filings required by applicable law, regulation or legal process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice</U>. All notices and other communications hereunder shall be in writing and shall be deemed given if
delivered personally or sent by overnight courier (providing proof of delivery), by facsimile transmission (providing confirmation of transmission) or by electronic transmission (providing confirmation of transmission) to the Company or Frequency,
as the case may be, in accordance with <U>Section</U><U></U><U>&nbsp;9.7</U> of the Merger Agreement and to each Stockholder at his, her or its address or email address (providing confirmation of transmission) set forth on
<U>Schedule</U><U></U><U>&nbsp;1</U> attached hereto (or at such other address for a party as shall be specified by like notice). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. Any term or provision of this Agreement that is invalid or unenforceable in any situation in
any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is
invalid or unenforceable, the parties hereto agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that
is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power
granted to it in the prior sentence, the parties hereto agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other
purposes of such invalid or unenforceable term or provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Assignability</U>. This Agreement shall be
binding upon, and shall be enforceable by and inure solely to the benefit of, the parties hereto and their respective successors and assigns; <I>provided, however</I>, that neither this Agreement nor any of a party&#146;s rights or obligations
hereunder may be assigned or delegated by such party without the prior written consent of the other parties hereto, and any attempted assignment or delegation of this Agreement or any of such rights or obligations by such party without the other
party&#146;s prior written consent shall be void and of no effect. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the parties hereto) any right, benefit or remedy of any nature whatsoever
under or by reason of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Waivers</U>. No waivers of any breach of this Agreement extended
by the Company or Frequency to such Stockholder shall be construed as a waiver of any rights or remedies of the Company or Frequency, as applicable, with respect to any other stockholder of the Company who has executed an agreement substantially in
the form of this Agreement with respect to Shares held or subsequently held by such stockholder or with respect to any subsequent breach of Stockholder or any other such stockholder of the Company. No waiver of any provisions hereof by any party
shall be deemed a waiver of any other provisions hereof by any such party, nor shall any such waiver be deemed a continuing waiver of any provision hereof by such party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Applicable Law; Jurisdiction</U>. This Agreement shall be governed by, and construed in accordance with, the
Laws of the state of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of Laws. In any action or Legal Proceeding between any of the parties arising out of or relating to this Agreement, each of
the parties: (i)&nbsp;irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the state of Delaware or to the extent such court does not have subject matter jurisdiction, the Superior
Court of the State of Delaware or the United States District Court for the District of Delaware, (ii)&nbsp;agrees that all claims in respect of such action or Legal Proceeding shall be heard and determined exclusively in accordance with clause
(i)&nbsp;of this Section&nbsp;19, (iii)&nbsp;waives any objection to laying venue in any such action or Legal Proceeding in such courts, (iv)&nbsp;waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any
party, and (v)<U></U>&nbsp;agrees that service of process upon such party in any such action or Legal Proceeding shall be effective if notice is given in accordance with <U>Section&nbsp;15</U> of this Agreement. Each party irrevocably consents to
service of process inside or outside the territorial jurisdiction of the courts referred to in this <U>Section&nbsp;19</U> in the manner provided for notices in <U>Section&nbsp;15</U>. Nothing in this Agreement will affect the right of any party to
serve process in any other manner permitted by applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Jury Trial</U>. The parties hereto hereby waive any
right to trial by jury with respect to any action or Legal Proceeding related to or arising out of this Agreement, any document executed in connection herewith and the matters contemplated hereby and thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Agreement Until Executed</U>. Irrespective of negotiations among the parties or the exchanging of drafts of
this Agreement, this Agreement shall not constitute or be deemed to evidence a Contract, agreement, arrangement or understanding between the parties hereto unless and until (a)&nbsp;the Company Board has approved, for purposes of any applicable
anti-takeover Laws and regulations and any applicable provision of the certificate of incorporation of the Company, the Merger Agreement and the Contemplated Transactions, (b)&nbsp;the Merger Agreement is executed by all parties thereto, and
(c)&nbsp;this Agreement is executed by all parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement; Counterparts; Exchanges by
Facsimile</U>. This Agreement and the other agreements referred to in this Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the parties with respect to
the subject matter hereof and thereof. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in
counterparts or otherwise) by all parties by facsimile or electronic transmission via &#147;.pdf&#148; shall be sufficient to bind the parties to the terms and conditions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.&nbsp;&nbsp;&nbsp;&nbsp;Amendment. This Agreement may not be amended, supplemented or modified, and no provisions hereof may be modified or
waived, except by an instrument in writing signed on behalf of each party hereto; <I>provided</I>, <I>however</I>, that the rights or obligations of any Stockholder may be waived, amended or otherwise modified in a writing signed by Frequency, the
Company and such Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24.&nbsp;&nbsp;&nbsp;&nbsp;<U>Fees and Expenses</U>. Except as otherwise specifically provided herein, the
Merger Agreement or any other agreement contemplated by the Merger Agreement to which a party hereto is a party, each party hereto shall bear its own expenses in connection with this Agreement and the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25.&nbsp;&nbsp;&nbsp;&nbsp;<U>Voluntary Execution of Agreement</U>. This Agreement is executed voluntarily and without any duress or undue
influence on the part or behalf of the parties. Each of the parties hereby acknowledges, represents and warrants that (i)&nbsp;it has read and fully understood this Agreement and the implications and consequences thereof; (ii)&nbsp;it has been
represented in the preparation, negotiation, and execution of this Agreement by legal counsel of its own choice, or it has made a voluntary and informed decision to decline to seek such counsel; and (iii)&nbsp;it is fully aware of the legal and
binding effect of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26.&nbsp;&nbsp;&nbsp;&nbsp;<U>Definition of Merger Agreement</U>. For purposes of this Agreement, the
term &#147;<U>Merger Agreement</U>&#148; may include such agreement as amended or modified as long as such amendments or modifications (a)&nbsp;do not (i)&nbsp;change the form or amount of consideration payable under the Merger Agreement,
(ii)&nbsp;extend the Outside Date past November&nbsp;14, 2023 (other than </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any extension provided for in <U>Section</U><U></U><U>&nbsp;8.1(b)</U> of the Merger Agreement with respect to the Proxy Statement), or (iii)&nbsp;otherwise change the terms and conditions of the
Merger, the Concurrent Financing or the other Contemplated Transaction in a manner materially adverse to such Stockholder or (b)&nbsp;have been agreed to in writing by such Stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27.&nbsp;&nbsp;&nbsp;&nbsp;<U>Construction</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, whenever the context requires: the singular number shall include the
plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto agree that any rule of construction to the effect that ambiguities are to be
resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;As used in this Agreement, the words &#147;include&#148; and &#147;including,&#148; and variations
thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#147;without limitation.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise indicated, all references in this Agreement to &#147;Sections,&#148; and
&#147;Schedules&#148; are intended to refer to Sections of this Agreement and Schedules to this Agreement, respectively. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The underlined headings contained in this Agreement are for convenience of reference only, shall not
be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page has Intentionally Been Left Blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXECUTED as of the date first above written. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">[STOCKHOLDER]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I></I></B><I>Signature Page to Korro Support Agreement</I><B><I> </I></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXECUTED as of the date first above written. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FREQUENCY THERAPEUTICS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Title:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>KORRO BIO, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Title:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I></I></B><I>Signature Page to Korro Support Agreement</I><B><I> </I></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name, Address and Email Address of Stockholder</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;of&nbsp;Frequency<BR>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Frequency<BR>Options</B></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>d651936dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">July&nbsp;14, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Korro Bio, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Kendall Square </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Building <FONT STYLE="white-space:nowrap">600-700,</FONT> Suite <FONT STYLE="white-space:nowrap">6-401</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cambridge, MA 02139 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned signatory of this <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement (this
&#147;<B><I><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</I></B>&#148;) understands that Frequency Therapeutics, Inc., a Delaware corporation (&#147;<B><I>Frequency</I></B>&#148;), has entered into an Agreement and Plan of Merger, dated
as of July&nbsp;14, 2023 (as the same may be amended from time to time, the &#147;<B><I>Merger Agreement</I></B>&#148;) with Frequency Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Frequency, and Korro Bio, Inc., a
Delaware corporation (the &#147;<B><I>Company</I></B>&#148;).&nbsp;Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a condition and inducement to each of the parties to enter into the Merger Agreement, and for other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the undersigned hereby irrevocably agrees that, subject to the exceptions set forth herein, without the prior written consent of Frequency and, solely prior to the Closing, the Company, the
undersigned will not, during the period commencing upon the Closing and ending on the date that is 180 days after the Closing Date (the &#147;<B><I>Restricted Period</I></B>&#148;): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Frequency Common Stock or any securities convertible into or exercisable or exchangeable for Frequency Common Stock
(including without limitation, Frequency Common Stock or such other securities which may be deemed to be beneficially owned (as such term is used in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the Exchange Act) by the undersigned in
accordance with the rules and regulations of the SEC and securities of Frequency which may be issued upon exercise of an option to purchase Frequency Common Stock or warrant or settlement of a Frequency Restricted Stock Unit) that are currently or
hereafter owned by the undersigned (collectively, the &#147;<B><I>Undersigned&#146;s Shares</I></B>&#148;), or publicly disclose the intention to make any such offer, sale, pledge, grant, transfer or disposition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">enter into any swap, short sale, hedge or other agreement that transfers, in whole or in part, any of the
economic consequences of ownership of the Undersigned&#146;s Shares regardless of whether any such transaction described in clause (i)&nbsp;above or this clause (ii)&nbsp;is to be settled by delivery of Frequency Common Stock or other securities, in
cash or otherwise; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make any demand for, or exercise any right with respect to, the registration of any shares of Frequency Common
Stock or any security convertible into or exercisable or exchangeable for Frequency Common Stock (other than such rights set forth in the Merger Agreement or, to the extent the undersigned is party to it, the Registration Rights Agreement dated as
of [ ], 2023 (as the same may be amended from time to time) between the Company and the other parties thereto)). </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The restrictions and obligations contemplated by this <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreement shall not apply to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers of the Undersigned&#146;s Shares: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a <U>natural person</U>, (A)&nbsp;to any person related to the undersigned by blood or
adoption who is an immediate family member of the undersigned, or by marriage or domestic partnership (a &#147;<B><I>Family Member</I></B>&#148;), or to a trust formed for the direct or indirect benefit of the undersigned or any of the
undersigned&#146;s Family Members, (B)&nbsp;to the undersigned&#146;s estate, following the death of the undersigned, by will, intestacy or other operation of Law, (C)&nbsp;as a bona fide gift or a charitable contribution, as such term is described
in Section&nbsp;501(c)(3) of the Internal Revenue Code of 1986, as amended, (D)&nbsp;by operation of Law pursuant to a qualified domestic order or in connection with a divorce settlement, or (E)&nbsp;to any partnership, corporation or limited
liability company which is controlled by the undersigned and/or by any such Family Member(s); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a <U>corporation</U>, <U>partnership</U>, <U>limited liability company</U> or<U> other
entity</U>, (A)&nbsp;to another corporation, partnership, limited liability company, or other entity that is an affiliate (as defined under Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act) of the undersigned, including
investment funds or other entities under common control or management or advisement with the undersigned (including, for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or
any other funds managed by such partnership), (B) as a distribution or dividend to equity holders, including, without limitation, current or former general or limited partners, members or managers (or to the estates of any of the foregoing), as
applicable, of the undersigned (including upon the liquidation and dissolution of the undersigned pursuant to a plan of liquidation approved by the undersigned&#146;s equity holders), (C) as a bona fide gift or a charitable contribution, as such
term is described in Section&nbsp;501(c)(3) of the Internal Revenue Code of 1986, as amended, (D)&nbsp;transfers or dispositions not involving a change in beneficial ownership or (E)&nbsp;with prior written consent of Frequency; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a <U>trust</U>, to any grantors or beneficiaries of the trust; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that, in the case of any transfer or distribution pursuant to this clause (a), such transfer is not for value and each donee, heir, beneficiary or
other transferee or distributee shall sign and deliver to Frequency a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement in the form of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement with respect to the shares of Frequency
Common Stock or such other securities that have been so transferred or distributed; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the exercise of an option to purchase Frequency
Common Stock (including a net or cashless exercise of an option to purchase Frequency Common Stock), and any related transfer of shares of Frequency Common Stock to Frequency or sale of Frequency Common Stock in the open market, in each case, for
the purpose of paying the exercise price of such options or for paying taxes (including estimated taxes) during the Restricted Period due as a result of the exercise of such options; <I><U>provided</U></I><U></U><I><U>&nbsp;that</U></I>, for the
avoidance of doubt, the underlying shares of Frequency Common Stock held by the undersigned following such exercise and any such open market sales shall continue to be subject to the restrictions on transfer set forth in this <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the disposition (including a forfeiture or repurchase) to Frequency of any
shares of restricted stock granted pursuant to the terms of any employee benefit plan or restricted stock purchase agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) transfers to Frequency, or sales of Frequency Common Stock in the open market, in
connection with the vesting of any restricted stock unit or settlement of any other equity award that represents the right to receive shares of Frequency Common Stock settled in Frequency Common Stock, in each case, to pay any tax withholding
obligations due during the Restricted Period; <I><U>provided</U></I><U></U><I><U>&nbsp;that</U></I>, for the avoidance of doubt, the underlying shares of Frequency Common Stock held by the undersigned following such exercise and any such open market
sales shall continue to be subject to the restrictions on transfer set forth in this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) the establishment of a trading plan pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act (a &#147;<B><I><FONT
STYLE="white-space:nowrap">10b5-1</FONT> Plan</I></B>&#148;) for the transfer of Frequency Common Stock; provided that such plan does not provide for any transfers of Frequency Common Stock during the Restricted Period, or the sale of Frequency
Common Stock pursuant to a <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan existing as of the date of the Merger Agreement (which, for clarity, shall not be amended during the Restricted Period, but may be terminated during the Restricted
Period); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) transfers, sales, dispositions, or the entering into of transactions (including, without limitation, any swap, hedge or
similar agreement) by the undersigned of or relating to shares of capital stock or other securities of Frequency purchased or acquired by the undersigned on the open market, in a public offering by Frequency, or that otherwise do not involve or
relate to shares of Frequency Common Stock issued pursuant to the Merger Agreement in respect of shares of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) pursuant to a
bona-fide third party tender offer, merger, consolidation or other similar transaction made to all holders of Frequency&#146;s capital stock involving a change of control of Frequency, provided that in the event that such tender offer, merger,
consolidation or other such transaction is not completed, the Undersigned&#146;s Shares shall remain subject to the restrictions contained in this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) pursuant to an order of a court or regulatory agency; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) transfers, sales, dispositions, or the entering into of transaction (including, without limitation, any swap, hedge, or similar
agreement), by the undersigned relating to shares of Frequency Common Stock issued pursuant to the Merger Agreement in respect of shares of the Company, if any, purchased from the Company pursuant to the Concurrent Financing (as defined in the
Merger Agreement) or issued in exchange for, or on conversion or exercise of, any securities issued as part of the Concurrent Financing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">And
<I><U>provided, further</U></I>, that, with respect to each of (a), (b), (c), (d) and (e)&nbsp;above, no filing by any party (including any donor, donee, transferor, transferee, distributor or distributee) under Section&nbsp;16 of the Exchange Act
or other public announcement shall be made voluntarily in connection with such transfer or disposition during the Restricted Period; <I>provided</I> that (i)&nbsp;any filing under Section&nbsp;16 of the Exchange Act made during the Restricted Period
shall clearly indicate in the footnotes thereto that such filing relates to the circumstances described in (a), (b), (c), (d) or (e), as applicable and (ii)&nbsp;the foregoing shall not prevent the undersigned from filing a Form 13F, Schedule 13G or
Schedule 13D, or any amendment thereto, or from disclosing its holdings in Frequency as required by law or regulation or its internal disclosure policies in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any attempted transfer in violation of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement will be of no effect and null and void,
regardless of whether the purported transferee has any actual or constructive knowledge of the transfer restrictions set forth in this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, and will not be recorded on the share register of
Frequency.&nbsp;In furtherance of the foregoing, the undersigned agrees that Frequency and any duly appointed transfer agent for the registration or transfer of the securities described herein are hereby authorized to decline to make any transfer of
securities if such transfer would constitute a violation or breach of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement.&nbsp;Frequency may cause the legend set forth below, or a legend substantially equivalent thereto, to be placed
upon any certificate(s) or other documents, ledgers or instruments evidencing the undersigned&#146;s ownership of Frequency Common Stock: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AND MAY ONLY BE TRANSFERRED IN
COMPLIANCE WITH A <FONT STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreement.&nbsp;All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the
undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned understands that if the Merger Agreement is terminated for any reason, the undersigned shall be released
from all obligations under this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement.&nbsp;The undersigned understands that Frequency and the Company are proceeding with the Contemplated Transactions in reliance upon this <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreement. Notwithstanding anything to the contrary contained herein, this letter agreement will automatically terminate and the undersigned shall be released from all obligations under this letter agreement
upon the earliest to occur, if any, of (i)&nbsp;the Company advising the undersigned in writing that it has determined not to proceed with the Contemplated Transactions or (ii)&nbsp;the Merger Agreement being terminated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any and all remedies herein expressly conferred upon Frequency or the Company will be deemed cumulative with and not exclusive of any other
remedy conferred hereby, or by Law or equity, and the exercise by Frequency or the Company of any one remedy will not preclude the exercise of any other remedy.&nbsp;The undersigned agrees that irreparable damage could occur to Frequency and/or the
Company in the event that any provision of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement were not performed in accordance with its specific terms or were otherwise breached.&nbsp;It is accordingly agreed that Frequency and the
Company shall be entitled to seek an injunction or injunctions to prevent breaches of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and to enforce specifically the terms and provisions hereof in any court of the United States or any
state having jurisdiction, this being in addition to any other remedy to which Frequency or the Company is entitled at Law or in equity, and the undersigned waives any bond, surety or other security that might be required of Frequency or the Company
with respect thereto.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any holder of Frequency&#146;s securities that are subject to a substantially similar agreement
entered into by such holder, other than the undersigned, is permitted by Frequency (or prior to the Closing, the Company), including through any written consent granted under subparagraph a(ii)(E) above, to sell or otherwise transfer or dispose of
shares of Frequency Common Stock for value other than as permitted by this or a substantially similar agreement entered into by such holder or is granted an early release from the restrictions described herein during the Restricted Period, the same
percentage of shares of the Undersigned&#146;s Shares shall be immediately and fully released from any remaining restrictions set forth herein (the &#147;<B><I><FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Release</I></B>&#148;);
<I><U>provided</U></I>, <I><U>however</U></I>, that such <FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Release shall not be applied unless and until permission or early release has been granted by Frequency, and solely prior to the Closing, the
Company, to an equity holder or equity holders to sell or otherwise transfer or dispose of all or a portion of such equity holder&#146;s shares of Frequency Common Stock that, when combined with all such other such permissions and early releases,
represent an aggregate amount in excess of 1% of the number of shares of Frequency Common Stock originally subject to a substantially similar agreements. Frequency shall notify the undersigned of any Pro Rata Release of its shares on the same day
that any permission that triggers the Pro Rata Release is granted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the release of any of the Undersigned&#146;s Shares from this <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, Frequency will cooperate with the undersigned to facilitate the timely preparation and delivery of certificates representing the Undersigned&#146;s Shares without the restrictive legend above or
the withdrawal of any stop transfer instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and any claim,
controversy or dispute arising under or related to this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement shall be governed by and construed in accordance with the Laws of the State of Delaware, without regard to the conflict of Laws
principles thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement may be executed in several counterparts, each of which
shall be deemed an original and all of which shall constitute one and the same instrument.&nbsp;The exchange of a fully executed <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement (in counterparts or otherwise) by Frequency, the Company and
the undersigned by facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g.,
<U>www.docusign.com</U>) or electronic transmission in .pdf format shall be sufficient to bind such parties to the terms and conditions of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page Follows) </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">Print Name of Stockholder:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">[<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;</U> ]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">Signature (for individuals):</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="5" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">Signature (for entities):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="76%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accepted and Agreed</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Frequency Therapeutics, Inc.:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="76%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accepted and Agreed by</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Korro Bio, Inc.: </P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Lock-up Agreement] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>6
<FILENAME>d651936dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">July&nbsp;14, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Korro Bio, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Kendall Square </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Building
<FONT STYLE="white-space:nowrap">600-700,</FONT> Suite <FONT STYLE="white-space:nowrap">6-401</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cambridge, MA 02139 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned signatory
of this <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement (this &#147;<B><I><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</I></B>&#148;) understands that Frequency Therapeutics, Inc., a Delaware corporation
(&#147;<B><I>Frequency</I></B>&#148;), has entered into an Agreement and Plan of Merger, dated as of July&nbsp;14, 2023 (as the same may be amended from time to time, the &#147;<B><I>Merger Agreement</I></B>&#148;) with Frequency Merger Sub, Inc., a
Delaware corporation and a wholly owned subsidiary of Frequency, and Korro Bio, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;).&nbsp;Capitalized terms used but not otherwise defined herein shall have the respective meanings
ascribed to such terms in the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a condition and inducement to each of the parties to enter into the Merger Agreement,
and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the undersigned hereby irrevocably agrees that, subject to the exceptions set forth herein, without the prior written consent of Frequency
and, solely prior to the Closing, the Company, the undersigned will not, during the period commencing upon the Closing and ending on the date that is 180 days after the Closing Date (the &#147;<B><I>Restricted Period</I></B>&#148;): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Frequency Common Stock or any securities convertible into or exercisable or exchangeable for Frequency Common Stock
(including without limitation, Frequency Common Stock or such other securities which may be deemed to be beneficially owned (as such term is used in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the Exchange Act) by the undersigned in
accordance with the rules and regulations of the SEC and securities of Frequency which may be issued upon exercise of an option to purchase Frequency Common Stock or warrant or settlement of a Frequency Restricted Stock Unit) that are currently or
hereafter owned by the undersigned (collectively, the &#147;<B><I>Undersigned&#146;s Shares</I></B>&#148;), or publicly disclose the intention to make any such offer, sale, pledge, grant, transfer or disposition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">enter into any swap, short sale, hedge or other agreement that transfers, in whole or in part, any of the
economic consequences of ownership of the Undersigned&#146;s Shares regardless of whether any such transaction described in clause (i)&nbsp;above or this clause (ii)&nbsp;is to be settled by delivery of Frequency Common Stock or other securities, in
cash or otherwise; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make any demand for, or exercise any right with respect to, the registration of any shares of Frequency Common
Stock or any security convertible into or exercisable or exchangeable for Frequency Common Stock (other than such rights set forth in the Merger Agreement). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The restrictions and obligations contemplated by this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement shall not apply to: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) transfers of the Undersigned&#146;s Shares: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a <U>natural person</U>, (A)&nbsp;to any person related to the undersigned by blood or
adoption who is an immediate family member of the undersigned, or by marriage or domestic partnership (a &#147;<B><I>Family Member</I></B>&#148;), or to a trust formed for the direct or indirect benefit of the undersigned or any of the
undersigned&#146;s Family Members, (B)&nbsp;to the undersigned&#146;s estate, following the death of the undersigned, by will, intestacy or other operation of Law, (C)&nbsp;as a bona fide gift or a charitable contribution, as such term is described
in Section&nbsp;501(c)(3) of the Internal Revenue Code of 1986, as amended, (D)&nbsp;by operation of Law pursuant to a qualified domestic order or in connection with a divorce settlement, or (E)&nbsp;to any partnership, corporation or limited
liability company which is controlled by the undersigned and/or by any such Family Member(s); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a <U>corporation</U>, <U>partnership</U>, <U>limited liability company</U> or<U> other
entity</U>, (A)&nbsp;to another corporation, partnership, limited liability company, or other entity that is an affiliate (as defined under Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act) of the undersigned, including
investment funds or other entities under common control or management or advisement with the undersigned (including, for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or
any other funds managed by such partnership), (B) as a distribution or dividend to equity holders, including, without limitation, current or former general or limited partners, members or managers (or to the estates of any of the foregoing), as
applicable, of the undersigned (including upon the liquidation and dissolution of the undersigned pursuant to a plan of liquidation approved by the undersigned&#146;s equity holders), (C) as a bona fide gift or a charitable contribution, as such
term is described in Section&nbsp;501(c)(3) of the Internal Revenue Code of 1986, as amended, (D)&nbsp;transfers or dispositions not involving a change in beneficial ownership or (E)&nbsp;with prior written consent of Frequency; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a <U>trust</U>, to any grantors or beneficiaries of the trust; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that, in the case of any transfer or distribution pursuant to this clause (a), such transfer is not for value and each donee, heir, beneficiary or
other transferee or distributee shall sign and deliver to Frequency a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement in the form of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement with respect to the shares of Frequency
Common Stock or such other securities that have been so transferred or distributed; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the exercise of an option to purchase Frequency
Common Stock (including a net or cashless exercise of an option to purchase Frequency Common Stock), and any related transfer of shares of Frequency Common Stock to Frequency or sale of Frequency Common Stock in the open market, in each case, for
the purpose of paying the exercise price of such options or for paying taxes (including estimated taxes) during the Restricted Period due as a result of the exercise of such options; <I><U>provided</U></I><U></U><I><U>&nbsp;that</U></I>, for the
avoidance of doubt, the underlying shares of Frequency Common Stock held by the undersigned following such exercise and any such open market sales shall continue to be subject to the restrictions on transfer set forth in this <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the disposition (including a forfeiture or repurchase) to Frequency of any
shares of restricted stock granted pursuant to the terms of any employee benefit plan or restricted stock purchase agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) transfers to Frequency, or sales of Frequency Common Stock in the open market, in
connection with the vesting of any restricted stock unit or settlement of any other equity award that represents the right to receive shares of Frequency Common Stock settled in Frequency Common Stock, in each case, to pay any tax withholding
obligations due during the Restricted Period; <I><U>provided</U></I><U></U><I><U>&nbsp;that</U></I>, for the avoidance of doubt, the underlying shares of Frequency Common Stock held by the undersigned following such exercise and any such open market
sales shall continue to be subject to the restrictions on transfer set forth in this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) the establishment of a trading plan pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act (a &#147;<B><I><FONT
STYLE="white-space:nowrap">10b5-1</FONT> Plan</I></B>&#148;) for the transfer of Frequency Common Stock; provided that such plan does not provide for any transfers of Frequency Common Stock during the Restricted Period, or the sale of Frequency
Common Stock pursuant to a <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan existing as of the date of the Merger Agreement (which, for clarity, shall not be amended during the Restricted Period, but may be terminated during the Restricted
Period); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) transfers, sales, dispositions, or the entering into of transactions (including, without limitation, any swap, hedge or
similar agreement) by the undersigned of or relating to shares of capital stock or other securities of Frequency purchased or acquired by the undersigned on the open market, in a public offering by Frequency, or that otherwise do not involve or
relate to shares of Frequency Common Stock issued pursuant to the Merger Agreement in respect of shares of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) pursuant to a
bona-fide third party tender offer, merger, consolidation or other similar transaction made to all holders of Frequency&#146;s capital stock involving a change of control of Frequency, provided that in the event that such tender offer, merger,
consolidation or other such transaction is not completed, the Undersigned&#146;s Shares shall remain subject to the restrictions contained in this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) pursuant to an order of a court or regulatory agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">And <I><U>provided, further</U></I>, that, with respect to each of (a), (b), (c), (d) and (e)&nbsp;above, no filing by any party (including any donor, donee,
transferor, transferee, distributor or distributee) under Section&nbsp;16 of the Exchange Act or other public announcement shall be made voluntarily in connection with such transfer or disposition during the Restricted Period; <I>provided</I> that
(i)&nbsp;any filing under Section&nbsp;16 of the Exchange Act made during the Restricted Period shall clearly indicate in the footnotes thereto that such filing relates to the circumstances described in (a), (b), (c), (d) or (e), as applicable and
(ii)&nbsp;the foregoing shall not prevent the undersigned from filing a Form 13F, Schedule 13G or Schedule 13D, or any amendment thereto, or from disclosing its holdings in Frequency as required by law or regulation or its internal disclosure
policies in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any attempted transfer in violation of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreement will be of no effect and null and void, regardless of whether the purported transferee has any actual or constructive knowledge of the transfer restrictions set forth in this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, and
will not be recorded on the share register of Frequency.&nbsp;In furtherance of the foregoing, the undersigned agrees that Frequency and any duly appointed transfer agent for the registration or transfer of the securities described herein are hereby
authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement.&nbsp;Frequency may cause the legend set forth below, or a legend
substantially equivalent thereto, to be placed upon any certificate(s) or other documents, ledgers or instruments evidencing the undersigned&#146;s ownership of Frequency Common Stock: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AND MAY ONLY BE TRANSFERRED IN COMPLIANCE WITH A
<FONT STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement.&nbsp;All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or
personal representatives of the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned understands that if the Merger Agreement is terminated for any reason, the
undersigned shall be released from all obligations under this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement.&nbsp;The undersigned understands that Frequency and the Company are proceeding with the Contemplated Transactions in reliance
upon this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement. Notwithstanding anything to the contrary contained herein, this letter agreement will automatically terminate and the undersigned shall be released from all obligations under this
letter agreement upon the earliest to occur, if any, of (i)&nbsp;the Company advising the undersigned in writing that it has determined not to proceed with the Contemplated Transactions or (ii)&nbsp;the Merger Agreement being terminated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any and all remedies herein expressly conferred upon Frequency or the Company will be deemed cumulative with and not exclusive of any other
remedy conferred hereby, or by Law or equity, and the exercise by Frequency or the Company of any one remedy will not preclude the exercise of any other remedy.&nbsp;The undersigned agrees that irreparable damage could occur to Frequency and/or the
Company in the event that any provision of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement were not performed in accordance with its specific terms or were otherwise breached.&nbsp;It is accordingly agreed that Frequency and the
Company shall be entitled to seek an injunction or injunctions to prevent breaches of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and to enforce specifically the terms and provisions hereof in any court of the United States or any
state having jurisdiction, this being in addition to any other remedy to which Frequency or the Company is entitled at Law or in equity, and the undersigned waives any bond, surety or other security that might be required of Frequency or the Company
with respect thereto.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any holder of Frequency&#146;s securities that are subject to a substantially similar agreement
entered into by such holder, other than the undersigned, is permitted by Frequency (or prior to the Closing, the Company), including through any written consent granted under subparagraph a(ii)(E) above, to sell or otherwise transfer or dispose of
shares of Frequency Common Stock for value other than as permitted by this or a substantially similar agreement entered into by such holder or is granted an early release from the restrictions described herein during the Restricted Period, the same
percentage of shares of the Undersigned&#146;s Shares shall be immediately and fully released from any remaining restrictions set forth herein (the &#147;<B><I><FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Release</I></B>&#148;);
<I><U>provided</U></I>, <I><U>however</U></I>, that such <FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Release shall not be applied unless and until permission or early release has been granted by Frequency, and solely prior to the Closing, the
Company, to an equity holder or equity holders to sell or otherwise transfer or dispose of all or a portion of such equity holder&#146;s shares of Frequency Common Stock that, when combined with all such other such permissions and early releases,
represent an aggregate amount in excess of 1% of the number of shares of Frequency Common Stock originally subject to a substantially similar agreements. Frequency shall notify the undersigned of any Pro Rata Release of its shares on the same day
that any permission that triggers the Pro Rata Release is granted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the release of any of the Undersigned&#146;s Shares from this <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, Frequency will cooperate with the undersigned to facilitate the timely preparation and delivery of certificates representing the Undersigned&#146;s Shares without the restrictive legend above or
the withdrawal of any stop transfer instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and any claim,
controversy or dispute arising under or related to this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement shall be governed by and construed in accordance with the Laws of the State of Delaware, without regard to the conflict of Laws
principles thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement may be executed in several
counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument.&nbsp;The exchange of a fully executed <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement (in counterparts or otherwise) by
Frequency, the Company and the undersigned by facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other
applicable law, e.g., <U>www.docusign.com</U>) or electronic transmission in .pdf format shall be sufficient to bind such parties to the terms and conditions of this <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page Follows) </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">Print Name of Stockholder:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">[<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;</U> ]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">Signature (for individuals):</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="5" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">Signature (for entities):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="76%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accepted and Agreed</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Frequency Therapeutics, Inc.:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="76%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accepted and Agreed by</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Korro Bio, Inc.:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Lock-up Agreement] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>7
<FILENAME>d651936dex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Final Form</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONTINGENT VALUE RIGHTS AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BETWEEN </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FREQUENCY THERAPEUTICS,
INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COMPUTERSHARE
TRUST COMPANY, N.A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and COMPUTERSHARE INC., collectively, as Rights Agent </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of [&nbsp;<FONT STYLE="FONT-SIZE:70%">&#9899;</FONT>&nbsp;] </P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;1 DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;2 CONTINGENT VALUE RIGHTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Holders of CVRs; Appointment of Rights Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-transferable</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Certificate; Registration; Registration of Transfer; Change of Address</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment Procedures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Voting, Dividends or Interest; No Equity or Ownership Interest</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ability to Abandon CVR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;3 THE RIGHTS AGENT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Duties and Responsibilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Rights of Rights Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Resignation and Removal; Appointment of Successor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Acceptance of Appointment by Successor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;4 COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>List of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CVR Committee; Efforts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Prohibited Actions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;5 AMENDMENTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendments Without Consent of Holders or Rights Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendments with Consent of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Amendments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;6 CONSOLIDATION, MERGER, SALE OR CONVEYANCE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frequency May Not Consolidate, Etc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successor Substituted</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;7 MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices to Rights Agent and to Frequency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notice to Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Merger or Consolidation or Change of Name of Rights Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successors and Assigns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Benefits of Agreement; Action by Majority of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>WAIVER OF JURY TRIAL</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability Clause</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts; Effectiveness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Force Majeure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONTINGENT VALUE RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS CONTINGENT VALUE RIGHTS AGREEMENT</B> (this &#147;<U>Agreement</U>&#148;), dated as of <B>[</B><B>&nbsp;</B><B></B><FONT
STYLE="FONT-SIZE:70%">&#9899;</FONT><B></B><B></B><B></B><B>&nbsp;]</B>, is entered into by and between Frequency Therapeutics, Inc., a Delaware corporation (&#147;<U>Frequency</U>&#148;), and Computershare Inc., a Delaware corporation
(&#147;<U>Computershare</U>&#148;), and its affiliate, Computershare Trust Company, N.A., a national banking association, collectively, as initial Rights Agent (as defined herein). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PREAMBLE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
Frequency, Frequency Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Frequency (&#147;<U>Merger Sub</U>&#148;), and Korro Bio, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), have entered into an Agreement and
Plan of Merger, dated as of July&nbsp;14, 2023 (the &#147;<U>Merger Agreement</U>&#148;), pursuant to which Merger Sub will merge with and into the Company (the &#147;<U>Merger</U>&#148;), with the Company surviving the Merger as a wholly-owned
subsidiary of Frequency (the &#147;<U>Surviving Corporation</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in connection with the Merger Agreement, Frequency has
agreed to provide to the Holders (as defined herein) contingent value rights as hereinafter described; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the parties have done all
things necessary to make the contingent value rights, when issued pursuant to this Agreement, the valid obligations of Frequency and to make this Agreement a valid and binding agreement of Frequency, in accordance with its terms; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and the consummation of the transactions referred to above, it is mutually covenanted and
agreed, for the proportionate benefit of all Holders, as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1
<I>Definitions</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms used but not otherwise defined herein have the meanings ascribed thereto in the Merger Agreement.
The following terms have the meanings ascribed to them as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day other than a day on
which banks in the State of New York are authorized or obligated to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; means the date on which
the Closing actually takes place. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CVR</U>&#148; means a contingent contractual right of Holders to receive CVR Payments under
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CVR Payment</U>&#148; means the CVR Proceeds for a given payment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CVR Period</U>&#148; means the period beginning immediately following the Effective
Time and ending on the tenth anniversary of the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CVR Proceeds</U>&#148; means, upon the consummation of any MS
Asset Disposition following the Closing Date and prior to expiration of the Disposition Period or, if applicable, the fiscal quarter during the CVR Period in which the proceeds of any MS Asset Disposition are received, the amount of Gross Proceeds
actually received by Frequency or any of its Subsidiaries upon such consummation or during the applicable fiscal quarter, less the applicable reasonably documented Permitted Deductions with respect to such Gross Proceeds, in each case as calculated
in accordance with GAAP consistently applied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disposition Period</U>&#148; means the period beginning on the execution date of
the Merger Agreement and ending on the one year anniversary of the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Time</U>&#148; means the time at
which the Merger shall become effective at the time of the filing of the Certificate of Merger and the acceptance by the Secretary of State of the State of Delaware, or at such later time as may be specified in such Certificate of Merger with the
consent of Frequency and Korro. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Gross Proceeds</U>&#148; means, without duplication, all cash consideration that is paid to, or
is received by, Frequency or any of its Subsidiaries during the CVR Period in consideration for an MS Asset Disposition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Holder</U>&#148; means, at the relevant time, a Person in whose name CVRs are registered in the CVR Register. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Majority of Holders</U>&#148; means, at any time, the registered Holder or Holders of more than 50% of the total number of CVRs
registered at such time, as set forth on the CVR Register. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>MS Assets</U>&#148; means the assets, rights and interests held by or
on behalf of Frequency or any of its Subsidiaries as of the execution date of the Merger Agreement relating to Frequency&#146;s MS remyelination program, including but not limited to any such intellectual property rights and data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>MS Asset Disposition</U>&#148; means the sale, transfer, license, assignment or other divestiture, disposition or commercialization
of any MS Assets (including any such sale or disposition of equity securities in any Subsidiary that was established by Frequency during the Disposition Period solely to hold any right, title or interest in or to all or any MS Assets) in a
transaction or series of transactions, in each case entered into during the Disposition Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer&#146;s
Certificate</U>&#148; means a certificate signed by the chief executive officer or the chief financial officer of Frequency, in their respective official capacities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Deductions</U>&#148; means the following costs or expenses, without duplication: </P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any income Taxes required to be paid in cash by Frequency or any of its Subsidiaries with respect to the
taxable year in which such Gross Proceeds were received which income Taxes would not have been required to be paid by Frequency or its applicable Subsidiary but for its receipt of Gross Proceeds; <I><U>provided</U></I>, that, for purposes of
calculating any such income Taxes, (a)&nbsp;such income Taxes shall be computed after taking into account any net operating loss carryforwards or other Tax attributes (including Tax credits) of Frequency or any of its Subsidiaries that are available
to offset income or gain, after taking into account any limits of the usability of such attributes under applicable Law, including under Section&nbsp;382 of the Code, as reasonably determined by a nationally recognized tax advisor, which Tax
attributes were generated either (I)&nbsp;prior to the Closing Date or (II)&nbsp;after the Closing Date, in the case of this clause (II)&nbsp;if such Tax attributes relate to the MS Assets, and (b)&nbsp;for the avoidance of doubt, any item(s) of
income or gain resulting or arising from such Gross Proceeds shall be treated as the first item(s) of income or gain, as applicable, in the applicable taxable year; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any reasonable and documented
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred by Frequency or any of its Subsidiaries in respect of its performance of this Agreement following the Closing Date or in
respect of its negotiation, execution, delivery or performance of any agreement in connection with the MS Assets (for clarity, including any Sale Agreement), including (i)&nbsp;any costs related to the prosecution, maintenance or enforcement by
Frequency or any of its Subsidiaries of intellectual property rights (but excluding any costs related to a breach of this Agreement by Frequency, including costs incurred in litigation in respect of the same) or (ii)&nbsp;any costs related to
Liabilities of or relating to the MS Assets that remain with Frequency following the consummation of any MS Asset Disposition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any reasonable and documented
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs incurred or accrued by Frequency or any of its Subsidiaries in connection with the negotiation, entry into and closing of any MS Asset Disposition,
including any brokerage fee, finder&#146;s fee, opinion fee, success fee, transaction fee, service fee, regulatory and other filing fees, or other fee, commission or expense owed to any broker, finder, investment bank, auditor, accountant, counsel,
advisor or other third party in relation thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Losses incurred and paid or payable by Frequency or any of its Subsidiaries arising out of any third party
claims, demands, actions or other proceedings relating to or in connection with any MS Asset Disposition, including in respect of its performance of this Agreement, any Sale Agreement or any other agreement relating to any MS Asset Disposition and
Losses actually incurred or paid (or reasonably expected to be actually incurred or paid) in connection with indemnification obligations of Frequency or any of its Subsidiaries set forth in any Sale Agreement or any other agreement relating to any
MS Asset Disposition; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any liabilities borne by Frequency or any of its Subsidiaries pursuant to contracts related to the MS Assets,
including costs arising from the termination thereof (in each case only to the extent not included in the calculation of Frequency Net Cash (as defined in the Merger Agreement). </P></TD></TR></TABLE>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Transfer</U>&#148; means a Transfer of one or more CVRs (i)&nbsp;upon
death of a Holder by will or intestacy; (ii)&nbsp;by instrument to an <I>inter vivos</I> or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (iii)&nbsp;made pursuant to a court order of a court of
competent jurisdiction (such as in connection with divorce, bankruptcy or liquidation); (iv) made by operation of law (including a consolidation or merger) or without consideration in connection with the dissolution, liquidation or termination of
any corporation, limited liability company, partnership or other entity; (v)&nbsp;in the case of CVRs payable to a nominee, from a nominee to a beneficial owner (and, if applicable, through an intermediary) or from such nominee to another nominee
for the same beneficial owner, in each case as permitted by The Depository Trust Company; (vi)&nbsp;to Frequency or its Subsidiaries; or (vii)&nbsp;as provided in <U>Section</U><U></U><U>&nbsp;2.6</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any individual, partnership, joint venture, limited liability company, firm, corporation, unincorporated
association or organization, trust or other entity, and shall include any successor (by merger or otherwise) of any such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Record Date</U>&#148; means the close of business on the last Business Day prior to the day on which the Effective Time occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rights Agent</U>&#148; means the Rights Agent named in the first paragraph of this Agreement, until a successor Rights Agent shall
have been appointed pursuant to <U>Article</U><U></U><U>&nbsp;3</U> of this Agreement, and thereafter &#147;Rights Agent&#148; will mean such successor Rights Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer</U>&#148; means transfer, pledge, hypothecation, encumbrance, assignment or other disposition (whether by sale, merger,
consolidation, liquidation, dissolution, dividend, distribution or otherwise), the offer to make such a transfer or other disposition, and each contract, arrangement or understanding, whether or not in writing, to effect any of the foregoing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONTINGENT VALUE RIGHTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1
<I>Holders of CVRs; Appointment of Rights Agent</I>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The CVRs shall be issued to the holders of shares of Frequency Common Stock as of the Record Date.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Frequency hereby appoints the Rights Agent to act as rights agent for Frequency in accordance with the express
terms and conditions set forth in this Agreement, and the Rights Agent hereby accepts such appointment. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <I><FONT
STYLE="white-space:nowrap">Non-transferable</FONT></I>.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Holder may not at any time Transfer CVRs, other than pursuant to a Permitted
Transfer. Any attempted Transfer that is not a Permitted Transfer, in whole or in part, will be void <I>ab initio</I> and of no effect. The CVRs will not be listed on any quotation system or traded on any securities exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <I>No Certificate; Registration; Registration of Transfer; Change of Address</I>. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Holders&#146; rights and obligations in respect of CVRs derive solely from this Agreement; CVRs will not be
evidenced by a certificate or other instrument. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent will maintain an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">up-to-date</FONT></FONT> register (the &#147;<U>CVR Register</U>&#148;) for the purposes of (i)&nbsp;identifying the Holders of CVRs, (ii)&nbsp;determining Holders&#146; entitlement
to CVRs and (iii)&nbsp;registering the CVRs and Permitted Transfers thereof. The CVR Register will initially show one position for the The Depository Trust Company (or its nominee) representing all of the CVRs provided to the holders of shares of
Frequency Common Stock held as of the Record Date. Except as expressly provided herein with respect to the rights of the Rights Agent, neither Frequency nor its Subsidiaries will have any responsibility or liability whatsoever to any person other
than the Holders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the restriction on transferability set forth in <U>Section</U><U></U><U>&nbsp;2.2</U>, every request
made to Transfer CVRs must be in writing and accompanied by a written instrument of Transfer reasonably acceptable to the Rights Agent, together with the signature guarantee of a guarantor institution which is a participant in a signature guarantee
program approved by the Securities Transfer Association (a &#147;signature guarantee&#148;) and other requested documentation in a form reasonably satisfactory to the Rights Agent, duly executed and properly completed, as applicable, by the Holder
or Holders thereof, or by the duly appointed legal representative, personal representative or survivor of such Holder or Holders, setting forth in reasonable detail the circumstances relating to the Transfer. Upon receipt of such written notice, the
Rights Agent will, subject to its reasonable determination in accordance with its own internal procedures, that the Transfer instrument is in proper form and the Transfer, is a Permitted Transfer and otherwise complies on its face with the other
terms and conditions of this Agreement, register the Transfer of the applicable CVRs in the CVR Register. All Transfers of CVRs registered in the CVR Register will be the valid obligations of Frequency, evidencing the same right, and entitling the
transferee to the same benefits and rights under this Agreement, as those held by the transferor. Each of Frequency and the Rights Agent may require payment (without duplication) of a sum sufficient to cover any stamp or other transfer Tax or
governmental charge that is imposed in connection with (and would not have been imposed but for) any such registration of transfer, unless the transferee shall have established to the reasonable satisfaction of Frequency or the Rights Agent, as
applicable, that such Tax, if any, has been paid. No transfer of CVRs shall be valid until registered in the CVR Register and any transfer not duly registered in the CVR Register shall be void. Frequency shall not be responsible for any costs and
expenses related to any transfer or assignment of the CVRs (including the cost of any transfer tax). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A Holder may make a written request to the Rights Agent to change such Holder&#146;s address of record in the
CVR Register. Such written request must be duly executed by such Holder. Upon receipt of such written notice, the Rights Agent shall promptly record the change of address in the CVR Register. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <I>Payment Procedures</I>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As promptly as practicable (and, in any event, within twenty (20)&nbsp;days) after the consummation of any MS
Asset Dispositions and, in any event, not later than the date that is forty-five (45)&nbsp;days following the end of each fiscal quarter of Frequency following the Closing in which CVR Proceeds are actually received by Frequency or any of its
Subsidiaries, Frequency shall (i)&nbsp;deliver to the Rights Agent, an Officer&#146;s Certificate </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
certifying the aggregate amount of (A)&nbsp;the CVR Proceeds (if any) actually received by Frequency or its Subsidiaries during such fiscal quarter (or, in the case of the first delivery of such
an Officer&#146;s Certificate hereunder, all CVR Proceeds actually received through the end of such fiscal quarter); (B) the Permitted Deductions reflected in such CVR Proceeds; and (C)&nbsp;the CVR Payment payable to Holders, if any, in respect of
such CVR Proceeds, and (ii)&nbsp;deliver to the Rights Agent, or as the Rights Agent directs, the CVR Payment (if any) by wire transfer of immediately available funds to an account designated in writing by the Rights Agent. Upon receipt of the wire
transfer referred to in the foregoing sentence, the Rights Agent shall promptly (and in any event, within ten (10)&nbsp;Business Days) pay, by check mailed, first-class postage prepaid, to the address of each Holder set forth in the CVR Register at
such time or by other method of delivery as specified by the applicable Holder in writing to the Rights Agent, an amount equal to the product determined by multiplying (i)&nbsp;the quotient determined by dividing (A)&nbsp;the applicable CVR Payment
by (B)&nbsp;the total number of CVRs registered in the CVR Register at such time, by (ii)&nbsp;the number of CVRs registered to such Holder in the CVR Register at such time. For the avoidance of doubt Frequency shall have no further liability in
respect of the relevant CVR Payment upon delivery of such CVR Payment in accordance with this <U>Section</U><U></U><U>&nbsp;2.4(a)</U> and the satisfaction of each of Frequency&#146;s obligations set forth in this
<U>Section</U><U></U><U>&nbsp;2.4(a)</U>. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except to the extent otherwise required pursuant to a change in applicable Law after the date hereof, the
parties hereto agree to treat the issuance of the CVRs as not constituting a current distribution and all CVR Payments for all Tax purposes as distributions of money governed by Section&nbsp;301 of the U.S. Internal Revenue Code of 1986, as amended
(the &#147;<U>Code</U>&#148;), which will constitute a dividend to the extent payable out of Frequency and its Subsidiaries&#146; current and accumulated &#147;earnings and profits&#148; (pursuant to Section&nbsp;316 of the Code) in the taxable year
in which the CVR Payment is made. The parties hereto will not take any position to the contrary on any Tax Return or for other Tax purposes except as required by a change in applicable Law after the date hereof. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Frequency and the Rights Agent will be entitled to deduct and withhold, or cause to be deducted and withheld,
from any CVR Payment otherwise payable pursuant to this Agreement, such amounts as it is required to deduct and withhold with respect to the making of such payment under any provision of applicable Law relating to Taxes. To the extent that amounts
are so deducted and withheld and timely paid over to the appropriate Governmental Authority, such deducted and withheld amounts will be treated for all purposes of this Agreement as having been paid to the Holder in respect of which such deduction
and withholding was made. Prior to making any such Tax deductions or withholdings or causing any such Tax deductions or withholdings to be made with respect to any Holder, the Rights Agent will, to the extent reasonably practicable, provide notice
to the Holder of such potential Tax deduction or withholding and a reasonable opportunity for the Holder to provide any necessary Tax forms in order to avoid or reduce such withholding amounts; <I><U>provided</U></I> that the time period for payment
of a CVR Payment by the Rights Agent set forth in <U>Section</U><U></U><U>&nbsp;2.4(a)</U> will be extended by a period equal to any delay caused by the Holder providing such forms; <I><U>provided</U></I>, <I><U>further</U></I>, that in no event
shall such period be extended for more than ten (10)&nbsp;Business Days, unless otherwise requested by the Holder for the purpose of delivering such forms and agreed to by the Rights Agent. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any portion of a CVR Payment that remains undistributed to the Holders six (6)&nbsp;months after the applicable
fiscal quarter end (including by means of uncashed checks or invalid addresses on the CVR Register) will be delivered by the Rights Agent to Frequency or a person nominated in writing by Frequency (with written notice thereof from Frequency to the
Rights Agent), and any Holder will thereafter look only to Frequency for payment of such CVR Payment (which shall be without interest). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Neither Frequency nor the Rights Agent will be liable to any Person in respect of any CVR Payment amount
delivered to a public official pursuant to any applicable abandoned property, escheat or similar legal requirement under applicable law. In addition to and not in limitation of any other indemnity obligation herein, Frequency agrees to indemnify and
hold harmless the Rights Agent with respect to any liability, penalty, cost or expense the Rights Agent may incur or be subject to in connection with transferring such property to Frequency or a public official. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <I>No Voting, Dividends or Interest; No Equity or Ownership Interest</I>. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">CVRs will not have any voting or dividend rights, and interest will not accrue on any amounts payable in
respect of CVRs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">CVRs will not represent any equity or ownership interest in Frequency or any of its Subsidiaries or in the
Surviving Corporation. The sole right of the Holders to receive property hereunder is the right to receive CVR Payments, if any, in accordance with the terms hereof. It is hereby acknowledged and agreed that a CVR shall not constitute a security of
Frequency or any of its Subsidiaries or of the Surviving Corporation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is hereby acknowledged and agreed that the CVRs and the possibility of any payment hereunder with respect
thereto are highly speculative and subject to numerous factors outside of Frequency&#146;s control, and there is no assurance that Holders will receive any payments under this Agreement or in connection with the CVRs. Each Holder acknowledges that
it is highly possible that there will not be any Gross Proceeds that may be the subject of a CVR Payment Amount. It is further acknowledged and agreed that neither Frequency nor its Subsidiaries owe, by virtue of their obligations under this
Agreement, a fiduciary duty or any implied duties to the Holders and the parties hereto intend solely the express provisions of this Agreement to govern their contractual relationship with respect to the CVRs. It is acknowledged and agreed that this
<U>Section</U><U></U><U>&nbsp;2.5(c)</U> is an essential and material term of this Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <I>Ability to Abandon
CVR</I>.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Holder may at any time, at such Holder&#146;s option, abandon all of such Holder&#146;s remaining rights represented by CVRs by
transferring such CVR to Frequency or a person nominated in writing by Frequency (with written notice thereof from Frequency to the Rights Agent) without consideration or compensation therefor, and such rights will be cancelled, with the Rights
Agent being promptly notified in writing by Frequency of such transfer and cancellation. Nothing in this Agreement is intended to prohibit Frequency or its Subsidiaries from offering to acquire or acquiring CVRs, in private transactions or
otherwise, for consideration in its sole discretion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE RIGHTS AGENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1
<I>Certain Duties and Responsibilities</I>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent will not have any liability for any actions taken or not taken in connection with this
Agreement, except to the extent such liability arises as a result of the willful misconduct, bad faith or gross negligence of the Rights Agent (in each case as determined by a final <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment of
court of competent jurisdiction). Notwithstanding anything in this Agreement to the contrary, any liability of the Rights Agent under this Agreement will be limited to the amount of annual fees paid by Frequency to the Rights Agent during the twelve
(12)&nbsp;months immediately preceding the event for which recovery from the Rights Agent is being sought, except in the case of the willful misconduct, bad faith or fraud of the Rights Agent (in each case as determined by a final <FONT
STYLE="white-space:nowrap">non-appealable</FONT> judgment of court of competent jurisdiction). Anything to the contrary notwithstanding, in no event will the Rights Agent be liable for special, punitive, indirect, incidental or consequential loss or
damages of any kind whatsoever (including, without limitation, lost profits), even if the Rights Agent has been advised of the likelihood of such loss or damages, and regardless of the form of action. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand
from any Holder with respect to any action or default by any person or entity, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make
any demand upon Frequency or the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <I>Certain Rights of Rights Agent</I>. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this
Agreement, and no implied covenants or obligations will be read into this Agreement against the Rights Agent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent may rely and will be protected by Frequency in acting or refraining from acting upon any
resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document reasonably believed by it in the absence of bad faith to be genuine and to have been signed or presented by or on
behalf of Frequency. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent may engage and consult with counsel of its selection, and the advice or opinion of such
counsel will, in the absence of bad faith, gross negligence or willful misconduct (in each case, as determined by a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment of a court of competent jurisdiction) on the part of the
Rights Agent, be full and complete authorization and protection in respect of any action taken or not taken by the Rights Agent in reliance thereon. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any permissive rights of the Rights Agent hereunder will not be construed as a duty. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent will not be required to give any note or surety in respect of the execution of its powers or
otherwise under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Frequency agrees to indemnify the Rights Agent for, and to hold the Rights Agent harmless from and against, any
loss, liability, damage, judgment, fine, penalty, cost or expense (each, a &#147;<U>Loss</U>&#148;) suffered or incurred by the Rights Agent and arising out of or in connection with the Rights Agent&#146;s performance of its obligations under this
Agreement, including the reasonable and documented costs and expenses of defending the Rights Agent against any claims, charges, demands, actions or suits arising out of or in connection in connection with the execution, acceptance, administration,
exercise and performance of its duties under this Agreement, including the costs and expenses of defending against any claim of liability arising therefrom, directly or indirectly, or enforcing its rights hereunder, except to the extent such Loss
has been determined by a final <FONT STYLE="white-space:nowrap">non-appealable</FONT> decision of a court of competent jurisdiction to have resulted from the Rights Agent&#146;s gross negligence, bad faith or willful misconduct (in each case, as
determined by a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment of a court of competent jurisdiction). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In addition to the indemnification provided under <U>Section</U><U></U><U>&nbsp;3.2(f)</U>, Frequency agrees
(i)&nbsp;to pay the fees of the Rights Agent in connection with the Rights Agent&#146;s performance of its obligations hereunder, as agreed upon in writing by the Rights Agent and Frequency on or prior to the date of this Agreement, and (ii)&nbsp;to
reimburse the Rights Agent for all reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses and other disbursements incurred in the preparation, delivery, negotiation,
amendment, administration and execution of this Agreement and the exercise and performance of its duties hereunder, including all taxes (other than income, receipt, franchise or similar taxes) and governmental charges, incurred by the Rights Agent
in the performance of its obligations under this Agreement, except that Frequency will have no obligation to pay the fees of the Rights Agent or reimburse the Rights Agent for the fees of counsel in connection with any lawsuit initiated by the
Rights Agent on behalf of itself or the Holders, except in the case of any suit enforcing the provisions of <U>Section</U><U></U><U>&nbsp;2.4(a)</U>, <U>Section</U><U></U><U>&nbsp;2.4(b)</U> or <U>Section</U><U></U><U>&nbsp;3.2(f)</U>, if Frequency
is found by a court of competent jurisdiction to be liable to the Rights Agent or the Holders, as applicable in such suit. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise
incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers if it believes that repayment of such funds or adequate indemnification against such risk or liability is not
reasonably assured to it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent will not be deemed to have knowledge of any event of which it was supposed to receive notice
hereunder but has not received written notice of such event, and the Rights Agent will not incur any liability for failing to take action in connection therewith, in each case, unless and until it has received such notice in writing.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty
hereunder either itself or by or through its attorney or agents and the Rights Agent shall not be answerable or accountable for any act, default, neglect or misconduct of any such attorney or agents or for any loss to Frequency or the Company
resulting from any such act, default, neglect or misconduct, absent gross negligence, bad faith or willful misconduct (each as determined by a final <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment of a court of competent
jurisdiction) in the selection and continued employment thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Frequency shall perform, acknowledge and deliver or cause to be performed, acknowledged and delivered all such
further and other acts, documents, instruments and assurances as may be reasonably required by the Rights Agent for the carrying out or performing by the Rights Agent of the provisions of this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in
this Agreement (except its countersignature thereof) or be required to verify the same, and all such statements and recitals are and shall be deemed to have been made by Frequency only. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent shall act hereunder solely as agent for Frequency and shall not assume any obligations or
relationship of agency or trust with any of the owners or holders of the CVRs. The Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holders with respect to any action or default by
Frequency, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon Frequency. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent may rely on and be fully authorized and protected in acting or failing to act upon
(i)&nbsp;any guaranty of signature by an &#147;eligible guarantor institution&#148; that is a member or participant in the Securities Transfer Agents Medallion Program or other comparable &#147;signature guarantee program&#148; or insurance program
in addition to, or in substitution for, the foregoing; or (ii)&nbsp;any law, act, regulation or any interpretation of the same even though such law, act, or regulation may thereafter have been altered, changed, amended or repealed.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent shall not be liable or responsible for any failure of Frequency to comply with any of its
obligations relating to any registration statement filed with the Securities and Exchange Commission or this Agreement, including without limitation obligations under applicable Law. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Whenever the Rights Agent deems it desirable that a matter be proved or established prior to taking or omitting
any action hereunder, the Rights Agent may (i)&nbsp;rely upon an Officer&#146;s Certificate and (ii)&nbsp;incur no liability and be held harmless by the Company for or in respect of any action taken or omitted to be taken by it under the provisions
of this Agreement in reliance upon such Officer&#146;s Certificate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All funds received by Computershare under this Agreement that are to be distributed or applied by Computershare
in the performance of services hereunder (the &#147;<U>Funds</U>&#148;) shall be held by Computershare as agent for Frequency and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for Frequency. Until paid
pursuant to the terms of this Agreement, Computershare will hold the Funds through such accounts </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
in: deposit accounts of commercial banks with Tier 1 capital exceeding $1&nbsp;billion or with an average rating above investment grade by S&amp;P (LT Local Issuer Credit Rating), Moody&#146;s
(Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). Computershare shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by
Computershare in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party. Computershare may from time to time receive interest, dividends or other earnings in connection
with such deposits. Computershare shall not be obligated to pay such interest, dividends or earnings to Frequency, any holder or any other party. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The obligations of Frequency and the rights of the Rights Agent under this
<U>Section</U><U></U><U>&nbsp;3.2</U>, <U>Section</U><U></U><U>&nbsp;3.1</U> and <U>Section</U><U></U><U>&nbsp;2.4</U> shall survive the expiration of the CVRs and the termination of this Agreement and the resignation, replacement or removal of the
Rights Agent. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <I>Resignation and Removal; Appointment of Successor</I>. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent may resign at any time by written notice to Frequency. Any such resignation notice shall
specify the date on which such resignation will take effect (which shall be at least thirty (30)&nbsp;days following the date that such resignation notice is delivered), and such resignation will be effective on the earlier of (i)&nbsp;the date so
specified and (ii)&nbsp;the appointment of a successor Rights Agent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Frequency will have the right to remove the Rights Agent at any time by written notice to the Rights Agent,
specifying the date on which such removal will take effect. Such notice will be given at least thirty (30)&nbsp;days prior to the date so specified (or, if earlier, the appointment of the successor Rights Agent). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Rights Agent resigns, is removed or becomes incapable of acting, Frequency will promptly appoint a
qualified successor Rights Agent. Notwithstanding the foregoing, if Frequency fails to make such appointment within a period of thirty (30)&nbsp;days after giving notice of such removal or after it has been notified in writing of such resignation or
incapacity by the resigning or incapacitated Rights Agent, then the incumbent Rights Agent may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. The successor Rights Agent so appointed will, upon its acceptance
of such appointment in accordance with this <U>Section</U><U></U><U>&nbsp;3.3(c)</U> and <U>Section</U><U></U><U>&nbsp;3.4</U>, become the Rights Agent for all purposes hereunder. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Frequency will give notice to the Holders of each resignation or removal of the Rights Agent and each
appointment of a successor Rights Agent in accordance with <U>Section</U><U></U><U>&nbsp;7.2</U>. Each notice will include the name and address of the successor Rights Agent. If Frequency fails to send such notice within ten (10)&nbsp;Business Days
after acceptance of appointment by a successor Rights Agent, the successor Rights Agent will cause the notice to be mailed at the expense of Frequency. </P></TD></TR></TABLE> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything to the contrary in this <U>Section</U><U></U><U>&nbsp;3.3</U>, unless consented to in
writing by the Majority of Holders, Frequency will not appoint as a successor Rights Agent any Person that is not a stock transfer agent of national reputation or the corporate trust department of a commercial bank. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent will reasonably cooperate with Frequency and any successor Rights Agent in connection with the
transition of the duties and responsibilities of the Rights Agent to the successor Rights Agent, including the transfer of all relevant data, including the CVR Register, to the successor Rights Agent, but such predecessor Rights Agent shall not be
required to make any additional expenditure or assume any additional liability in connection with the foregoing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4
<I>Acceptance of Appointment by Successor</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every successor Rights Agent appointed hereunder will, at or prior to such appointment,
execute, acknowledge and deliver to Frequency and to the resigning or removed Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and such successor Rights Agent, without any further act, deed or conveyance,
will become vested with all the rights, powers, trusts and duties of the Rights Agent; <I><U>provided</U></I> that upon the request of Frequency or the successor Rights Agent, such resigning or removed Rights Agent will execute and deliver an
instrument transferring to such successor Rights Agent all the rights, powers and trusts of such resigning or removed Rights Agent. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;4 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <I>List of
Holders</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Frequency will furnish or cause to be furnished to the Rights Agent, in such form as Frequency receives from
Frequency&#146;s transfer agent (or other agent performing similar services for Frequency), the names and addresses of the Holders within fifteen (15)&nbsp;Business Days following the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <I>CVR Committee; Efforts</I>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Frequency Board has delegated, to a special committee of the Frequency Board (the &#147;<U>Special
Committee</U>&#148;) comprised of [ <FONT STYLE="FONT-SIZE:70%">&#9899;</FONT>&nbsp;]<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> (the &#147;<U>Initial Special Committee Members</U>&#148;) the sole responsibility, authority and discretion
during the Disposition Period with respect to (i)&nbsp;managing the MS Assets, (ii)&nbsp;conducting any sale process (including engagement of advisors, upon consent of the Frequency Board, not to be unreasonably withheld, conditioned or delayed)
with respect to an MS Asset Disposition during the Disposition Period or (iii)&nbsp;otherwise divesting or disposing of the MS Assets during the Disposition Period pursuant to an <FONT STYLE="white-space:nowrap">out-license</FONT> with a term of not
more than ten (10)&nbsp;years. The Special Committee shall also be empowered with the authority to authorize and direct any officer of Frequency to negotiate, execute and deliver a definitive written agreement with respect to an MS Asset Disposition
in a form approved by the Special Committee and consistent </P></TD></TR></TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Note to Draft</U>: Special Committee to be composed initially of the Frequency Designee, the 2 independent
directors and 1 designee of Korro. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
with this Agreement and the Merger Agreement (a &#147;<U>Sale Agreement</U>&#148;) in the name and on behalf of Frequency; <I><U>provided</U></I>, <I><U>however</U></I>, that no Sale Agreement
shall be entered into without the prior review and approval of the Frequency Board (such approval not to be unreasonably withheld, conditioned or delayed). In the event (A)&nbsp;any Initial Special Committee Member who is an independent director of
the Frequency Board no longer serves on the Special Committee during the Disposition Period, such vacancy on the Special Committee shall be filled with an independent director of the Frequency Board, (B)&nbsp;the Initial Special Committee Member who
was designated by the Company prior to Closing no longer serves on the Special Committee during the Disposition Period, such vacancy on the Special Committee shall be filled with a designee of the post-Closing Frequency Board, and (C)&nbsp;the
Initial Special Committee Member who was designated by Frequency no longer serves on the Special Committee during the Disposition Period, such vacancy on the Special Committee shall be filled with a designee selected by the member of the
post-Closing Frequency Board designated by Frequency. In each case of (A)-(C) above, the post-Closing Frequency Board agrees to install the applicable replacement on the Special Committee. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The delegation of responsibility and authority to the Special Committee set forth in
<U>Section</U><U></U><U>&nbsp;4.2(a)</U> shall not be revoked or modified at any time during the Disposition Period; <I><U>provided</U></I>, that the Special Committee shall automatically dissolve upon expiration of the Disposition Period and shall
have no further responsibility or authority thereafter. The Special Committee and Frequency Board shall not have any liability to the Holders for any actions taken or not taken in accordance with this Agreement in respect of the matters expressly
contemplated hereby. No provision of this Agreement shall require the Special Committee or any members thereof to expend or risk its, his or her own funds or otherwise incur any financial liability in the performance of any duties hereunder or in
the exercise of any rights or powers hereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Holders shall be intended third-party beneficiaries of the provisions of this Agreement;
<I><U>provided</U></I>, that under no circumstances shall the rights of Holders as third-party beneficiaries pursuant to this <U>Article 4</U> be enforceable by such Holders or any other Person acting for or on their behalf other than the Special
Committee (or the Frequency Board if the Special Committee no longer exists). The Special Committee (or the Frequency Board if the Special Committee no longer exists) has the sole power and authority to act on behalf of the Holders in enforcing any
of their rights hereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the Disposition Period, if and to the extent the Special Committee authorizes and directs the execution
and delivery of any Sale Agreement, Frequency will, and will cause its Subsidiaries to, use commercially reasonable efforts to (i)&nbsp;execute and deliver the Sale Agreement, and (ii)&nbsp;effectuate the MS Asset Disposition pursuant to such Sale
Agreement in accordance with its terms. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except as expressly set forth in <U>Article 3</U>, <U>Section</U><U></U><U>&nbsp;4.2(a)</U> or
<U>Section</U><U></U><U>&nbsp;4.2(b)</U>, none of Frequency or any of its Subsidiaries shall have any obligation or liability whatsoever to any Person relating to or in connection with any action, or failure to act, with respect to any MS Asset
Disposition. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the foregoing clause (d)&nbsp;and the other contractual obligations of Frequency expressly set forth
in this Agreement, (i)&nbsp;the Holders acknowledge that Frequency has a fiduciary obligation to operate its business in the best interests of its stockholders, and any potential obligation to pay CVR Proceeds will not create any express or implied
obligation to operate its business in any particular manner in order to maximize such CVR Proceeds, (ii)&nbsp;except as expressly set forth in this Agreement, the Holders are not relying on any representation of Frequency or any other Person with
regard to any MS Asset Disposition or other action involving the MS Assets following the Closing, and neither Frequency nor any other Person has provided, or can provide, any assurance to the Holders that any CVR Proceeds will in fact be earned and
paid, and (iii)&nbsp;none of Frequency or any of its Subsidiaries, officers or directors shall have any obligation or liability whatsoever to any Person relating to or in connection with any action, or failure to act, with respect to any MS Asset
Disposition. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Following the Disposition Period, Frequency shall be permitted to take any action in respect of the MS Assets
in order to satisfy any Liabilities of or arising from the MS Assets, including any wind-down or termination Liabilities. For clarity, following the CVR Period and following the Disposition Period without an MS Asset Disposition, Frequency may take
any action in respect of the MS Assets in its sole and absolute discretion. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <I>Prohibited Actions</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless approved by the Special Committee (or the Frequency Board if the Special Committee no longer exists), Frequency shall not grant any
lien, security interest, pledge or similar interest in any MS Assets (other than liens or security interests generally granted with respect to all assets of Frequency, and not specific to the MS Assets, and which do not prohibit the ability of
Frequency to complete an MS Asset Disposition and, in connection therewith, to deliver title to the MS Assets to the purchaser thereof, free and clear of such liens and security interests) or any CVR Proceeds. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;5 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <I>Amendments
Without Consent of Holders or Rights Agent</I>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Frequency, at any time and from time to time, may (without the consent of any Person, other than the Rights
Agent, which such consent not to be unreasonably withheld, conditioned, or delayed) enter into one or more amendments to this Agreement for any of the following purposes, without the consent of any of the Holders or the Rights Agent:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to evidence the appointment of another Person as a successor Rights Agent and the assumption by any successor
Rights Agent of the covenants and obligations of the Rights Agent herein in accordance with the provisions hereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">subject to <U>Section</U><U></U><U>&nbsp;6.1</U>, to evidence the succession of another person to Frequency and
the assumption of any such successor of the covenants of Frequency outlined herein in a transaction contemplated by <U>Section</U><U></U><U>&nbsp;6.1</U>; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add to the covenants of Frequency such further covenants, restrictions, conditions or provisions for the
protection and benefit of the Holders; <I><U>provided</U></I> that in each case, such provisions shall not adversely affect the interests of the Holders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to cure any ambiguity, to correct or supplement any provision in this Agreement that may be defective or
inconsistent with any other provision in this Agreement, or to make any other provisions with respect to matters or questions arising under this Agreement; <I><U>provided</U></I> that in each case, such provisions shall not adversely affect the
interests of the Holders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as may be necessary or appropriate to ensure that CVRs are not subject to registration under the U.S.
Securities Act of 1933, as amended, or the U.S. Securities Exchange Act of 1934, as amended and the rules and regulations made thereunder, or any applicable state securities or &#147;blue sky&#148; laws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as may be necessary or appropriate to ensure that Frequency is not required to produce a prospectus or an
admission document in order to comply with applicable Law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to cancel CVRs (i)&nbsp;in the event that any Holder has abandoned its rights in accordance with
<U>Section</U><U></U><U>&nbsp;2.6</U>, or (ii)&nbsp;following a transfer of such CVRs to Frequency or its Subsidiaries in accordance with <U>Section</U><U></U><U>&nbsp;2.2</U> or <U>Section</U><U></U><U>&nbsp;2.3</U>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as may be necessary or appropriate to ensure that Frequency complies with applicable Law; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to effect any other amendment to this Agreement that would provide any additional rights or benefits to the
Holders or that does not adversely affect the legal rights under this Agreement of any such Holder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Promptly after the execution by Frequency of any amendment pursuant to this
<U>Section</U><U></U><U>&nbsp;5.1</U>, Frequency will (or will cause the Rights Agent to) notify the Holders in general terms of the substance of such amendment in accordance with <U>Section</U><U></U><U>&nbsp;7.2</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <I>Amendments with Consent of Holders</I>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In addition to any amendments to this Agreement that may be made by Frequency without the consent of any Holder
or the Rights Agent pursuant to <U>Section</U><U></U><U>&nbsp;5.1</U>, with the consent of the Majority of Holders, Frequency and the Rights Agent may enter into one or more amendments to this Agreement for the purpose of adding, eliminating or
amending any provisions of this Agreement, even if such addition, elimination or amendment is adverse to the interests of the Holders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Promptly after the execution by Frequency and the Rights Agent of any amendment pursuant to the provisions of
this <U>Section</U><U></U><U>&nbsp;5.2</U>, Frequency will (or will cause the Rights Agent to) notify the Holders in general terms of the substance of such amendment in accordance with <U>Section</U><U></U><U>&nbsp;7.2</U>. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <I>Effect of Amendments</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the execution of any amendment under this <U>Article</U><U></U><U>&nbsp;5</U>, this Agreement will be modified in accordance therewith,
such amendment will form a part of this Agreement for all purposes and every Holder will be bound thereby. Upon the delivery of a certificate from an appropriate officer of Frequency which states that the proposed supplement or amendment is in
compliance with the terms of this <U>Article</U><U></U><U>&nbsp;5</U>, the Rights Agent shall execute such supplement or amendment. Notwithstanding anything in this Agreement to the contrary, the Rights Agent shall not be required to execute any
supplement or amendment to this Agreement that it has determined would adversely affect its own rights, duties, obligations or immunities under this Agreement. No supplement or amendment to this Agreement shall be effective unless duly executed by
the Rights Agent. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;6 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATION, MERGER, SALE OR CONVEYANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <I>Frequency May Not Consolidate, Etc.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the CVR Period, Frequency shall not consolidate with or merge into any other Person or convey, transfer or lease all or substantially
all of its properties and assets to any Person, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Person formed by such consolidation or into which Frequency is merged or the Person that acquires by
conveyance or transfer, or that leases, all or substantially all of the properties and assets of Frequency (the &#147;<U>Surviving Person</U>&#148;) shall expressly assume Frequency&#146;s obligations under this Agreement, including payment of
amounts on all CVRs in accordance with the applicable terms; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Frequency has delivered to the Rights Agent an Officer&#146;s Certificate, stating that such consolidation,
merger, conveyance, transfer or lease complies with this <U>Article 6</U>. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <I>Successor Substituted</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any consolidation of or merger by Frequency with or into any other Person, or any conveyance, transfer or lease of the properties and
assets substantially as an entirety to any Person in accordance with <U>Section</U><U></U><U>&nbsp;6.1</U>, the Surviving Person shall succeed to, and be substituted for, and may exercise every right and power of, and shall assume all of the
obligations of Frequency under this Agreement with the same effect as if the Surviving Person had been named as Frequency herein. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;7 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1 <I>Notices
to Rights Agent and to </I><I>Frequency</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices, requests and other communications (each, a &#147;<U>Notice</U>&#148;) to any
party hereunder shall be in writing. Such Notice shall be deemed given (a)&nbsp;on the date of delivery, if delivered in person, by Fedex or other internationally recognized overnight courier service or, (except with respect to any Person other than
the Rights Agent), by <FONT STYLE="white-space:nowrap">e-mail</FONT> (upon confirmation of receipt) prior to 5:00&nbsp;p.m. in the time zone of the receiving party or on the next Business Day, if delivered after 5:00&nbsp;p.m. in the time zone of
the receiving party or (b)&nbsp;on the first Business Day following the date of dispatch, if delivered by FedEx or by other internationally recognized overnight courier service (upon proof of delivery), addressed as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to the Rights Agent, to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Computershare Trust Company, N.A. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">150 Royall Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Canton, MA 02021 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to Frequency, to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Frequency Therapeutics </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">75 Hayden Ave </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Lexington, MA 02421 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: [&nbsp;<FONT STYLE="FONT-SIZE:70%">&#9899;</FONT>&nbsp;] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: [&nbsp;<FONT STYLE="FONT-SIZE:70%">&#9899;</FONT>&nbsp;] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy, which shall not constitute notice, to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Goodwin Procter LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">100 Northern Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts 02210 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Kingsley L. Taft, Andrew H. Goodman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: ktaft@goodwinlaw.com, agoodman@goodwinlaw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address or facsimile number as such party may hereafter specify for the purpose by notice to the other parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <I>Notice to Holders</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All
Notices required to be given to the Holders will be given (unless otherwise herein expressly provided) in writing and mailed, first-class postage prepaid, to each Holder at such Holder&#146;s address as set forth in the CVR Register, not later than
the latest date, and not earlier than the earliest date, prescribed for the sending of such Notice, if any, and will be deemed given on the date of mailing. In any case where notice to the Holders is given by mail, neither the failure to mail such
Notice, nor any defect in any Notice so mailed, to any particular Holder will affect the sufficiency of such Notice with respect to other Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3 <I>Entire Agreement</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
between Frequency and the Rights Agent, this Agreement constitutes the entire agreement between the parties with respect to the subject matter of this Agreement, notwithstanding the reference to any other agreement herein, and supersedes all prior
agreements and understandings, both written and oral, among or between any of the parties with respect to the subject matter of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4 <I>Merger or Consolidation or Change of Name of Rights Agent</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Person into which the Rights Agent or any successor Rights Agent may be merged or with which it may be consolidated, or Person resulting
from any merger or consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any Person succeeding to the stock transfer or other shareholder services business of the Rights Agent or any successor Rights Agent, shall
be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto, <I><U>provided</U></I> that such Person would be eligible for appointment as a
successor Rights Agent under the provisions of <U>Section</U><U></U><U>&nbsp;3.3</U>. The purchase of all or substantially all of the Rights Agent&#146;s assets employed in the performance of transfer agent activities shall be deemed a merger or
consolidation for purposes of this <U>Section</U><U></U><U>&nbsp;7.4</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.5 <I>Successors and Assigns</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement will be binding upon, and will be enforceable by and inure solely to the benefit of, the Holders, Frequency and the Rights
Agent and their respective successors and assigns. Except for assignments pursuant to <U>Section</U><U></U><U>&nbsp;7.4</U>, the Rights Agent may not assign this Agreement without Frequency&#146;s prior written consent. Subject to
<U>Section</U><U></U><U>&nbsp;5.1(a)(ii)</U> and <U>Article</U><U></U><U>&nbsp;6</U> hereof, Frequency may assign, in its sole discretion and without the consent of any other party, any or all of its rights, interests and obligations hereunder to
one or more of its Affiliates or to any Person with whom Frequency is merged or consolidated, or any entity resulting from any merger or consolidation to which Frequency shall be a party (each, an &#147;<U>Assignee</U>&#148;);
<I><U>provided</U></I>, <I><U>however</U></I>, that in connection with any assignment to an Assignee, Frequency shall agree to remain liable for the performance by Frequency of its obligations hereunder (to the extent Frequency exists following such
assignment). Frequency or an Assignee may not otherwise assign this Agreement without the prior consent of the Majority of Holders. Any attempted assignment of this Agreement in violation of this <U>Section</U><U></U><U>&nbsp;7.5</U> will be void
<I>ab initio</I> and of no effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.6 <I>Benefits of Agreement; Action by Majority of Holders</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Agreement, express or implied, will give to any Person (other than Frequency, the Rights Agent, the Holders and their
respective permitted successors and assigns hereunder) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole
benefit of Frequency, the Rights Agent, the Holders and their permitted successors and assigns. The Holders will have no rights hereunder except as are expressly set forth herein. Except for the rights of the Rights Agent set forth herein, the
Majority of Holders will have the sole right, on behalf of all Holders, by virtue of or under any provision of this Agreement, to institute any action or proceeding at law or in equity with respect to this Agreement, and no individual Holder or
other group of Holders will be entitled to exercise such rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.7 <I>Governing Law</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement and the CVRs will be governed by, and construed in accordance with, the laws of the State of Delaware without regard to the
conflicts of law rules of such state. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.8 <I>Jurisdiction</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In any action or proceeding between any of the parties hereto arising out of or relating to this Agreement or any of the transactions
contemplated hereby, each of the parties hereto: (a)&nbsp;irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Chancery Court of the State of Delaware, County of New Castle, or, if under applicable Law
exclusive jurisdiction is vested in the Federal courts, the United States District Court for the District of Delaware (and appellate courts thereof); (b) agrees that all claims in respect of such action or proceeding shall be heard and determined
exclusively in accordance with clause (a)&nbsp;of this <U>Section</U><U></U><U>&nbsp;7.8</U>; (c) waives any objection to laying venue in any such action or proceeding in such courts; (d)&nbsp;waives any objection that such courts are an
inconvenient forum or do not have jurisdiction over any Party; and (e)&nbsp;agrees that service of process upon such Party in any such action or proceeding shall be effective if notice is given in accordance with
<U>Section</U><U></U><U>&nbsp;7.1</U> or <U>Section</U><U></U><U>&nbsp;7.2</U> of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.9 <B><I>WAIVER OF JURY TRIAL</I></B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>EACH OF THE PARTIES HERETO (AND BY ACCEPTING THE CVR&#146; S, THE HOLDERS) HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY
JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II)&nbsp;EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATION OF THIS WAIVER, (III)&nbsp;EACH PARTY MAKES THIS WAIVER VOLUNTARILY,
AND (IV)&nbsp;EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION</U><U></U><U>&nbsp;7.9</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10 <I>Severability Clause</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any provision of this Agreement, or the application of any such provision to any Person or set of circumstances, is for any
reason determined to be invalid, unlawful, void or unenforceable to any extent, the remainder of this Agreement, and the application of such provision to Persons or circumstances other than those as to which it is determined to be invalid, unlawful,
void or unenforceable, will not be impaired or otherwise affected and will continue to be valid and enforceable to the fullest extent permitted by applicable Law. Upon such a determination, the parties hereto will negotiate in good faith to modify
this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible;
<I><U>provided</U></I>, <I><U>however</U></I>, that if an excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately upon written notice to
Frequency. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11 <I>Counterparts; Effectiveness</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement may be signed in any number of counterparts, each of which will be deemed an original, with the same effect as if the
signatures thereto and hereto were upon the same instrument. This Agreement or any counterpart may be executed and delivered by facsimile copies or delivered by electronic communications by portable document format (.pdf), each of which shall be
deemed an original. This Agreement will become effective when each party hereto will have received a counterpart hereof signed by the other party hereto. Until and unless each party has received a counterpart hereof signed by the other party hereto,
this Agreement will have no effect and no party will have any right or obligation hereunder (whether by virtue of any oral or written agreement or any other communication). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12 <I>Termination</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
Agreement will automatically terminate and be of no further force or effect and, except as provided in <U>Section</U><U></U><U>&nbsp;3.2</U>, the parties hereto will have no further liability hereunder, and the CVRs will expire without any
consideration or compensation therefor, upon the expiration of the CVR Period. The termination of this Agreement will not affect or limit the right of Holders to receive the CVR Payments under <U>Section</U><U></U><U>&nbsp;2.4</U> to the extent
earned prior to the termination of this Agreement, and the provisions applicable thereto will survive the expiration or termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.13 <I>Force Majeure</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained herein, none of the Rights Agent, Frequency or any of its Subsidiaries (except as it
relates to the obligations of the Company under <U>Article</U><U></U><U>&nbsp;3</U>) will be liable for any delays or failures in performance resulting from acts beyond its reasonable control including acts of God, pandemics (including <FONT
STYLE="white-space:nowrap">COVID-19),</FONT> terrorist acts, shortage of supply, breakdowns or malfunctions, interruptions or malfunctions of computer facilities, or loss of data due to power failures or mechanical difficulties with information
storage or retrieval systems, labor difficulties, war or civil unrest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.14 <I>Construction</I>. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For purposes of this Agreement, whenever the context requires: singular terms will include the plural, and vice
versa; the masculine gender will include the feminine and neuter genders; the feminine gender will include the masculine and neuter genders; and the neuter gender will include the masculine and feminine genders. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As used in this Agreement, the words &#147;include&#148; and &#147;including,&#148; and variations thereof,
will not be deemed to be terms of limitation, but rather will be deemed to be followed by the words &#147;without limitation.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The headings contained in this Agreement are for convenience of reference only, will not be deemed to be a part
of this Agreement and will not be referred to in connection with the construction or interpretation of this Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any reference in this Agreement to a date or time shall be deemed to be such date or time in New York City,
United States, unless otherwise specified. The parties hereto and Frequency have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall
be construed as if drafted jointly by the parties and Frequency and no presumption or burden of proof shall arise favoring or disfavoring any Person by virtue of the authorship of any provision of this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All references herein to &#147;$&#148; are to United States Dollars. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed as of the
day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">FREQUENCY THERAPEUTICS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">COMPUTERSHARE TRUST COMPANY, N.A. and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">COMPUTERSHARE INC., collectively as Rights Agent</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title:</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>freq-20230714.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/15/2023 12:50:06 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:freq="http://frequencytx.com/20230714"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://frequencytx.com/20230714"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="freq-20230714_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="freq-20230714_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>freq-20230714_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/15/2023 12:50:06 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>freq-20230714_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/15/2023 12:50:06 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="freq-20230714.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140300831915632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001703647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 14,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FREQUENCY THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-2324450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">75 Hayden Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lexington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(781)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">315-4600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FREQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>d651936d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="freq-20230714.xsd" xlink:type="simple"/>
    <context id="duration_2023-07-14_to_2023-07-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-07-14_to_2023-07-14">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-07-14_to_2023-07-14"
      id="Hidden_dei_EntityCentralIndexKey">0001703647</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-07-14_to_2023-07-14">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-07-14_to_2023-07-14">2023-07-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-07-14_to_2023-07-14">FREQUENCY THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-07-14_to_2023-07-14">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-07-14_to_2023-07-14">001-39062</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-07-14_to_2023-07-14">47-2324450</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-07-14_to_2023-07-14">75 Hayden Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-07-14_to_2023-07-14">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-07-14_to_2023-07-14">Lexington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-07-14_to_2023-07-14">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-07-14_to_2023-07-14">02421</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-07-14_to_2023-07-14">(781)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-07-14_to_2023-07-14">315-4600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-07-14_to_2023-07-14">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-07-14_to_2023-07-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-07-14_to_2023-07-14">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-07-14_to_2023-07-14">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-07-14_to_2023-07-14">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-07-14_to_2023-07-14">FREQ</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-07-14_to_2023-07-14">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-07-14_to_2023-07-14">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2023-07-14_to_2023-07-14">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ CX;N5F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( (^&[E:4 4"5[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( (^&[E:97)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ CX;N5O:HWRR&!   RQ$  !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( (^&[E:?H!OPL0(
M .(,   -              "  <H,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "H4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d651936d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d651936d8k.htm">d651936d8k.htm</File>
    <File>d651936dex101.htm</File>
    <File>d651936dex102.htm</File>
    <File>d651936dex103.htm</File>
    <File>d651936dex104.htm</File>
    <File>d651936dex105.htm</File>
    <File>d651936dex21.htm</File>
    <File>freq-20230714.xsd</File>
    <File>freq-20230714_lab.xml</File>
    <File>freq-20230714_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d651936d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d651936d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "freq-20230714_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "freq-20230714_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "freq-20230714.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "freq",
   "nsuri": "http://frequencytx.com/20230714",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d651936d8k.htm",
      "contextRef": "duration_2023-07-14_to_2023-07-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d651936d8k.htm",
      "contextRef": "duration_2023-07-14_to_2023-07-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://frequencytx.com//20230714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-23-187318-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-187318-xbrl.zip
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M%7=[*!!W')T;!AR)=^=QN<%B!C_MA\\6)_U.S^M*91T2@@LEW79^>K['@!?
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M91\XF2NO].53$@/Q@!. <L_SD1GI;EFJA\0*AH,T>5_80M) +N5N"Y.BC-V
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MAT>_ZH=OXJB<;KW=>!VG3X(PB:]2&$!-RB?TFC/]V"S,K^+T:9G-MY[/R^U
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MQ$&K%U7(>@>-7/2-$Q7\>G1T1!:"6(.>.0)O'UM1#Z<#1H^T9=SZ9B"4H@7
M&\7G8CW6]/(;^I#D;3I&P:IX8>$,+142NN-IF%[)Q^B2#L@Z\=R=>;@ <4RG
M%Y=?-U)=U\0E!G[.OF.GH '!L!8Y>S2KR@KDGUY!:)_D$>8A4%=14,3L0(V+
M-A[>&7IY+V<H8J<1ENLHU15\(1*>7?%5I"BK(3 VXA(>5' 68B*:Y\;02 TG
M0")-!6GCFL/AJ 'W)];$-C]>%A%; T9,JHBU)ZF\3XMUQW14)GU"6^[%&BAP
MTNX']GML4MY,%:U^M-"CY6.<&PR&KVN&U_Q3:28W,(<LB6=H6,'# QSU*IZ4
MY#V-55'0AQ*]P) J\6DH6U',DYB=,# SP2*YA@,%"T"S%K1='H_,,G%FV@4Q
M@L]:I%[LU4B@HAK] 3L#\M(]:4@B$X\H6F@H3Q<8"02>)[(68CPLZ-R#C5N1
MP66LY$<X4J\^.[YPKDHP6[T(P[O[>BK]7B,>;(P=-#9SV(ADP>Z^_FM@M0_8
MF@D&(C&=(J;QA.Q*M'[S@>^H G.@DTCJZW9V)-,5'4R'E8[!YB-G=O60R&M0
M1XX[NQZ05A*>%.O>,J2C.R-%(6>7A>%QQYOBB*>6 65>%70FW'"H_C)T(Q<%
MK#-!IS[/43^96*,KD5@6M;T5_KK*P[2T,H8-Z1L.G8,?DN4I\+L_(H>L026Q
M! 4163=1UAW%[45T%V3VYV#3PG;.>7O8^M4+XC'=Y<"'G&4K@2>1 "TA'F$N
ME[7@[";*92-F+/\]S$6Q9HO5.*G?:V6E]<[=)=:U"KQFV9.*89]NIK_*E01&
M0NT:WA!)2DJ'-90+R",\Q9B#Y)@RG-&\4DR.<99KVI@@,]M(.!:\!R6R!(*
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M%XA^N/@2TJ$M0HH0\4"P\'R8Q+;X$SB0ZAX.Y.H2&7R..XODNXEU:RW3@.@
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M[(8+F8@MES]T=HX8U(T*&R-U&LF9SMLF*B*MS:TO70C&I@V:LB;Z/[2-L&Q
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MA6VJC802Y^E@BIN1+SK)']A(OUB9;68U.30Z[2 7AM:!L;#E%P0*R7+[?DJ
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M)Q?A%2W!5DQ/,5W$:"C<O9)OI*ZFT-]0&P*+3:07$ I,C3N";S2:&:<%U>)
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M\LHEQD,18K?3PW.F6]O6W>XG?-J^!!EZ<7EZ\/?WI\? S/_ZBL1[<8=G'I;
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M$J8)*@C.W72A9DVFD.+PI_Q'Y!?]!6)1D]Z2\?MO@:HWJ@21E61/2;GOP(Z
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MQT"HPO<A,?82_P*A#21"W8DG?PU<J$@VRQ&O[#PZQQ[F0=2>_58T94[K@8]
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MQ%0"L'I,A7;M2YE;^'QW-\+7U)LZ@"$<2EN3K<U>>T]OR1052GCR*E$NB-D
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MUJU$-1G9H.)O14K398?G$=SX;X?<^ O/1V JOV<O08)5+:Q<("C&HA>X"9R
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M1)<P#>@%W0NTZF&...868S/)O-?0,8>D>HL,87UB:MGHB%^<24&^AJ^M4ZJ
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M\&FWFBR?Q0/:/6*=*1ZD0<P\2,#[3M@UCK+ G3OG+6>14C,Q,A(C"QRF<T;
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M6_#L+L4#8E^.QS"8\CDR<^E*VNQMP[DO1QLO5X9SF\2C"U^CE+H$(4&&\;C
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M(V70R&><#6M,AM5+;5&A>UDD67-_EW*UU-A47D]I6UQXQ:[P;G6HG4:7KF5
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M"0*Y3880J@PXP3L$*'!FWKQ;^Z$MM>V>R))'%XCWU^^Y=$LM6380()<=IJ8
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M-D8/5?+MECA,H_F.NCM"#RH9#@2707/#?)! "W?G#7W%*F=R5^?0"%)\*]\
MINSAG,,7NX;;I@5W4R/5*0 /$(-T4I9EP0S)/Y!U=@WZ#;&TK>&+C:(1A%&O
M.IY6WU:Y@5NM#HOE^_4B>BMI;OS7+$A@1=TLR4!5.-T@5IS9F!MH4#=I6B6>
MJ_2'-X>H@Z 68-:BY"KR<TMN4U>#^JS9;LDB':5*9O-WO11 K-/F FLJ9'Q8
MH^ Y6^=.I\/J"6*YORD>1+>O(PI4&Y]IM_BASC<(BD8=MW"*#(%7@9F*I2(?
MB,1SE<;(K7!**TAL$S!95G39*BXP._ ]<+@,:QJ+.[$J*^%TAE@7.Y;1YU8+
MXX$::IZJ\FD#*=Y0],$A)<T[1W%S8B--]2/7-"(U\&S5XY(&.2T>L0/3\:PY
M,:O.8YE[YJK3>ABY(+,Z*A+O2I;G= 9\ ]$:=ZKJVVXAT+I!0"MXB(2!:&"^
M(JMHZD2GI@4)\<@XM/ANN;1&9MSRNJD,B)_4/L/P;H6I%@&N2DL#=(H29;<B
M*LU"50-IHB;$<#/'9#;.@V*IQHG4BP0-B(1;/*'*;!O*\OI#MDF)FDKL'5KA
MIG%*4G.=])U=LZD5_+K>>5*3I,CN/H^HVRA/,C815.,=)]B=@^NVLG/U?O#%
M+L14U5 0/ ?0,\%Z"!OT,?98Q\=L)Q3AB>M#_.'C#XCH,5*#D,2I#_5 -@3N
MZ['-L7OG\TH&BZ5\<815? P[MEO6M..U$F?T2NPL3FJ@H^E-K&YD;+]LV@8L
M9=E811E%<1[Y;K794+%V@JKE((4);KXW% Q4X=3J1L?U@7@9A??WB-G8 6&Y
M!TPQ?+OYQ(CDE6"2B95#)1.:4:!]-.H%HAIGH,N$8@+#22FME3#$L!=(K<+Z
M.O'S*7:$8B%R94NI03YP*T=U>,.HV'Q#J<&)VYE7MNJ<" 9R+F.X:FD#-FX:
MZJ1XBZ#P]K.WGKCPP6-CK+O][!V^V?E\Z-G*'(J)3"TVS9B^H2%-GP!%#I#I
MF7PKK29M$NNI2W\<RBM'HXW=Q*>UW4$SH^:):K=F8%Y]=/8VG4W@#0BRHVE@
M9&^8 P$J3;]!1R1R)\,ZS@H:"Z1>ZCB4Y9;G[>URN^6B[ZQM,!18"@4^R.?&
MQRBG=JI 8,;I+:E:+Q#:Q"52*6H=IO7ULYPWD=&=94G.C:E%TV2YTV/F5_%
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M)]Y4<\".4:BY%@<' &\-3MW7L]!N",>C'Q>]?OZ(7G]'RF4J#!6=LL]RG&)
M)$-4M!QGC74BJ5>4FW!:5ZB$P5.HI(;]8@':U&YV]@D1Z[#I'3FP<M_,03+L
ML4U<IL,A9D'HET]YG9#R<FJ5B <K"-LM)]:J8'0-&2E8 G *Y.U!H16>DIC$
MD?:!LQ#DU:IKG*_YI/&<#HJ^5$X9X8?-BTTQ4@$U7?<N0!BY5F8DGFYM;7F8
MM5/#7:\<JX+MP<U,M7/#A7T9ATSGM.&=5FIPW#9L+)^ N6R.-^FL@JNKJTW<
M[D22-R% PV"9=D*=Z9"KL5$','AS%HRH,5 ZYK,X0YDB)MQ9*-O:=5G+4N(8
MQ4'0]P"?/'PQU\*_%-'?6R\X+\XPUWI+I?5I1W">\F-:\!=_!PM>-);7^[WK
M_>"55SM]X_?:D+Z'<^#F<DM<V1^^_?,:MT47W]BV;V9S2:.]<:'!?/7S30\]
MN^-+7]Z5Z*?V.C6#E_RQC%_2>B]NR?@;<*3^W6(G_[T^+4"$0"#APHNUO=\Q
MS0#7":YQCL5J7LF2*CN<>3G3.NKUWQT-@,DOJT0YU\O7/;W!/2_=1?F:"W+;
MPPTJ0=?F%EFB6P5>9Q"39^($HQ?P300-,.RQ4QQ3\!W(Q[^*/K+_I9_MEN7"
MASWQ[[^KR-]-QNYK+>Y/5LM8:7UDSO6[U$$NP[2S<Y,U_OP]L'759*U],C'!
M_NE@</H>"1?4X"%^VJ+_FE[C\&G9L+<9]5%;OIE%KDFY/=#L9B+^@ MSDWN>
M_PT7;V]_OO/02OWLH93Z[JNR_9VNRAV?=E&$N@QB3+=C\(,'6OG'U?YN5GN
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M0CGFN;ZR$6S#/8*Y6\V-4FH68;AK!A/N2X%,C8JY;KEB $EJ>C738[#6PA[
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MM@!XA,I=5W".^'></_*6ZX*[NR!R&-^EN&L3. 1@S33!#1N+A+ZB^ 5R^Q$
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MW#$_HLM)^Z)TMNI?0D>O=/#/]%>_+:% H;2P>V5]09-8:\FKD4R=9U4RTM#
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M<MB9['-JT\^\;96;@%[0QI8_/\W.$6M3ZVX[KT..$6A>F$ _L8E4)GN>:;C
M>TRI2X^<&76E6Z_U)L1_ZRM;\UMQNJVWL.^$DSAE_]:.=WVCWH#(C-UL*QN^
M6+S!^!"+Y:TMKC/="- 80R]C,BW5R%W!9O$++--9G"5.U_-+G!I4+F)4(0(B
MZ95' [@=EHG2:4Z[8(R-.ACE=..GS#,4M[>:.P(KI2RQ(+=%03%H6<!;.H/V
MLSGU,F%+K[.0EQ_#+S6%X;8H<9.,+?Z\TXU,'S?82\R<-[:;4/O)8[?).HW
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MT6 &L)6H%O[+@7@:CC-J.9M-"M*;K([-HC<^F6HU.*AR9 -C$!8ZOYRTPY&
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M?7*CE3I9J9.[JT[05+W#4;FMQ2;WZ]_>'NQ\@0\_''_<>_/_ 5!+ P04
M" "/ANY6U";WN>M] 0 VX@@ $    &0V-3$Y,S9D97@R,2YH=&WLO6M3VUBV
M/_R>*KZ#JL_,*:@R-+=<.LFDBH#3S0P-_(&DSSSO9'L;U)$ECR1#F$__K-N^
MR9+M@&*;M*?.Z6!;EWU9>]W7;[W[[?KWT_?O?FL?'K]?7WMW?7)]VG[?_K^M
MO>W==S_S)_CZ9_D]>/?A_/C?P8=?C\Y/SR__\=,?OYU<MW\*KJ[_?=K^QT]Q
ME*BM6Q7=W!9OSM)L$,8_O0_6U^#^(Y44*GO_[OCDL[[X/NH5MV]>;[^(DI^"
M,(YN$GB ZA<_T6LN]&6#,+N)DJTB';[9&19O _G<28LB'?!7_30IMO+HO^K-
MKOW<#P=1_/#F.AJH/#A3]\%E.@CA38>G)[^>_>.G# ?YT_MW']ZWO]Y&G:@(
M8,+!NY\_O'_W\P7.N&H NWO?903O3F 0JCLJHC0)/JLLQW_?_7SR?LIP]@X:
M'$Z7=HC&<_CK9;O]>_OL.C@\.PXN3@_/@O./P>_MRU_;EW-=(F=,G8<@3'I!
M.$B3FS>+&L3'R_;_^]0^._IW</U;^_+PHOWI^N3HJA6<G!UMOUW\H&2'KCY]
M6/"0<*?TJZN/\O=Z\[_.+R_/@P\GY[P"R+D6,8SCL%! K'F0]H-_?CK]]_\F
MG7SX=O>@%>SM[.V[V_(S<$3X6_@C<#[ZOW?#("\>8N4/5@W&QHI?#<,;M=7)
M5/AEJZ/Z::;>A/%]^) #[WWW\Q!?\AL0Q<G_!U/?_TD_E_CWF__YA?[W4_#'
MR?'U;__X:7=GY^]F/D?  =J72\O!G>6^/OQPVD8>=70.0SZ[OJHD?.<EN.VE
M88V-ZJ?WO&M$/2@9Z25'[=/3JXO#HY.S7__QT\Y/]/GB\/A8?_86\L/YY7'[
MDKZ7,? W6[#ZIX<75^TW^H^)4RZOS]@2X ;1$"_?RQ_'>B '?X<5^OGZV/[P
M66[FF=H1ZPO]^W_9>>0#)O\-_[GD+R[UTCAD'"5YU ,RODNC7C#STKS&/:L>
MH]E*.[_O=\74ZX!,D8;@B[WR5NK%Z*193V6:&G>W=V#;@SR-83W^9X?^1X1_
M 6O&I#[3L&G5+;%4' QG"7]KG_SZV_4_?GKMC'??IY&J2PY^^GX[3,1?GB<<
M8'^$#NL)_$,>5#(?^0HY%ZTT\M1"?2U@D#W8E3=;^LMOX5+O#R]!-P"&<1(<
MMS^>G)U<GYR?79%"=8)L]>*R?7UX??*Y'5Q<GG\^N<)?D=,\AKS.SO\ 960&
M>JV^L*20[G_;HROV>1H]3:6AO24ELR>1UGYCI+6+IMDLI#*)!_'.OC]6_2B)
MT/+(?P32^POL_5YC>W]>W*HLL!00QF1CG: D&F:J"(OH3@4767H7Y<M!(+N_
M?'?FM!)V3Q%V)V@9BR&Z'.)L;V<ESY:<I^TU*,^N;U7PN\IN5/9#D-Y?8.^;
MDV='<9I'R<UJXY_'QN\WI\AD-V$2_3<4)>8X[8X&,++\;7 <9:I;I%E.FLUY
MOQ]U5;8$BLR*0F:AD(/F6$.:W$E@)>T'5[=AIE94\$RHX$635%" @(#!!)_#
M>*2"2]R'):"#E>$[ QV\;%I10%;PKS3+TO_]G]V#EV_SX#H+D[P/-O&'-/VR
M#/QA11<ST,6KQNCB:I1E"@:3&<H(CM+! (3&59%VOZP(XGD0Q.OF&$48=T<Q
MZ95($F>J"(["_'8)".%@10C3">&7Q@CAXR@C9^EA%VEA"?;_Y6K_9W K[31&
M ']$Q>UM&O>6P[_P]-U?N<&_JQO\)+AL7URVK]IG&.75D=\_#B\O#\^N3]I7
MF*Q"N4I+XB3__@2U<I(_C;;VFPSZ@NGK^LS>!E>C#BQ:%&;14OA%5M)M!GIH
M,!!<XS]= DIXM:*$Z930G"?]<%3<IEE4/+P-/L"@T$ER%A:C3*'Y<WB3*86$
ML:*+YT$7S?G//Z>%"B[5?T91IGJK[7\>V]^<X_S=Q_.S:Y/V?1L5:BL?AEWU
M)DGOLQ"F?)8F6^A=S\([&#&J%.]^QGO>!_!MOI(ESX=H&O2RA\.H"&/1*Y9@
M_U^O]G_Z_C?G3?\8)6'2C4"AO"K"0BV)1KF_BKG.0 7-N= /.\#^NZ0_'MV&
MR<TRV)?[NRL:F$X#S7G/'1KX!$9%WHW37/6"TRCL1'%4+(7/8443,_F@FO.H
M7T=%K((B#0[S7"V%9%A1P"P4T)P;\E*!;G"1I4.5H</A5(6YPAC+$I#"WHH4
M9B"%YCR06',2QZI;C!R26-'!,Z&#!OV/VL68MP+V)W0+SMW%1)RH6!8C8A6@
MF(4NFLS?'0SC",Q)]3:X4!E00OXVN%1YD47=92E>7+D79J&)YIR2I^J&A457
M*8Q4 $6<8]7\$M#"P<K), LM-.=KO Z_!K^'1;$<N[\R)&;9_>8\C6T0#NF#
M4J0HG(:=--/$\#;XH!+5CXK@(@Z704H<K#)X9Z&-YOR/[>0NRM($%4>0%LO#
M(UZLZ& &.FC.!WF2Y*,,%<C5WC^/O=]KSM5XE@8V&'78NXOR=,4#G@T=- @.
M@/5=(1N,P7U4W :'_7X$=F6Q#!&(@Y53819R:,[I>)%%=V&7@46/PR(,KE1W
MA,EO*UIX)K30G./Q*$VZ5/U7:%&Q#(4>!X])68+_(%0EWA6\&]:@<([M4N"N
M_NL2_.7<P#RC0. VUW]@:%3<S168Z+<\8 8PT3*HY5^!_37G7P<-F='@+M4P
M4YBP&;*6E&;!'V$&>M-R9&D\BB'ZA+&J?/N>E6^?9RA\LXCE^)M%+5^.6K@Y
MD-BJ%NYIU';P%ZJ%.UB%%6>@A[]"+=R*$F:AA+]>+=R*+F:ABQ^V%N[@Z9C(
M?X'M7]7"K8CFFXGFQZV%>[%*4)IA_QM$EFL?!1^CF+/4EK,P[L4JUWD&DOBQ
M"^->K&#E9J"!OU9AW(HF9G)(_<"%<2L*F(D"_@J%<2M2F(D4?OC"N!4=S$0'
MWZ,P;@DV?^4\F&7S_U+5;R]7-2^ST,1?HOKMY:K&919:^$&KWU:[/]/N_R6K
MWUZNU,99:..'KWY[N:I\F84.?LCJMY<K&,Y9$IH:]"<N==73RU7VRBSDT)QS
M<4F+(5=T,!,=-.=9_!S&L#8G>3YBQP+0Q8>PAQV.TB7HG;PBAYG(H3D'XQ(7
M0ZYH829::,[?>#Z,$FEY-R8JEH <5N[G6<BA.5?C<RD.:X P5L5AW[$X[#.,
M[7/[[/#L^FHY2KU>/3T+<E7J]7T9V8L&2[V.TJ0WZA9C;9\_C/(H4?D2<+ &
M"/(O0!'-V4 .17S,U']&*ND^+"%5K#)S9Z"*!G,MNEW8=[*$3I([E1?1S9*D
M[;]:Q4]FH(1&81&NTCCJ1L6R$, J<#(# 31I^A11/^J:#O!'*BO"*%F>2-JK
M%5#4# 317*K%[U><EAT<1_DPS:,E80LK*IB!"II+N;A4-U%>9,P63!'76TS'
M^OI@OU@"PEBY3F<@C.;R+<BN! )(NU\P85]EP1]9!*(BT;6_2T 2*_?I#"31
M7.J%,2P]LOA=J6(I( 9?KUP.LSBAFDO':/?[:<8)W#>C."S2["$X' ZS]"Z,
MET"A?+UR-LQ"#PT"4''9YRA;AA#*ZU7R[BR[WYP'TDJ'\^&2E'*L:& F&FC.
MWVAI0-?TJ!XK"\&G)%J&BJ\52<Q$$LTY'BU)M*\N+I:  ![C>'[WG(&H5TC4
M*R3J%1+UK)RO.8_["8QDD'A.]_,^?%(91^2.HTQABNHR2,55-&X6VOA!ZQQ?
MKWSNL^Q^<T[WTRA?$I?9:N=GV?GFO.JGZD8EO64X\ZO:M5EVOCGG^=**_A4A
MS)*HUV 1(\*>)&-Y&!86ARCD$G=G&<AC%7:=A3R:<Z)?*:IOY>MW7RZ1EKBB
MA%DHH3F'^F$<IV(Z(I-@0W()RMY7A# 3(33G53\+\U[XG^!2W0$C4,'5,(Z6
M(/MB108SD4&#M8R=6-*W<U0<?E?9C<JPQ\^*%IX)+33G6[P.OZCT#K>_"(O1
M4L!?O%YE8\U" \WY$-TDK--H>4H[5H0P$R$TYTY<SHZ_*S*8B0R:\RTZD?;_
MC*+B@:#R%D\'OZS2,F>A@^^1IGNPL[OQ9?.'(($5G,'WA#,X@<&='9]PF]OK
M<_QT]>GWWZGO+?:YO?ZM+=UMEP/N8 X$M8([>!IMO6P8[B!BP_<B4UV%P\*V
M(B6+N!UV;X.+<"G:"JRDWBPDTBS^P0PD0E5-2T =*XSY&:BC.0_J;-2Q!'2Q
M*EF9@2Z:3$X>F>)7C,7&:8[-D2VY+ %)/#UA?:4[?U?=&93GT_.KD[-?@^/V
MZ<GG]N5)>TE0P>9 .RLU^6ED]*I)-5G8U[&*HSN516JI5)Y5X<T,Q-"@0EQ)
M#,8W]$,0Q$JP?5_!=A)<MR]_/SDC/]"2B+2G5RJL1-KWY6*O&Q1I3K+D#T%[
M?X'-;TZ$M?M]Q9"6RT4&*^2Z&<B@.>=-^^M0);G*W[ID$'Q4RY#T\LO3"VA6
M2LQW5&)._B_XM7W6OCP\#2XNSS^?7&&$:TDTF:<77JPTF>_+Q7YI4)-Y]_'\
M[-J4LM]&A=K*AV%7O4G2^RR$*9^ER=;5*+N+[L+XW<]X]7L4?>5.!5@<LDRM
M"AH@X[\ '358%3!026\Y(!E76S_+UC>G"/T1HB=G"?9]E>T]P[XW%Z5J ZO/
ME*T0?!L<I2,$%AF&!+_7_MJ]#9,;&$#G(6C'8#-E:1)U VJ7.(CRG,);6? Q
M[.81#'<):HA6)#0+"357+W X',91-^S$*C@-[]\&_QQE4=Z+NDMB4:^H809J
M:*YRX!!8PDT2=J)X*;KBK;9_ENUOKEX 6P%TE\)V6)4(S+#QS54('*7I4&7+
MXD9=;?X,F]]<6< 5E@\O#<_?W5DER,[B?VH.=T0WOARH7H3.]*NAZB*F0'"A
MLGZ:#;!W\HHNG@M=--I%_?HVRGI;E#D??%") JJ(PFPIW(N/HP>X^%DCMOXE
M(%N_VWJ^?_?A??O_?COY<')]!1/\\+ZT?<ZS]BP5U!*%1P1(AL\29_;5K#"Q
M^]-P9N6$S0\<5G.JY0@MMK_>1IVH" X?&T;T!,I'D+Q>8I[76^5J-!RF66%=
M?]\]$CC?P/%2;NR'1C=VO(_2:E,7L*E'W^FT3@WKGL+&;WT:ZHCN:M/GN.G'
MW^$DKS9\B3>\_9U9=U4+O-66?M<M_=C(EAY]OJPZB8Z=6&D>O';F5V^=E R$
MYV=OWJW,S0:7$ZS/PU\OV^W?8;C!X=EQ<'%Z2"@:C*!A+%*80]60R":M&I-[
MI@[^_HW'Z?K=U>^'IZ?O?SNY>O<S_PD6#/^A!VM^D.]A[.:K"_D.IE*^[/RC
M^>9W^4J@0N3;C>(VRM?7_O=_=@]>O<75L0?QPWO\]O7;3?B:%B;*8>H]16EN
MM)ZJ%T1)D08AU2_]<Q0_\!'9/6@%>SM[^RU,>L"KPT&:W "[X)=>MO_?I_;9
MT;_-(,P"M(''M3]=GQR9A6@%)_+CV9'^;KL5A%@[%=Z'F0JZ:08J.R<>PT@W
M],!I.DY-E9E.:WVM=B35BW0EWW[Z8+[ZEE'A"MR#E(H?@O0^@47+1QV0#E&8
M/904UO+P71Q).WZ]'_C<?^F-OKP\-X/[(%^>F*]@SE4C-D^J'OB&&8@4*IHQ
M;.L[-41V-QQ&!1SK_\+T@#(&>3#*B3P")##+WP-\1T_UHX1_??=)HRJ_^_G3
M>_@D_P@A89+GI_?;P80SN7?P??C$9?OHY/KPM-)+]=U9PN&V)8OU-=IH4GC@
MN"GX &=.<0%&& R81CS4T> ^*FZ)[NA\\KUPU%50(BUG2W$WPBYL?P^C#?R$
M\MXA/+XFE-/P?COX- 0RZ8+&-1H,3*D^OH<?W_+'%,=!5X6YHO%_C7)^(H^.
M?NVH;CH !B/'97UMXGEALICGMGS8#JYA<ITTS'HXE)[N%>"?8W^E[?<?\#YW
MR6^!<VY$FTSL/550#87JK:\5MV%!ZPC:;*$&PSC$;GV4-!9V)=D8]J ?1ADL
M)G">WEV44PH1;SK=VU&PPA$QZKPH#9$N@R]SJT'G+1B+'DQ(O6+AG7AA3W7C
M$+F]?4T%94P<;@L&THU'/2Q[Q0NC/!\1G<&H\EMX.(X/&+,9X!$S%.E0" 2#
M=[FCM5; <)3APPI]%?,?(D1WD#2]\<4.[%K#..#;P*3Q8J?U89J',:]V8XM\
M5[7C:9 A]>.[6\$(SY6="SX(#L&?>.)EDET+FY*K(L!NO[?C[+9E9U=>.SO,
MN[2@([D1^IM?L\F90JEN+IE(HW#'1D<_=53<IAF<-(\ X(PSQZC;^@JV)*#;
MTJHGN!S!EKQXN?^B=/#DLA--:GHWW1-((]3[$>)4B;N:G0F^U[Z$H'7!$@Z&
M!:@%P :&&2X:IP&&?21#?!H&?W->=%@F),+!J!B%J$K8P<)V^#1'QV+A1&2V
M.Q]A?Y4(GN0=<%A3&!]O,KQYC"U\3UY0HI1#/=9><(7,*#A)NAE)J@J::97(
M6DY""'1J&$>1.E/%^UZ^S4'VF4X!.")@B(ZN944ZCJP*5KXT9O,;+0I?,3Y:
M'"OL7WJC*,5 I+H*IL^X%7BOF\ <7;T0K=3YRN2C23+943^JU!_Z85:I'%0*
MY?6U&:1R:[+$< 9C1$8:>R3^/64STW.U;)S _5@O;9"CE)8".4J.SPU[Z;!X
MLC"::$1\'](\W@XL_C.P;'/ZU%?5'1G;L,<P( \5;(J,9]@@NZY"2;U15PFG
M8<ZGF0SJT2 4$Y73VI$]0U8 *I7E/5 EU21U&V'5*+=V6U/7?,.8ZZ?WP9@P
MMXWG@ZONK>JAK-Y ZH;UX ,!AP6LQ["+L,AA7B]B-NEPR=*!V,\E5A?:[DSP
MP'YXEV96'D3)^AJ:#P76Y)'<U&(U"(LBQ!$%2$7LQ8#I."'D3^]K-?FJF"'9
MB=4>%&-HN^+I_C;JWL(L$!@3YHI'YC:\ UY1.E)6>E<>+CH$4=)R% *2Q3!9
MK5O!"AL=>Y*>9=:NBE+JM"G+7^HEQ';P7/VONROW:Y,<L?V=..+ZFL\2QW2O
M6K982>N:#[8<)DC"SN5-&V-:%9RS0[@SCD#XY)N6"<W$,OG2;V67P-VJ].!O
MY)66)\"WCV*7'RK8Y4SI%8_CD<34FV&2006/Y)'/RA\7H%E\7'[-XBFZQ(?9
M=0F?SJ=F ,28 3 R&0#^>9B9\F&O/[GI*TCZW33&\DY8[_B!5^"=]N0WD)+B
M&5ES]WO^"G;=/.AM'FQ[*E=VB6]]K9XM+X3R7)Y[7$=X)0[\C42WOK8D5/?;
M=G "EG(.JSR$"6H+W'K-C)OL4MU$!BP8VVXQ1<&MQCQFYPHL4C!*>G(;[/@H
MBQ"K(SCL%BWD8W5^)>O#LA8ID?1$5ZDV9V'?D+(C' B_W@VC6)^=)OOS["9,
MHO_2?$  ':?=$9,*14F8Z)1[XLC[Q.0+]O"]I,)T.14&"2S-:-)ID'8H7L>K
MQD/21.Y*ZL\H'1]+F&TF3 678%!T@D(PEK2CR<V-<4XE\ E/'*?@N<KIDZ?*
MZ19Y#7''HN1.Y<324 /21  4B,Z2O)M%0]8I#0UZL7=:*/;8X.NU,I6$ ]73
MVE&PD6E &^1H2%(W\+0;]%>B#R@JZ+E)&L3$CV_#1+M<=(^K$QHD778X0""$
MS58P19\CDJ8I6=T,;NG>4J 0'I^,!AUV#HTI:*X+>4S9"Z(!UE/!Z#&2.,RB
M--/:8MLP ]PQI',X*HGP?[-'5;V[2BIN]=(OE&O^<YN;;6@!AD 4R.'DI'($
MF78/B O][I^2".F(V&8>]!6<(N YZ)V&I2G"K[@;8,:KO.6R--JV_XS E.P_
ML&#G1<E4ZC O<4+CD@K3&2CX$=81AN>U4]Y_^7HCW-0ZWPD*>F1]Z.5.1K@7
M/7*:[_[R^F6+WH=>!ACV!DW2NJGANG)\!Q]XC<[M$9PP$!6C.)28)&TUD-10
M+ DF3R7+9[01-XS=<F+6%!24>0^I0@M985"Y!,SVQZ;<,5/&D;=DO)XLB7+9
M-#X;R-2+J" !H"<^C$.*O%>^&?=8;Z&S['FP_^*@%>R_W*67PF#<D7#2RDS;
M-G9;U5I/5T+\YMK;\."MO8V;3:TOE?;Y1*_(-1 HOK"H/GC/T.6TMW(Y?:^,
MO\6D]Z&\92;<DI-,61!IT%$@26](L^J L.R)>P+96Q]TGO0^?[.(S"<#T#@E
M]>D[;==Q^^/)&?<[ U/D[#@X04*[N&Q?'UZ??&X[8)$+2<W:W=Y%7?<8<]AT
M(Y(I*6K?9R ;T6;PL<3;*;1K@]QNSDV4SY9LMSF1YFJG\DU#-VP<LT1U2\R3
M!(D E3)NCFE"V*#V@:Z!$@AU4L571^9J+?P\)R9;*1R?1 .F2Z=J6LY$L(&J
M*:C)9@F3M)"3.DI0K($]UA$]_E;%<&*-.P.>"YL!FGSX '_"\U5$SF$JW08U
M&!7K[ [W @6R270(*_7;FC0)'DDY!83"LO!"44I@,DXJ&NG:T^:SOO;-$WJ4
M8OL4(KFZN*BE";X4P[[I@Q(3WAH12"!R6XE,UM>>0B=3EW6)R81-P6^EDV^?
MT+S)!%E'7DTG\(9;-HD,01GSH)X/S7$"A]VN&A:4P@&F9S]"L1"%B E395K2
MI,2AZEUK-Q%^0=<!\7_.V,!M'8"=E[$_A^QX3$/)(C:'1=NW=K])ZS"@A@]L
M7],/H9M?9LR FJ&W O45)\CF?_VH$R16'*@,'S;I(<"SV0.[)XY;()FFV1))
MFFSE:1QUHT(0E02S-T/OQ2TB-J+;+LIM8LB<=AA(+&?O]TF"WK>'\H:.&Z4A
M'R6T#3',27>A(MG#3#))N=;I1#A#.M-YP?PC(?@8SN9/Z5S2KH7H3WKTDZ@*
M!+X#GCE ;UO/L)56(!E"P!>"6\H]0W!+:TCKGVDHMY*<YGS%7(,=O??I*.ZM
MKSGLIZ,<7S"ZH4+Z%V;CKJS-8+,S9I^!05H<7V5R;5P%ASGZD8ZC')Y@HQ1U
MWJ#':7U/IYV*/+_IQ(/>Q3Y*D R)7U;H_E9"V.(VQ?@FNG]*Q#)V)]' ^EJ9
M"/!VX+0*N&[?^NG23%Y/J6TV1%Y-+16/L7)J^J.F4%;7Y(>1.R/C7^\CT!,R
M)=\223UX-.5DDM$:8P!:=[2=%YW-G44YD[:4MKXF@@=6J'!6!4G!]+*BI<1#
MZJ89;DQ8ID<M"]:LW*4Q:DMOGJV[9W_E[FG:*D;2'$@!$KI+01/HD>0"LAN$
M\4TXD$^D2:-:0AC-K: SRB.*-7?304>ZF;3\4H7<Q SA8<Y9*?WD>V+QLZF0
MDV_(?YDQ9VV9,5A.RX>%0*'#S#U(;X*-0\G4!>6(7=;"YM%7'!H/,9X55+"0
M0VU\J+B%(C#X+C[]-UDZ&HHXV0ASITR/(Z,:RQJ#I>9<9B-0(BDF.XIO^,RC
M>DCN;O)MZS@/A^1C8N&H<L@G6D,T9SH:W"QFU0-+/JA>,LMOHZ&_OH$7J!H
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MG:3;.8!'7C(OT=F^1V<V9XSU,_R4.7@.U1F_\YRTC3H?B@":9/<%.EK _'N
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MC%/(%Z>N#Y'2]2)]2DGIWE8M+V77&4?LP"1_=)1=P8J0%%U:N8SCB]B2!\
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MP!W9@,,?I1Y0^F*,V?$S'9<-6LBZ52T]5.,LPV6Z@HXJZ[AB.O>IFUKIC#K
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M\[YPY^P[UCEY.?E-S,6N3I=;\KC1D>L9],MY$Q!K%&12^1YC,;;>$E0]>%L
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M])O,*P>&)DAE!O+.1*":7L]KB,=ODY6C #N$"7;>],HM*0+]2M( AC_R^]?
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M)L@!9:3//!W]5HT (!MSEEMMWRR'M!>>BA!D9:8*E?%I3=7FH)9L\R7LOIJ
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MCZ*Y=$^*\_^OC0L9B8!>HI:WXG+"'H/MOC8"L-]CI'_^(])_X-+]<[" "K:
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M><]:M%-&6"R9-X3O365![-J5;GC=/*S"NTV=@>SEN/T)N@C>"K*53MA1Z&
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MA@#64\_4IT!E>.WXZ3B5#D!U=QMUNLLUPX7QVW,WL'HOS*KGIV!8?Z]1T8>
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M-.JA&.&:V&*@%P29E2"EEU:2LC>@4]!S,\2Q"%/),IF5OSH[D67T  $CNZ?
MBK[&^ =P %:B=P///IR!?GIR_AQ^<9R%@P[C)P0Z&ME[HT3/N\3=KZO+39G.
MWHFV<C#P'N=-?LO]O>VLQ(EG'"G?>R\,<$"2UC<G/8\&N.*ATCZ\8?@ZRK]F
M$RQ&9Y-I68DP[Z2H\'M$%>1C"IMJ'@9J2;8VM!I1#Y[9LBNHO,^E#8F=1^0(
M9)&AR+@IRG;!/RY%> C3 [WVSS:R P'\)^C>:)=W9J,/6K.3OM=1I?MEP'1F
MBM\1GT?$@Y;YBD)G0A$[3Z[&7L=MG$.V6<T9X1QYQAL?+5;L^S4!,GCPA6&L
M*"_*IK)WFP;;<L=/0 GW95G<L#-HI*XLKK/_U,(0IV-2"\*@)=8_(M19$G*/
MO67.'7G"M7,"N[P/>H70@OXWUG_7I=3K>/[<;$+J9_91WA1CA^ 16S!K@&<-
M7.TBZD2B+]SJY0/#V.E3$)B,]T5"1?05,S'8<,A_%MIZJ"[(^PE3+9SVZS9(
M\:"ZK:/^BG67D@QQ:#2:,@S9&'I2)QARC!2=17Q2V&1.%,.2LVLQG[GQ(K]$
M)F++2PFF,3!!;MU<0-T 6OS?_A<6:8^"?%%N*=;@LM+MQ VB_KJ)<N[Q,>1;
M[?X/4_MVI=Y0"&BG,F/ )[Y@%J_CS)5)%8>>)J'L9G?2\P5N+68W&!%V/)A?
M.G_R!>(OYW%>O/_S[>O?W@!Q$+B< R/X$@&@&\#[-^_>O_G@ JR+/]_^\?N'
MR<7OOT"?[/N+W_]\^^;#Y(]?)[^^?_-__OGF]]?_'_[M'V_>__V-B^+^^6K;
M@+^,46.TCZ=Z:KM'IU*<^H77>AR!A#YNG9K01_IZP@)#:A$[L\\7,T&"1'90
M%/;].NZW+?[:5WMYB/["']Z\EB__HBRII)FLF]]]9B+=.@LJ\\.YQS*\4'=V
M>^GHC&^K@@J_(!H]=M=IN5/:<.-\JQEP!WARTDKN*(6R-Q M-755S@X/L(;[
M]QRV#.RKBRI?WD$S+%SL?;%NW"$+\%/,&DV.H _RZ$*H0=GWN*0V'N%MI"RQ
M#P9X-YH9(#6G35,AKY\\BI\2WU,4/][1*T5J*(VNNYE?%O94\B['59'C9VD5
MO"_;CX<'OZ+*:"M")=4\NA(![]J/K32TJ.].5W%OS9G=^:-E72-KM.>.Y4OB
MI4!LDM%EYO!K"U4G(-.^YHFZ0T>V_])HZG+L%,R;.^#7*)!SYP9]O?A[[IY5
M#DT$+A;"MC<D^L9I<;:WGGOGZ1J[B";#BWKB5[.+<+U#-(<S?VZ^;$6+8!I]
MP-:F(K8G)\"L";_*X*/PHW!1-_2+Q_1' [!VKXME IS'%M!UZVGH+4".:A;+
M97W;_OS]IO:>_TCM/>2QXY89+*Y?-B!AX^GD7P9I^#U* PA0.ESTW?*3]XG\
MACBF[OF9;ZST03"&Z"+IXLX\K'_R!RDQI-TH0#.#,P-I,HSI43B\;-<2U3LS
M<0F&1$%GWN8BH(:#LI <3)#(\?"L<H#4^M',%% 20.IPQ+JAK9;.&B.#17$L
M%*OP!EKLDM[.O*K0U5<F ?L94_(" @Y$W?C*E_< @#J"<CK8,*3P!KA:T!S#
MI<2!FZ<^#N;?U]XZS4ET,_J'I5>O?;T0#@F3S>(R[=+*M*;(%$Z<$]11:RJ)
M1OV:>W.-Q96D8E%=.CNB1R.S4V @XM,BB0 (3OGM64U@J;5;0!R83N<(: WJ
M?%DW<$\EYI&;USVM\]:*2EZI#[\(H&^:=RC'UMEO1Z$+8<KQ[J/4'FXWWW&6
MV*&P..R'6D8.8%(;_0=9"_?>4I-H1TGINJ4@CR:!&TYY$@1_$"RCOF&&K;IM
M?7C@IW(;/L= ?5 F4'-DB>9)_SY[L3S[4+W0A@E M8SNF !':Q:(?@Q&^-;_
MXG1<R ;@WY0Q%+!P_??F=4%V@_"Z\D+\3[=D1V;YJERC( -IFFHV 98-=VTV
M@ AG'I]%N7:/SC+8B#,L6N7NX37,\H@"LTF/P-;=W] 9F7RN$_-0PJ3&1Q;\
M6X]0IG[JO9F1]/%"P_!,'N)I&2GYJ8%@R#TE2&>O,7ZMO4:B[C\ZXD\Z;VW-
ME2^Q*3A>.C$*Y=0A[A#W5_]ME1R"P:@T$)D3/4Z@71KI-8K4-;&K?L-O0[MM
M2N)UXE=NB;0EF+3OPSP08#1Q_)EMV\U$N?FRJ)#9GR>.:;3Z7A+V12Z]9J?D
MHHNIE4&Q1ZO0<D7WH1<DN3/S2W\5>9*O?C8].3D'HV =7C=PC>O(W0T73%!9
MYGAJH+U5YJWO%MA\U!?(>>J#,&UL[ D=@A[$%J 6X?SIO3%OHQA)M9>W@* "
M[0Y_.7G%E;+?];@U:O;8$I=T*"*'+'26U:E/N<W(JPAV$NIZZUJ@7<->9*(F
MS+4CY'TIAM/:5*3V#_"JSAOGQ0+'0E&LD3 3PY%9CBP!1-6YG$.UOC6MKZ)+
M(G(:@_>D= IPB:*R$G09XB;';F1V!*9%N]8SHTU[;6&J6CMUB'R)!SLO9L[^
MP@]ZF]2$#6?^PPPW-(HB>#D %?CAO6:;2<@"=@7#"H44ZPS\@HK81FPAK-QH
M"XR=:2B]$2_>//(4Z#6^E[_F-K$5#\7H9V$$XU[N=YN.>?$C'?,9T_GOH)UM
MEQ=O)5P7X5(#@Z3'RFNW"R!3>:'IY7<NBJY;:)C9MN@FU%=^O0)'#/^-7+)D
M$#3E3+>3I#78C^O-FH(']IL@R+B+#S'NIP439ZPRV[@ID%NX4^D:*.REEL&D
MNF+?/CV@?0M$Y+KV+7+/T<#5RV#FG!FXTP%A>E<O#IW]\XF:OEUM'.W\_QFV
M,1FU,H=XK*@@FH1G)2K1.HOF\:)9N*E1E<0]8[U:]SP1U,^1;1N7Z=:3+KB$
M\N3B :>"Y(;K+ZY>1:<[M:JZT^!:C@:@KLLM15;61R(H+#990',?HW7P.P+8
M"0 Z_>Y:%J!ZI,^DV.:J)-1_5)*I \=[(W<@ "]%NC3)>_#;$'WQ7[!:WC/V
M?F]MCX<'8&ORQ:+$_-Q-0:L8;):[W5^U(+_7U"H,E3% ;O->,(4=LRO^08X8
M.F44TOUK4S>;:U2CH@K+L4"]ZLHM9;DE%MF\R<40'KCAL<Q?-!U@0NBX>)_5
M' 3I77AX<"_G";=_RH&RR,Q!_XF-*2_CWB:7<-145]Q+!A)$+][&69W4NR:]
M$7, _E(L<^RZ  (H?\Y>"-$H%*>G5&+-QJP$%E;_C*5@4:(!JD?RP3,@[L>4
M(:4J@]("1#HB*3CL0&#1!!_D 79)=7C@8<X>&VRV(@ J03YQC&\#R*QBWO9?
M3*SOE@LAX;RA-UV,?>64);*OO6-ZY'D\7G+@@9)V*DU?T+-=+34+'>#HLU5?
MRT!%J](<DV.793YN61ZMZTOBF,.STHT;"D[(6A! 6^1(ZEFV<&P9?,M>SL^G
M<'YN94#XO:X>48(1$IQ0E!5"A-?D,^^S+OO!^R>T'^2\&3']ZAU[I7!\^>$Z
MX3/&ZC/8#:K8RL,##1JH!,3N7V8(I!M)Z?B3,#A6 Z<SR+11!EBC /:XQ]-(
ML[A/3Z+_* U@QEJGA3 ?_SSTEI_UO&3^%82Q^)(_6SYJ)JL1NVFJQ;(4&@,"
M]VOO;)".-&ED!)6V0K*W)4$:O)(N">K+ 7?S*\W(+E.B"5<[-UB*04&&?L5E
M+&O8OCP")2,]->0= 8-45)=;@K$)@>7<[FAF95MP]X6+:%E5!!M"60^W+!:4
MZJ3$_F_4T0S_)'$;;5T*]DRW=S,L(7!I7XOY6,&/-UZ' 16D7208>OG]ILE^
M^I$F^\);\;/WXD38EDTDH\>/V*0Q&S;<GTUQ4T/13QJA(+1O5YC<(?K*B-L=
M6[^X -O/!*X 6:@-I'913%%/7_"U/FK[D6SAX8'MB3?YZ?XMG!E6X\Y6_@9L
M\\VH]8#EC^"\:K2J1B_;KAMI"3+&44\T64$);(14B</%DS#F/WM4,9=1@CZD
MI/7V=,&#=U;(<$@[K.H*33%%DA9WG#C79YK//F8L/TB-!5= I@BSH$Z5(L_]
M"!#%,CR,U['D0\$0FC4WZ7=<M2V/AI'<+P$A;')'40P.?QCUIK@'*.)*(_;:
MRI,YX%+)Y!T%4V9[.#'>W+L'Y[:$7\V8&[IVL967E *N'+.2WU3.%YL2F2SF
MH=/-0V05=CW7)T>FR^J=]K6:>[9[4)= T)H?5Z"[S4'7+F2L+M*#GS43, @L
M2NYDLW,\S'%<E!4HK(R-MGQG!F@<HHJJ^R-*ULH7]0>-QFP:T(9H5"+Q*BO$
M ,RQ*RA/(AE;IN(]Z#)2;3G(Z2.GVB43C^"/9!U-ZQ<]&W*V$/;&QXT=AAZ6
M9*1B"CY,ZVD%E\CT--"VEZ!HN\W)3<7]@4JN(2NBJG/Q&Y C2(\"I7,6H5CC
MC\NR Y;NS!X<"3CIYP?"GQ7KGH!S^_5A?RD\A608.D5(1#"*8N6<WM<:WP\T
M.G.L%"2ZB@JWJ=;/C%90&^C.KCU2%>! 4Y9YBCI$0T&=T\?!3H)02R5S5178
M72BX2]_;-81)/:_74!?M]F9!MI";=F#'N(/4S1EXIZ0Q2P>M8._P*6#$Y'EB
M#TS#BNDKT.G@(=#+R1)KT/B<=->!D>TA?_<,R5 H-\HV:M\%,,\B%(-&S=Z
M=UYR]1OR.>>GI]DI_6<2S3-*+^/W@4VS@=+HIIC\[?3D]/0,5AA]>'*4:">T
MN6F39LW@PI0T>/PL^^G\67;^XJG<TY,8J8SK'$OZ-A%.#!;_L5D*W?%Y=GAP
M?GK^6+H V&J=I1YIU8AD^?V>ZIU^?^#!@ #D\QX(")P?6^2A H7A7"<7&^]
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ML8I+-V\9IQ:V/IS50J7/\FD;PU(T;09-)02;(AIEN!=T1[7\CG!/UBV&;_&
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M*C%=,LTD]=7C*^!:MS0 5' )4#!&8(P[_G+!(8$E)EG$OSU^>IJ=GIZ^_ 8
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MSL"_6V4S8#"]%.8+G5,'XZ@IZ L^X@!6UE%<873/V*>.\JIK_,)=03(L7%=
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MN*MI5I+76^ ZE8Y20!5W68K,-='-]F:T#V$D7Y)S[D4--?1-NQ+"#]1W_"0
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M<--]S+Y ]+0Y\$T<1=CT-U8G/,(2@]/@615@=>4)3.A];HSC#7<9 [)>OQ1
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M%<+TT8D2%7@Q:AQ4$8HML(+@*IG=@Q&!P0]02SJSGH\8XY)RY$ "" '1KF6
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M-(TD(7<^5Z:U_QW@2"1U2':W;L'D9DN5B<[39^BE1^)5;%# AA[5CIEHV7O
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M3.>51X1."=. OM86+<3V]B"UR"] (?8"J0\8[PUK82PXE%&A#D,5XZ"E< 6
MT+%UHB+0,J<2RR5=R(_UNK+I>I"ZBBA@X?3[+2^]T&'04-0FCAU.P@%UVZ1A
M5MZO;/2&:2Z8!.X1'*UY*9) G]MLLDBIL9A[ -5VC/"DQ/S"$RCA69++*K&]
MV'@?NIX6ETM5R_MQL!S *DZL"!C"6M"%=R=8B\&TPM-GR0)R"2ZIX1[J"BZZ
M$T714Z+LI;7YYZZBW&N^0;86VX4$D'.(9"%%#9Y41VBR?W7!<[//H.BFQQJ?
M2'&L=L0Z6Q8U0:\B1V9/V#I$03#,3*]0[QBQ)#:CSV\A0F2/'*<FIY,86WIL
MMA U8+X;CT/%HP):%?FU))NML0V]C 1V:J.XL@<N= H5RC/$I'KQJVZV^]3R
MV0"T%!!QR;]W9;5;VU+1A#/K1)04C&<Z@>\@O$N-8E#U6$ HF(DR #-H:A0)
M;YK=$#CSN,6RR\/S*KZE]QF&EH+&9P-[Z]<C&TW5;+G&.UO\4>ZJ#5=$?\IU
M[3= B[""&O>!OV2; /$W!1N7CCD'=8*A"S;=1PNGY!-D# OU?B2BE"0[_.?R
M$F .].0GC^&. X.U(BT2ZU^]N6E-SMBU:G8/-UKPX^/OT8)O5T'AL8/OTW3E
M:([6-H89*!0;HFNC888N&\Q7.VV3J_-T2:O,;Q)86%99$%T8]D->6,J0&3:^
M\3WU>)F<"[L.Y@'"5;;K&[)(],<J1B_L$>ZM'R7IZA,Q'.!PWP#CSOQB9*RC
MZ.FU,13P(*8'#/L**T8\!A*;D_!E]L5!8,7X!6E7"*)_T)W!$=5=(AH8"1][
MB^!(:\*M"$GWR/Y4P1&*YTFDT0L)>B@[(),!)8%BE0*J2SL[V:"P<M5 *'=4
M-.#Y+/>>+)WW= D-3&Y$L[D&4L-:S;*T]3:/&FZF8.F41O7U2CU&^\Y.4_TZ
MC ^+6-GZJFJ;V9$6*;'.3'[<)[0<25+ 4$6#M+/T)"Y$QODAEB_L%0H_%%*1
M8]/>7*?#$$5+91H.2R<!VE?T0(LH88-49>L0V-NC6]&M9C_4T8CPMA"BJ1N;
MVH6!M?H9H<=N#.&P<U&[2A\P1R3; #Y"#,R"GSF^ U:";1H=7>8;"DBY!I+$
MGIEK=DV?;-(K$#3V^ZYN.%6IHSL$CK9\LNU@3TU@!71^.MH/(.=YW7+:@G!F
MF!Y>LF!H. 4ZE9W08SDOY5+(R582!.%05=4_E^[UC!TYQCGQF"Q,XMM(]]U<
M_G<G[]-)-$IZQ'$GXB\E_BY6&R1GL".96O^Q<G;L5?4E4,9'P9 O+"\D)E:/
M!IT.D Y(%W-O 'GNP1[#E8/#J=$O1GI19U I6V"E=DL.A8$\.$X<^5!XE9OF
MS0 7LB3&\ <J#L5UW$O+D;)QU&7,JYX04_8JO\X(\D:FC>9'5'V,*3."WC^2
MRW$+DBQQC+FM"^%&J))I=>#+P>KHPQUTL5;0/94A4U1[*%9YM;6Q9"$"BRHA
MCZX>XU1!>4FT$:[5HUP]%5.D07<N9C+.ZX+#I/89Q]TZ5QS!O72NF"9R +]6
M^?['(G-H/E2?MZ1==_3*NB(VDI8*,#  +9%2>V-3$=6R^0+$7+)+&] R/OD,
MS]FKLMJ6E6H1WN]EBD*CZ"?2OC!AG9@I7?)Y'*4^5:7V2#$2,NZYQ ^E&MJK
M(MZ=)^E*Q$%*T#NDXCO-P^$%U+N;VU7Y&J*YO$W^>QQNT9(6VRX5? Q=8'KK
MEYYB=;#9;:#YU^0TN"*JJ'<$#$EB-DF'KZM<YUO9;9YUGE-#1)RPOQH9)"/L
MDAO1%&0$7EY&D$H7*X( +K=T6!OY*;8KWBRD<3U^P%'-T^]1S;N&*;24D@]5
MZ,\4=T;"IA,;P6_#_T8' P\-2HA=0RGG;^ ;8KERGS6_<U8\VN<K@0-$.W*,
M=G0TPU87LU1Y7Q6S0C.XAMTNIA.:&-JEI'@+ :F^1RJ&05:RTZ>+1R^$E@R#
M',/?R!^=H930ES2[@TLXZZKZSF;A"?5TL1T[I(U&]XPEY*=!!/<V4WO[JM(O
M+P#N\^T6X,Y;ODZZGRQW:XR!>%8LS/*)+L#;IF(WE%H+$ 3@V\=$N+Y)YM7F
M/W;]2+NC&*W<^@&@1*>/0>&]IB3*2X K "D)U.B><RSND"VV "'29FD9ZG6R
M7F=<Q=%3]3*N(R\VPVAW"51(7!K66D!.1!"A*>R<*@?<.BISRH'@M<572 '5
M0?:O 0\5'GKYQJ;=5"F&_!A5=A'/KBE^:B^]QN &7 5!]:DA>V7U:O3T-; *
M/7R_3P;X*P587F$D&^ W^AX]_LHIP\.L1R^OH)(\,?"7.V3\*XV[A"M-*3J_
M.]8^J<A5L23=76S^,/>Z$%?A=65A+;;HBS3,#,O+TQ%P:]<S:[_\*);@BRDB
M?B^X7P"L40E*>XJLJ1#I@WS/%6,Q#K3>!MJMGIYCY1S96CT[CFI)4G)SJ(YE
M/ZI=!:3B0\AG'OG9\,5.82QL)4_WH2*&)?]8X$&(C+L)/VDN23J _RB-H8%@
M$B-^YSNC$*LB0@LWH$^89XI>IA!Z<,*Y=T+F,VAJXHW$=K:(CT9#Y4+B5.'&
M"H"!A;\]CD2+<7)>=BOH:EA@4TYFD.-QAJT,T<0@]E)8B@5&5:RY3I+P,]0C
M-E+H^U^[FL*C"!"*KDGI-CZSM6=^P\(Q8\/5)'Y#<_BJ36YVFX\)%KWG@-B&
MGFQ-M:-6A[ >QAFB=UH9L*#G#AF)(I8ZGKJFG%V<? V1==VM*[G](=?D8K#6
MQE15EP2O]63#]<%(\R>+TC&/D)Z:QYK81B>U;CBS+TH8J]K ]&Q:4W(T@=AC
M!.O#+$DLASCIJXTENZ'>:J[3,<\?>XBH!>@]W?V[T-/TF$O8/#^[=\ ]AYI]
M=O<BBG7CSSZ5(FS'ADI/,8HV+[8944 0?R?[\=8(Z!9746@L/&RH01X66Q%<
MBF:VDF^/F]=UR#=:N/>,MXSSL@0VHXQ+XQT#$Q@9EGB)Y)UT]@8^*2\U:XF.
MH8TM>A64H,1HGQQY6 U9)-R<%IWPS1YDPM[]V3_G?$"$<!4U/8IS;QM%@YSJ
M)(DJ\"3**%39$"Y)C64FNU4&C6:!,:;YG!-_QCJD_6QS4Y6Q]KH]^@&2(/EZ
MQM@V2ZX8Z\,;N3=O58K_$$.?9]]#GW?LEY^"7^YZM;(7WO):L:TR'/1V@+1V
MP28HA]D U@43-"#7RCC=E-I,ML@T;3KS'<9'JX=LMYW?0Y<&.?+Y\H+T"F1#
M@;51T-U!E.M(.$Z1^0O/7I7DW,"XMCD(Z9S,K>"(X,MS',$0$&ZY?K>*PD=_
M=0W<0CVJ@!&6$('R7N&,U$1TOVT?E=K1QDHUKTHMTE&UL7J)E0#2($X9_VYX
MTTDW2&*W9;4%P!>ZQ0>C7'HZ/OU>X+_'[ '=+X!YY887K9:>"B@><)NHB2)D
M)V_?<^62V:XXF%>[2TU_S,J#-(W[HC*8W8/J#M!Z[=N#[+<#BVUT2Q0V1H2'
M&2]DNLK(!,)QP#G,5C?&PA<3I:1S8!1 G;-=A%PX1LF8<T(5-\N\RI%I!D(>
M#N9$3U(?P,R)>7)=VM('ZX<IUKNLHF" 1JELP6PM=[6_7'4J!] M&HZ"?QM2
MBUOR;G_%(D5(<(L.0[1/3TE!#E"E9RP&FSQ?"(V\:X[L(C**\C7:<P%L5)6<
M\98B;<V9=F/E&MSX\NUSEPWGGQ:VVRZ/NCL5M"=*+S!@-!X$H+XJ?C<\ROSX
M0(%C(PQG?H'L6T3^\!4:[\[:G3LGE<_89,7BJZ#;W'L#.6>P#0K(D-%&?+>X
M<BG+),"/<,2J#FB"W@CSS^5?(%A5ZU9_H&YVF_S+%K1PBO_$SS _SPY5A5=V
M1K-7..OYW AJE7'1'W@E7LL7O,>-<"Q@B(CP5@OF-UY+N4'A96XI[J<3;K:G
MRF%YE0]!CWGZQ!>%]V9UJ@*3LE27\D_C:=Z!9" B=:QH)/M+AF>7B(B(/, =
M[L#A42&(SIL>?8UA)#-@V&S;<J&Q53UB67(O2JB?15/,,7WGU;5#W7US"4LZ
M!8QB9F(=0;"M8WGJO$'XV]>MSW0R:H$27I]4K2D!8:AQ$5540;@J';LJ0&^V
M Z]T5.\C\\ML)0]RWV,9\5=DZ&&,1Z4T>@"1C)^MGI)A;JP2E#&P999]L6!<
MO_TIP3-Q9WDQ:?FX8+Q_+:)\3[JV&"MC-TJ:C7QCWH3[X6ALHQL=AADM"P"*
MS1X;9(RQ^6XEW1\8%74CYLLZ^U*L=VLT)W:8FM5OILB29+>$&K3#;+$C9$NS
M=XQ]W<Y&+R.YDY5Q*_#7NZV5PQQ>V "IVXH)$^BC.400K73IJ<*LLOK**Q81
M=6G6""2+XS88M.MK9-HMM-,)2BWMX:)$(Q&;J=Y:02:^?N2D8ZB4:K^Q.2%4
M6Q5/;MQGCT]?)!<;B," 5CC_#/?2NU6VH<9C5!K'^0K0&/!<U*<2AG+>FRXB
MB>O!#)^>/?Q.J3\^^1ZHNF,#ZZEO8+W^\.X=F5/G+ENJ(APZ,^?W]-7)T^DD
M8%F,6V#,S]5A>77:4)N20$/(&XT(5G95J_D5N/[R.VO0"'!/XWZQH8K7'1YM
M$_^Y%((S$L%6CYTG7_\.#J;4+BQAP/3]"@V>AL!_\'@"WGI-+R%+;F:VS6ZJ
M$FEM@99!\ ]D=^(56\QX?>STT F%.U7PBBZCW?'B:([8%P+2-$=S7G.\K_U/
M3"<VI;-I+%6B,>[6?!GZPXVL%3Y&@\H;HEZ0D*![?->-I;AUPN<"BR\$!1,I
M>>&$J\NON_!>2#IOK/V.;NI-NWMX3SORNQ+]R*H5=4)A0C+3QQF>AW'GGX&*
MN3#?7V\\".M;8#T1JH"?"^@R4E:'Q*O](O" P%QOKHP%=$D25Q=?,&BS@:H;
M]/VT7O":;01/0;]'9=]\8 1\X</.6!K7&!74]1U2#D4+>.,0TL;J6J.(XR.9
M <989,1L\AE#2+8K0V?5KE)H^ UX@#0$Z77MLF3!FX8JBG;3GYETMDI%V6!-
M=Z =?_[?V7K[\NUT8F7$2#2'\#P5B247-;$HS5=9L3:K:<X;AB]7!859"OAA
MD:W-S6[^\<=N<8EARQ3BJ;9UF\4-+7/XU+RL&<(#17X;?)XJSV$D1DTZ#K^#
M'UX4]<SL*,=% XHNI_OAX4%[8W2 %]$.)I@X@;FE'&: \#F@EXQ"F.=DG>/=
MI=+>CHEH;L1G9294%: 9(!NT,/]@"BLJZE??!)<UJPI46)"6*I=<=:1Z]&$$
M-M-\%[Q=2;A;" @&^<'RHB'1F$Y*1^3M)D"TZA1<Q67(%U8(L?(<DE7V>@LE
M4O"-<XSCRNAW9E\ 9QJ"'&+<_(BNZ)ZA]$[0%7@,K1"PD(B0WF:&ORSA#TAH
M:J/U^VXUN00C5(BN$#/GH"PV#:,7:DA_ (*.$TI2PA[#I4<?YV!4W0N%S3WX
MSF6F:&-?NSQ,8N'Q%) GW=4P2[A=0W0K:7UMORMLS(![Q_6S/F6IG\)JKO*-
ME_7R2:\1QF-,+BDUO":B_V+)1.7@RZ_I6@TIWO6XVYTI,*^C+[S#P"X_7C%X
MHY8:R59)3B<1>:N5AC^AM$OP*8^7?YGO5EM[UPL36L8M9 $H*3<^@2?%&/#$
MVN*X^/O0B4H[U>-GXY7[6.H9RS:#D+QMGJW020#2.O8 (+A2?$EN\JRJG> '
M5SM8IU 6AY0L.&8J*6!V%NR>Q*1!N>TIXMC3(9ZZ69ASMMA!@:XY J+J>N]?
M;#GLUDVOJ-_MB++C7(JIZXAZ,\+$\!C5 ):5>F"YN0@H#=*$80]/,WZNOZ0N
M*INY4C9L7L4U$=)&N=<H40>+'B:]S*[-AV%*MY7GI"W."+H>*<\(ZH*<[]>*
M\ ,.VSS]'K:Y:U:A7P@9N^BQACRZ^?CYH9-H+*0E&#8(3[PJ-QP;88BV>2;C
M-50,7S?V@'AKER4 6?B!C)&XS&%]27 ^]>$FM3F^G\; HZ&8VS(X""#1X1M0
M;_9,L T=).<DM*T%G$P),'(M!I1\ ",/5:C:N&3TONE.F<32<8C-&W]SC]C
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MW*'*3*7L;DZM-5+&X "8_69%)>N9JO*UA-6VXHM/\"S?Y,NB03YZ]RD, Z,
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MU9\A99P&$;^-@>)O/T#^%1QD'.#7#;AH^WUH]Z4MLI"8=>_?[50:R0SP8#Q
M@@Z<GN3H!]MNR2+D4VD;;U'F\IVC<\L>LJN2HZ?'EO[1W'I>,P\Z@?3>3)^
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M+C6?*:<NH#E:MLG+7;VZ4?D8#@?##M_PP!UUMMGJC,NL..&FH"A@+1$)$]Y
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MX [I,8+:VG\Z&5#_:7C*BZ77M&AI#1=D"A*)7!7Y-3%IN  WW9)%0\$\:?K
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M?X&"_$ @\.]5L 88C*0J1<1M@IB9.2*<#RYI? T'7SGLMP.RE 4&;"'L"S[
M=((,46/>T+THP2R8P+S%J,N5F[?>S8%-C"*7N_=0BLSO?!.QIYG91+^M1^J
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M*ZK[E:M+WOZ9>W^IT7BU:'%J8%6A%F<(;I-1P?3)=AZY!--)__'PE^#L3I?
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M[>!^=FK.P#/L1JW2&T82ARK <2%UOJ@_A6Q,Z//YOW?FML3-?E>5V[(&3&%
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M_=7.M,X:F.6.VOYRD5M'7^7@:?=+H_Q_4$L#!!0    ( (^&[E;C@S?V0P,
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M/0G)Q)BI;D71?#ZOI2,FM.0S@R%U+9%91,+0M>\./I+?5MVU2!\X4 TDH]J
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M     &0V-3$Y,S9D.&LN:'1M4$L! A0#%     @ CX;N5C?SQZZU*P   L4
M !$              ( !_"L  &0V-3$Y,S9D97@Q,#$N:'1M4$L! A0#%
M  @ CX;N5B"!IA(2*P  +<   !$              ( !X%<  &0V-3$Y,S9D
M97@Q,#(N:'1M4$L! A0#%     @ CX;N5CC85]'^&@  &HL  !$
M     ( !(8,  &0V-3$Y,S9D97@Q,#,N:'1M4$L! A0#%     @ CX;N5J"0
M.YA+&@  3X8  !$              ( !3IX  &0V-3$Y,S9D97@Q,#0N:'1M
M4$L! A0#%     @ CX;N5E$,>4%'6@  U4X" !$              ( !R+@
M &0V-3$Y,S9D97@Q,#4N:'1M4$L! A0#%     @ CX;N5M0F][GK?0$ -N((
M !               ( !/A,! &0V-3$Y,S9D97@R,2YH=&U02P$"% ,4
M" "/ANY6XX,W]D,#  !*"P  $0              @ %7D0( 9G)E<2TR,#(S
M,#<Q-"YX<V102P$"% ,4    " "/ANY6S6334JP&  "E20  %0
M    @ ')E ( 9G)E<2TR,#(S,#<Q-%]L86(N>&UL4$L! A0#%     @ CX;N
M5A?ER=W?!   _BT  !4              ( !J)L" &9R97$M,C R,S W,31?
=<')E+GAM;%!+!08     "@ * 'H"  "ZH (    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
